data_2jsn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jsn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.9 tttm . . . . . 0 N--CA 1.462 0.149 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.5 p -72.09 145.41 48.2 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.838 1.255 . . . . 0.0 110.823 173.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -139.95 159.08 42.99 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.965 1.306 . . . . 0.0 108.723 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.0 m -158.87 174.89 14.3 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.307 2.243 . . . . 0.0 106.701 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -141.5 159.6 59.94 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.733 0.813 . . . . 0.0 109.233 -173.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -64.4 154.27 74.63 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 120.036 1.049 . . . . 0.0 110.976 -10.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 tp -157.36 155.94 31.44 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.242 1.417 . . . . 0.0 107.67 -173.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -76.01 58.93 1.24 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.71 1.204 . . . . 0.0 110.224 171.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -153.23 133.62 13.57 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.73 2.012 . . . . 0.0 106.048 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.7 tp -139.25 145.44 39.21 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.0 mt -125.21 155.57 39.85 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.996 1.318 . . . . 0.0 108.605 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 164.64 29.52 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.209 1.404 . . . . 0.0 109.757 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.2 tp -98.19 127.45 44.14 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.33 138.24 27.72 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.292 1.437 . . . . 0.0 107.514 169.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 44.8 48.45 9.02 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.598 1.559 . . . . 0.0 113.18 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 56.91 30.45 18.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.278 1.431 . . . . 0.0 113.252 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -134.8 148.85 50.29 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.742 1.217 . . . . 0.0 108.379 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -92.32 125.68 44.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 mp -123.61 152.97 41.34 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 125.961 1.704 . . . . 0.0 108.926 -173.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.72 121.04 14.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.34 -38.05 14.44 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.904 1.282 . . . . 0.0 111.306 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.5 t80 . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 124.815 1.246 . . . . 0.0 108.355 179.622 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.86 -11.09 60.7 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.537 -1.146 . . . . 0.0 113.647 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -66.96 155.62 38.07 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.595 1.698 . . . . 0.0 108.291 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.67 140.64 52.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.922 1.289 . . . . 0.0 110.156 -169.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.14 146.2 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.9 mt -130.12 -35.17 1.61 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.695 1.198 . . . . 0.0 110.595 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.07 159.98 43.55 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.461 1.028 . . . . 0.0 110.117 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.3 mt -134.96 131.82 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.5 p30 42.92 24.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.579 2.352 . . . . 0.0 115.139 -173.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.25 -14.27 58.3 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.112 1.339 . . . . 0.0 112.902 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.6 mtt -74.73 105.86 6.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.813 1.307 . . . . 0.0 108.603 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.35 122.38 12.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.6 m -77.68 132.17 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.491 0.662 . . . . 0.0 109.385 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -74.79 73.46 2.08 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.768 1.627 . . . . 0.0 107.146 169.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.02 -72.29 0.4 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.627 2.06 . . . . 0.0 112.808 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -133.74 11.02 4.01 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.878 1.671 . . . . 0.0 111.947 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -120.79 154.88 35.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.4 p -69.62 175.39 4.19 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.483 1.038 . . . . 0.0 109.911 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.85 -37.89 77.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.407 169.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.43 -37.25 74.37 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.717 0.807 . . . . 0.0 111.661 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 6.24 7.77 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.528 1.061 . . . . 0.0 114.099 172.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.71 136.04 54.93 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.066 1.433 . . . . 0.0 107.385 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.43 128.07 34.76 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.0 t -56.45 -39.95 64.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.669 1.188 . . . . 0.0 111.633 -170.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.5 -40.47 93.1 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.702 0.683 . . . . 0.0 110.585 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.55 -39.17 67.67 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.414 0.552 . . . . 0.0 110.029 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -59.58 -46.54 88.63 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.6 1.16 . . . . 0.0 110.518 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.56 -33.9 60.67 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.66 0.784 . . . . 0.0 110.749 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.62 -30.84 75.18 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.381 -0.677 . . . . 0.0 112.742 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -62.28 115.32 15.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.511 1.125 . . . . 0.0 109.861 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.475 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.6 Cg_endo -70.47 -16.1 34.52 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.67 1.58 . . . . 0.0 114.003 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.35 -14.86 54.55 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.335 0.97 . . . . 0.0 111.147 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -134.64 28.93 3.58 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.376 2.27 . . . . 0.0 109.251 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.475 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.2 m-30 -60.77 -54.41 54.78 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 117.158 -1.401 . . . . 0.0 111.815 170.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.59 122.17 8.02 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.629 1.617 . . . . 0.0 109.673 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 m -149.74 172.02 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.734 1.214 . . . . 0.0 109.778 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -125.75 139.93 53.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.2 mt -133.41 147.72 31.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -170.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -119.47 130.6 55.32 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -152.71 164.77 37.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.28 -165.22 33.89 Favored Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -170.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.7 tttt . . . . . 0 C--O 1.236 0.387 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -80.04 144.43 33.2 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.201 1.4 . . . . 0.0 107.351 168.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -142.21 171.2 14.38 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.377 1.071 . . . . 0.0 110.234 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.9 m -156.22 175.68 13.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.0 2.52 . . . . 0.0 106.455 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -123.87 153.9 67.32 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.552 0.741 . . . . 0.0 109.909 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.17 -39.19 1.34 Allowed 'Cis proline' 0 CA--C 1.537 0.627 0 CA-C-N 119.64 0.907 . . . . 0.0 112.038 -5.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.9 tp 48.04 -75.54 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.087 2.955 . . . . 0.0 114.548 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -166.65 -28.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.531 2.333 . . . . 0.0 109.313 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.0 tp -55.69 131.76 47.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.806 1.642 . . . . 0.0 112.315 -174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.11 128.72 11.48 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.98 154.96 33.75 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 161.74 40.48 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.958 0.903 . . . . 0.0 109.961 -177.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.9 tp -96.25 125.4 40.74 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -153.2 144.15 22.9 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.434 1.093 . . . . 0.0 108.752 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.4 t70 47.87 39.34 10.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.583 1.153 . . . . 0.0 111.804 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 64.96 6.09 3.24 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.036 2.135 . . . . 0.0 115.877 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -118.67 149.71 40.96 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.965 1.257 . . . . 0.0 109.403 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -76.26 135.09 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 76.1 mt -126.49 149.55 49.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.868 1.267 . . . . 0.0 108.187 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.4 t -68.88 139.78 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -120.63 -41.6 2.58 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.936 0.895 . . . . 0.0 110.647 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 C--N 1.331 -0.205 0 C-N-CA 125.983 1.713 . . . . 0.0 106.766 170.328 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 CA--C 1.546 0.82 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.71 0.43 86.06 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.28 -0.887 . . . . 0.0 113.258 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -75.57 154.89 36.47 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.152 0.976 . . . . 0.0 109.544 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.84 147.06 27.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.7 t -74.28 144.56 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 172.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -111.1 -33.39 6.49 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 124.986 1.314 . . . . 0.0 109.847 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.47 160.22 41.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.198 1.363 . . . . 0.0 111.738 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.1 mt -136.05 135.74 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 49.34 30.34 3.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 112.076 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.87 -9.14 57.7 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.823 1.201 . . . . 0.0 113.686 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.2 mmt -84.27 119.12 24.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.102 1.451 . . . . 0.0 107.922 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -49.02 142.8 6.25 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.516 1.127 . . . . 0.0 109.834 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.3 m -111.3 149.1 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.822 0.82 . . . . 0.0 110.026 172.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -125.21 101.64 7.09 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.116 2.167 . . . . 0.0 105.907 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.02 -80.29 0.19 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.19 1.376 . . . . 0.0 110.622 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.42 25.49 0.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.996 1.318 . . . . 0.0 111.116 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -127.79 143.54 51.12 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.6 p -70.13 172.5 7.92 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.009 0.822 . . . . 0.0 110.387 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.87 -38.66 67.8 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.997 0.919 . . . . 0.0 110.861 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.51 -38.07 71.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.494 0.717 . . . . 0.0 111.529 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.71 3.1 7.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.907 1.241 . . . . 0.0 113.737 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.93 133.65 53.64 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.809 1.304 . . . . 0.0 108.167 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.22 120.82 13.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.9 -40.16 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -169.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.13 -40.52 68.03 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.986 1.266 . . . . 0.0 109.758 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.29 -44.81 93.97 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.792 0.724 . . . . 0.0 110.11 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -58.49 -44.42 89.4 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.164 0.986 . . . . 0.0 111.209 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.08 -37.8 72.45 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.289 1.036 . . . . 0.0 110.786 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.5 -30.62 73.19 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.124 0.869 . . . . 0.0 112.333 -175.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -58.01 114.45 8.58 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.31 1.044 . . . . 0.0 109.629 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.48 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 72.0 Cg_endo -70.87 -13.73 32.08 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.558 1.505 . . . . 0.0 113.749 -175.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.27 -15.24 56.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.417 1.008 . . . . 0.0 110.612 169.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -132.59 34.22 3.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.309 2.644 . . . . 0.0 108.468 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.48 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -65.0 -52.52 48.63 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 117.18 -1.39 . . . . 0.0 111.498 169.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.36 125.41 11.27 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.667 1.631 . . . . 0.0 108.87 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.05 171.04 2.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.195 0.998 . . . . 0.0 110.524 -170.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.5 m -125.61 138.85 53.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 169.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.3 mt -136.48 139.58 44.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.6 mtp-105 -117.24 132.66 56.58 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -143.76 167.05 23.21 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.361 1.464 . . . . 0.0 109.185 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.52 -165.72 38.96 Favored Glycine 0 CA--C 1.52 0.399 0 O-C-N 121.543 -0.723 . . . . 0.0 111.656 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 117.983 -1.008 . . . . 0.0 108.301 170.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.2 tttp . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.6 m -91.31 142.2 27.96 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -139.09 162.77 34.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.064 1.345 . . . . 0.0 109.28 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.5 p -153.94 176.67 11.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.017 2.527 . . . . 0.0 107.402 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -135.22 156.29 78.21 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.243 1.017 . . . . 0.0 109.481 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.11 -23.88 9.07 Favored 'Cis proline' 0 C--N 1.351 0.675 0 CA-C-N 119.945 1.016 . . . . 0.0 113.518 -0.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tt 37.7 -91.39 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.603 2.761 . . . . 0.0 113.06 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -160.58 -38.79 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.471 1.508 . . . . 0.0 110.06 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.2 tp -57.51 130.57 46.94 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.961 0.904 . . . . 0.0 109.533 171.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.1 mt -142.54 153.17 43.34 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.337 1.455 . . . . 0.0 107.729 170.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.44 154.53 36.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.676 1.19 . . . . 0.0 108.902 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.14 154.89 46.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.441 1.096 . . . . 0.0 109.122 170.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.4 tp -92.52 132.48 36.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.532 1.133 . . . . 0.0 108.374 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -153.61 139.66 18.3 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.624 1.17 . . . . 0.0 107.958 169.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 t70 44.3 49.61 7.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.649 1.58 . . . . 0.0 112.672 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 59.08 22.87 11.0 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.637 1.575 . . . . 0.0 114.211 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -129.41 156.64 43.76 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 120.931 -1.106 . . . . 0.0 108.841 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.26 130.88 52.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.41 153.5 38.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.882 1.273 . . . . 0.0 108.39 -173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.11 104.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 125.905 1.682 . . . . 0.0 107.339 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.31 -39.54 68.16 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.678 0.791 . . . . 0.0 109.814 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 175.762 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.9 t . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.95 -10.22 63.58 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.745 -1.031 . . . . 0.0 113.57 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -71.59 170.66 12.93 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.272 1.536 . . . . 0.0 108.674 169.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.57 143.65 50.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.208 1.003 . . . . 0.0 109.662 -172.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 p -70.27 140.82 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 169.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -116.77 -32.39 5.15 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.791 1.636 . . . . 0.0 109.867 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.51 158.61 40.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.091 0.859 . . . . 0.0 110.394 169.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.2 mt -131.65 130.17 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 p30 40.15 27.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.918 2.487 . . . . 0.0 115.314 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.33 -16.18 57.0 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.161 1.363 . . . . 0.0 112.789 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.65 109.29 11.5 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.645 1.223 . . . . 0.0 108.102 171.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -51.62 141.1 17.08 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.691 1.197 . . . . 0.0 108.881 169.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -103.87 116.33 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.387 1.089 . . . . 0.0 110.223 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -76.92 86.67 3.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.659 1.584 . . . . 0.0 108.041 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.02 -78.71 0.4 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.01 1.291 . . . . 0.0 111.963 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -135.84 13.63 3.39 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.927 1.291 . . . . 0.0 112.639 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -126.42 145.69 50.37 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.7 p -69.76 170.25 11.35 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.823 0.82 . . . . 0.0 110.155 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.5 -38.06 68.67 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.728 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.8 -37.09 73.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.657 0.783 . . . . 0.0 111.784 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.3 4.24 7.74 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.769 1.176 . . . . 0.0 113.944 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -67.93 137.69 55.39 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.903 1.352 . . . . 0.0 107.867 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -67.88 127.69 33.73 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.82 -40.56 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.536 0.734 . . . . 0.0 111.419 -170.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.7 mt -65.36 -36.8 85.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.072 0.851 . . . . 0.0 110.815 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -74.46 -40.61 61.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.455 0.57 . . . . 0.0 109.688 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -59.24 -51.05 71.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.775 0.83 . . . . 0.0 110.103 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.29 -30.0 64.39 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.601 0.76 . . . . 0.0 110.627 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.7 -38.06 95.65 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.517 -0.602 . . . . 0.0 111.812 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -63.93 117.08 32.25 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 117.738 0.769 . . . . 0.0 109.003 173.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.473 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 65.9 Cg_endo -67.34 -12.14 34.73 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.987 1.792 . . . . 0.0 114.009 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.57 -17.55 46.98 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.455 1.025 . . . . 0.0 111.211 169.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -120.67 21.05 11.64 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.703 1.601 . . . . 0.0 110.332 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.473 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 3.1 m-30 -61.06 -59.25 14.38 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 117.075 -1.441 . . . . 0.0 110.166 170.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.55 106.13 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.833 1.689 . . . . 0.0 109.603 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.02 156.45 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 123.197 0.599 . . . . 0.0 110.438 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -84.28 142.19 30.42 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 169.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.6 mt -139.73 147.04 24.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -121.3 138.13 54.38 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -133.28 151.77 51.91 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.299 1.84 . . . . 0.0 109.655 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.96 -168.93 22.61 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -73.75 145.72 44.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.951 1.3 . . . . 0.0 109.632 169.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -142.74 163.7 32.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.405 1.482 . . . . 0.0 109.599 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 p -158.47 175.47 13.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.025 2.13 . . . . 0.0 107.612 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -137.22 158.86 71.68 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 123.816 0.847 . . . . 0.0 110.167 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.96 156.95 79.49 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.759 0.949 . . . . 0.0 111.271 -9.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HG ' ' H ' ' A' ' 28' ' ' LEU . 36.6 tp -158.03 159.36 36.29 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.768 1.227 . . . . 0.0 108.579 -173.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.0 -31.57 72.73 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.795 0.838 . . . . 0.0 112.18 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.416 ' H ' ' HG ' ' A' ' 26' ' ' LEU . 2.9 tt -67.59 121.47 15.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.1 mt -133.58 156.22 48.22 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.084 1.754 . . . . 0.0 107.94 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -131.79 155.4 47.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.172 0.989 . . . . 0.0 111.215 -169.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.53 153.72 40.71 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.723 1.209 . . . . 0.0 110.112 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.3 tp -78.66 130.75 36.21 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -153.55 138.49 17.2 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.831 1.252 . . . . 0.0 107.932 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.1 t70 48.44 43.56 19.8 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.19 1.396 . . . . 0.0 113.091 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 58.25 25.41 12.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.823 1.649 . . . . 0.0 113.336 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -130.15 167.99 17.5 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.305 1.842 . . . . 0.0 108.167 173.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.5 t -112.91 116.03 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.02 152.13 26.3 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.146 1.378 . . . . 0.0 109.201 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.05 104.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.979 1.712 . . . . 0.0 107.561 172.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.94 -32.6 57.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.827 1.251 . . . . 0.0 110.874 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 175.391 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 120.974 0.416 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.83 -16.17 60.7 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.119 -0.823 . . . . 0.0 113.333 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -69.19 166.49 18.24 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.708 1.254 . . . . 0.0 108.255 169.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.45 152.29 51.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.269 0.628 . . . . 0.0 111.124 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 83.4 t -66.24 142.45 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -126.4 -30.11 2.9 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.605 1.162 . . . . 0.0 110.906 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.79 158.01 43.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.06 1.3 . . . . 0.0 110.551 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.4 mt -139.97 135.15 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 49.6 28.84 2.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.604 1.562 . . . . 0.0 112.229 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.35 -11.28 66.12 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.119 1.342 . . . . 0.0 113.734 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.3 mtt -82.81 111.96 19.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.938 1.369 . . . . 0.0 109.076 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.74 131.48 50.42 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.3 m -90.42 119.43 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -72.91 98.49 2.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.085 1.354 . . . . 0.0 107.949 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.2 -93.59 0.09 OUTLIER Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -175.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 ptt85 -124.78 14.32 8.63 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.755 1.622 . . . . 0.0 112.226 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -123.54 148.08 46.66 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.5 p -68.87 172.93 5.83 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.563 1.074 . . . . 0.0 110.355 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.61 -38.56 75.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.596 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.69 -39.14 77.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.818 0.847 . . . . 0.0 111.412 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.3 1.59 7.22 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.604 1.097 . . . . 0.0 113.988 172.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -61.29 140.92 57.88 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 119.092 1.446 . . . . 0.0 108.776 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.71 127.37 31.69 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.3 t -56.45 -43.38 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.61 0.764 . . . . 0.0 111.698 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.9 -36.7 82.87 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.351 0.523 . . . . 0.0 110.458 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.28 -42.92 68.12 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.293 0.497 . . . . 0.0 109.691 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -58.88 -46.53 87.6 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.718 1.207 . . . . 0.0 110.634 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.16 -33.67 59.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.492 0.717 . . . . 0.0 111.005 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.1 -32.02 79.31 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.308 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -61.18 114.17 9.93 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.154 . . . . 0.0 109.939 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.48 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 84.2 Cg_endo -71.06 -14.66 32.12 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.638 1.559 . . . . 0.0 113.789 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.23 -15.42 57.03 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.436 1.017 . . . . 0.0 110.869 169.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -133.36 32.83 3.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.884 2.474 . . . . 0.0 108.639 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.48 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -64.97 -53.78 39.53 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.189 -1.386 . . . . 0.0 110.398 169.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.02 124.36 10.49 Favored 'Trans proline' 0 C--N 1.352 0.756 0 CA-C-N 121.559 1.593 . . . . 0.0 109.369 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.1 m -150.66 172.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.251 1.42 . . . . 0.0 109.778 -172.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 m -121.46 138.22 54.38 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.5 mt -136.49 140.39 43.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -114.62 138.12 51.05 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.734 1.614 . . . . 0.0 106.852 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -125.54 169.47 12.41 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.899 1.28 . . . . 0.0 110.164 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.55 -160.92 25.51 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 170.016 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.0 tptt . . . . . 0 C--O 1.233 0.218 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -79.84 141.49 36.14 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -138.25 161.29 37.25 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.008 1.323 . . . . 0.0 109.024 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.0 p -156.63 175.32 14.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.319 2.248 . . . . 0.0 106.983 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -139.83 161.5 55.86 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 123.924 0.89 . . . . 0.0 109.125 -171.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.08 145.83 60.99 Favored 'Cis proline' 0 C--N 1.351 0.669 0 CA-C-N 120.261 1.129 . . . . 0.0 111.262 -6.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 tp -159.74 162.07 34.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.125 1.77 . . . . 0.0 107.009 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.57 -28.69 69.52 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.369 0.668 . . . . 0.0 112.502 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.7 tp -57.54 126.0 25.39 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.967 0.907 . . . . 0.0 110.101 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.9 tp -147.47 151.61 36.69 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.204 1.401 . . . . 0.0 107.535 172.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -121.31 156.04 33.43 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.633 1.173 . . . . 0.0 109.598 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.51 151.65 51.26 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.688 0.795 . . . . 0.0 109.321 169.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.19 124.43 28.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -152.82 142.45 21.87 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.489 1.115 . . . . 0.0 108.337 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.69 44.11 17.24 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.487 1.515 . . . . 0.0 112.126 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 59.36 6.86 0.83 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.718 2.007 . . . . 0.0 115.319 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -109.56 -178.75 3.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.464 1.906 . . . . 0.0 107.439 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.55 130.37 74.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 169.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.5 mt -127.93 154.87 45.06 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.402 1.081 . . . . 0.0 108.769 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.6 t -58.72 111.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.244 1.418 . . . . 0.0 108.094 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.07 -36.55 24.81 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.573 1.149 . . . . 0.0 110.463 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 174.517 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 121.063 0.459 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.06 -9.63 65.76 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.214 -1.326 . . . . 0.0 113.939 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -68.44 155.2 40.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.093 1.947 . . . . 0.0 109.278 169.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.23 146.48 30.26 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.924 0.889 . . . . 0.0 109.619 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -81.09 139.1 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 169.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.75 -37.44 3.93 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.437 1.495 . . . . 0.0 109.761 -174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.7 160.18 44.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.667 1.121 . . . . 0.0 110.676 170.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.5 mt -136.82 131.41 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.285 0.0 OUTLIER 36.83 34.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 128.564 2.746 . . . . 0.0 114.817 -176.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.84 -15.85 57.94 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.469 1.509 . . . . 0.0 113.15 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.4 mtt -82.94 108.75 16.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.497 1.149 . . . . 0.0 108.948 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.03 133.26 55.38 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 m -98.01 125.24 51.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -88.84 100.05 12.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.266 1.826 . . . . 0.0 107.53 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.78 -80.96 0.23 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.855 1.217 . . . . 0.0 110.781 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.23 23.16 1.5 Allowed 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.131 1.372 . . . . 0.0 111.767 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -126.23 146.72 49.87 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.9 p -68.54 173.58 4.91 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.795 0.807 . . . . 0.0 110.338 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.16 -38.41 73.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.666 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -70.05 -39.52 75.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.744 0.818 . . . . 0.0 111.406 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.6 -1.59 6.45 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.653 1.12 . . . . 0.0 114.089 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -61.9 134.29 56.5 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.095 1.447 . . . . 0.0 108.566 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.14 126.11 26.67 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.4 t -56.68 -38.31 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.367 1.067 . . . . 0.0 111.703 -169.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.12 -40.25 94.22 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.548 0.613 . . . . 0.0 110.33 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -74.43 -38.29 63.07 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.939 0.496 . . . . 0.0 110.136 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -59.32 -45.99 89.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.365 1.066 . . . . 0.0 110.454 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.5 mt -76.97 -31.49 56.58 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.462 0.705 . . . . 0.0 110.874 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.26 -33.64 87.35 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.404 -0.664 . . . . 0.0 112.502 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -63.2 114.47 12.83 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.562 1.145 . . . . 0.0 110.136 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.485 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 88.5 Cg_endo -71.64 -15.75 30.36 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.632 1.555 . . . . 0.0 113.905 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.97 -14.24 44.99 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.313 0.96 . . . . 0.0 111.201 169.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -132.1 22.49 4.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.026 2.13 . . . . 0.0 109.881 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.485 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.7 m-30 -59.37 -53.63 64.15 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 116.942 -1.504 . . . . 0.0 112.117 171.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.84 112.06 3.45 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.827 1.688 . . . . 0.0 109.681 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 m -148.42 152.22 12.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 123.889 0.875 . . . . 0.0 110.069 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.4 m -84.58 144.11 28.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.0 mt -134.0 135.94 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -103.6 121.9 43.88 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -106.99 176.09 5.29 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.55 1.14 . . . . 0.0 108.348 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.03 173.31 44.67 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 173.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? . . . . . 0 N--CA 1.464 0.273 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.5 p -78.7 145.32 34.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.3 1.04 . . . . 0.0 109.515 169.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -141.08 158.49 43.85 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.51 1.524 . . . . 0.0 110.009 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.8 m -146.67 175.15 10.82 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.608 2.763 . . . . 0.0 106.84 175.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -140.05 165.05 33.43 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.428 1.091 . . . . 0.0 109.108 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.96 -31.77 0.68 Allowed 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 120.591 1.247 . . . . 0.0 114.446 -7.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.7 tp 44.52 -123.59 0.95 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.565 1.546 . . . . 0.0 109.736 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.55 43.85 0.59 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.973 1.26 . . . . 0.0 110.625 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.45 161.55 39.43 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.046 1.338 . . . . 0.0 109.75 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.8 tp -154.44 152.49 30.21 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.874 1.27 . . . . 0.0 108.613 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.1 mt -121.76 155.37 35.42 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.807 1.243 . . . . 0.0 109.617 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.25 154.82 43.48 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.515 1.126 . . . . 0.0 109.451 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.88 126.85 33.38 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -155.67 144.76 20.71 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.044 1.338 . . . . 0.0 108.258 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 50.72 43.21 28.03 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.335 1.054 . . . . 0.0 111.823 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.282 10.5 pt-20 50.41 26.46 2.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.174 2.59 . . . . 0.0 115.298 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 mtp-105 -134.68 159.84 40.0 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.157 -0.965 . . . . 0.0 110.76 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 m -80.37 131.85 33.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 169.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.0 mt -120.07 154.06 35.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.63 1.172 . . . . 0.0 108.252 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.99 106.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.988 1.315 . . . . 0.0 107.476 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.05 -37.07 66.99 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.703 0.801 . . . . 0.0 110.022 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.9 t80 . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 107.697 177.197 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.93 -7.56 74.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.107 -1.385 . . . . 0.0 114.021 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -73.22 163.95 27.38 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.015 1.908 . . . . 0.0 108.613 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.09 155.66 21.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.52 1.128 . . . . 0.0 110.467 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.9 t -71.86 136.88 24.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 169.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -111.71 -36.75 5.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.669 1.188 . . . . 0.0 109.473 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.67 160.24 43.7 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.305 0.957 . . . . 0.0 111.094 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.1 mt -132.84 132.66 59.38 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 45.76 32.76 1.31 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.503 1.921 . . . . 0.0 112.118 -174.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.5 -9.46 73.38 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.0 1.286 . . . . 0.0 114.069 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.2 mtt -83.4 115.94 22.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.067 1.434 . . . . 0.0 108.808 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -49.66 124.73 10.13 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.755 1.222 . . . . 0.0 110.335 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.08 140.34 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 109.91 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -79.32 67.68 5.11 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.556 1.542 . . . . 0.0 108.535 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.74 -66.0 1.11 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.203 1.859 . . . . 0.0 113.974 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -136.74 9.14 3.08 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.892 1.677 . . . . 0.0 111.79 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -120.4 152.16 38.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.4 p -66.84 171.47 5.29 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.851 0.834 . . . . 0.0 109.427 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.08 76.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.599 169.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.28 -37.84 74.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.556 0.742 . . . . 0.0 111.578 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.76 1.94 6.32 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.359 -1.245 . . . . 0.0 115.878 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -69.11 144.52 53.88 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.315 2.058 . . . . 0.0 107.578 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.28 131.46 47.38 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.2 -37.39 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.345 1.058 . . . . 0.0 110.748 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.21 -40.22 95.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.082 0.401 . . . . 0.0 110.368 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -73.86 -41.79 61.72 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.391 0.541 . . . . 0.0 110.005 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -58.65 -51.1 71.34 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.251 0.62 . . . . 0.0 110.103 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.9 mt -76.76 -30.32 56.5 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.783 0.833 . . . . 0.0 110.848 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.3 -36.73 93.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.0 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -62.92 117.06 28.92 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 117.918 0.859 . . . . 0.0 109.067 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.495 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 68.4 Cg_endo -67.79 -11.8 33.3 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.875 1.717 . . . . 0.0 114.165 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.82 -17.47 49.89 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.42 1.009 . . . . 0.0 111.012 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -121.85 23.61 10.01 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.18 1.792 . . . . 0.0 110.099 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.495 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.8 m-30 -61.54 -57.62 23.82 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 117.087 -1.435 . . . . 0.0 110.501 169.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.88 107.15 2.41 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.903 1.736 . . . . 0.0 109.715 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.93 171.23 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.135 0.974 . . . . 0.0 109.829 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.5 m -105.9 143.12 34.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.2 mt -139.35 148.21 23.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -120.61 136.41 54.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -121.27 162.47 20.2 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.154 1.382 . . . . 0.0 107.938 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.69 -175.54 41.47 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.6 mmt-85 . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 117.796 -1.097 . . . . 0.0 108.467 175.594 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.7 tttt . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.4 m -126.09 142.72 51.4 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.395 1.078 . . . . 0.0 108.593 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -142.05 -178.79 5.87 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 127.006 2.122 . . . . 0.0 107.46 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.5 m -151.56 157.2 41.92 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.798 -1.189 . . . . 0.0 108.685 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -77.25 154.95 82.26 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -81.68 0.87 47.56 Favored 'Cis proline' 0 CA--C 1.544 1.011 0 CA-C-N 119.823 0.972 . . . . 0.0 111.909 -10.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -54.92 -38.89 68.21 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 124.662 1.185 . . . . 0.0 111.482 -172.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -144.22 142.4 30.48 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 121.215 0.531 . . . . 0.0 109.924 169.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -160.17 13.9 0.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.39 2.676 . . . . 0.0 110.024 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.9 mt -82.22 69.45 8.95 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.903 1.281 . . . . 0.0 110.635 -169.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.48 155.59 50.08 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.245 1.418 . . . . 0.0 108.744 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.6 150.84 46.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.385 0.674 . . . . 0.0 110.624 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tt -79.11 124.78 28.64 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -155.29 143.16 19.91 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.593 1.157 . . . . 0.0 108.298 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 47.91 41.94 15.48 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.522 1.529 . . . . 0.0 112.612 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 53.47 26.78 5.8 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.292 1.837 . . . . 0.0 113.35 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -126.17 -176.1 3.55 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.94 2.496 . . . . 0.0 106.203 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.33 132.49 71.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.0 mp -121.0 147.15 45.89 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.652 1.181 . . . . 0.0 108.734 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.9 t -60.18 111.24 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 170.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.42 -30.49 37.7 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.692 0.797 . . . . 0.0 111.252 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 69.4 t80 . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 125.336 1.454 . . . . 0.0 107.541 169.919 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.2 t . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.55 -6.28 77.94 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.547 -1.14 . . . . 0.0 114.139 169.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -62.51 135.27 57.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.476 1.638 . . . . 0.0 107.47 169.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.13 147.88 26.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.048 0.939 . . . . 0.0 108.511 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.2 t -74.0 136.48 25.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.31 -37.18 7.76 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.159 1.784 . . . . 0.0 108.942 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.1 159.51 44.45 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.219 0.918 . . . . 0.0 111.068 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.57 139.53 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.65 34.11 3.46 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.685 1.994 . . . . 0.0 112.444 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.36 13.84 82.83 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.018 -0.879 . . . . 0.0 113.534 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.3 mmt -118.56 121.61 40.64 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.19 1.396 . . . . 0.0 107.508 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -50.8 139.1 17.41 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.593 1.157 . . . . 0.0 110.011 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.3 m -102.21 122.17 54.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -73.17 85.28 1.37 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.566 1.546 . . . . 0.0 107.187 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.34 -100.92 0.39 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -106.75 8.61 31.0 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.195 1.398 . . . . 0.0 111.887 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -127.82 150.02 50.02 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 119.291 0.95 . . . . 0.0 109.17 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.1 p -69.77 175.45 4.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.624 0.726 . . . . 0.0 110.457 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.51 -38.81 72.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.437 0.695 . . . . 0.0 110.696 169.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.72 -39.89 69.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.769 0.828 . . . . 0.0 111.371 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.2 -0.67 7.07 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.502 1.048 . . . . 0.0 113.94 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -58.75 135.95 57.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.936 1.368 . . . . 0.0 108.008 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.99 131.14 45.53 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.29 -38.63 70.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.009 0.924 . . . . 0.0 113.251 -169.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.6 mt -69.35 -38.72 78.25 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.337 0.971 . . . . 0.0 110.692 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.0 -41.93 85.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -60.46 -46.22 90.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.18 0.992 . . . . 0.0 111.323 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.0 mt -70.78 -38.35 73.39 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.978 0.511 . . . . 0.0 109.927 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.68 -28.13 69.75 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.763 0.697 . . . . 0.0 112.929 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -53.45 118.14 13.8 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.27 1.428 . . . . 0.0 109.96 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.39 -14.36 39.88 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.0 1.8 . . . . 0.0 113.504 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.7 -12.69 61.05 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.375 0.989 . . . . 0.0 112.026 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -128.79 41.41 3.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.94 2.096 . . . . 0.0 108.599 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -47.1 96.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.486 -1.245 . . . . 0.0 113.398 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.27 138.91 18.28 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 121.527 1.581 . . . . 0.0 108.356 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.63 130.72 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -172.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.9 m -105.06 138.93 40.51 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 mt -140.55 139.47 35.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -115.23 133.2 56.25 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -148.5 160.78 42.74 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.523 1.129 . . . . 0.0 109.035 -169.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.38 -173.74 43.15 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.521 0 O-C-N 121.192 -1.181 . . . . 0.0 107.878 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.432 ' HE2' ' CE2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.9 m -79.67 142.75 35.25 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.432 ' CE2' ' HE2' ' A' ' 20' ' ' LYS . 89.3 m-85 -116.27 165.12 13.54 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.313 1.845 . . . . 0.0 109.324 -174.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -146.98 167.45 23.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.05 1.74 . . . . 0.0 107.079 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -116.36 161.0 33.78 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.211 1.004 . . . . 0.0 109.499 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -62.08 160.92 51.46 Favored 'Cis proline' 0 C--N 1.35 0.633 0 CA-C-N 119.762 0.951 . . . . 0.0 110.93 -10.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.439 ' HG ' ' H ' ' A' ' 28' ' ' LEU . 51.8 tp -139.67 149.75 44.07 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.771 0.829 . . . . 0.0 110.417 -169.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.4 -31.9 72.95 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.903 1.281 . . . . 0.0 112.586 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.439 ' H ' ' HG ' ' A' ' 26' ' ' LEU . 55.2 mt -63.59 144.81 56.7 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.284 0.634 . . . . 0.0 110.146 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -140.41 132.36 27.72 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.9 mt -113.56 155.58 25.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.696 0.798 . . . . 0.0 110.209 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 145.74 50.97 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.573 1.149 . . . . 0.0 108.836 170.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tt -75.5 130.69 39.29 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -150.62 130.13 13.01 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.285 1.034 . . . . 0.0 108.234 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.2 t0 47.93 47.48 18.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.416 1.486 . . . . 0.0 112.188 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 61.12 10.79 3.09 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.566 1.946 . . . . 0.0 114.876 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.8 mtm-85 -110.36 179.37 4.1 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.447 1.499 . . . . 0.0 108.537 169.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.27 131.74 72.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.4 mp -120.23 143.36 48.32 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.833 1.253 . . . . 0.0 108.245 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.52 105.5 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 125.851 1.66 . . . . 0.0 107.534 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.95 -29.6 24.98 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 124.334 1.054 . . . . 0.0 111.26 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.0 t80 . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 173.322 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.17 -6.49 66.31 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.985 -0.897 . . . . 0.0 112.702 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -63.96 158.97 20.96 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.11 153.12 41.91 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.308 1.043 . . . . 0.0 109.103 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.15 137.4 24.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.31 -36.81 3.02 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.507 1.123 . . . . 0.0 110.058 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.98 157.73 43.71 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.734 0.697 . . . . 0.0 109.889 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 83.9 mt -136.48 139.53 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 170.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 42.33 38.95 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.515 2.326 . . . . 0.0 112.626 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 10.14 77.32 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.725 -1.042 . . . . 0.0 114.075 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 98.7 mmm -121.65 120.28 34.28 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.029 1.415 . . . . 0.0 108.485 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.62 129.05 37.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.601 1.161 . . . . 0.0 109.161 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.15 144.37 9.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.54 0.686 . . . . 0.0 111.369 -171.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -78.82 62.91 3.42 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.047 1.339 . . . . 0.0 107.603 169.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.78 -112.58 4.21 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.407 1.004 . . . . 0.0 110.978 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.05 2.09 28.65 Favored 'General case' 0 N--CA 1.46 0.062 0 C-N-CA 123.697 0.799 . . . . 0.0 112.023 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -119.68 147.99 43.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 119.091 0.86 . . . . 0.0 109.613 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.8 p -69.95 175.63 4.28 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.722 0.773 . . . . 0.0 110.038 172.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.99 -38.63 79.61 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.59 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.14 -37.11 69.5 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.793 0.837 . . . . 0.0 111.598 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.36 6.4 8.89 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.498 1.047 . . . . 0.0 114.072 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -63.13 140.28 58.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.292 1.546 . . . . 0.0 107.83 170.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.62 125.2 26.15 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 169.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.56 -33.18 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.049 0.54 . . . . 0.0 111.577 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.1 -42.02 97.05 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.326 0.512 . . . . 0.0 110.034 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -68.58 -46.1 70.29 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.08 -46.17 85.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.436 0.694 . . . . 0.0 111.375 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.6 mt -78.12 -33.98 50.24 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.105 0.962 . . . . 0.0 110.436 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.33 -31.31 68.72 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.509 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -53.97 116.46 10.31 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.171 1.389 . . . . 0.0 110.67 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.37 -17.44 44.25 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.028 1.819 . . . . 0.0 113.543 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.24 -11.64 59.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.927 0.785 . . . . 0.0 112.497 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -129.67 31.96 4.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.573 1.549 . . . . 0.0 110.07 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -53.53 -51.26 77.65 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 116.776 -1.583 . . . . 0.0 113.629 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.43 125.3 8.95 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 122.153 1.805 . . . . 0.0 109.513 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.1 135.63 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.748 0.819 . . . . 0.0 108.984 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 m -84.62 134.52 34.38 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.8 mt -140.56 147.35 23.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -124.65 140.71 52.68 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -120.73 153.83 36.44 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.91 -179.99 33.21 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.4 mmt-85 . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 169.963 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -76.41 142.45 41.09 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -143.0 153.41 42.95 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.609 0.764 . . . . 0.0 109.587 172.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -144.07 174.71 10.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.038 2.135 . . . . 0.0 106.235 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -137.05 160.18 67.08 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.881 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -64.96 155.37 76.45 Favored 'Cis proline' 0 C--N 1.351 0.68 0 CA-C-N 120.249 1.125 . . . . 0.0 111.903 -5.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.421 ' HG ' ' H ' ' A' ' 28' ' ' LEU . 45.3 tp -157.58 155.38 30.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.425 1.49 . . . . 0.0 107.995 -173.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.25 -31.82 72.43 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.292 0.637 . . . . 0.0 112.164 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.421 ' H ' ' HG ' ' A' ' 26' ' ' LEU . 11.6 tp -59.44 139.96 56.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.732 1.213 . . . . 0.0 109.657 173.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.8 tp -146.55 153.78 40.76 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.9 mt -122.49 155.6 35.86 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.317 1.447 . . . . 0.0 108.291 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.18 153.49 51.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.437 0.562 . . . . 0.0 110.387 170.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.9 tp -90.94 123.8 34.71 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.294 1.438 . . . . 0.0 107.168 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -149.16 137.13 20.61 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.729 1.212 . . . . 0.0 108.34 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.2 t70 45.82 43.1 9.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.521 1.529 . . . . 0.0 112.605 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 53.98 32.02 14.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.757 1.623 . . . . 0.0 113.991 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -130.29 164.2 25.13 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 125.779 1.631 . . . . 0.0 107.511 169.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.2 t -122.28 117.88 53.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -116.45 147.36 41.77 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.211 1.404 . . . . 0.0 108.061 -169.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.84 108.98 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 173.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.03 -40.95 21.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.747 1.219 . . . . 0.0 111.578 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 . . . . . 0 C--O 1.233 0.188 0 C-N-CA 124.685 1.194 . . . . 0.0 108.512 -176.353 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.08 -12.79 57.18 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.3 0.952 . . . . 0.0 113.911 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -79.68 174.75 11.27 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.851 1.325 . . . . 0.0 109.086 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.64 148.33 51.52 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.087 0.555 . . . . 0.0 111.398 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.2 t -61.85 137.25 24.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.8 mt -120.21 -33.1 3.99 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.896 1.279 . . . . 0.0 109.423 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.0 159.91 44.27 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.492 1.042 . . . . 0.0 110.9 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.3 mt -132.05 130.94 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.7 p30 41.69 26.25 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.559 2.343 . . . . 0.0 115.091 -174.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.63 -15.32 57.3 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.174 1.369 . . . . 0.0 113.151 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 76.7 mtm -75.32 106.93 7.1 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.836 1.318 . . . . 0.0 108.957 172.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.7 125.55 22.8 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.2 m -80.38 128.25 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -75.36 74.95 2.45 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.471 1.509 . . . . 0.0 107.918 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.17 -70.95 0.79 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 126.458 1.98 . . . . 0.0 112.157 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -129.35 -4.82 4.85 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.706 2.402 . . . . 0.0 111.522 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -117.94 156.18 28.93 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.2 p -70.61 175.65 4.72 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.277 -0.89 . . . . 0.0 109.629 169.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.14 79.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.141 169.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.29 -29.64 67.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.548 1.139 . . . . 0.0 111.992 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.66 3.88 19.96 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.075 1.321 . . . . 0.0 113.385 170.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -71.41 136.26 47.63 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.96 129.05 38.51 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 171.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 t -55.75 -41.96 67.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.987 0.915 . . . . 0.0 111.356 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.5 mt -66.55 -37.28 84.65 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.72 0.691 . . . . 0.0 110.927 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.68 -43.48 65.93 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -58.06 -46.78 84.83 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.619 1.168 . . . . 0.0 110.749 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.88 -32.83 59.86 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.65 0.78 . . . . 0.0 111.128 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.89 -32.1 76.82 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.427 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -60.19 114.69 10.57 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.204 1.001 . . . . 0.0 109.814 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.475 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.7 Cg_endo -71.06 -15.87 32.22 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.72 1.613 . . . . 0.0 113.838 -175.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.96 -14.54 48.55 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.222 0.919 . . . . 0.0 111.105 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -133.52 27.27 4.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.311 2.244 . . . . 0.0 109.438 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.475 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.4 m-30 -59.4 -53.15 68.87 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-O 117.046 -1.454 . . . . 0.0 112.264 170.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.16 119.44 6.17 Favored 'Trans proline' 0 C--N 1.351 0.691 0 CA-C-N 121.813 1.683 . . . . 0.0 109.755 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 m -147.44 174.05 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.642 1.577 . . . . 0.0 110.031 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.2 m -125.67 137.81 53.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 168.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.9 mt -131.33 137.72 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -173.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.1 ttp-105 -116.62 135.01 54.15 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -141.86 165.12 28.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.852 0.861 . . . . 0.0 110.45 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.74 -173.68 33.64 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 124.28 0.943 . . . . 0.0 111.038 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.489 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.774 0.321 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -83.58 142.99 30.44 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.834 1.253 . . . . 0.0 108.43 169.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -142.66 174.93 10.2 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.959 0.903 . . . . 0.0 110.343 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.9 m -151.22 175.53 12.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.905 2.482 . . . . 0.0 106.558 169.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.27 160.61 67.98 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.85 0.86 . . . . 0.0 110.24 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.25 -36.14 1.57 Allowed 'Cis proline' 0 C--N 1.351 0.704 0 CA-C-N 119.884 0.994 . . . . 0.0 111.425 -8.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 45.4 30.67 0.74 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.325 2.25 . . . . 0.0 114.156 169.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.7 t0 43.23 57.28 3.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.262 1.425 . . . . 0.0 112.192 -172.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.8 tp -144.28 140.7 29.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.932 1.693 . . . . 0.0 107.72 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.3 tp -146.95 142.01 27.09 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.657 0.783 . . . . 0.0 109.692 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -126.46 155.23 42.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.978 2.111 . . . . 0.0 107.165 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 153.43 41.17 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.053 0.842 . . . . 0.0 111.75 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.0 tp -73.55 127.67 33.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.891 1.676 . . . . 0.0 109.296 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -158.47 144.41 16.92 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.952 1.301 . . . . 0.0 108.406 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 51.36 39.81 25.04 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.935 1.294 . . . . 0.0 112.312 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 55.53 15.55 1.53 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.115 2.166 . . . . 0.0 114.658 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -118.71 -174.19 2.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.284 1.833 . . . . 0.0 107.102 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -123.26 142.09 41.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.4 mt -118.26 145.72 44.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.55 126.86 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 169.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -107.68 -38.05 5.98 Favored 'General case' 0 C--O 1.231 0.132 0 C-N-CA 123.483 0.713 . . . . 0.0 112.22 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.8 t80 . . . . . 0 C--O 1.233 0.231 0 C-N-CA 123.571 0.748 . . . . 0.0 108.995 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 121.057 0.456 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 1.21 38.8 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 117.846 -1.53 . . . . 0.0 113.634 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -60.95 136.68 58.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.281 2.04 . . . . 0.0 108.843 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.68 138.04 32.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.2 t -65.97 147.61 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 171.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.3 mt -126.37 -36.11 2.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.705 2.002 . . . . 0.0 109.488 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.7 159.48 44.08 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.005 0.82 . . . . 0.0 110.763 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 74.6 mt -136.08 136.0 49.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 45.78 32.67 1.3 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.918 2.087 . . . . 0.0 112.882 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.61 7.57 75.17 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.159 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.5 mmt -114.18 120.64 41.2 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.92 1.36 . . . . 0.0 107.894 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -53.43 133.87 40.47 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.275 1.03 . . . . 0.0 109.132 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.24 145.67 12.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.462 0.649 . . . . 0.0 110.133 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -78.06 62.59 2.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.762 1.625 . . . . 0.0 108.264 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.04 -107.79 1.07 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.876 1.227 . . . . 0.0 111.137 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -76.91 -6.88 54.25 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.339 1.056 . . . . 0.0 112.372 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -120.62 146.56 46.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 119.042 0.837 . . . . 0.0 109.247 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.6 p -69.17 177.32 2.79 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.66 0.743 . . . . 0.0 110.386 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.76 75.0 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.563 169.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.11 -38.2 63.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.753 0.821 . . . . 0.0 111.633 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.57 4.72 8.05 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.551 1.072 . . . . 0.0 113.92 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -61.8 140.66 58.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.198 1.499 . . . . 0.0 107.995 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -68.26 124.8 24.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.29 -32.9 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 122.93 0.492 . . . . 0.0 111.629 -170.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.89 -39.84 95.11 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.91 0.777 . . . . 0.0 110.662 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.22 -42.69 71.95 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -58.7 -44.69 90.4 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.8 0.84 . . . . 0.0 111.283 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.53 -32.17 53.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.482 1.113 . . . . 0.0 110.829 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.35 -28.31 73.33 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.94 0.781 . . . . 0.0 112.522 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -61.41 114.36 10.69 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.373 1.069 . . . . 0.0 109.279 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.502 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 94.4 Cg_endo -71.52 -13.05 30.0 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.347 1.365 . . . . 0.0 113.847 -175.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.66 -14.78 55.14 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.429 1.013 . . . . 0.0 110.66 169.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -132.91 33.43 3.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.297 2.639 . . . . 0.0 108.749 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -66.57 -53.49 28.97 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 117.099 -1.429 . . . . 0.0 111.562 169.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.7 125.84 12.07 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 121.786 1.673 . . . . 0.0 108.974 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 m -149.53 170.88 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.781 0.832 . . . . 0.0 111.302 -169.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.8 m -125.59 133.22 52.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.2 mm -128.93 137.47 57.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.3 ttt85 -112.29 133.41 54.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -144.69 166.41 25.27 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.773 1.229 . . . . 0.0 108.565 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.5 -173.22 37.59 Favored Glycine 0 N--CA 1.452 -0.28 0 O-C-N 121.813 -0.554 . . . . 0.0 111.805 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 118.507 -0.758 . . . . 0.0 109.093 -178.128 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -137.09 142.61 42.35 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -142.85 175.45 9.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.468 1.507 . . . . 0.0 110.529 -171.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.9 m -150.72 174.16 13.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.181 2.592 . . . . 0.0 106.197 169.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -132.78 159.59 71.93 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.524 -0.751 . . . . 0.0 109.922 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.62 155.96 82.55 Favored 'Cis proline' 0 CA--C 1.535 0.575 0 CA-C-N 120.009 1.039 . . . . 0.0 111.492 -6.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 tp -156.0 154.33 30.91 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.147 1.379 . . . . 0.0 108.267 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.6 56.46 1.45 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.16 1.384 . . . . 0.0 110.756 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.1 tp -142.91 135.98 28.15 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.924 2.09 . . . . 0.0 106.368 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.1 tp -145.84 143.65 29.76 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.0 mp -128.94 154.28 46.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.317 1.847 . . . . 0.0 107.365 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.91 152.69 42.33 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.041 0.837 . . . . 0.0 111.748 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.7 tp -71.82 129.26 38.19 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.906 1.282 . . . . 0.0 108.556 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -154.37 134.35 13.07 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.086 1.355 . . . . 0.0 108.087 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.3 t70 48.7 46.53 21.43 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.288 1.435 . . . . 0.0 112.578 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 55.69 16.1 1.84 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.41 1.884 . . . . 0.0 114.396 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.59 174.62 5.97 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 125.331 1.452 . . . . 0.0 107.387 169.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.65 133.8 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.0 mt -121.01 153.28 37.57 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.419 1.088 . . . . 0.0 108.313 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.8 122.35 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.75 -36.94 11.5 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.456 1.503 . . . . 0.0 111.235 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 t80 . . . . . 0 CA--C 1.529 0.145 0 C-N-CA 124.869 1.267 . . . . 0.0 107.935 173.454 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 120.884 0.373 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.82 -11.29 64.87 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.928 174.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -68.61 139.24 55.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.323 1.562 . . . . 0.0 107.478 169.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.36 143.4 27.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 p -76.02 135.38 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 168.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.62 -29.43 6.47 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.668 1.587 . . . . 0.0 110.071 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.39 160.25 43.85 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.573 1.079 . . . . 0.0 110.626 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.5 mt -138.71 134.54 42.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 44.8 36.08 1.71 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.328 1.851 . . . . 0.0 111.972 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.89 -16.3 57.19 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.449 1.499 . . . . 0.0 113.671 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.4 mmt -88.44 121.49 30.88 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.846 1.323 . . . . 0.0 109.014 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.42 135.98 32.38 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.337 1.055 . . . . 0.0 109.84 169.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 m -93.2 128.93 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.667 0.746 . . . . 0.0 109.029 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -73.81 76.93 1.6 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.849 1.66 . . . . 0.0 107.424 169.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.61 -79.06 0.25 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.68 1.61 . . . . 0.0 111.968 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -128.91 11.07 6.03 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.399 1.479 . . . . 0.0 112.048 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.51 152.15 42.05 Favored 'General case' 0 C--N 1.334 -0.077 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.2 p -71.64 174.69 6.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.36 0.982 . . . . 0.0 110.118 173.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.39 75.13 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.506 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.47 -37.61 71.31 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.784 0.834 . . . . 0.0 111.576 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.67 5.86 8.18 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.553 1.073 . . . . 0.0 114.088 173.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -63.28 137.81 58.32 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.171 1.486 . . . . 0.0 107.729 172.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -68.41 131.61 45.6 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 169.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -56.57 -41.42 73.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.576 1.15 . . . . 0.0 110.912 -174.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.4 mt -65.42 -37.65 87.55 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 118.091 0.405 . . . . 0.0 110.723 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.63 -45.32 68.76 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -60.14 -45.26 93.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.468 0.707 . . . . 0.0 111.405 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.49 -30.25 33.35 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.811 0.444 . . . . 0.0 111.156 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.43 -34.93 63.4 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.696 0.68 . . . . 0.0 112.0 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -60.39 117.66 26.53 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.353 1.061 . . . . 0.0 110.219 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.72 -31.57 32.19 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.771 1.647 . . . . 0.0 111.955 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.42 -3.56 1.46 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -169.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.41 45.18 2.84 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.14 1.376 . . . . 0.0 111.503 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -40.86 -55.15 4.87 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.36 117.97 5.39 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 122.264 1.844 . . . . 0.0 109.713 -172.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.52 131.13 34.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.7 m -98.8 139.02 35.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 mm -132.17 142.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -172.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 mtp-105 -119.79 139.88 51.64 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -128.35 170.41 13.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.229 1.412 . . . . 0.0 108.438 -173.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.85 -178.73 40.54 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.004 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 tttm . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -83.73 143.07 30.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.922 2.089 . . . . 0.0 110.62 172.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -140.1 162.71 34.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.461 1.104 . . . . 0.0 109.194 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.4 m -153.42 167.7 28.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.075 1.75 . . . . 0.0 107.044 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.63 175.87 3.32 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 117.392 -1.289 . . . . 0.0 109.73 -169.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.85 148.6 7.81 Favored 'Cis proline' 0 C--N 1.356 0.957 0 CA-C-N 122.614 1.969 . . . . 0.0 115.87 6.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.94 138.9 57.22 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.352 1.061 . . . . 0.0 111.014 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -136.12 20.48 3.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.622 1.569 . . . . 0.0 109.809 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 pp -148.15 169.36 20.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.234 3.014 . . . . 0.0 105.624 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.1 mt -143.21 145.82 33.12 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.9 mp -127.14 154.79 44.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.975 1.71 . . . . 0.0 107.178 174.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 154.08 43.79 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.738 0.815 . . . . 0.0 110.16 174.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.5 tp -76.29 121.86 23.57 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -153.25 144.2 22.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.288 1.435 . . . . 0.0 108.485 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 43.16 50.77 5.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.223 1.409 . . . . 0.0 111.753 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 60.05 7.76 1.28 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.821 2.048 . . . . 0.0 115.943 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -125.87 160.62 29.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.945 1.248 . . . . 0.0 109.851 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.31 124.41 40.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.4 mt -114.84 148.63 38.27 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.96 109.9 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.43 -38.11 71.4 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.8 1.24 . . . . 0.0 110.37 175.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.6 t80 . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 124.174 0.99 . . . . 0.0 109.146 171.96 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.4 0.55 70.05 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.733 -1.037 . . . . 0.0 114.013 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -65.89 136.38 56.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.235 1.517 . . . . 0.0 108.736 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.84 140.48 29.63 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.623 1.169 . . . . 0.0 108.988 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.99 142.62 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.2 mt -120.05 -32.57 4.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.313 1.045 . . . . 0.0 109.803 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.37 159.7 42.5 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.676 1.125 . . . . 0.0 110.75 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.9 mt -136.12 135.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 49.93 29.13 3.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.078 1.751 . . . . 0.0 112.122 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.63 -9.49 67.93 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.943 1.258 . . . . 0.0 113.795 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.3 mmt -85.62 115.16 23.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.973 1.387 . . . . 0.0 108.302 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -51.58 132.73 30.58 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.483 1.113 . . . . 0.0 109.559 169.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.71 133.97 32.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -78.15 71.77 4.64 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.325 1.45 . . . . 0.0 107.34 169.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.45 -59.6 0.29 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 128.032 2.729 . . . . 0.0 114.342 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -137.36 -4.61 1.86 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.003 2.121 . . . . 0.0 111.658 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -117.56 154.1 32.08 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.7 p -69.88 177.22 3.21 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.188 0.904 . . . . 0.0 110.113 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.32 -38.69 74.44 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.612 169.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.36 -37.93 68.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.672 0.789 . . . . 0.0 111.558 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.47 4.88 7.39 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.548 1.071 . . . . 0.0 113.874 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -64.22 136.93 57.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.785 1.292 . . . . 0.0 107.736 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.05 125.99 26.66 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.6 t -57.33 -37.39 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.191 0.596 . . . . 0.0 111.707 -170.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.47 -42.42 98.6 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.674 0.67 . . . . 0.0 110.09 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.66 -37.5 70.8 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.059 -0.401 . . . . 0.0 110.212 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -60.12 -43.62 95.48 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.801 0.84 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.62 -36.06 60.35 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.441 0.696 . . . . 0.0 110.575 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.13 -33.01 86.1 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.688 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -59.65 116.07 15.22 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.93 1.292 . . . . 0.0 110.453 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.508 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.6 Cg_endo -70.25 -14.6 34.7 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.92 1.746 . . . . 0.0 114.086 -177.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.51 -14.12 55.68 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.536 1.062 . . . . 0.0 110.901 169.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -135.58 34.74 2.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.764 2.426 . . . . 0.0 108.638 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.508 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -63.28 -55.4 36.48 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.669 -1.157 . . . . 0.0 111.583 171.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.32 127.99 13.24 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 121.382 1.529 . . . . 0.0 109.219 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.3 m -149.16 169.32 2.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 123.992 0.917 . . . . 0.0 110.852 -172.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.4 m -126.04 137.17 53.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 169.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.1 mt -132.73 143.59 39.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -123.55 130.81 53.22 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -138.47 172.2 13.25 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.054 0.942 . . . . 0.0 108.788 -176.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -176.46 39.41 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm . . . . . 0 C--O 1.236 0.354 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -73.17 145.06 46.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.67 1.188 . . . . 0.0 109.162 169.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -140.81 162.3 35.76 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.054 1.342 . . . . 0.0 108.849 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.1 m -148.34 175.64 10.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.384 2.274 . . . . 0.0 106.788 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -137.49 153.56 74.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.581 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.06 152.71 87.55 Favored 'Cis proline' 0 CA--C 1.538 0.691 0 CA-C-N 119.642 0.908 . . . . 0.0 110.412 -10.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.5 tp -160.66 170.88 19.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.222 1.409 . . . . 0.0 108.143 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.11 -33.21 68.88 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.286 1.035 . . . . 0.0 112.168 174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 tp -62.56 128.34 35.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.65 0.78 . . . . 0.0 109.841 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.6 tp -142.48 150.33 40.37 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.772 1.629 . . . . 0.0 107.2 172.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -132.59 155.54 48.51 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.507 1.123 . . . . 0.0 109.833 -170.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 155.42 44.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.788 0.835 . . . . 0.0 110.333 172.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.41 131.12 40.41 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.895 1.278 . . . . 0.0 107.83 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -152.72 138.76 18.19 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 t70 44.42 49.17 8.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.518 1.527 . . . . 0.0 112.839 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 60.22 14.54 4.64 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.991 1.716 . . . . 0.0 114.702 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 155.77 28.68 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 120.975 -1.078 . . . . 0.0 108.78 171.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.5 t -102.49 130.74 51.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.73 150.61 40.1 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.133 1.373 . . . . 0.0 107.967 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.56 108.01 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.74 -29.79 23.6 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.588 1.155 . . . . 0.0 111.759 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.794 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.99 -15.8 46.26 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.694 1.14 . . . . 0.0 114.03 173.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -72.33 158.6 35.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.095 1.447 . . . . 0.0 109.932 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.73 144.1 33.86 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.705 1.202 . . . . 0.0 109.271 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -63.61 152.04 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 174.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.6 mt -132.62 -41.5 0.95 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.645 1.178 . . . . 0.0 110.63 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.56 158.84 44.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.375 0.989 . . . . 0.0 110.368 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 78.4 mt -138.54 139.94 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 176.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 46.67 31.02 1.27 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.872 2.069 . . . . 0.0 112.745 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.66 18.48 65.81 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.709 -1.051 . . . . 0.0 113.816 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -125.29 133.05 52.78 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.036 1.418 . . . . 0.0 109.198 170.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -50.71 141.86 12.18 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.391 1.076 . . . . 0.0 109.579 169.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.4 m -115.13 128.74 72.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 122.146 0.975 . . . . 0.0 109.164 174.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -76.35 74.9 3.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.969 2.107 . . . . 0.0 108.967 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.93 -66.74 1.13 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.382 1.944 . . . . 0.0 112.943 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.59 9.47 2.43 Favored 'General case' 0 CA--C 1.526 0.051 0 C-N-CA 125.146 1.378 . . . . 0.0 112.457 175.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -121.51 143.68 49.13 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.7 p -71.64 174.01 7.32 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.257 0.935 . . . . 0.0 110.152 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.14 -38.18 76.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.469 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.67 -39.58 73.49 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.972 0.909 . . . . 0.0 111.406 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.78 -0.21 7.84 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.648 1.118 . . . . 0.0 114.187 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -61.48 143.69 55.49 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.181 1.49 . . . . 0.0 108.499 173.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -69.34 134.73 49.44 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 t -55.25 -45.7 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.771 1.228 . . . . 0.0 111.014 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.41 -36.41 81.22 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.478 0.581 . . . . 0.0 110.669 -176.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -70.63 -43.2 69.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.412 0.551 . . . . 0.0 109.746 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -60.28 -45.05 94.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.506 1.123 . . . . 0.0 110.703 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.39 -33.18 60.97 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.685 0.794 . . . . 0.0 111.001 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.43 -30.66 73.33 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.843 0.735 . . . . 0.0 112.456 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -60.49 114.56 10.46 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.285 1.034 . . . . 0.0 109.674 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.487 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 80.5 Cg_endo -70.87 -14.61 32.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.627 1.552 . . . . 0.0 113.832 -175.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.41 -15.04 56.41 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.393 0.997 . . . . 0.0 110.857 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -133.68 33.35 3.5 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.883 2.473 . . . . 0.0 108.648 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.487 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -65.24 -52.6 45.95 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 117.085 -1.436 . . . . 0.0 111.121 169.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.93 125.4 10.95 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.794 1.677 . . . . 0.0 109.251 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.1 m -150.45 171.83 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.188 1.395 . . . . 0.0 110.127 -170.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 m -125.74 138.72 53.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 169.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 mt -138.63 143.65 31.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -118.45 132.77 56.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -145.0 166.25 25.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.214 1.406 . . . . 0.0 107.317 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.74 -156.97 28.31 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.767 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -123.71 142.49 51.02 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.394 1.478 . . . . 0.0 108.086 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -141.73 167.18 22.77 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.607 0.718 . . . . 0.0 110.607 -173.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.8 m -155.07 174.47 15.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.719 2.008 . . . . 0.0 107.08 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -136.56 163.78 47.33 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.64 6.63 21.13 Favored 'Cis proline' 0 CA--C 1.541 0.856 0 CA-C-N 121.74 1.657 . . . . 0.0 114.562 5.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.1 tp -44.9 130.61 7.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.254 1.022 . . . . 0.0 110.023 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.59 123.88 17.79 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.251 1.02 . . . . 0.0 112.813 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.6 tp -161.27 153.41 19.87 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.763 2.425 . . . . 0.0 104.835 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 44.2 tp -147.05 137.21 23.37 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.642 1.11 . . . . 0.0 109.674 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.5 mp -131.06 150.62 52.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.433 2.293 . . . . 0.0 106.172 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 154.4 41.85 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.251 0.932 . . . . 0.0 111.196 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -77.4 124.61 28.11 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -154.73 144.72 21.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.235 1.414 . . . . 0.0 109.044 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 46.79 45.07 14.77 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.484 1.135 . . . . 0.0 111.655 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 62.5 0.92 0.68 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.378 2.271 . . . . 0.0 116.609 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -119.79 159.58 24.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 121.12 1.782 . . . . 0.0 109.97 173.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.84 131.76 33.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 169.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.9 mt -118.22 153.32 34.07 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.072 1.349 . . . . 0.0 107.572 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.43 121.77 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.07 -39.51 23.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.601 0.76 . . . . 0.0 110.409 171.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 61.7 t80 . . . . . 0 C--O 1.234 0.255 0 C-N-CA 124.154 0.982 . . . . 0.0 109.913 178.362 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.66 -8.76 67.59 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.809 -0.995 . . . . 0.0 113.719 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -77.93 143.98 37.22 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.302 1.551 . . . . 0.0 108.351 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.04 143.75 28.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.968 1.307 . . . . 0.0 109.724 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.04 143.53 15.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.95 -32.39 2.31 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.398 1.079 . . . . 0.0 110.583 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.61 158.83 44.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.902 1.228 . . . . 0.0 110.266 169.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -139.98 134.94 37.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 105.834 -1.914 . . . . 0.0 105.834 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 49.56 28.2 2.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.658 1.583 . . . . 0.0 112.46 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.17 -11.74 68.55 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.944 1.259 . . . . 0.0 113.799 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 78.8 mtm -80.35 112.63 17.87 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.303 1.551 . . . . 0.0 108.056 173.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.47 124.26 19.8 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.5 m -96.95 138.2 22.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 122.014 0.911 . . . . 0.0 110.865 -169.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -76.29 70.39 2.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.725 2.01 . . . . 0.0 108.622 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.13 -59.71 0.8 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 127.794 2.616 . . . . 0.0 114.395 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -142.86 0.89 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.792 2.037 . . . . 0.0 111.073 -174.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -124.76 144.64 50.14 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.8 p -68.35 175.58 3.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.034 0.834 . . . . 0.0 110.386 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.31 -38.43 74.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.671 169.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.22 -38.09 72.03 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.553 0.741 . . . . 0.0 111.502 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.4 4.7 7.5 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.827 1.203 . . . . 0.0 113.68 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -63.34 134.16 55.31 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -64.79 126.69 28.75 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.3 t -55.32 -42.44 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.476 1.111 . . . . 0.0 111.745 -170.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.67 -40.7 88.7 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.593 0.633 . . . . 0.0 110.311 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -69.95 -41.04 75.06 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.842 0.457 . . . . 0.0 110.034 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -59.33 -44.98 92.55 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.41 1.084 . . . . 0.0 110.875 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.17 -35.28 63.99 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.457 0.703 . . . . 0.0 110.629 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.67 -30.74 74.98 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.865 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -59.57 116.76 17.83 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.668 1.187 . . . . 0.0 110.149 177.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.498 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 74.2 Cg_endo -69.62 -15.66 37.74 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.896 1.731 . . . . 0.0 114.136 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.91 -14.26 52.14 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.439 1.018 . . . . 0.0 111.088 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -135.39 33.68 3.03 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.674 2.39 . . . . 0.0 108.828 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -62.4 -55.29 41.09 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.768 172.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.44 128.34 13.52 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 121.661 1.629 . . . . 0.0 109.41 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 m -147.93 164.69 5.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 123.551 0.74 . . . . 0.0 111.323 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -122.14 137.54 54.79 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.7 mt -137.76 133.94 45.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -107.13 138.01 44.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -145.22 168.6 20.02 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.748 1.219 . . . . 0.0 108.193 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.45 -174.18 44.48 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.0 mmm-85 . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.902 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -82.2 143.22 31.54 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.899 1.28 . . . . 0.0 109.019 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -143.66 168.44 19.88 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.23 1.412 . . . . 0.0 109.81 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.7 m -142.66 175.25 9.95 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.07 2.548 . . . . 0.0 105.951 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -133.96 159.74 71.22 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 119.071 0.851 . . . . 0.0 110.193 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.66 155.08 27.54 Favored 'Cis proline' 0 C--N 1.351 0.678 0 CA-C-N 120.261 1.129 . . . . 0.0 112.826 -10.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.6 156.34 37.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.93 1.292 . . . . 0.0 107.562 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -67.26 -30.4 70.28 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.96 0.904 . . . . 0.0 112.361 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.0 tp -59.03 133.8 56.42 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.341 1.056 . . . . 0.0 109.223 173.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.2 tp -140.14 141.97 36.02 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.86 1.264 . . . . 0.0 107.822 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.6 mp -127.09 155.4 43.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.294 1.838 . . . . 0.0 107.882 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 152.45 45.29 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.531 0.732 . . . . 0.0 110.58 173.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.12 128.72 34.23 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -151.68 138.27 18.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.48 1.112 . . . . 0.0 108.369 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.8 t70 44.8 50.5 8.72 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.828 1.651 . . . . 0.0 112.558 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 56.5 16.43 2.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.986 2.114 . . . . 0.0 114.456 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -126.38 -169.7 2.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.131 2.172 . . . . 0.0 107.553 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.38 136.48 56.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.6 mt -127.45 156.23 42.45 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.894 1.278 . . . . 0.0 108.601 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.6 t -65.43 122.33 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.98 -38.35 19.38 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.4 1.08 . . . . 0.0 110.623 172.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.9 t80 . . . . . 0 C--O 1.231 0.123 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.291 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.85 -7.6 73.56 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.638 -1.09 . . . . 0.0 113.688 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -72.22 158.92 34.97 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.443 1.621 . . . . 0.0 108.028 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.86 141.03 47.15 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 123.203 0.601 . . . . 0.0 110.52 -169.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.11 134.28 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.92 -25.58 4.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.865 0.866 . . . . 0.0 109.921 -172.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.44 153.83 42.32 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.72 1.145 . . . . 0.0 109.446 168.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.6 mt -136.64 137.19 47.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 46.79 33.5 2.18 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.089 1.756 . . . . 0.0 112.418 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.06 11.27 79.09 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.733 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.6 mmt -120.18 121.77 39.48 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.849 1.325 . . . . 0.0 108.294 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.75 124.28 16.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.341 1.056 . . . . 0.0 109.283 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.4 m -73.24 140.82 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -79.87 61.6 3.84 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.176 1.39 . . . . 0.0 107.849 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.95 -112.1 3.58 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.103 1.335 . . . . 0.0 110.843 -172.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -72.32 -13.23 61.44 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.449 1.099 . . . . 0.0 111.959 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -112.03 155.43 23.82 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.394 0.678 . . . . 0.0 109.397 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.2 p -71.95 175.44 5.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.41 -0.806 . . . . 0.0 109.454 169.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.65 80.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.517 169.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.61 -36.34 68.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.427 0.691 . . . . 0.0 111.457 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.41 -1.22 7.03 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.554 -1.137 . . . . 0.0 114.96 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -67.43 147.77 52.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.925 1.863 . . . . 0.0 107.829 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -66.33 130.95 44.95 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 170.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 t -53.99 -41.75 51.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 125.192 1.397 . . . . 0.0 111.311 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.2 mt -66.98 -39.67 87.23 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.547 0.612 . . . . 0.0 110.546 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -71.5 -37.9 71.21 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.349 0.522 . . . . 0.0 110.226 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -60.97 -53.74 53.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.019 0.928 . . . . 0.0 109.929 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.26 -32.5 73.96 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.05 -0.406 . . . . 0.0 110.122 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.53 -9.67 78.43 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.236 -1.313 . . . . 0.0 114.187 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -83.33 112.51 39.61 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 119.979 1.89 . . . . 0.0 110.343 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.544 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 84.0 Cg_endo -72.23 -16.33 28.27 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.651 1.567 . . . . 0.0 114.669 -170.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.19 -11.9 24.23 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.06 0.845 . . . . 0.0 112.136 169.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.8 31.1 3.06 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.952 1.301 . . . . 0.0 111.829 173.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.544 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.1 m-30 -53.52 -40.51 80.83 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 116.136 -1.888 . . . . 0.0 115.519 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.68 122.08 9.01 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 CA-C-N 123.117 2.149 . . . . 0.0 109.206 172.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.23 169.66 7.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.998 1.319 . . . . 0.0 110.374 -172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -126.19 138.1 53.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.2 mm -128.87 140.77 48.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -174.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -130.08 127.04 39.05 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -144.55 163.29 34.32 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.121 0.968 . . . . 0.0 111.321 -169.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.69 -170.93 37.0 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 170.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 m -106.86 142.77 35.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.352 1.061 . . . . 0.0 108.346 -176.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -141.55 161.81 37.01 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.889 1.276 . . . . 0.0 109.695 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.4 m -155.96 170.9 21.07 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.522 1.929 . . . . 0.0 107.189 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -136.94 161.83 59.29 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.85 0.86 . . . . 0.0 109.521 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.92 141.76 61.27 Favored 'Cis proline' 0 CA--C 1.536 0.612 0 CA-C-N 119.966 1.023 . . . . 0.0 110.317 -10.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.1 tp -161.54 -58.02 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.606 1.162 . . . . 0.0 107.985 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.76 135.44 6.52 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.481 1.913 . . . . 0.0 106.636 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.6 tp -145.32 31.56 1.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.285 1.034 . . . . 0.0 109.163 171.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.56 68.93 2.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.461 1.104 . . . . 0.0 109.579 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.04 155.73 30.94 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.045 2.138 . . . . 0.0 106.996 172.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.25 154.01 49.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.541 0.609 . . . . 0.0 110.375 171.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tt -81.99 122.6 28.0 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -157.26 145.49 19.33 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.698 1.199 . . . . 0.0 107.964 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.1 t70 54.66 37.66 28.59 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.477 1.111 . . . . 0.0 111.716 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 52.93 25.28 3.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.244 1.817 . . . . 0.0 113.136 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -128.6 -177.3 4.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 127.547 2.339 . . . . 0.0 107.289 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.2 t -120.75 127.82 75.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 169.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.2 mt -123.19 157.45 32.98 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.7 1.2 . . . . 0.0 109.09 -171.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.26 120.18 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.391 1.077 . . . . 0.0 108.4 171.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.41 -29.27 20.36 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.903 0.881 . . . . 0.0 111.314 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.7 t80 . . . . . 0 C--O 1.232 0.154 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 171.18 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.6 m . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.34 0.114 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.49 -13.22 68.04 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.327 -1.263 . . . . 0.0 113.989 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -67.14 153.44 43.66 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.792 1.796 . . . . 0.0 107.764 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.61 146.5 44.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.281 1.432 . . . . 0.0 110.151 -170.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -68.21 138.15 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 169.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.8 mt -121.9 -29.09 4.35 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.47 1.108 . . . . 0.0 111.013 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.91 158.29 43.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 120.084 1.311 . . . . 0.0 110.558 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -140.38 135.12 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 50.46 27.9 3.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.774 1.63 . . . . 0.0 112.377 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.07 -11.0 63.86 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.845 1.212 . . . . 0.0 113.633 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.5 mtt -78.69 107.92 11.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.958 1.379 . . . . 0.0 108.518 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.34 121.77 12.26 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.6 m -76.44 137.0 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.718 0.77 . . . . 0.0 110.755 -169.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -79.31 67.04 4.94 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 169.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.41 -107.54 1.03 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.828 1.204 . . . . 0.0 111.302 -173.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -77.66 -10.55 59.58 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.61 1.164 . . . . 0.0 112.121 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -116.02 155.28 28.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.016 0.826 . . . . 0.0 109.54 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -71.14 177.65 3.69 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.26 -0.9 . . . . 0.0 109.703 169.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.68 82.19 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.346 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.6 -38.99 74.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.895 0.878 . . . . 0.0 111.412 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.08 -2.61 6.79 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.517 1.056 . . . . 0.0 114.161 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -60.51 135.36 57.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.05 1.425 . . . . 0.0 108.265 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -68.43 129.96 41.46 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 t -53.96 -43.57 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.185 1.394 . . . . 0.0 112.087 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.67 -39.76 88.31 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.859 0.754 . . . . 0.0 110.502 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -69.51 -41.16 76.42 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -59.7 -45.2 92.83 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.248 1.019 . . . . 0.0 110.801 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.53 -34.49 60.77 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.21 0.604 . . . . 0.0 110.895 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.39 -32.12 78.59 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.513 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -60.22 115.55 13.76 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.754 1.222 . . . . 0.0 110.179 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.5 Cg_endo -70.49 -15.03 34.32 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.844 1.696 . . . . 0.0 113.988 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.97 -14.72 56.08 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.412 1.006 . . . . 0.0 110.986 169.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -135.26 34.96 3.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.744 2.418 . . . . 0.0 108.607 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -64.72 -54.59 34.89 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 117.543 -1.217 . . . . 0.0 111.371 169.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.82 125.04 10.68 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.521 1.579 . . . . 0.0 109.133 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.3 m -149.97 170.9 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.165 0.986 . . . . 0.0 110.402 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.6 m -125.61 139.9 53.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.3 mt -137.27 145.1 30.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -120.19 140.33 51.3 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 171.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -124.55 172.81 8.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.459 1.504 . . . . 0.0 109.16 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.41 -154.82 13.7 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.509 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 p -78.88 142.88 36.44 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.594 1.158 . . . . 0.0 109.803 172.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.65 162.73 34.39 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.567 1.547 . . . . 0.0 109.29 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -159.0 175.18 13.86 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.59 2.756 . . . . 0.0 106.837 178.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -132.56 156.97 79.48 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.758 0.823 . . . . 0.0 109.569 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.5 156.38 81.87 Favored 'Cis proline' 0 CA--C 1.536 0.584 0 CA-C-N 119.729 0.939 . . . . 0.0 111.824 -5.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.33 167.68 29.57 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.37 1.468 . . . . 0.0 107.59 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.64 61.61 3.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.932 1.293 . . . . 0.0 110.056 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.5 mt -139.15 154.37 48.08 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.081 1.752 . . . . 0.0 108.683 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.3 tp -148.45 127.66 12.94 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -123.34 149.83 44.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.96 164.45 33.72 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.8 1.24 . . . . 0.0 110.114 -176.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.6 tp -86.73 133.98 33.62 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 171.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -150.18 129.43 12.82 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.84 1.256 . . . . 0.0 108.066 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 45.25 50.01 9.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.317 1.447 . . . . 0.0 112.367 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 62.35 18.45 10.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.704 1.602 . . . . 0.0 114.318 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 -127.72 143.51 51.14 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.75 -1.218 . . . . 0.0 109.179 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.28 127.74 39.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 169.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.43 145.37 48.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.641 1.576 . . . . 0.0 108.599 -176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.08 107.62 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.81 1.644 . . . . 0.0 106.861 171.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.89 -29.68 44.52 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.788 0.835 . . . . 0.0 111.826 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.0 t80 . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.735 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.788 0.804 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.49 3.94 64.43 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.721 -1.044 . . . . 0.0 112.626 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -55.81 128.46 35.05 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.936 1.368 . . . . 0.0 108.096 169.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.02 141.13 30.52 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.36 140.59 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.6 mt -122.52 -32.31 3.62 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.616 -174.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.29 160.12 42.66 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.773 1.169 . . . . 0.0 110.672 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.0 mt -140.4 139.21 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 173.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.0 p30 47.27 21.58 0.2 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.102 2.161 . . . . 0.0 114.556 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.86 -27.84 18.46 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.484 1.516 . . . . 0.0 113.013 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 73.7 mtm -74.79 117.93 17.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.709 1.254 . . . . 0.0 109.675 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.72 135.54 55.22 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 169.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.4 m -97.87 126.9 50.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.596 0.712 . . . . 0.0 109.578 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -72.88 74.93 1.16 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.909 1.684 . . . . 0.0 107.874 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.34 -70.85 0.35 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 126.823 2.154 . . . . 0.0 113.12 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -134.21 12.84 3.89 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.936 1.295 . . . . 0.0 112.209 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -125.9 146.14 49.96 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.0 p -69.76 171.75 8.67 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.99 0.814 . . . . 0.0 109.924 172.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.03 75.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.56 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.06 -40.08 78.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 111.512 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.31 0.26 6.88 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.459 1.028 . . . . 0.0 114.378 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -59.69 136.24 57.93 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.375 1.587 . . . . 0.0 108.305 174.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.86 128.89 38.16 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.32 -41.74 88.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.283 1.033 . . . . 0.0 111.162 -171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.9 mt -66.66 -42.46 86.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.317 0.962 . . . . 0.0 110.295 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.52 -42.43 92.05 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -60.91 -53.14 60.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.845 0.858 . . . . 0.0 110.248 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.3 mt -66.27 -26.95 67.58 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.766 -0.584 . . . . 0.0 110.477 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.77 -15.31 77.99 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.421 -1.211 . . . . 0.0 113.778 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -84.39 112.99 45.9 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.787 1.793 . . . . 0.0 110.464 -177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.526 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 64.7 Cg_endo -68.24 -22.42 40.32 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.939 1.759 . . . . 0.0 114.117 -171.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.57 -10.99 21.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.761 0.71 . . . . 0.0 112.825 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.71 28.21 3.6 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.39 1.076 . . . . 0.0 111.956 173.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.526 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 6.4 m-30 -53.14 -47.57 95.35 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 116.643 -1.646 . . . . 0.0 112.633 169.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.22 104.82 1.6 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 122.102 1.787 . . . . 0.0 110.581 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.81 157.65 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.597 0.759 . . . . 0.0 109.961 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.6 m -84.27 146.25 27.86 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.0 mt -136.46 144.89 31.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -117.81 132.46 56.44 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 169.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -141.53 165.05 28.57 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.01 -174.16 37.99 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -173.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.789 171.946 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptp . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -79.44 142.46 35.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.936 1.695 . . . . 0.0 110.414 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.07 160.53 40.73 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.341 1.056 . . . . 0.0 110.296 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.3 m -150.87 175.13 12.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.271 2.228 . . . . 0.0 107.388 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -127.19 158.99 67.44 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 0.0 108.269 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.64 145.14 45.47 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 120.058 1.056 . . . . 0.0 111.404 -10.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.7 tp -160.38 158.44 29.57 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.551 1.541 . . . . 0.0 107.297 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.21 -22.56 61.99 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.64 127.3 31.33 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.7 mt -138.79 157.0 46.88 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 173.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.27 153.22 42.02 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.901 1.28 . . . . 0.0 108.211 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.01 164.99 28.58 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.777 1.231 . . . . 0.0 109.072 173.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.1 tp -108.03 127.05 53.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -150.78 140.83 22.07 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.432 1.093 . . . . 0.0 108.241 175.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 46.73 43.89 13.37 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.184 1.393 . . . . 0.0 112.606 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 58.87 24.78 12.85 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.911 1.684 . . . . 0.0 113.75 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -130.03 139.15 51.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 O-C-N 120.834 -1.166 . . . . 0.0 108.33 174.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.34 127.46 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 mt -126.44 155.75 41.73 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.617 1.567 . . . . 0.0 109.036 -172.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.16 117.94 3.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 124.693 1.197 . . . . 0.0 107.905 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.13 -41.86 14.37 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.592 1.157 . . . . 0.0 110.881 175.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--O 1.233 0.222 0 C-N-CA 126.401 1.881 . . . . 0.0 107.546 -178.133 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 CA--C 1.538 0.497 0 CA-C-O 120.822 0.344 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.61 -7.98 74.16 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 119.037 -0.869 . . . . 0.0 114.177 171.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -70.89 151.17 45.01 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.942 1.371 . . . . 0.0 108.074 169.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.67 147.76 25.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.286 1.035 . . . . 0.0 109.786 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.39 137.86 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 169.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.63 -37.55 3.94 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.824 1.249 . . . . 0.0 109.486 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.47 160.49 43.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.238 0.926 . . . . 0.0 110.391 169.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 93.1 mt -135.59 133.28 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 48.23 31.21 2.5 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.008 1.723 . . . . 0.0 112.561 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.74 -12.75 66.25 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.974 1.273 . . . . 0.0 113.635 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.9 mtt -80.09 108.41 13.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.01 1.405 . . . . 0.0 108.755 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.65 124.33 17.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -82.05 133.54 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.685 0.755 . . . . 0.0 109.407 -173.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -78.6 70.69 4.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.71 -58.46 0.33 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 128.187 2.803 . . . . 0.0 114.828 174.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -134.84 -5.28 2.45 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.894 2.078 . . . . 0.0 111.529 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -120.2 155.57 32.88 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.9 p -71.08 177.08 3.94 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.405 1.002 . . . . 0.0 110.085 170.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.73 77.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.601 169.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.33 -36.85 71.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.649 0.78 . . . . 0.0 111.532 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.87 4.8 8.51 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.625 1.107 . . . . 0.0 113.727 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -63.17 134.47 56.03 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.67 128.7 37.25 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.8 t -58.51 -39.79 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.701 0.801 . . . . 0.0 111.263 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.6 mt -65.45 -42.74 92.02 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.738 0.699 . . . . 0.0 110.328 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.51 -41.71 83.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.017 0.527 . . . . 0.0 109.687 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -59.82 -52.43 65.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.137 0.975 . . . . 0.0 110.395 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.5 mt -67.0 -34.15 77.12 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.641 0.376 . . . . 0.0 109.998 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.92 -17.89 73.9 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.517 -1.157 . . . . 0.0 113.783 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -75.31 114.12 32.5 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 119.545 1.672 . . . . 0.0 110.596 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.463 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 61.4 Cg_endo -67.54 -21.09 46.68 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.34 2.027 . . . . 0.0 114.014 -171.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.86 -11.35 55.39 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 176.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.95 28.52 2.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.507 1.049 . . . . 0.0 112.756 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.463 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 6.4 m-30 -48.75 -48.68 69.54 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 116.438 -1.744 . . . . 0.0 115.015 175.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.49 120.61 7.41 Favored 'Trans proline' 0 C--N 1.35 0.635 0 CA-C-N 122.497 1.928 . . . . 0.0 109.948 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.9 m -146.38 171.6 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.519 1.528 . . . . 0.0 109.926 -175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -120.38 137.06 54.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.24 -2.134 . . . . 0.0 105.24 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.1 mt -132.35 138.5 52.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -107.93 136.04 48.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 170.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -123.13 160.47 26.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.248 1.819 . . . . 0.0 108.746 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.08 178.16 39.56 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.826 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 m -131.57 141.16 49.63 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.235 1.414 . . . . 0.0 107.327 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -145.67 167.47 23.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.465 1.506 . . . . 0.0 109.941 -170.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.4 m -144.16 175.1 10.32 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.594 2.357 . . . . 0.0 106.304 169.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -134.78 162.21 59.1 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.517 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.01 149.42 28.87 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.373 1.169 . . . . 0.0 112.429 -10.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -157.9 150.58 22.68 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.403 1.481 . . . . 0.0 107.243 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.79 59.63 3.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.195 0.998 . . . . 0.0 110.414 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.9 tp -140.11 135.74 32.85 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.833 2.453 . . . . 0.0 105.524 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -145.92 145.21 30.6 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.5 mt -130.58 154.05 48.25 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.79 1.636 . . . . 0.0 107.432 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 156.26 45.6 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.558 0.617 . . . . 0.0 110.793 -178.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.5 tp -90.65 128.26 36.56 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.902 1.281 . . . . 0.0 108.137 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -156.91 145.23 19.6 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.587 1.155 . . . . 0.0 108.137 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.8 t70 51.81 37.79 21.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.175 0.99 . . . . 0.0 111.404 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 55.23 17.57 2.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.301 2.241 . . . . 0.0 114.414 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.08 161.92 20.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.84 1.256 . . . . 0.0 108.216 174.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.4 t -97.5 134.54 35.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.46 150.48 41.49 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.198 1.399 . . . . 0.0 107.623 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.52 117.37 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.15 -29.41 31.59 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.06 0.544 . . . . 0.0 111.497 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 C--O 1.232 0.184 0 C-N-CA 125.014 1.325 . . . . 0.0 107.494 174.923 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 121.32 0.581 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.34 -15.64 38.84 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.031 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -76.95 148.24 36.46 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.948 1.374 . . . . 0.0 108.649 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.54 141.84 29.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.39 1.076 . . . . 0.0 109.319 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.8 t -72.62 141.49 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.0 mt -128.97 -30.65 2.21 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.427 1.091 . . . . 0.0 111.139 -172.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.61 158.97 41.95 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.122 1.328 . . . . 0.0 110.089 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.0 mt -140.72 135.26 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 106.176 -1.786 . . . . 0.0 106.176 173.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 50.27 28.7 3.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.542 1.537 . . . . 0.0 112.093 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.33 -9.53 63.95 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.805 1.193 . . . . 0.0 113.68 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.4 mtt -77.72 108.61 11.06 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.088 1.444 . . . . 0.0 108.495 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.74 114.4 1.54 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.286 1.434 . . . . 0.0 109.68 169.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.53 142.52 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 124.198 0.999 . . . . 0.0 108.447 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -125.31 113.57 17.77 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.158 2.183 . . . . 0.0 105.355 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.61 -113.83 5.98 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -116.84 23.5 11.9 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.354 1.061 . . . . 0.0 110.672 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -126.65 140.08 52.68 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.1 p -67.39 176.85 2.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.541 1.064 . . . . 0.0 110.013 174.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.95 -39.27 74.25 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.85 169.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.32 -39.56 74.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.546 0.738 . . . . 0.0 111.098 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.53 -2.59 6.12 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.655 1.122 . . . . 0.0 113.736 171.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -61.11 133.43 56.0 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.007 1.404 . . . . 0.0 109.182 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -59.78 120.38 9.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.6 t -54.47 -44.53 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.95 1.3 . . . . 0.0 111.696 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.71 -38.17 83.27 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.375 0.534 . . . . 0.0 110.392 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.37 -38.01 63.29 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.301 0.5 . . . . 0.0 110.272 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -58.69 -44.62 90.34 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.473 1.109 . . . . 0.0 110.296 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.25 -34.99 61.46 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.66 0.784 . . . . 0.0 110.983 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.7 -33.5 87.41 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.368 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -60.29 114.93 11.25 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.659 1.184 . . . . 0.0 110.071 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.486 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 73.6 Cg_endo -70.73 -15.01 33.46 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.792 1.661 . . . . 0.0 113.912 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.53 -14.82 54.92 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.36 0.982 . . . . 0.0 110.899 169.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -134.28 33.91 3.31 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.826 2.45 . . . . 0.0 108.721 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -64.54 -53.24 46.54 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.186 -1.387 . . . . 0.0 111.289 169.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.97 123.76 9.56 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 121.717 1.649 . . . . 0.0 109.262 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -150.95 164.47 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 124.214 1.006 . . . . 0.0 110.873 -172.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -118.51 140.63 49.57 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.2 mt -136.55 139.49 45.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -171.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.7 ttt85 -115.55 135.95 53.57 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 172.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -146.85 164.09 33.98 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.943 1.297 . . . . 0.0 108.467 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.26 -169.0 40.56 Favored Glycine 0 C--N 1.33 0.21 0 O-C-N 121.518 -0.738 . . . . 0.0 112.135 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 . . . . . 0 C--O 1.239 0.511 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.232 172.015 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 121.022 0.439 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 p -78.3 143.05 37.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.024 1.73 . . . . 0.0 108.574 169.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -144.48 167.79 21.66 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.171 0.988 . . . . 0.0 110.048 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.4 m -137.71 166.66 23.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.369 1.868 . . . . 0.0 107.219 171.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.01 153.83 39.77 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.739 -175.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.8 133.69 15.75 Favored 'Cis proline' 0 C--N 1.35 0.638 0 CA-C-N 120.7 1.286 . . . . 0.0 110.155 -7.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.8 tp -66.59 123.86 21.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.682 0.793 . . . . 0.0 111.147 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -62.67 -42.63 99.73 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 111.485 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 tp -75.56 57.54 0.97 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.704 1.601 . . . . 0.0 109.113 170.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 46.1 tp -53.64 141.37 26.24 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.338 -0.851 . . . . 0.0 109.342 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.1 mt -125.27 155.99 39.29 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.249 1.019 . . . . 0.0 109.635 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.67 153.66 50.84 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 tt -92.65 123.98 36.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -150.95 136.46 17.88 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.718 1.207 . . . . 0.0 108.386 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.29 39.97 17.16 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.271 1.428 . . . . 0.0 111.819 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 59.44 0.43 0.21 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.411 2.285 . . . . 0.0 115.272 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -95.99 -177.72 4.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 120.67 1.577 . . . . 0.0 107.777 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.2 m -123.35 139.95 48.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 169.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.5 mt -133.13 151.45 51.99 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.113 0.965 . . . . 0.0 108.828 -175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.55 105.66 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.514 1.526 . . . . 0.0 107.651 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.26 60.06 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.678 1.591 . . . . 0.0 111.706 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 t80 . . . . . 0 C--O 1.232 0.137 0 C-N-CA 123.851 0.861 . . . . 0.0 109.327 179.845 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.6 t . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.32 0.75 86.56 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.26 -0.745 . . . . 0.0 114.271 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -72.1 162.82 28.91 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.599 1.2 . . . . 0.0 108.866 169.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.19 156.1 17.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.032 0.933 . . . . 0.0 109.131 170.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.42 144.61 11.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 169.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -114.35 -30.67 6.51 Favored 'General case' 0 CA--C 1.524 -0.034 0 CA-C-O 117.405 -1.283 . . . . 0.0 110.544 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.41 160.04 42.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.879 1.672 . . . . 0.0 111.793 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.9 mt -138.62 136.73 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 50.46 29.15 3.75 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.598 1.559 . . . . 0.0 112.272 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.21 -9.0 56.5 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.698 1.142 . . . . 0.0 113.65 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.4 mtt -80.37 111.97 17.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.091 1.445 . . . . 0.0 108.3 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -53.43 130.63 36.1 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 169.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -89.35 124.14 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.782 0.801 . . . . 0.0 109.496 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -76.48 80.24 3.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.018 1.327 . . . . 0.0 107.534 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.15 -58.73 1.08 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.91 2.195 . . . . 0.0 114.614 172.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -143.55 2.38 1.24 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.283 1.833 . . . . 0.0 111.874 176.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.79 151.75 38.33 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 119.424 1.011 . . . . 0.0 108.327 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 p -68.07 173.81 4.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.608 1.095 . . . . 0.0 109.528 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.82 -38.15 72.19 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.764 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.83 -37.84 76.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.582 0.753 . . . . 0.0 111.573 175.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.53 3.17 6.13 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.498 1.047 . . . . 0.0 114.112 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.23 129.68 40.65 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.044 1.422 . . . . 0.0 107.805 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.1 129.83 41.15 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 174.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 t -52.67 -44.19 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.396 1.478 . . . . 0.0 112.826 -169.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.2 mt -67.1 -42.48 84.5 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.978 0.808 . . . . 0.0 110.435 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -69.03 -40.84 78.37 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -59.88 -43.79 94.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.254 1.022 . . . . 0.0 111.158 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.87 -36.88 62.3 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.276 0.631 . . . . 0.0 110.476 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.04 -31.15 78.54 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.772 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -54.83 118.72 18.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.017 1.327 . . . . 0.0 110.157 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.475 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 60.0 Cg_endo -66.79 -17.67 52.31 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.365 2.043 . . . . 0.0 113.741 -176.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.45 -13.83 62.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.13 0.877 . . . . 0.0 112.356 170.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -135.18 37.01 3.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.922 1.689 . . . . 0.0 109.617 -171.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.475 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.0 m-30 -63.48 -57.36 20.27 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.359 -1.305 . . . . 0.0 111.348 169.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.23 126.96 11.51 Favored 'Trans proline' 0 C--N 1.352 0.719 0 CA-C-N 121.459 1.557 . . . . 0.0 109.101 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 m -150.31 171.42 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.378 1.071 . . . . 0.0 110.365 -172.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.2 m -125.83 139.55 53.4 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 168.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.5 mt -136.27 140.2 44.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -118.56 132.33 56.21 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 172.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -141.66 163.4 33.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.561 1.545 . . . . 0.0 109.312 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.31 -165.37 38.56 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -170.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.375 0.131 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.22 -61.43 4.39 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.779 1.181 . . . . 0.0 112.068 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 47.05 38.78 6.87 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.163 1.785 . . . . 0.0 112.302 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -64.07 155.49 31.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.168 0.987 . . . . 0.0 110.595 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -152.71 159.52 43.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.023 1.329 . . . . 0.0 108.336 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -152.94 155.38 36.88 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.69 1.596 . . . . 0.0 107.693 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -153.44 163.8 39.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.704 1.202 . . . . 0.0 109.582 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -66.21 172.68 3.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.579 1.151 . . . . 0.0 110.327 172.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 tp -46.52 122.44 4.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.024 1.33 . . . . 0.0 110.162 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -55.32 -32.79 62.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.52 1.528 . . . . 0.0 113.11 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -64.37 -22.64 67.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.52 1.128 . . . . 0.0 113.353 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.14 164.12 12.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -169.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -162.55 159.24 20.15 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.953 2.501 . . . . 0.0 106.862 169.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.21 150.69 7.16 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.761 2.974 . . . . 0.0 113.356 172.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -55.03 158.51 2.81 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.733 1.213 . . . . 0.0 113.085 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.22 158.08 27.15 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.748 0.819 . . . . 0.0 110.845 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -86.43 167.77 14.4 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 171.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.36 160.43 16.07 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.478 0.711 . . . . 0.0 111.187 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -61.28 142.34 56.91 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.259 0.624 . . . . 0.0 109.463 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -142.41 142.22 32.36 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.267 1.027 . . . . 0.0 108.4 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.5 p -72.09 145.41 48.2 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.838 1.255 . . . . 0.0 110.823 173.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -139.95 159.08 42.99 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.965 1.306 . . . . 0.0 108.723 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.0 m -158.87 174.89 14.3 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.307 2.243 . . . . 0.0 106.701 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -141.5 159.6 59.94 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.733 0.813 . . . . 0.0 109.233 -173.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -64.4 154.27 74.63 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 120.036 1.049 . . . . 0.0 110.976 -10.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 tp -157.36 155.94 31.44 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.242 1.417 . . . . 0.0 107.67 -173.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -76.01 58.93 1.24 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.71 1.204 . . . . 0.0 110.224 171.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -153.23 133.62 13.57 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.73 2.012 . . . . 0.0 106.048 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.7 tp -139.25 145.44 39.21 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.0 mt -125.21 155.57 39.85 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.996 1.318 . . . . 0.0 108.605 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 164.64 29.52 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.209 1.404 . . . . 0.0 109.757 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.2 tp -98.19 127.45 44.14 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.33 138.24 27.72 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.292 1.437 . . . . 0.0 107.514 169.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 44.8 48.45 9.02 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.598 1.559 . . . . 0.0 113.18 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 56.91 30.45 18.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.278 1.431 . . . . 0.0 113.252 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -134.8 148.85 50.29 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.742 1.217 . . . . 0.0 108.379 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -92.32 125.68 44.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 mp -123.61 152.97 41.34 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 125.961 1.704 . . . . 0.0 108.926 -173.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.72 121.04 14.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.34 -38.05 14.44 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.904 1.282 . . . . 0.0 111.306 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -160.78 157.04 26.15 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.815 1.246 . . . . 0.0 108.355 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.57 -3.34 2.91 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.781 1.182 . . . . 0.0 112.55 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -57.93 141.82 48.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.242 1.817 . . . . 0.0 111.998 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -72.49 -30.01 64.13 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.5 169.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.3 -38.82 0.11 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.877 0.871 . . . . 0.0 111.793 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.42 -31.51 0.06 OUTLIER Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.421 -0.655 . . . . 0.0 114.047 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 pt -70.29 31.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 126.159 1.783 . . . . 0.0 115.185 -172.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 -42.24 0.6 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.236 -1.54 . . . . 0.0 111.979 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 m -58.35 143.57 12.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 119.675 1.125 . . . . 0.0 109.809 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.86 -11.09 60.7 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.537 -1.146 . . . . 0.0 113.647 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -66.96 155.62 38.07 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.595 1.698 . . . . 0.0 108.291 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.67 140.64 52.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.922 1.289 . . . . 0.0 110.156 -169.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.14 146.2 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.9 mt -130.12 -35.17 1.61 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.695 1.198 . . . . 0.0 110.595 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.07 159.98 43.55 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.461 1.028 . . . . 0.0 110.117 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.3 mt -134.96 131.82 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.5 p30 42.92 24.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.579 2.352 . . . . 0.0 115.139 -173.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.25 -14.27 58.3 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.112 1.339 . . . . 0.0 112.902 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.6 mtt -74.73 105.86 6.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.813 1.307 . . . . 0.0 108.603 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.35 122.38 12.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.6 m -77.68 132.17 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.491 0.662 . . . . 0.0 109.385 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -74.79 73.46 2.08 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.768 1.627 . . . . 0.0 107.146 169.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.02 -72.29 0.4 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.627 2.06 . . . . 0.0 112.808 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -133.74 11.02 4.01 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.878 1.671 . . . . 0.0 111.947 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -120.79 154.88 35.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.4 p -69.62 175.39 4.19 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.483 1.038 . . . . 0.0 109.911 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.85 -37.89 77.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.407 169.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.43 -37.25 74.37 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.717 0.807 . . . . 0.0 111.661 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 6.24 7.77 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.528 1.061 . . . . 0.0 114.099 172.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.71 136.04 54.93 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.066 1.433 . . . . 0.0 107.385 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.43 128.07 34.76 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.0 t -56.45 -39.95 64.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.669 1.188 . . . . 0.0 111.633 -170.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.5 -40.47 93.1 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.702 0.683 . . . . 0.0 110.585 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.55 -39.17 67.67 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.414 0.552 . . . . 0.0 110.029 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -59.58 -46.54 88.63 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.6 1.16 . . . . 0.0 110.518 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.56 -33.9 60.67 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.66 0.784 . . . . 0.0 110.749 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.62 -30.84 75.18 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.381 -0.677 . . . . 0.0 112.742 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -62.28 115.32 15.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.511 1.125 . . . . 0.0 109.861 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.475 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.6 Cg_endo -70.47 -16.1 34.52 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.67 1.58 . . . . 0.0 114.003 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.35 -14.86 54.55 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.335 0.97 . . . . 0.0 111.147 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -134.64 28.93 3.58 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.376 2.27 . . . . 0.0 109.251 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.475 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.2 m-30 -60.77 -54.41 54.78 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 117.158 -1.401 . . . . 0.0 111.815 170.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.59 122.17 8.02 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.629 1.617 . . . . 0.0 109.673 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 m -149.74 172.02 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.734 1.214 . . . . 0.0 109.778 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -125.75 139.93 53.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.2 mt -133.41 147.72 31.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -170.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -119.47 130.6 55.32 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -152.71 164.77 37.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.28 -165.22 33.89 Favored Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -170.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.08 142.23 98.56 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.36 167.26 17.06 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.417 2.078 . . . . 0.0 110.082 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 51.93 40.19 27.59 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.554 1.142 . . . . 0.0 111.686 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.3 tp -54.2 -37.47 64.58 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.543 -0.723 . . . . 0.0 110.038 170.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.6 m -153.49 155.69 36.72 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.9 m -63.92 -19.08 64.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 . . . . . 0 C--O 1.249 1.063 0 C-N-CA 125.433 1.493 . . . . 0.0 107.913 177.445 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 145.93 -179.02 23.27 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.783 1.174 . . . . 0.0 110.924 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -62.08 -11.2 12.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.671 1.188 . . . . 0.0 113.169 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -59.0 -25.15 63.38 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.727 1.211 . . . . 0.0 111.993 169.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.8 m80 54.17 17.56 1.5 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.238 1.815 . . . . 0.0 114.138 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -148.06 161.25 41.78 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.364 1.465 . . . . 0.0 108.306 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -144.11 167.91 21.28 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.435 1.494 . . . . 0.0 107.583 170.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -60.44 130.42 46.49 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.3 mt -84.4 62.47 7.24 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -76.57 64.84 2.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.382 1.473 . . . . 0.0 109.969 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 p -155.23 158.78 39.39 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.12 1.368 . . . . 0.0 110.01 -171.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -84.95 -13.63 50.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.715 0.806 . . . . 0.0 111.874 172.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 144.79 90.87 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.925 0.89 . . . . 0.0 111.239 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.59 -0.67 0.81 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.644 3.563 . . . . 0.0 116.862 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -56.81 -9.53 0.82 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -169.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.73 -14.59 53.76 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.514 1.052 . . . . 0.0 111.398 169.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -134.18 163.57 29.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.365 1.866 . . . . 0.0 108.668 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.7 167.08 30.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.47 1.908 . . . . 0.0 108.146 172.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.45 155.58 33.77 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.393 0.677 . . . . 0.0 110.233 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -162.83 164.08 26.26 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.739 0.816 . . . . 0.0 109.663 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -80.04 144.43 33.2 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.201 1.4 . . . . 0.0 107.351 168.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -142.21 171.2 14.38 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.377 1.071 . . . . 0.0 110.234 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.9 m -156.22 175.68 13.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.0 2.52 . . . . 0.0 106.455 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -123.87 153.9 67.32 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.552 0.741 . . . . 0.0 109.909 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.17 -39.19 1.34 Allowed 'Cis proline' 0 CA--C 1.537 0.627 0 CA-C-N 119.64 0.907 . . . . 0.0 112.038 -5.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.9 tp 48.04 -75.54 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.087 2.955 . . . . 0.0 114.548 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -166.65 -28.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.531 2.333 . . . . 0.0 109.313 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.0 tp -55.69 131.76 47.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.806 1.642 . . . . 0.0 112.315 -174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.11 128.72 11.48 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.98 154.96 33.75 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 161.74 40.48 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.958 0.903 . . . . 0.0 109.961 -177.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.9 tp -96.25 125.4 40.74 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -153.2 144.15 22.9 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.434 1.093 . . . . 0.0 108.752 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.4 t70 47.87 39.34 10.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.583 1.153 . . . . 0.0 111.804 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 64.96 6.09 3.24 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.036 2.135 . . . . 0.0 115.877 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -118.67 149.71 40.96 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.965 1.257 . . . . 0.0 109.403 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -76.26 135.09 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 76.1 mt -126.49 149.55 49.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.868 1.267 . . . . 0.0 108.187 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.4 t -68.88 139.78 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -120.63 -41.6 2.58 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.936 0.895 . . . . 0.0 110.647 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -139.4 165.53 26.97 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.983 1.713 . . . . 0.0 106.766 170.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.79 -20.73 5.1 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.696 1.141 . . . . 0.0 111.338 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -139.84 36.6 1.98 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.594 1.558 . . . . 0.0 109.602 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -58.18 -11.34 2.54 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -53.4 -23.02 8.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.792 1.637 . . . . 0.0 111.775 169.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.19 -171.58 19.35 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.506 1.05 . . . . 0.0 110.952 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.6 pt -81.4 0.97 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.672 0.789 . . . . 0.0 112.385 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -70.71 6.53 1.43 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -169.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 m -69.51 168.31 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 120.1 1.318 . . . . 0.0 108.646 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.71 0.43 86.06 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.28 -0.887 . . . . 0.0 113.258 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -75.57 154.89 36.47 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.152 0.976 . . . . 0.0 109.544 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.84 147.06 27.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.7 t -74.28 144.56 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 172.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -111.1 -33.39 6.49 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 124.986 1.314 . . . . 0.0 109.847 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.47 160.22 41.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.198 1.363 . . . . 0.0 111.738 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.1 mt -136.05 135.74 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 49.34 30.34 3.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 112.076 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.87 -9.14 57.7 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.823 1.201 . . . . 0.0 113.686 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.2 mmt -84.27 119.12 24.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.102 1.451 . . . . 0.0 107.922 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -49.02 142.8 6.25 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.516 1.127 . . . . 0.0 109.834 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.3 m -111.3 149.1 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.822 0.82 . . . . 0.0 110.026 172.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -125.21 101.64 7.09 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.116 2.167 . . . . 0.0 105.907 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.02 -80.29 0.19 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.19 1.376 . . . . 0.0 110.622 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.42 25.49 0.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.996 1.318 . . . . 0.0 111.116 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -127.79 143.54 51.12 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.6 p -70.13 172.5 7.92 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.009 0.822 . . . . 0.0 110.387 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.87 -38.66 67.8 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.997 0.919 . . . . 0.0 110.861 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.51 -38.07 71.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.494 0.717 . . . . 0.0 111.529 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.71 3.1 7.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.907 1.241 . . . . 0.0 113.737 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.93 133.65 53.64 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.809 1.304 . . . . 0.0 108.167 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.22 120.82 13.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.9 -40.16 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -169.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.13 -40.52 68.03 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.986 1.266 . . . . 0.0 109.758 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.29 -44.81 93.97 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.792 0.724 . . . . 0.0 110.11 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -58.49 -44.42 89.4 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.164 0.986 . . . . 0.0 111.209 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.08 -37.8 72.45 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.289 1.036 . . . . 0.0 110.786 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.5 -30.62 73.19 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.124 0.869 . . . . 0.0 112.333 -175.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -58.01 114.45 8.58 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.31 1.044 . . . . 0.0 109.629 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.48 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 72.0 Cg_endo -70.87 -13.73 32.08 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.558 1.505 . . . . 0.0 113.749 -175.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.27 -15.24 56.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.417 1.008 . . . . 0.0 110.612 169.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -132.59 34.22 3.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.309 2.644 . . . . 0.0 108.468 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.48 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -65.0 -52.52 48.63 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 117.18 -1.39 . . . . 0.0 111.498 169.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.36 125.41 11.27 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.667 1.631 . . . . 0.0 108.87 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.05 171.04 2.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.195 0.998 . . . . 0.0 110.524 -170.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.5 m -125.61 138.85 53.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 169.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.3 mt -136.48 139.58 44.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.6 mtp-105 -117.24 132.66 56.58 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -143.76 167.05 23.21 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.361 1.464 . . . . 0.0 109.185 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.52 -165.72 38.96 Favored Glycine 0 CA--C 1.52 0.399 0 O-C-N 121.543 -0.723 . . . . 0.0 111.656 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -59.15 142.4 85.91 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 117.983 -1.008 . . . . 0.0 108.301 170.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.64 -42.25 29.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.415 2.743 . . . . 0.0 113.037 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -150.32 165.89 31.67 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.408 1.883 . . . . 0.0 105.954 169.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 46.9 tp -59.27 -30.54 68.37 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.318 -0.864 . . . . 0.0 111.923 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.2 p -68.51 -19.07 64.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.029 0.931 . . . . 0.0 112.669 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.1 m -78.67 36.64 0.27 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.611 1.564 . . . . 0.0 111.805 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 . . . . . 0 C--O 1.249 1.055 0 C-N-CA 125.928 1.691 . . . . 0.0 107.789 179.815 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -167.67 168.16 40.45 Favored Glycine 0 C--N 1.334 0.463 0 O-C-N 121.493 -0.754 . . . . 0.0 111.687 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -140.63 112.41 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.6 t60 65.79 -37.39 0.25 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.633 2.373 . . . . 0.0 113.295 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -149.1 169.24 21.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.417 1.887 . . . . 0.0 107.795 169.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -52.47 139.23 25.68 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.868 1.267 . . . . 0.0 110.73 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -68.95 151.44 46.53 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -155.5 161.1 40.99 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.042 1.337 . . . . 0.0 108.246 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.99 147.61 42.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.698 0.799 . . . . 0.0 109.366 170.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -139.06 155.4 47.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.01 1.324 . . . . 0.0 108.88 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.2 m -63.25 155.47 28.35 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.937 1.295 . . . . 0.0 112.147 -174.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -67.55 166.47 14.79 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.852 0.861 . . . . 0.0 109.972 169.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.53 150.34 37.55 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 124.031 0.932 . . . . 0.0 109.062 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.53 135.15 33.38 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.426 2.75 . . . . 0.0 111.214 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -69.96 141.74 52.98 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.48 173.29 16.85 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.839 1.655 . . . . 0.0 107.813 -171.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -139.29 -0.52 1.81 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.22 147.73 29.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.58 141.32 18.01 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -167.49 174.07 8.18 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.909 0.884 . . . . 0.0 109.648 -174.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.6 m -91.31 142.2 27.96 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -139.09 162.77 34.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.064 1.345 . . . . 0.0 109.28 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.5 p -153.94 176.67 11.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.017 2.527 . . . . 0.0 107.402 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -135.22 156.29 78.21 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.243 1.017 . . . . 0.0 109.481 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.11 -23.88 9.07 Favored 'Cis proline' 0 C--N 1.351 0.675 0 CA-C-N 119.945 1.016 . . . . 0.0 113.518 -0.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tt 37.7 -91.39 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.603 2.761 . . . . 0.0 113.06 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -160.58 -38.79 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.471 1.508 . . . . 0.0 110.06 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.2 tp -57.51 130.57 46.94 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.961 0.904 . . . . 0.0 109.533 171.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.1 mt -142.54 153.17 43.34 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.337 1.455 . . . . 0.0 107.729 170.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.44 154.53 36.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.676 1.19 . . . . 0.0 108.902 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.14 154.89 46.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.441 1.096 . . . . 0.0 109.122 170.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.4 tp -92.52 132.48 36.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.532 1.133 . . . . 0.0 108.374 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -153.61 139.66 18.3 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.624 1.17 . . . . 0.0 107.958 169.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 t70 44.3 49.61 7.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.649 1.58 . . . . 0.0 112.672 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 59.08 22.87 11.0 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.637 1.575 . . . . 0.0 114.211 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -129.41 156.64 43.76 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 120.931 -1.106 . . . . 0.0 108.841 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.26 130.88 52.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.41 153.5 38.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.882 1.273 . . . . 0.0 108.39 -173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.11 104.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 125.905 1.682 . . . . 0.0 107.339 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.31 -39.54 68.16 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.678 0.791 . . . . 0.0 109.814 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -146.29 138.18 24.92 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.1 144.61 4.1 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -151.88 157.84 42.39 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.383 1.073 . . . . 0.0 110.302 -172.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.4 mmp_? 62.28 168.49 0.12 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.248 2.619 . . . . 0.0 113.517 174.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t0 43.85 42.58 4.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.307 1.843 . . . . 0.0 112.674 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.11 -18.35 28.03 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.911 1.243 . . . . 0.0 113.959 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.2 mm -70.75 129.61 34.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 173.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -146.64 149.7 34.01 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.9 t -59.11 141.33 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.95 -10.22 63.58 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.745 -1.031 . . . . 0.0 113.57 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -71.59 170.66 12.93 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.272 1.536 . . . . 0.0 108.674 169.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.57 143.65 50.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.208 1.003 . . . . 0.0 109.662 -172.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 p -70.27 140.82 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 169.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -116.77 -32.39 5.15 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.791 1.636 . . . . 0.0 109.867 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.51 158.61 40.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.091 0.859 . . . . 0.0 110.394 169.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.2 mt -131.65 130.17 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 p30 40.15 27.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.918 2.487 . . . . 0.0 115.314 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.33 -16.18 57.0 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.161 1.363 . . . . 0.0 112.789 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.65 109.29 11.5 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.645 1.223 . . . . 0.0 108.102 171.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -51.62 141.1 17.08 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.691 1.197 . . . . 0.0 108.881 169.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -103.87 116.33 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.387 1.089 . . . . 0.0 110.223 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -76.92 86.67 3.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.659 1.584 . . . . 0.0 108.041 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.02 -78.71 0.4 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.01 1.291 . . . . 0.0 111.963 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -135.84 13.63 3.39 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.927 1.291 . . . . 0.0 112.639 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -126.42 145.69 50.37 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.7 p -69.76 170.25 11.35 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.823 0.82 . . . . 0.0 110.155 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.5 -38.06 68.67 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.728 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.8 -37.09 73.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.657 0.783 . . . . 0.0 111.784 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.3 4.24 7.74 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.769 1.176 . . . . 0.0 113.944 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -67.93 137.69 55.39 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.903 1.352 . . . . 0.0 107.867 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -67.88 127.69 33.73 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.82 -40.56 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.536 0.734 . . . . 0.0 111.419 -170.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.7 mt -65.36 -36.8 85.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.072 0.851 . . . . 0.0 110.815 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -74.46 -40.61 61.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.455 0.57 . . . . 0.0 109.688 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -59.24 -51.05 71.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.775 0.83 . . . . 0.0 110.103 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.29 -30.0 64.39 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.601 0.76 . . . . 0.0 110.627 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.7 -38.06 95.65 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.517 -0.602 . . . . 0.0 111.812 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -63.93 117.08 32.25 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 117.738 0.769 . . . . 0.0 109.003 173.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.473 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 65.9 Cg_endo -67.34 -12.14 34.73 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.987 1.792 . . . . 0.0 114.009 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.57 -17.55 46.98 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.455 1.025 . . . . 0.0 111.211 169.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -120.67 21.05 11.64 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.703 1.601 . . . . 0.0 110.332 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.473 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 3.1 m-30 -61.06 -59.25 14.38 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 117.075 -1.441 . . . . 0.0 110.166 170.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.55 106.13 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.833 1.689 . . . . 0.0 109.603 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.02 156.45 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 123.197 0.599 . . . . 0.0 110.438 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -84.28 142.19 30.42 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 169.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.6 mt -139.73 147.04 24.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -121.3 138.13 54.38 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -133.28 151.77 51.91 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.299 1.84 . . . . 0.0 109.655 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.96 -168.93 22.61 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 165.53 22.69 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.67 156.42 4.44 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.66 1.574 . . . . 0.0 110.691 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -28.97 10.93 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 54.7 tp -51.71 -28.2 14.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.684 1.193 . . . . 0.0 112.858 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -129.82 23.63 5.36 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.77 1.228 . . . . 0.0 110.226 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.9 m -148.75 76.36 1.34 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.361 1.464 . . . . 0.0 107.891 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.049 175.608 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.14 -43.7 0.23 Allowed Glycine 0 C--N 1.34 0.765 0 O-C-N 121.971 -0.455 . . . . 0.0 112.455 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -62.86 -9.82 11.04 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -171.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -64.96 -25.44 67.87 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.908 0.776 . . . . 0.0 112.21 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -68.09 161.26 27.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.227 0.611 . . . . 0.0 111.033 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -148.73 160.18 43.43 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.806 1.642 . . . . 0.0 107.385 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -60.14 147.22 40.4 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.899 0.48 . . . . 0.0 109.997 172.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -154.03 164.68 38.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.539 1.536 . . . . 0.0 108.264 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.3 tp -62.54 136.72 58.03 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -145.71 152.86 40.28 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.154 1.382 . . . . 0.0 107.365 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.8 m -62.79 -30.5 71.51 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.71 1.204 . . . . 0.0 112.005 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -157.02 177.36 11.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.184 1.794 . . . . 0.0 107.894 172.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.58 146.31 55.04 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.393 1.077 . . . . 0.0 108.165 173.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.66 163.41 35.24 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.93 2.42 . . . . 0.0 111.419 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -74.8 17.73 0.2 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.984 0.914 . . . . 0.0 112.071 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.66 132.78 54.87 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.28 11.1 pt-20 45.47 36.5 2.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.403 1.881 . . . . 0.0 112.499 -174.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.81 176.18 9.64 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.783 2.033 . . . . 0.0 108.442 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.87 155.75 38.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.719 0.808 . . . . 0.0 110.718 -172.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -158.82 166.96 30.71 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.749 1.22 . . . . 0.0 108.832 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -73.75 145.72 44.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.951 1.3 . . . . 0.0 109.632 169.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -142.74 163.7 32.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.405 1.482 . . . . 0.0 109.599 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 p -158.47 175.47 13.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.025 2.13 . . . . 0.0 107.612 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -137.22 158.86 71.68 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 123.816 0.847 . . . . 0.0 110.167 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.96 156.95 79.49 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.759 0.949 . . . . 0.0 111.271 -9.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HG ' ' H ' ' A' ' 28' ' ' LEU . 36.6 tp -158.03 159.36 36.29 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.768 1.227 . . . . 0.0 108.579 -173.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.0 -31.57 72.73 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.795 0.838 . . . . 0.0 112.18 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.416 ' H ' ' HG ' ' A' ' 26' ' ' LEU . 2.9 tt -67.59 121.47 15.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.1 mt -133.58 156.22 48.22 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.084 1.754 . . . . 0.0 107.94 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -131.79 155.4 47.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.172 0.989 . . . . 0.0 111.215 -169.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.53 153.72 40.71 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.723 1.209 . . . . 0.0 110.112 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.3 tp -78.66 130.75 36.21 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -153.55 138.49 17.2 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.831 1.252 . . . . 0.0 107.932 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.1 t70 48.44 43.56 19.8 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.19 1.396 . . . . 0.0 113.091 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 58.25 25.41 12.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.823 1.649 . . . . 0.0 113.336 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -130.15 167.99 17.5 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.305 1.842 . . . . 0.0 108.167 173.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.5 t -112.91 116.03 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.02 152.13 26.3 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.146 1.378 . . . . 0.0 109.201 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.05 104.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.979 1.712 . . . . 0.0 107.561 172.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.94 -32.6 57.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.827 1.251 . . . . 0.0 110.874 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -155.34 156.07 34.8 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.46 8.11 0.03 OUTLIER Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.181 0.896 . . . . 0.0 113.31 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -64.11 -13.13 45.59 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.729 1.211 . . . . 0.0 113.126 -170.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -112.23 -27.43 8.34 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.708 1.14 . . . . 0.0 110.58 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.11 -46.43 89.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.064 0.847 . . . . 0.0 109.128 169.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.22 33.29 0.54 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.526 1.06 . . . . 0.0 112.76 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.9 tt -142.74 120.11 6.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 CA-C-N 119.348 1.574 . . . . 0.0 108.298 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -75.72 149.81 37.98 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m -62.35 154.61 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.892 0.877 . . . . 0.0 110.958 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.83 -16.17 60.7 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.119 -0.823 . . . . 0.0 113.333 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -69.19 166.49 18.24 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.708 1.254 . . . . 0.0 108.255 169.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.45 152.29 51.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.269 0.628 . . . . 0.0 111.124 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 83.4 t -66.24 142.45 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -126.4 -30.11 2.9 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.605 1.162 . . . . 0.0 110.906 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.79 158.01 43.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.06 1.3 . . . . 0.0 110.551 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.4 mt -139.97 135.15 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 49.6 28.84 2.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.604 1.562 . . . . 0.0 112.229 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.35 -11.28 66.12 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.119 1.342 . . . . 0.0 113.734 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.3 mtt -82.81 111.96 19.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.938 1.369 . . . . 0.0 109.076 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.74 131.48 50.42 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.3 m -90.42 119.43 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -72.91 98.49 2.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.085 1.354 . . . . 0.0 107.949 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.2 -93.59 0.09 OUTLIER Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -175.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 ptt85 -124.78 14.32 8.63 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.755 1.622 . . . . 0.0 112.226 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -123.54 148.08 46.66 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.5 p -68.87 172.93 5.83 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.563 1.074 . . . . 0.0 110.355 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.61 -38.56 75.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.596 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.69 -39.14 77.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.818 0.847 . . . . 0.0 111.412 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.3 1.59 7.22 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.604 1.097 . . . . 0.0 113.988 172.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -61.29 140.92 57.88 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 119.092 1.446 . . . . 0.0 108.776 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.71 127.37 31.69 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.3 t -56.45 -43.38 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.61 0.764 . . . . 0.0 111.698 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.9 -36.7 82.87 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.351 0.523 . . . . 0.0 110.458 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.28 -42.92 68.12 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.293 0.497 . . . . 0.0 109.691 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -58.88 -46.53 87.6 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.718 1.207 . . . . 0.0 110.634 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.16 -33.67 59.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.492 0.717 . . . . 0.0 111.005 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.1 -32.02 79.31 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.308 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -61.18 114.17 9.93 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.154 . . . . 0.0 109.939 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.48 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 84.2 Cg_endo -71.06 -14.66 32.12 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.638 1.559 . . . . 0.0 113.789 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.23 -15.42 57.03 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.436 1.017 . . . . 0.0 110.869 169.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -133.36 32.83 3.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.884 2.474 . . . . 0.0 108.639 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.48 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -64.97 -53.78 39.53 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.189 -1.386 . . . . 0.0 110.398 169.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.02 124.36 10.49 Favored 'Trans proline' 0 C--N 1.352 0.756 0 CA-C-N 121.559 1.593 . . . . 0.0 109.369 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.1 m -150.66 172.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.251 1.42 . . . . 0.0 109.778 -172.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 m -121.46 138.22 54.38 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.5 mt -136.49 140.39 43.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -114.62 138.12 51.05 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.734 1.614 . . . . 0.0 106.852 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -125.54 169.47 12.41 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.899 1.28 . . . . 0.0 110.164 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.55 -160.92 25.51 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -67.27 152.97 95.58 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 170.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.04 -45.11 30.48 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.296 2.664 . . . . 0.0 113.357 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -147.03 161.94 39.8 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.977 1.711 . . . . 0.0 106.489 171.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 38.5 tp -149.55 152.92 36.34 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 p -65.72 -39.43 91.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.287 1.035 . . . . 0.0 111.172 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.4 m 49.48 36.16 9.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.007 1.723 . . . . 0.0 112.692 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 123.71 0.804 . . . . 0.0 110.087 176.673 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 159.08 -35.39 0.49 Allowed Glycine 0 C--N 1.34 0.77 0 C-N-CA 123.086 0.374 . . . . 0.0 112.76 172.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -62.76 -20.65 65.17 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.298 1.049 . . . . 0.0 112.641 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -62.88 -12.89 28.0 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.112 -0.993 . . . . 0.0 112.977 171.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -131.55 -23.45 2.34 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.827 1.251 . . . . 0.0 112.436 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -140.6 -167.81 2.43 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.507 1.049 . . . . 0.0 111.834 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -54.43 166.19 0.46 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.197 2.199 . . . . 0.0 112.517 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -49.74 -40.99 42.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.88 1.272 . . . . 0.0 114.165 -169.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.8 mt -144.59 154.72 43.14 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.238 1.415 . . . . 0.0 108.955 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -146.97 -21.82 0.41 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.747 1.619 . . . . 0.0 111.613 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 m -65.32 164.04 14.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.571 1.948 . . . . 0.0 112.599 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -65.87 -16.95 64.31 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.01 146.5 77.04 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.478 0.711 . . . . 0.0 111.217 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.41 143.16 35.89 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.504 2.803 . . . . 0.0 112.617 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -83.66 -13.35 54.37 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.55 159.53 18.53 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.439 0.638 . . . . 0.0 110.538 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -129.35 166.26 19.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.478 1.911 . . . . 0.0 108.049 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.63 149.13 31.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.262 0.625 . . . . 0.0 111.713 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mp0 -63.04 153.04 35.25 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.009 0.924 . . . . 0.0 110.662 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -147.21 143.23 28.03 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -79.84 141.49 36.14 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -138.25 161.29 37.25 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.008 1.323 . . . . 0.0 109.024 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.0 p -156.63 175.32 14.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.319 2.248 . . . . 0.0 106.983 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -139.83 161.5 55.86 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 123.924 0.89 . . . . 0.0 109.125 -171.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.08 145.83 60.99 Favored 'Cis proline' 0 C--N 1.351 0.669 0 CA-C-N 120.261 1.129 . . . . 0.0 111.262 -6.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 tp -159.74 162.07 34.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.125 1.77 . . . . 0.0 107.009 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.57 -28.69 69.52 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.369 0.668 . . . . 0.0 112.502 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.7 tp -57.54 126.0 25.39 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.967 0.907 . . . . 0.0 110.101 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.9 tp -147.47 151.61 36.69 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.204 1.401 . . . . 0.0 107.535 172.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -121.31 156.04 33.43 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.633 1.173 . . . . 0.0 109.598 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.51 151.65 51.26 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.688 0.795 . . . . 0.0 109.321 169.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.19 124.43 28.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -152.82 142.45 21.87 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.489 1.115 . . . . 0.0 108.337 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.69 44.11 17.24 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.487 1.515 . . . . 0.0 112.126 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 59.36 6.86 0.83 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.718 2.007 . . . . 0.0 115.319 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -109.56 -178.75 3.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.464 1.906 . . . . 0.0 107.439 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.55 130.37 74.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 169.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.5 mt -127.93 154.87 45.06 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.402 1.081 . . . . 0.0 108.769 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.6 t -58.72 111.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.244 1.418 . . . . 0.0 108.094 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.07 -36.55 24.81 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.573 1.149 . . . . 0.0 110.463 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -145.16 135.12 23.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.79 125.17 1.24 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.52 172.82 16.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.847 1.259 . . . . 0.0 109.205 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? 64.31 -33.54 0.14 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 128.671 2.788 . . . . 0.0 115.377 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.31 -36.57 78.22 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.796 1.18 . . . . 0.0 111.569 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.09 -46.27 0.51 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.4 pt -65.22 162.28 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 123.7 0.8 . . . . 0.0 109.251 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -141.81 163.15 33.69 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.9 m -51.41 143.32 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.063 0.459 . . . . 0.0 110.846 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.06 -9.63 65.76 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.214 -1.326 . . . . 0.0 113.939 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -68.44 155.2 40.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.093 1.947 . . . . 0.0 109.278 169.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.23 146.48 30.26 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.924 0.889 . . . . 0.0 109.619 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -81.09 139.1 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 169.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.75 -37.44 3.93 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.437 1.495 . . . . 0.0 109.761 -174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.7 160.18 44.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.667 1.121 . . . . 0.0 110.676 170.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.5 mt -136.82 131.41 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.285 0.0 OUTLIER 36.83 34.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 128.564 2.746 . . . . 0.0 114.817 -176.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.84 -15.85 57.94 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.469 1.509 . . . . 0.0 113.15 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.4 mtt -82.94 108.75 16.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.497 1.149 . . . . 0.0 108.948 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.03 133.26 55.38 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 m -98.01 125.24 51.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -88.84 100.05 12.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.266 1.826 . . . . 0.0 107.53 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.78 -80.96 0.23 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.855 1.217 . . . . 0.0 110.781 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.23 23.16 1.5 Allowed 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.131 1.372 . . . . 0.0 111.767 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -126.23 146.72 49.87 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.9 p -68.54 173.58 4.91 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.795 0.807 . . . . 0.0 110.338 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.16 -38.41 73.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.666 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -70.05 -39.52 75.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.744 0.818 . . . . 0.0 111.406 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.6 -1.59 6.45 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.653 1.12 . . . . 0.0 114.089 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -61.9 134.29 56.5 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.095 1.447 . . . . 0.0 108.566 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.14 126.11 26.67 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.4 t -56.68 -38.31 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.367 1.067 . . . . 0.0 111.703 -169.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.12 -40.25 94.22 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.548 0.613 . . . . 0.0 110.33 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -74.43 -38.29 63.07 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.939 0.496 . . . . 0.0 110.136 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -59.32 -45.99 89.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.365 1.066 . . . . 0.0 110.454 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.5 mt -76.97 -31.49 56.58 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.462 0.705 . . . . 0.0 110.874 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.26 -33.64 87.35 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.404 -0.664 . . . . 0.0 112.502 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -63.2 114.47 12.83 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.562 1.145 . . . . 0.0 110.136 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.485 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 88.5 Cg_endo -71.64 -15.75 30.36 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.632 1.555 . . . . 0.0 113.905 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.97 -14.24 44.99 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.313 0.96 . . . . 0.0 111.201 169.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -132.1 22.49 4.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.026 2.13 . . . . 0.0 109.881 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.485 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.7 m-30 -59.37 -53.63 64.15 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 116.942 -1.504 . . . . 0.0 112.117 171.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.84 112.06 3.45 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.827 1.688 . . . . 0.0 109.681 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 m -148.42 152.22 12.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 123.889 0.875 . . . . 0.0 110.069 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.4 m -84.58 144.11 28.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.0 mt -134.0 135.94 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -103.6 121.9 43.88 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -106.99 176.09 5.29 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.55 1.14 . . . . 0.0 108.348 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.03 173.31 44.67 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 173.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.31 140.63 92.98 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.11 151.47 50.53 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.803 1.668 . . . . 0.0 110.71 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -63.85 150.42 44.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 169.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.4 tp -134.15 -173.75 3.35 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.933 1.693 . . . . 0.0 107.284 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.4 p -56.08 -53.29 58.84 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.977 -1.077 . . . . 0.0 109.31 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.3 m -58.4 153.1 16.35 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.374 1.07 . . . . 0.0 111.5 171.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.839 0 CA-C-O 117.886 -1.054 . . . . 0.0 108.25 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ttt . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.61 -50.57 0.02 OUTLIER Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -61.89 152.85 30.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 66.87 -46.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.478 2.311 . . . . 0.0 111.906 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -69.93 -42.35 73.39 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.952 0.901 . . . . 0.0 110.833 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -66.77 126.74 29.98 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -157.56 166.86 31.79 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.881 1.673 . . . . 0.0 106.956 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -151.07 174.42 13.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.435 1.094 . . . . 0.0 109.494 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 tp -56.28 145.44 26.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.883 0.873 . . . . 0.0 110.148 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -53.34 -34.55 57.96 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.611 1.564 . . . . 0.0 113.629 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -64.2 174.31 1.64 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.907 2.083 . . . . 0.0 113.037 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -63.23 164.23 9.09 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.367 0.604 . . . . 0.0 110.194 169.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.06 169.28 9.9 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.881 1.673 . . . . 0.0 107.808 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -51.01 -20.46 7.24 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.799 3.0 . . . . 0.0 116.519 -176.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -134.36 15.72 3.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.085 0.857 . . . . 0.0 113.003 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.14 139.5 41.23 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.786 1.175 . . . . 0.0 110.117 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -99.62 26.77 5.86 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.507 1.523 . . . . 0.0 112.204 -169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 72.82 166.64 0.3 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.743 2.417 . . . . 0.0 113.961 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -84.16 137.18 33.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.187 0.995 . . . . 0.0 109.887 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -138.58 157.47 46.08 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 169.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.5 p -78.7 145.32 34.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.3 1.04 . . . . 0.0 109.515 169.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -141.08 158.49 43.85 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.51 1.524 . . . . 0.0 110.009 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.8 m -146.67 175.15 10.82 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.608 2.763 . . . . 0.0 106.84 175.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -140.05 165.05 33.43 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.428 1.091 . . . . 0.0 109.108 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.96 -31.77 0.68 Allowed 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 120.591 1.247 . . . . 0.0 114.446 -7.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.7 tp 44.52 -123.59 0.95 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.565 1.546 . . . . 0.0 109.736 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.55 43.85 0.59 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.973 1.26 . . . . 0.0 110.625 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.45 161.55 39.43 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.046 1.338 . . . . 0.0 109.75 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.8 tp -154.44 152.49 30.21 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.874 1.27 . . . . 0.0 108.613 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.1 mt -121.76 155.37 35.42 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.807 1.243 . . . . 0.0 109.617 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.25 154.82 43.48 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.515 1.126 . . . . 0.0 109.451 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.88 126.85 33.38 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -155.67 144.76 20.71 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.044 1.338 . . . . 0.0 108.258 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 50.72 43.21 28.03 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.335 1.054 . . . . 0.0 111.823 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.282 10.5 pt-20 50.41 26.46 2.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.174 2.59 . . . . 0.0 115.298 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 mtp-105 -134.68 159.84 40.0 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.157 -0.965 . . . . 0.0 110.76 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 m -80.37 131.85 33.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 169.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.0 mt -120.07 154.06 35.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.63 1.172 . . . . 0.0 108.252 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.99 106.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.988 1.315 . . . . 0.0 107.476 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.05 -37.07 66.99 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.703 0.801 . . . . 0.0 110.022 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -154.13 150.03 27.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 107.697 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.52 -44.79 0.18 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 42.19 38.63 1.17 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.126 2.57 . . . . 0.0 115.134 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -139.61 158.2 44.51 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -54.76 123.17 12.47 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.31 -16.9 56.45 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 117.916 -1.491 . . . . 0.0 113.531 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.7 pt -141.83 54.89 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.74 2.016 . . . . 0.0 108.244 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -62.79 134.76 56.75 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -59.86 136.45 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.93 -7.56 74.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.107 -1.385 . . . . 0.0 114.021 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -73.22 163.95 27.38 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.015 1.908 . . . . 0.0 108.613 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.09 155.66 21.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.52 1.128 . . . . 0.0 110.467 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.9 t -71.86 136.88 24.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 169.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -111.71 -36.75 5.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.669 1.188 . . . . 0.0 109.473 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.67 160.24 43.7 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.305 0.957 . . . . 0.0 111.094 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.1 mt -132.84 132.66 59.38 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 45.76 32.76 1.31 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.503 1.921 . . . . 0.0 112.118 -174.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.5 -9.46 73.38 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.0 1.286 . . . . 0.0 114.069 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.2 mtt -83.4 115.94 22.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.067 1.434 . . . . 0.0 108.808 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -49.66 124.73 10.13 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.755 1.222 . . . . 0.0 110.335 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.08 140.34 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 109.91 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -79.32 67.68 5.11 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.556 1.542 . . . . 0.0 108.535 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.74 -66.0 1.11 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.203 1.859 . . . . 0.0 113.974 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -136.74 9.14 3.08 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.892 1.677 . . . . 0.0 111.79 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -120.4 152.16 38.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.4 p -66.84 171.47 5.29 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.851 0.834 . . . . 0.0 109.427 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.08 76.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.599 169.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.28 -37.84 74.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.556 0.742 . . . . 0.0 111.578 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.76 1.94 6.32 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.359 -1.245 . . . . 0.0 115.878 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -69.11 144.52 53.88 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.315 2.058 . . . . 0.0 107.578 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.28 131.46 47.38 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.2 -37.39 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.345 1.058 . . . . 0.0 110.748 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.21 -40.22 95.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.082 0.401 . . . . 0.0 110.368 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -73.86 -41.79 61.72 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.391 0.541 . . . . 0.0 110.005 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -58.65 -51.1 71.34 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.251 0.62 . . . . 0.0 110.103 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.9 mt -76.76 -30.32 56.5 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.783 0.833 . . . . 0.0 110.848 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.3 -36.73 93.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.0 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -62.92 117.06 28.92 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 117.918 0.859 . . . . 0.0 109.067 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.495 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 68.4 Cg_endo -67.79 -11.8 33.3 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.875 1.717 . . . . 0.0 114.165 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.82 -17.47 49.89 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.42 1.009 . . . . 0.0 111.012 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -121.85 23.61 10.01 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.18 1.792 . . . . 0.0 110.099 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.495 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.8 m-30 -61.54 -57.62 23.82 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 117.087 -1.435 . . . . 0.0 110.501 169.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.88 107.15 2.41 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.903 1.736 . . . . 0.0 109.715 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.93 171.23 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.135 0.974 . . . . 0.0 109.829 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.5 m -105.9 143.12 34.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.2 mt -139.35 148.21 23.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -120.61 136.41 54.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -121.27 162.47 20.2 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.154 1.382 . . . . 0.0 107.938 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.69 -175.54 41.47 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.6 mmt-85 -64.02 143.77 98.21 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.796 -1.097 . . . . 0.0 108.467 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.24 -170.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 124.576 3.518 . . . . 0.0 114.787 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp-105 -51.98 -38.26 56.02 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.292 -0.88 . . . . 0.0 111.225 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.22 133.11 36.75 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 169.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.9 m -70.66 -25.45 63.01 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.749 0.42 . . . . 0.0 111.935 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 p -64.61 135.95 56.49 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.536 0.734 . . . . 0.0 109.234 169.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 123.715 0.806 . . . . 0.0 109.801 -178.634 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.88 46.4 0.29 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -63.27 -26.19 68.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.96 0.904 . . . . 0.0 112.092 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -150.74 174.74 12.68 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.464 1.906 . . . . 0.0 107.691 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -143.86 139.44 29.26 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 171.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -140.99 156.2 46.09 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.183 1.793 . . . . 0.0 106.753 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -57.94 123.88 17.35 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.84 124.75 25.51 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -171.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.5 tp -58.05 142.56 46.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.261 1.025 . . . . 0.0 108.318 169.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -63.13 137.61 58.29 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -169.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.6 p -124.82 -18.2 5.64 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.501 2.32 . . . . 0.0 112.981 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -158.36 -13.97 0.07 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.7 144.04 97.93 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 120.928 1.694 . . . . 0.0 111.345 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.42 169.31 20.05 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.041 2.494 . . . . 0.0 112.017 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 56.82 112.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.422 2.689 . . . . 0.0 114.441 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.4 76.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.497 169.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -155.29 158.14 38.32 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.789 1.236 . . . . 0.0 109.042 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.76 170.05 20.72 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.058 1.743 . . . . 0.0 108.951 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -142.44 137.13 30.13 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -156.79 166.02 34.57 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.838 0.855 . . . . 0.0 109.081 -175.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.4 m -126.09 142.72 51.4 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.395 1.078 . . . . 0.0 108.593 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -142.05 -178.79 5.87 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 127.006 2.122 . . . . 0.0 107.46 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.5 m -151.56 157.2 41.92 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.798 -1.189 . . . . 0.0 108.685 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -77.25 154.95 82.26 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -81.68 0.87 47.56 Favored 'Cis proline' 0 CA--C 1.544 1.011 0 CA-C-N 119.823 0.972 . . . . 0.0 111.909 -10.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -54.92 -38.89 68.21 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 124.662 1.185 . . . . 0.0 111.482 -172.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -144.22 142.4 30.48 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 121.215 0.531 . . . . 0.0 109.924 169.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -160.17 13.9 0.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.39 2.676 . . . . 0.0 110.024 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.9 mt -82.22 69.45 8.95 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.903 1.281 . . . . 0.0 110.635 -169.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.48 155.59 50.08 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.245 1.418 . . . . 0.0 108.744 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.6 150.84 46.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.385 0.674 . . . . 0.0 110.624 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tt -79.11 124.78 28.64 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -155.29 143.16 19.91 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.593 1.157 . . . . 0.0 108.298 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 47.91 41.94 15.48 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.522 1.529 . . . . 0.0 112.612 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 53.47 26.78 5.8 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.292 1.837 . . . . 0.0 113.35 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -126.17 -176.1 3.55 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.94 2.496 . . . . 0.0 106.203 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.33 132.49 71.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.0 mp -121.0 147.15 45.89 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.652 1.181 . . . . 0.0 108.734 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.9 t -60.18 111.24 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 170.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.42 -30.49 37.7 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.692 0.797 . . . . 0.0 111.252 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -155.75 157.68 36.95 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.336 1.454 . . . . 0.0 107.541 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.36 0.79 0.03 OUTLIER Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.491 -1.172 . . . . 0.0 114.956 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -62.39 -35.61 79.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.955 1.878 . . . . 0.0 111.287 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -65.3 -40.65 94.09 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.067 0.547 . . . . 0.0 110.521 177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.21 -39.15 75.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.805 0.442 . . . . 0.0 110.912 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.55 25.36 1.44 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.89 1.233 . . . . 0.0 113.146 173.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.5 pt -130.27 151.8 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 119.251 1.525 . . . . 0.0 109.838 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -69.0 141.53 54.87 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.2 t -68.47 155.98 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.55 -6.28 77.94 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.547 -1.14 . . . . 0.0 114.139 169.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -62.51 135.27 57.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.476 1.638 . . . . 0.0 107.47 169.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.13 147.88 26.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.048 0.939 . . . . 0.0 108.511 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.2 t -74.0 136.48 25.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.31 -37.18 7.76 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.159 1.784 . . . . 0.0 108.942 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.1 159.51 44.45 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.219 0.918 . . . . 0.0 111.068 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.57 139.53 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.65 34.11 3.46 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.685 1.994 . . . . 0.0 112.444 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.36 13.84 82.83 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.018 -0.879 . . . . 0.0 113.534 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.3 mmt -118.56 121.61 40.64 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.19 1.396 . . . . 0.0 107.508 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -50.8 139.1 17.41 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.593 1.157 . . . . 0.0 110.011 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.3 m -102.21 122.17 54.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -73.17 85.28 1.37 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.566 1.546 . . . . 0.0 107.187 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.34 -100.92 0.39 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -106.75 8.61 31.0 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.195 1.398 . . . . 0.0 111.887 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -127.82 150.02 50.02 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 119.291 0.95 . . . . 0.0 109.17 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.1 p -69.77 175.45 4.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.624 0.726 . . . . 0.0 110.457 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.51 -38.81 72.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.437 0.695 . . . . 0.0 110.696 169.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.72 -39.89 69.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.769 0.828 . . . . 0.0 111.371 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.2 -0.67 7.07 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.502 1.048 . . . . 0.0 113.94 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -58.75 135.95 57.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.936 1.368 . . . . 0.0 108.008 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.99 131.14 45.53 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.29 -38.63 70.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.009 0.924 . . . . 0.0 113.251 -169.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.6 mt -69.35 -38.72 78.25 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.337 0.971 . . . . 0.0 110.692 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.0 -41.93 85.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -60.46 -46.22 90.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.18 0.992 . . . . 0.0 111.323 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.0 mt -70.78 -38.35 73.39 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.978 0.511 . . . . 0.0 109.927 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.68 -28.13 69.75 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.763 0.697 . . . . 0.0 112.929 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -53.45 118.14 13.8 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.27 1.428 . . . . 0.0 109.96 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.39 -14.36 39.88 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.0 1.8 . . . . 0.0 113.504 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.7 -12.69 61.05 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.375 0.989 . . . . 0.0 112.026 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -128.79 41.41 3.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.94 2.096 . . . . 0.0 108.599 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -47.1 96.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.486 -1.245 . . . . 0.0 113.398 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.27 138.91 18.28 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 121.527 1.581 . . . . 0.0 108.356 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.63 130.72 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -172.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.9 m -105.06 138.93 40.51 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 mt -140.55 139.47 35.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -115.23 133.2 56.25 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -148.5 160.78 42.74 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.523 1.129 . . . . 0.0 109.035 -169.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.38 -173.74 43.15 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.27 142.34 94.65 Favored Pre-proline 0 CA--C 1.539 0.521 0 O-C-N 121.192 -1.181 . . . . 0.0 107.878 173.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.47 -27.83 62.23 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.487 2.124 . . . . 0.0 112.059 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -139.2 143.09 37.93 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 169.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -61.02 122.37 14.77 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 122.127 0.965 . . . . 0.0 108.799 -174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 m -155.08 136.72 14.32 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 126.892 2.077 . . . . 0.0 106.161 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.4 p -158.16 10.16 0.16 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.261 0.625 . . . . 0.0 112.498 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.1 t30 . . . . . 0 C--O 1.247 0.952 0 C-N-CA 125.645 1.578 . . . . 0.0 108.176 -175.463 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.53 -176.22 47.78 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -130.33 10.43 5.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.227 1.011 . . . . 0.0 111.989 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 49.47 37.54 12.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.674 1.59 . . . . 0.0 112.305 -177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -151.6 160.26 43.73 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.757 1.623 . . . . 0.0 108.153 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -152.75 162.01 41.83 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.48 1.512 . . . . 0.0 108.124 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -58.98 124.45 19.94 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -81.64 -8.86 59.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.88 0.472 . . . . 0.0 111.61 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tt -74.21 65.09 1.14 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.319 1.448 . . . . 0.0 108.437 171.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -146.22 -31.87 0.35 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.355 1.862 . . . . 0.0 111.063 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -62.82 158.62 18.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.686 1.194 . . . . 0.0 111.532 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -144.63 -47.05 0.25 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.557 1.143 . . . . 0.0 110.177 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.1 -31.35 5.28 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -66.29 -10.82 28.89 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.629 2.219 . . . . 0.0 115.921 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.7 tpt85 -51.39 120.82 5.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.928 1.24 . . . . 0.0 111.067 -171.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.94 159.76 43.16 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.05 1.34 . . . . 0.0 108.834 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -74.76 167.78 21.15 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.056 0.943 . . . . 0.0 108.466 169.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.71 82.6 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.404 -0.81 . . . . 0.0 111.391 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 47.98 -155.8 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.85 1.66 . . . . 0.0 112.949 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.432 ' HE2' ' CE2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -158.12 174.07 15.77 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.828 2.051 . . . . 0.0 108.797 -169.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.9 m -79.67 142.75 35.25 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.432 ' CE2' ' HE2' ' A' ' 20' ' ' LYS . 89.3 m-85 -116.27 165.12 13.54 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.313 1.845 . . . . 0.0 109.324 -174.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -146.98 167.45 23.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.05 1.74 . . . . 0.0 107.079 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -116.36 161.0 33.78 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.211 1.004 . . . . 0.0 109.499 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -62.08 160.92 51.46 Favored 'Cis proline' 0 C--N 1.35 0.633 0 CA-C-N 119.762 0.951 . . . . 0.0 110.93 -10.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.439 ' HG ' ' H ' ' A' ' 28' ' ' LEU . 51.8 tp -139.67 149.75 44.07 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.771 0.829 . . . . 0.0 110.417 -169.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.4 -31.9 72.95 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.903 1.281 . . . . 0.0 112.586 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.439 ' H ' ' HG ' ' A' ' 26' ' ' LEU . 55.2 mt -63.59 144.81 56.7 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.284 0.634 . . . . 0.0 110.146 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -140.41 132.36 27.72 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.9 mt -113.56 155.58 25.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.696 0.798 . . . . 0.0 110.209 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 145.74 50.97 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.573 1.149 . . . . 0.0 108.836 170.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tt -75.5 130.69 39.29 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -150.62 130.13 13.01 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.285 1.034 . . . . 0.0 108.234 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.2 t0 47.93 47.48 18.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.416 1.486 . . . . 0.0 112.188 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 61.12 10.79 3.09 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.566 1.946 . . . . 0.0 114.876 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.8 mtm-85 -110.36 179.37 4.1 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.447 1.499 . . . . 0.0 108.537 169.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.27 131.74 72.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.4 mp -120.23 143.36 48.32 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.833 1.253 . . . . 0.0 108.245 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.52 105.5 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 125.851 1.66 . . . . 0.0 107.534 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.95 -29.6 24.98 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 124.334 1.054 . . . . 0.0 111.26 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -149.57 152.61 35.79 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.17 40.03 0.04 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -70.02 -4.13 19.48 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -116.24 -37.41 3.8 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.473 1.488 . . . . 0.0 110.177 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.63 -26.39 62.54 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.936 0.789 . . . . 0.0 111.405 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.58 -150.0 5.7 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.233 1.873 . . . . 0.0 109.158 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 tp -153.04 -38.12 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 117.451 0.625 . . . . 0.0 112.145 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -77.73 82.95 4.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.925 0.784 . . . . 0.0 110.363 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.9 m -56.97 158.69 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.467 0.707 . . . . 0.0 109.135 169.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.17 -6.49 66.31 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.985 -0.897 . . . . 0.0 112.702 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -63.96 158.97 20.96 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.11 153.12 41.91 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.308 1.043 . . . . 0.0 109.103 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.15 137.4 24.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.31 -36.81 3.02 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.507 1.123 . . . . 0.0 110.058 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.98 157.73 43.71 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.734 0.697 . . . . 0.0 109.889 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 83.9 mt -136.48 139.53 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 170.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 42.33 38.95 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.515 2.326 . . . . 0.0 112.626 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 10.14 77.32 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.725 -1.042 . . . . 0.0 114.075 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 98.7 mmm -121.65 120.28 34.28 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.029 1.415 . . . . 0.0 108.485 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.62 129.05 37.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.601 1.161 . . . . 0.0 109.161 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.15 144.37 9.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.54 0.686 . . . . 0.0 111.369 -171.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -78.82 62.91 3.42 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.047 1.339 . . . . 0.0 107.603 169.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.78 -112.58 4.21 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.407 1.004 . . . . 0.0 110.978 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.05 2.09 28.65 Favored 'General case' 0 N--CA 1.46 0.062 0 C-N-CA 123.697 0.799 . . . . 0.0 112.023 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -119.68 147.99 43.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 119.091 0.86 . . . . 0.0 109.613 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.8 p -69.95 175.63 4.28 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.722 0.773 . . . . 0.0 110.038 172.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.99 -38.63 79.61 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.59 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.14 -37.11 69.5 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.793 0.837 . . . . 0.0 111.598 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.36 6.4 8.89 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.498 1.047 . . . . 0.0 114.072 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -63.13 140.28 58.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.292 1.546 . . . . 0.0 107.83 170.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.62 125.2 26.15 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 169.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.56 -33.18 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.049 0.54 . . . . 0.0 111.577 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.1 -42.02 97.05 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.326 0.512 . . . . 0.0 110.034 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -68.58 -46.1 70.29 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.08 -46.17 85.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.436 0.694 . . . . 0.0 111.375 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.6 mt -78.12 -33.98 50.24 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.105 0.962 . . . . 0.0 110.436 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.33 -31.31 68.72 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.509 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -53.97 116.46 10.31 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.171 1.389 . . . . 0.0 110.67 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.37 -17.44 44.25 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.028 1.819 . . . . 0.0 113.543 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.24 -11.64 59.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.927 0.785 . . . . 0.0 112.497 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -129.67 31.96 4.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.573 1.549 . . . . 0.0 110.07 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -53.53 -51.26 77.65 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 116.776 -1.583 . . . . 0.0 113.629 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.43 125.3 8.95 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 122.153 1.805 . . . . 0.0 109.513 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.1 135.63 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.748 0.819 . . . . 0.0 108.984 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 m -84.62 134.52 34.38 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.8 mt -140.56 147.35 23.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -124.65 140.71 52.68 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -120.73 153.83 36.44 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.91 -179.99 33.21 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.4 mmt-85 -68.24 158.46 84.34 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.8 162.31 3.83 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.578 1.519 . . . . 0.0 109.561 168.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -58.87 -18.04 29.34 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 43.9 tp -56.23 -17.0 6.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.3 1.44 . . . . 0.0 112.662 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 m 64.58 46.39 3.24 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.263 1.425 . . . . 0.0 110.197 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m -71.03 58.3 0.22 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.202 2.201 . . . . 0.0 111.832 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.4 t30 . . . . . 0 C--O 1.249 1.073 0 C-N-CA 124.978 1.311 . . . . 0.0 111.731 -174.21 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.13 -176.37 40.25 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 121.705 -0.622 . . . . 0.0 111.95 -174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -59.41 -19.78 49.81 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.727 1.611 . . . . 0.0 114.1 -169.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -128.01 13.29 6.76 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.938 0.895 . . . . 0.0 110.901 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -138.63 51.97 1.82 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 127.01 2.124 . . . . 0.0 106.241 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -68.29 90.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -57.95 161.8 3.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.394 1.078 . . . . 0.0 110.896 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -66.78 12.57 0.07 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.18 2.592 . . . . 0.0 114.636 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.1 tp -55.48 153.71 7.25 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.89 2.076 . . . . 0.0 111.369 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -58.99 -6.22 0.77 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.683 1.993 . . . . 0.0 114.354 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -51.93 -21.51 3.08 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.909 1.684 . . . . 0.0 113.225 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -141.63 166.42 24.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.504 1.121 . . . . 0.0 109.153 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.556 ' H ' ' CD ' ' A' ' 14' ' ' PRO . . . -143.0 -25.35 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 116.45 -1.738 . . . . 0.0 114.922 -177.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.556 ' CD ' ' H ' ' A' ' 13' ' ' ALA . 80.0 Cg_exo -51.69 156.79 6.08 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.56 2.173 . . . . 0.0 114.163 175.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.24 -5.21 1.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.81 0.844 . . . . 0.0 113.095 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.06 154.29 43.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.807 1.243 . . . . 0.0 107.799 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 50.75 45.03 27.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.651 1.18 . . . . 0.0 109.826 -171.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.36 160.65 38.96 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.537 1.535 . . . . 0.0 108.674 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -141.12 142.71 34.07 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.439 1.096 . . . . 0.0 108.975 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -146.18 147.48 31.53 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.573 1.149 . . . . 0.0 110.075 -173.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -76.41 142.45 41.09 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -143.0 153.41 42.95 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.609 0.764 . . . . 0.0 109.587 172.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -144.07 174.71 10.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.038 2.135 . . . . 0.0 106.235 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -137.05 160.18 67.08 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.881 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -64.96 155.37 76.45 Favored 'Cis proline' 0 C--N 1.351 0.68 0 CA-C-N 120.249 1.125 . . . . 0.0 111.903 -5.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.421 ' HG ' ' H ' ' A' ' 28' ' ' LEU . 45.3 tp -157.58 155.38 30.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.425 1.49 . . . . 0.0 107.995 -173.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.25 -31.82 72.43 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.292 0.637 . . . . 0.0 112.164 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.421 ' H ' ' HG ' ' A' ' 26' ' ' LEU . 11.6 tp -59.44 139.96 56.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.732 1.213 . . . . 0.0 109.657 173.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.8 tp -146.55 153.78 40.76 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.9 mt -122.49 155.6 35.86 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.317 1.447 . . . . 0.0 108.291 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.18 153.49 51.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.437 0.562 . . . . 0.0 110.387 170.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.9 tp -90.94 123.8 34.71 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.294 1.438 . . . . 0.0 107.168 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -149.16 137.13 20.61 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.729 1.212 . . . . 0.0 108.34 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.2 t70 45.82 43.1 9.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.521 1.529 . . . . 0.0 112.605 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 53.98 32.02 14.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.757 1.623 . . . . 0.0 113.991 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -130.29 164.2 25.13 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 125.779 1.631 . . . . 0.0 107.511 169.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.2 t -122.28 117.88 53.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -116.45 147.36 41.77 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.211 1.404 . . . . 0.0 108.061 -169.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.84 108.98 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 173.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.03 -40.95 21.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.747 1.219 . . . . 0.0 111.578 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -147.8 159.54 43.72 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.685 1.194 . . . . 0.0 108.512 -176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.06 50.96 0.02 OUTLIER Glycine 0 CA--C 1.52 0.403 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -63.32 -30.52 71.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.627 0.713 . . . . 0.0 110.875 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -65.82 -30.02 70.59 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.011 0.524 . . . . 0.0 110.939 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -82.31 -57.16 3.49 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.381 0.672 . . . . 0.0 110.721 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.39 -16.73 58.69 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 117.35 -1.806 . . . . 0.0 115.165 170.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.0 tt -146.31 -25.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 121.013 2.407 . . . . 0.0 114.62 -170.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -17.96 64.24 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.715 -1.241 . . . . 0.0 111.723 173.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -54.76 145.17 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.765 1.166 . . . . 0.0 109.825 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.08 -12.79 57.18 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.3 0.952 . . . . 0.0 113.911 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -79.68 174.75 11.27 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.851 1.325 . . . . 0.0 109.086 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.64 148.33 51.52 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.087 0.555 . . . . 0.0 111.398 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.2 t -61.85 137.25 24.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.8 mt -120.21 -33.1 3.99 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.896 1.279 . . . . 0.0 109.423 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.0 159.91 44.27 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.492 1.042 . . . . 0.0 110.9 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.3 mt -132.05 130.94 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.7 p30 41.69 26.25 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.559 2.343 . . . . 0.0 115.091 -174.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.63 -15.32 57.3 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.174 1.369 . . . . 0.0 113.151 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 76.7 mtm -75.32 106.93 7.1 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.836 1.318 . . . . 0.0 108.957 172.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.7 125.55 22.8 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.2 m -80.38 128.25 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -75.36 74.95 2.45 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.471 1.509 . . . . 0.0 107.918 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.17 -70.95 0.79 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 126.458 1.98 . . . . 0.0 112.157 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -129.35 -4.82 4.85 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.706 2.402 . . . . 0.0 111.522 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -117.94 156.18 28.93 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.2 p -70.61 175.65 4.72 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.277 -0.89 . . . . 0.0 109.629 169.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.14 79.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.141 169.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.29 -29.64 67.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.548 1.139 . . . . 0.0 111.992 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.66 3.88 19.96 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.075 1.321 . . . . 0.0 113.385 170.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -71.41 136.26 47.63 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.96 129.05 38.51 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 171.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 t -55.75 -41.96 67.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.987 0.915 . . . . 0.0 111.356 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.5 mt -66.55 -37.28 84.65 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.72 0.691 . . . . 0.0 110.927 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.68 -43.48 65.93 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -58.06 -46.78 84.83 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.619 1.168 . . . . 0.0 110.749 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.88 -32.83 59.86 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.65 0.78 . . . . 0.0 111.128 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.89 -32.1 76.82 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.427 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -60.19 114.69 10.57 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.204 1.001 . . . . 0.0 109.814 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.475 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.7 Cg_endo -71.06 -15.87 32.22 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.72 1.613 . . . . 0.0 113.838 -175.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.96 -14.54 48.55 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.222 0.919 . . . . 0.0 111.105 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -133.52 27.27 4.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.311 2.244 . . . . 0.0 109.438 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.475 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.4 m-30 -59.4 -53.15 68.87 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-O 117.046 -1.454 . . . . 0.0 112.264 170.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.16 119.44 6.17 Favored 'Trans proline' 0 C--N 1.351 0.691 0 CA-C-N 121.813 1.683 . . . . 0.0 109.755 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 m -147.44 174.05 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.642 1.577 . . . . 0.0 110.031 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.2 m -125.67 137.81 53.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 168.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.9 mt -131.33 137.72 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -173.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.1 ttp-105 -116.62 135.01 54.15 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -141.86 165.12 28.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.852 0.861 . . . . 0.0 110.45 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.74 -173.68 33.64 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 124.28 0.943 . . . . 0.0 111.038 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -63.79 129.06 93.56 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.81 166.96 24.51 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 121.446 1.431 . . . . 0.0 110.703 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -64.52 145.54 55.97 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -52.93 -40.89 63.96 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.948 0.899 . . . . 0.0 112.12 -170.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.6 -23.79 29.48 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.705 1.602 . . . . 0.0 113.138 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -68.07 -18.99 64.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.613 0.765 . . . . 0.0 112.894 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.2 t30 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 124.36 1.064 . . . . 0.0 111.032 -179.581 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.8 mtm . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.6 168.92 38.61 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -74.92 35.51 0.11 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.481 1.912 . . . . 0.0 111.954 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -59.72 -32.04 70.16 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 120.934 -1.104 . . . . 0.0 111.209 173.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -138.35 146.2 42.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.867 2.067 . . . . 0.0 106.075 173.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -63.77 -34.35 77.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.758 0.423 . . . . 0.0 110.868 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -83.0 46.55 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.039 1.336 . . . . 0.0 110.988 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -153.54 -53.13 0.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.763 1.625 . . . . 0.0 108.449 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 tp -149.79 144.18 25.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.924 2.09 . . . . 0.0 106.336 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.45 -33.84 0.97 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.513 0.725 . . . . 0.0 111.644 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.5 m -163.28 169.73 18.71 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.141 2.177 . . . . 0.0 107.729 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.05 101.8 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.002 2.121 . . . . 0.0 114.38 169.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.15 148.51 38.43 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.149 1.379 . . . . 0.0 107.721 169.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.2 143.81 24.74 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.655 2.903 . . . . 0.0 112.885 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -148.69 46.28 1.02 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.293 1.037 . . . . 0.0 110.474 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.82 -15.07 57.91 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.85 157.96 43.88 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.295 1.438 . . . . 0.0 108.593 175.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.05 169.93 21.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.369 1.868 . . . . 0.0 108.604 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.31 135.71 24.14 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.888 0.875 . . . . 0.0 108.662 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -147.68 153.0 38.77 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.778 0.831 . . . . 0.0 110.334 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -83.58 142.99 30.44 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.834 1.253 . . . . 0.0 108.43 169.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -142.66 174.93 10.2 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.959 0.903 . . . . 0.0 110.343 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.9 m -151.22 175.53 12.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.905 2.482 . . . . 0.0 106.558 169.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.27 160.61 67.98 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.85 0.86 . . . . 0.0 110.24 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.25 -36.14 1.57 Allowed 'Cis proline' 0 C--N 1.351 0.704 0 CA-C-N 119.884 0.994 . . . . 0.0 111.425 -8.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 45.4 30.67 0.74 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.325 2.25 . . . . 0.0 114.156 169.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.7 t0 43.23 57.28 3.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.262 1.425 . . . . 0.0 112.192 -172.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.8 tp -144.28 140.7 29.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.932 1.693 . . . . 0.0 107.72 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.3 tp -146.95 142.01 27.09 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.657 0.783 . . . . 0.0 109.692 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -126.46 155.23 42.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.978 2.111 . . . . 0.0 107.165 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 153.43 41.17 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.053 0.842 . . . . 0.0 111.75 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.0 tp -73.55 127.67 33.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.891 1.676 . . . . 0.0 109.296 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -158.47 144.41 16.92 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.952 1.301 . . . . 0.0 108.406 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 51.36 39.81 25.04 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.935 1.294 . . . . 0.0 112.312 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 55.53 15.55 1.53 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.115 2.166 . . . . 0.0 114.658 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -118.71 -174.19 2.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.284 1.833 . . . . 0.0 107.102 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -123.26 142.09 41.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.4 mt -118.26 145.72 44.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.55 126.86 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 169.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -107.68 -38.05 5.98 Favored 'General case' 0 C--O 1.231 0.132 0 C-N-CA 123.483 0.713 . . . . 0.0 112.22 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -156.89 154.67 30.16 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.571 0.748 . . . . 0.0 108.995 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.46 15.84 79.08 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.145 -0.809 . . . . 0.0 113.461 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -63.26 102.72 0.42 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.665 1.233 . . . . 0.0 109.962 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -65.61 -26.32 67.78 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.053 -0.405 . . . . 0.0 111.555 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.69 -31.06 71.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.172 0.989 . . . . 0.0 112.793 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.4 165.98 21.47 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -21.01 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -171.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -77.54 74.12 4.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.271 0.942 . . . . 0.0 110.046 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 m -53.68 164.79 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.185 0.994 . . . . 0.0 109.847 169.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 1.21 38.8 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 117.846 -1.53 . . . . 0.0 113.634 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -60.95 136.68 58.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.281 2.04 . . . . 0.0 108.843 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.68 138.04 32.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.2 t -65.97 147.61 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 171.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.3 mt -126.37 -36.11 2.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.705 2.002 . . . . 0.0 109.488 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.7 159.48 44.08 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.005 0.82 . . . . 0.0 110.763 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 74.6 mt -136.08 136.0 49.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 45.78 32.67 1.3 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.918 2.087 . . . . 0.0 112.882 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.61 7.57 75.17 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.159 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.5 mmt -114.18 120.64 41.2 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.92 1.36 . . . . 0.0 107.894 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -53.43 133.87 40.47 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.275 1.03 . . . . 0.0 109.132 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.24 145.67 12.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.462 0.649 . . . . 0.0 110.133 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -78.06 62.59 2.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.762 1.625 . . . . 0.0 108.264 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.04 -107.79 1.07 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.876 1.227 . . . . 0.0 111.137 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -76.91 -6.88 54.25 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.339 1.056 . . . . 0.0 112.372 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -120.62 146.56 46.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 119.042 0.837 . . . . 0.0 109.247 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.6 p -69.17 177.32 2.79 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.66 0.743 . . . . 0.0 110.386 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.76 75.0 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.563 169.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.11 -38.2 63.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.753 0.821 . . . . 0.0 111.633 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.57 4.72 8.05 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.551 1.072 . . . . 0.0 113.92 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -61.8 140.66 58.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.198 1.499 . . . . 0.0 107.995 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -68.26 124.8 24.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.29 -32.9 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 122.93 0.492 . . . . 0.0 111.629 -170.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.89 -39.84 95.11 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.91 0.777 . . . . 0.0 110.662 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.22 -42.69 71.95 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -58.7 -44.69 90.4 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.8 0.84 . . . . 0.0 111.283 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.53 -32.17 53.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.482 1.113 . . . . 0.0 110.829 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.35 -28.31 73.33 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.94 0.781 . . . . 0.0 112.522 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -61.41 114.36 10.69 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.373 1.069 . . . . 0.0 109.279 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.502 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 94.4 Cg_endo -71.52 -13.05 30.0 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.347 1.365 . . . . 0.0 113.847 -175.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.66 -14.78 55.14 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.429 1.013 . . . . 0.0 110.66 169.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -132.91 33.43 3.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.297 2.639 . . . . 0.0 108.749 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -66.57 -53.49 28.97 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 117.099 -1.429 . . . . 0.0 111.562 169.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.7 125.84 12.07 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 121.786 1.673 . . . . 0.0 108.974 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 m -149.53 170.88 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.781 0.832 . . . . 0.0 111.302 -169.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.8 m -125.59 133.22 52.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.2 mm -128.93 137.47 57.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.3 ttt85 -112.29 133.41 54.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -144.69 166.41 25.27 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.773 1.229 . . . . 0.0 108.565 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.5 -173.22 37.59 Favored Glycine 0 N--CA 1.452 -0.28 0 O-C-N 121.813 -0.554 . . . . 0.0 111.805 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -60.41 132.6 90.74 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.507 -0.758 . . . . 0.0 109.093 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.81 -15.53 50.74 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.903 2.402 . . . . 0.0 113.858 169.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -129.24 157.86 40.65 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.584 2.353 . . . . 0.0 107.415 -169.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.07 -49.18 78.85 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.685 0.675 . . . . 0.0 110.301 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -69.1 140.38 54.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.984 1.314 . . . . 0.0 109.187 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -68.97 -21.54 64.17 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 174.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 117.98 -1.009 . . . . 0.0 108.766 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.5 mtm . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.27 46.17 0.22 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -60.28 -22.9 63.68 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -66.5 -40.13 89.09 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.699 0.681 . . . . 0.0 111.432 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -72.76 -35.38 67.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.35 0.66 . . . . 0.0 109.945 171.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 67.11 172.11 0.26 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.208 2.203 . . . . 0.0 111.476 -172.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -70.48 -174.9 0.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.963 1.705 . . . . 0.0 111.254 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -57.06 -34.43 68.24 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.943 0.897 . . . . 0.0 111.914 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.54 127.71 32.98 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.91 -29.71 69.75 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -146.21 170.27 17.07 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.722 2.009 . . . . 0.0 107.661 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -62.88 158.32 19.3 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 169.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.48 134.38 7.9 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -52.19 -18.41 7.47 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.364 3.376 . . . . 0.0 116.752 -172.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -61.38 -22.96 65.45 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.226 -0.921 . . . . 0.0 112.109 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.85 -37.92 0.48 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.944 0.898 . . . . 0.0 113.296 -175.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -146.84 158.32 43.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.243 1.017 . . . . 0.0 111.101 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.23 166.38 28.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.649 1.179 . . . . 0.0 109.079 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -152.55 131.71 12.71 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -150.56 170.93 17.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.3 1.44 . . . . 0.0 109.483 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -137.09 142.61 42.35 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -142.85 175.45 9.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.468 1.507 . . . . 0.0 110.529 -171.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.9 m -150.72 174.16 13.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.181 2.592 . . . . 0.0 106.197 169.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -132.78 159.59 71.93 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.524 -0.751 . . . . 0.0 109.922 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.62 155.96 82.55 Favored 'Cis proline' 0 CA--C 1.535 0.575 0 CA-C-N 120.009 1.039 . . . . 0.0 111.492 -6.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 tp -156.0 154.33 30.91 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.147 1.379 . . . . 0.0 108.267 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.6 56.46 1.45 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.16 1.384 . . . . 0.0 110.756 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.1 tp -142.91 135.98 28.15 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.924 2.09 . . . . 0.0 106.368 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.1 tp -145.84 143.65 29.76 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.0 mp -128.94 154.28 46.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.317 1.847 . . . . 0.0 107.365 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.91 152.69 42.33 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.041 0.837 . . . . 0.0 111.748 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.7 tp -71.82 129.26 38.19 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.906 1.282 . . . . 0.0 108.556 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -154.37 134.35 13.07 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.086 1.355 . . . . 0.0 108.087 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.3 t70 48.7 46.53 21.43 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.288 1.435 . . . . 0.0 112.578 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 55.69 16.1 1.84 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.41 1.884 . . . . 0.0 114.396 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.59 174.62 5.97 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 125.331 1.452 . . . . 0.0 107.387 169.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.65 133.8 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.0 mt -121.01 153.28 37.57 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.419 1.088 . . . . 0.0 108.313 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.8 122.35 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.75 -36.94 11.5 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.456 1.503 . . . . 0.0 111.235 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -154.14 151.22 28.99 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.869 1.267 . . . . 0.0 107.935 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.5 -5.91 1.2 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.364 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -60.17 157.54 13.04 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.925 1.362 . . . . 0.0 111.487 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 56.45 25.57 9.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.33 1.452 . . . . 0.0 112.592 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -153.2 -37.99 0.1 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.875 1.27 . . . . 0.0 110.08 172.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.66 -158.45 7.54 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.686 2.088 . . . . 0.0 109.461 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.0 mm -55.28 140.3 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.465 1.106 . . . . 0.0 109.766 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -67.64 151.71 46.84 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 122.26 -0.275 . . . . 0.0 110.427 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m -51.99 150.5 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.406 1.082 . . . . 0.0 111.578 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.82 -11.29 64.87 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.928 174.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -68.61 139.24 55.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.323 1.562 . . . . 0.0 107.478 169.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.36 143.4 27.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 p -76.02 135.38 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 168.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.62 -29.43 6.47 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.668 1.587 . . . . 0.0 110.071 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.39 160.25 43.85 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.573 1.079 . . . . 0.0 110.626 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.5 mt -138.71 134.54 42.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 44.8 36.08 1.71 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.328 1.851 . . . . 0.0 111.972 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.89 -16.3 57.19 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.449 1.499 . . . . 0.0 113.671 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.4 mmt -88.44 121.49 30.88 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.846 1.323 . . . . 0.0 109.014 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.42 135.98 32.38 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.337 1.055 . . . . 0.0 109.84 169.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 m -93.2 128.93 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.667 0.746 . . . . 0.0 109.029 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -73.81 76.93 1.6 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.849 1.66 . . . . 0.0 107.424 169.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.61 -79.06 0.25 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.68 1.61 . . . . 0.0 111.968 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -128.91 11.07 6.03 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.399 1.479 . . . . 0.0 112.048 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.51 152.15 42.05 Favored 'General case' 0 C--N 1.334 -0.077 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.2 p -71.64 174.69 6.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.36 0.982 . . . . 0.0 110.118 173.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.39 75.13 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.506 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.47 -37.61 71.31 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.784 0.834 . . . . 0.0 111.576 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.67 5.86 8.18 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.553 1.073 . . . . 0.0 114.088 173.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -63.28 137.81 58.32 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.171 1.486 . . . . 0.0 107.729 172.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -68.41 131.61 45.6 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 169.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -56.57 -41.42 73.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.576 1.15 . . . . 0.0 110.912 -174.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.4 mt -65.42 -37.65 87.55 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 118.091 0.405 . . . . 0.0 110.723 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.63 -45.32 68.76 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -60.14 -45.26 93.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.468 0.707 . . . . 0.0 111.405 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.49 -30.25 33.35 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.811 0.444 . . . . 0.0 111.156 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.43 -34.93 63.4 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.696 0.68 . . . . 0.0 112.0 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -60.39 117.66 26.53 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.353 1.061 . . . . 0.0 110.219 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.72 -31.57 32.19 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.771 1.647 . . . . 0.0 111.955 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.42 -3.56 1.46 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -169.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.41 45.18 2.84 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.14 1.376 . . . . 0.0 111.503 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -40.86 -55.15 4.87 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.36 117.97 5.39 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 122.264 1.844 . . . . 0.0 109.713 -172.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.52 131.13 34.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.7 m -98.8 139.02 35.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 mm -132.17 142.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -172.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 mtp-105 -119.79 139.88 51.64 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -128.35 170.41 13.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.229 1.412 . . . . 0.0 108.438 -173.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.85 -178.73 40.54 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -66.76 149.34 98.37 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.4 -19.11 49.73 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.448 2.098 . . . . 0.0 113.214 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -138.08 151.02 47.42 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.044 1.338 . . . . 0.0 107.503 169.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.1 152.03 49.99 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 175.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.1 p -60.88 123.46 17.61 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.797 0.839 . . . . 0.0 109.885 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.0 m 52.1 28.99 5.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.533 1.533 . . . . 0.0 113.821 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 C--O 1.25 1.117 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -178.096 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.55 -178.83 48.76 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -141.51 161.73 37.2 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.53 1.532 . . . . 0.0 108.301 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -143.01 161.75 37.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.918 1.287 . . . . 0.0 108.993 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -136.74 166.56 23.3 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.373 1.869 . . . . 0.0 107.221 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -137.87 142.83 40.7 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.497 1.119 . . . . 0.0 108.263 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -146.84 159.33 43.65 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.503 1.521 . . . . 0.0 107.736 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -138.94 -169.19 2.58 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.892 1.677 . . . . 0.0 108.099 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.8 tp -51.33 117.72 2.8 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.275 1.03 . . . . 0.0 109.958 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.0 t0 42.77 34.51 0.59 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.723 2.409 . . . . 0.0 115.343 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.3 m -65.61 169.81 5.8 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.565 -0.709 . . . . 0.0 110.938 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -59.0 160.92 5.47 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 169.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.42 166.71 15.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.883 1.273 . . . . 0.0 108.982 -174.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.41 -6.01 1.31 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.264 3.309 . . . . 0.0 116.716 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -110.07 11.32 23.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.022 1.329 . . . . 0.0 111.546 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.41 172.35 3.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.745 0.702 . . . . 0.0 110.104 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.7 -176.8 4.52 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.698 0.799 . . . . 0.0 110.374 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.41 165.82 4.44 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.774 1.273 . . . . 0.0 113.314 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -135.89 120.42 18.18 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 102.474 -3.158 . . . . 0.0 102.474 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -152.64 154.44 35.34 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.247 0.93 . . . . 0.0 112.345 -169.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -83.73 143.07 30.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.922 2.089 . . . . 0.0 110.62 172.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -140.1 162.71 34.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.461 1.104 . . . . 0.0 109.194 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.4 m -153.42 167.7 28.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.075 1.75 . . . . 0.0 107.044 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.63 175.87 3.32 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 117.392 -1.289 . . . . 0.0 109.73 -169.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.85 148.6 7.81 Favored 'Cis proline' 0 C--N 1.356 0.957 0 CA-C-N 122.614 1.969 . . . . 0.0 115.87 6.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.94 138.9 57.22 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.352 1.061 . . . . 0.0 111.014 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -136.12 20.48 3.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.622 1.569 . . . . 0.0 109.809 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 pp -148.15 169.36 20.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.234 3.014 . . . . 0.0 105.624 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.1 mt -143.21 145.82 33.12 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.9 mp -127.14 154.79 44.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.975 1.71 . . . . 0.0 107.178 174.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 154.08 43.79 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.738 0.815 . . . . 0.0 110.16 174.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.5 tp -76.29 121.86 23.57 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -153.25 144.2 22.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.288 1.435 . . . . 0.0 108.485 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 43.16 50.77 5.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.223 1.409 . . . . 0.0 111.753 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 60.05 7.76 1.28 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.821 2.048 . . . . 0.0 115.943 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -125.87 160.62 29.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.945 1.248 . . . . 0.0 109.851 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.31 124.41 40.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.4 mt -114.84 148.63 38.27 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.96 109.9 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.43 -38.11 71.4 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.8 1.24 . . . . 0.0 110.37 175.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -158.83 142.23 14.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.174 0.99 . . . . 0.0 109.146 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.3 22.77 0.09 OUTLIER Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.468 1.033 . . . . 0.0 110.6 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -69.59 -25.96 64.23 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.05 0.925 . . . . 0.0 112.539 -169.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -68.73 -36.66 78.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.07 0.85 . . . . 0.0 111.214 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.14 -41.7 85.64 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 170.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.64 -11.34 2.18 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.676 1.608 . . . . 0.0 112.376 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.8 mt -71.38 120.98 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.52 1.128 . . . . 0.0 109.369 -169.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -61.56 137.39 58.24 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 169.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.88 144.1 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.698 0.799 . . . . 0.0 109.069 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.4 0.55 70.05 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.733 -1.037 . . . . 0.0 114.013 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -65.89 136.38 56.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.235 1.517 . . . . 0.0 108.736 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.84 140.48 29.63 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.623 1.169 . . . . 0.0 108.988 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.99 142.62 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.2 mt -120.05 -32.57 4.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.313 1.045 . . . . 0.0 109.803 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.37 159.7 42.5 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.676 1.125 . . . . 0.0 110.75 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.9 mt -136.12 135.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 49.93 29.13 3.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.078 1.751 . . . . 0.0 112.122 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.63 -9.49 67.93 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.943 1.258 . . . . 0.0 113.795 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.3 mmt -85.62 115.16 23.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.973 1.387 . . . . 0.0 108.302 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -51.58 132.73 30.58 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.483 1.113 . . . . 0.0 109.559 169.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.71 133.97 32.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -78.15 71.77 4.64 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.325 1.45 . . . . 0.0 107.34 169.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.45 -59.6 0.29 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 128.032 2.729 . . . . 0.0 114.342 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -137.36 -4.61 1.86 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.003 2.121 . . . . 0.0 111.658 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -117.56 154.1 32.08 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.7 p -69.88 177.22 3.21 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.188 0.904 . . . . 0.0 110.113 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.32 -38.69 74.44 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.612 169.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.36 -37.93 68.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.672 0.789 . . . . 0.0 111.558 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.47 4.88 7.39 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.548 1.071 . . . . 0.0 113.874 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -64.22 136.93 57.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.785 1.292 . . . . 0.0 107.736 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.05 125.99 26.66 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.6 t -57.33 -37.39 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.191 0.596 . . . . 0.0 111.707 -170.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.47 -42.42 98.6 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.674 0.67 . . . . 0.0 110.09 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.66 -37.5 70.8 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.059 -0.401 . . . . 0.0 110.212 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -60.12 -43.62 95.48 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.801 0.84 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.62 -36.06 60.35 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.441 0.696 . . . . 0.0 110.575 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.13 -33.01 86.1 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.688 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -59.65 116.07 15.22 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.93 1.292 . . . . 0.0 110.453 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.508 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.6 Cg_endo -70.25 -14.6 34.7 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.92 1.746 . . . . 0.0 114.086 -177.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.51 -14.12 55.68 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.536 1.062 . . . . 0.0 110.901 169.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -135.58 34.74 2.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.764 2.426 . . . . 0.0 108.638 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.508 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -63.28 -55.4 36.48 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.669 -1.157 . . . . 0.0 111.583 171.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.32 127.99 13.24 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 121.382 1.529 . . . . 0.0 109.219 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.3 m -149.16 169.32 2.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 123.992 0.917 . . . . 0.0 110.852 -172.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.4 m -126.04 137.17 53.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 169.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.1 mt -132.73 143.59 39.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -123.55 130.81 53.22 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -138.47 172.2 13.25 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.054 0.942 . . . . 0.0 108.788 -176.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -176.46 39.41 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.34 147.28 98.91 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 169.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.96 -20.18 70.89 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.972 2.448 . . . . 0.0 112.642 175.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -126.67 95.93 4.5 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 101.817 -3.401 . . . . 0.0 101.817 169.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.0 tp -45.14 -44.89 11.01 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -169.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 p -81.55 2.07 30.78 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.591 1.157 . . . . 0.0 113.577 -172.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 69.4 p -67.9 -8.63 38.31 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.444 1.02 . . . . 0.0 113.224 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.915 0 C-N-CA 126.088 1.755 . . . . 0.0 106.38 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.77 6.9 0.65 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.567 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -68.78 -3.64 13.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.08 1.44 . . . . 0.0 113.24 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -61.63 -28.81 69.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.734 0.814 . . . . 0.0 111.709 172.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -65.68 137.34 57.24 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.451 0.569 . . . . 0.0 109.957 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -144.87 163.96 32.53 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.182 1.793 . . . . 0.0 107.816 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -59.27 139.16 57.25 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.907 0.483 . . . . 0.0 109.715 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -157.0 -32.86 0.08 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.41 1.084 . . . . 0.0 111.628 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.88 141.71 54.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.326 1.05 . . . . 0.0 109.315 173.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.45 -30.29 69.97 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.453 0.701 . . . . 0.0 112.796 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 m -59.7 155.6 15.49 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.336 1.454 . . . . 0.0 111.895 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -64.59 168.06 6.43 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.31 0.576 . . . . 0.0 110.739 172.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.08 163.01 40.32 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.601 1.56 . . . . 0.0 108.366 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.56 149.11 4.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.422 2.748 . . . . 0.0 112.667 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -109.14 41.65 1.59 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.164 0.986 . . . . 0.0 109.512 -172.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.2 153.34 18.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.411 0.684 . . . . 0.0 110.275 175.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -131.54 -5.29 3.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.307 1.443 . . . . 0.0 110.854 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.99 154.03 36.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.767 1.227 . . . . 0.0 109.564 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -153.95 101.53 2.44 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 169.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -155.07 154.93 33.19 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -171.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -73.17 145.06 46.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.67 1.188 . . . . 0.0 109.162 169.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -140.81 162.3 35.76 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.054 1.342 . . . . 0.0 108.849 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.1 m -148.34 175.64 10.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.384 2.274 . . . . 0.0 106.788 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -137.49 153.56 74.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.581 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.06 152.71 87.55 Favored 'Cis proline' 0 CA--C 1.538 0.691 0 CA-C-N 119.642 0.908 . . . . 0.0 110.412 -10.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.5 tp -160.66 170.88 19.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.222 1.409 . . . . 0.0 108.143 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.11 -33.21 68.88 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.286 1.035 . . . . 0.0 112.168 174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 tp -62.56 128.34 35.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.65 0.78 . . . . 0.0 109.841 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.6 tp -142.48 150.33 40.37 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.772 1.629 . . . . 0.0 107.2 172.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -132.59 155.54 48.51 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.507 1.123 . . . . 0.0 109.833 -170.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 155.42 44.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.788 0.835 . . . . 0.0 110.333 172.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.41 131.12 40.41 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.895 1.278 . . . . 0.0 107.83 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -152.72 138.76 18.19 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 t70 44.42 49.17 8.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.518 1.527 . . . . 0.0 112.839 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 60.22 14.54 4.64 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.991 1.716 . . . . 0.0 114.702 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 155.77 28.68 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 120.975 -1.078 . . . . 0.0 108.78 171.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.5 t -102.49 130.74 51.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.73 150.61 40.1 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.133 1.373 . . . . 0.0 107.967 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.56 108.01 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.74 -29.79 23.6 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.588 1.155 . . . . 0.0 111.759 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -146.64 144.54 29.57 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.03 93.91 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 106.283 -2.727 . . . . 0.0 106.283 -169.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -145.21 174.99 10.6 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.003 0.921 . . . . 0.0 110.527 -170.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 67.09 -47.13 0.48 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.236 2.614 . . . . 0.0 113.523 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.79 -35.72 80.78 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.051 0.841 . . . . 0.0 110.58 172.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.18 178.6 48.4 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.6 pt -76.67 54.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.258 1.023 . . . . 0.0 110.339 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -66.14 -30.61 71.12 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.928 -1.107 . . . . 0.0 111.748 -169.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -44.66 141.46 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.323 1.049 . . . . 0.0 112.65 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.99 -15.8 46.26 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.694 1.14 . . . . 0.0 114.03 173.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -72.33 158.6 35.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.095 1.447 . . . . 0.0 109.932 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.73 144.1 33.86 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.705 1.202 . . . . 0.0 109.271 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -63.61 152.04 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 174.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.6 mt -132.62 -41.5 0.95 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.645 1.178 . . . . 0.0 110.63 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.56 158.84 44.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.375 0.989 . . . . 0.0 110.368 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 78.4 mt -138.54 139.94 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 176.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 46.67 31.02 1.27 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.872 2.069 . . . . 0.0 112.745 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.66 18.48 65.81 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.709 -1.051 . . . . 0.0 113.816 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -125.29 133.05 52.78 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.036 1.418 . . . . 0.0 109.198 170.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -50.71 141.86 12.18 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.391 1.076 . . . . 0.0 109.579 169.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.4 m -115.13 128.74 72.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 122.146 0.975 . . . . 0.0 109.164 174.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -76.35 74.9 3.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.969 2.107 . . . . 0.0 108.967 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.93 -66.74 1.13 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.382 1.944 . . . . 0.0 112.943 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.59 9.47 2.43 Favored 'General case' 0 CA--C 1.526 0.051 0 C-N-CA 125.146 1.378 . . . . 0.0 112.457 175.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -121.51 143.68 49.13 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.7 p -71.64 174.01 7.32 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.257 0.935 . . . . 0.0 110.152 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.14 -38.18 76.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.469 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.67 -39.58 73.49 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.972 0.909 . . . . 0.0 111.406 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.78 -0.21 7.84 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.648 1.118 . . . . 0.0 114.187 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -61.48 143.69 55.49 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.181 1.49 . . . . 0.0 108.499 173.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -69.34 134.73 49.44 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 t -55.25 -45.7 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.771 1.228 . . . . 0.0 111.014 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.41 -36.41 81.22 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.478 0.581 . . . . 0.0 110.669 -176.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -70.63 -43.2 69.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.412 0.551 . . . . 0.0 109.746 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -60.28 -45.05 94.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.506 1.123 . . . . 0.0 110.703 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.39 -33.18 60.97 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.685 0.794 . . . . 0.0 111.001 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.43 -30.66 73.33 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.843 0.735 . . . . 0.0 112.456 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -60.49 114.56 10.46 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.285 1.034 . . . . 0.0 109.674 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.487 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 80.5 Cg_endo -70.87 -14.61 32.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.627 1.552 . . . . 0.0 113.832 -175.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.41 -15.04 56.41 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.393 0.997 . . . . 0.0 110.857 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -133.68 33.35 3.5 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.883 2.473 . . . . 0.0 108.648 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.487 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -65.24 -52.6 45.95 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 117.085 -1.436 . . . . 0.0 111.121 169.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.93 125.4 10.95 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.794 1.677 . . . . 0.0 109.251 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.1 m -150.45 171.83 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.188 1.395 . . . . 0.0 110.127 -170.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 m -125.74 138.72 53.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 169.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 mt -138.63 143.65 31.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -118.45 132.77 56.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -145.0 166.25 25.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.214 1.406 . . . . 0.0 107.317 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.74 -156.97 28.31 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -68.94 158.3 86.68 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.31 154.91 43.62 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.906 1.737 . . . . 0.0 110.435 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -72.61 -7.35 49.82 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.0 tp -137.83 161.1 37.5 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.287 1.835 . . . . 0.0 107.228 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.3 p -62.2 -23.11 66.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.583 1.153 . . . . 0.0 113.315 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 m -56.65 126.91 28.85 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.607 1.163 . . . . 0.0 110.078 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.027 179.504 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.88 -168.57 39.15 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -56.66 -19.49 16.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.566 1.147 . . . . 0.0 113.999 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.521 ' HD1' ' CG ' ' A' ' 6' ' ' HIS . 9.6 p80 -61.49 -22.87 65.48 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.173 0.989 . . . . 0.0 112.918 174.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.3 m80 41.61 51.03 3.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.523 1.929 . . . . 0.0 114.253 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.521 ' CG ' ' HD1' ' A' ' 4' ' ' HIS . 62.2 m170 -69.13 -10.13 56.13 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.44 -0.788 . . . . 0.0 111.416 169.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -140.24 164.11 30.96 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.671 1.989 . . . . 0.0 107.482 171.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.98 144.7 56.88 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 122.825 0.45 . . . . 0.0 109.911 173.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.8 tp -81.81 69.66 8.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.91 152.38 16.25 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.665 0.786 . . . . 0.0 110.697 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.5 m -64.65 -33.46 75.99 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.88 139.62 50.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -162.16 154.99 16.92 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.268 2.227 . . . . 0.0 106.363 169.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.29 -33.98 57.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.895 3.063 . . . . 0.0 113.54 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -141.61 133.78 27.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.46 19.74 1.53 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.793 1.237 . . . . 0.0 110.378 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -130.82 157.86 41.74 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.689 1.596 . . . . 0.0 110.176 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.0 174.08 15.14 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.38 1.872 . . . . 0.0 108.608 173.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -142.64 146.89 34.94 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.136 0.974 . . . . 0.0 108.62 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -153.96 172.74 16.96 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.663 1.185 . . . . 0.0 108.877 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -123.71 142.49 51.02 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.394 1.478 . . . . 0.0 108.086 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -141.73 167.18 22.77 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.607 0.718 . . . . 0.0 110.607 -173.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.8 m -155.07 174.47 15.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.719 2.008 . . . . 0.0 107.08 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -136.56 163.78 47.33 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.64 6.63 21.13 Favored 'Cis proline' 0 CA--C 1.541 0.856 0 CA-C-N 121.74 1.657 . . . . 0.0 114.562 5.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.1 tp -44.9 130.61 7.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.254 1.022 . . . . 0.0 110.023 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.59 123.88 17.79 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.251 1.02 . . . . 0.0 112.813 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.6 tp -161.27 153.41 19.87 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.763 2.425 . . . . 0.0 104.835 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 44.2 tp -147.05 137.21 23.37 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.642 1.11 . . . . 0.0 109.674 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.5 mp -131.06 150.62 52.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.433 2.293 . . . . 0.0 106.172 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 154.4 41.85 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.251 0.932 . . . . 0.0 111.196 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -77.4 124.61 28.11 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -154.73 144.72 21.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.235 1.414 . . . . 0.0 109.044 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 46.79 45.07 14.77 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.484 1.135 . . . . 0.0 111.655 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 62.5 0.92 0.68 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.378 2.271 . . . . 0.0 116.609 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -119.79 159.58 24.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 121.12 1.782 . . . . 0.0 109.97 173.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.84 131.76 33.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 169.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.9 mt -118.22 153.32 34.07 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.072 1.349 . . . . 0.0 107.572 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.43 121.77 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.07 -39.51 23.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.601 0.76 . . . . 0.0 110.409 171.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -150.71 132.67 15.16 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.154 0.982 . . . . 0.0 109.913 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.98 26.83 0.25 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.612 1.577 . . . . 0.0 110.954 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.45 -27.15 67.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.803 0.841 . . . . 0.0 112.595 -169.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.5 ptt85 -60.19 -29.19 68.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 118.796 -0.621 . . . . 0.0 112.323 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -91.31 -41.25 11.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.769 0.713 . . . . 0.0 110.578 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.8 -164.77 37.17 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 pt -70.59 33.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 125.9 1.68 . . . . 0.0 113.73 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -25.66 63.54 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.582 -1.324 . . . . 0.0 112.395 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.6 t -46.01 129.42 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.272 1.029 . . . . 0.0 110.066 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.66 -8.76 67.59 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.809 -0.995 . . . . 0.0 113.719 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -77.93 143.98 37.22 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.302 1.551 . . . . 0.0 108.351 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.04 143.75 28.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.968 1.307 . . . . 0.0 109.724 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.04 143.53 15.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.95 -32.39 2.31 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.398 1.079 . . . . 0.0 110.583 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.61 158.83 44.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.902 1.228 . . . . 0.0 110.266 169.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -139.98 134.94 37.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 105.834 -1.914 . . . . 0.0 105.834 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 49.56 28.2 2.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.658 1.583 . . . . 0.0 112.46 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.17 -11.74 68.55 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.944 1.259 . . . . 0.0 113.799 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 78.8 mtm -80.35 112.63 17.87 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.303 1.551 . . . . 0.0 108.056 173.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.47 124.26 19.8 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.5 m -96.95 138.2 22.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 122.014 0.911 . . . . 0.0 110.865 -169.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -76.29 70.39 2.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.725 2.01 . . . . 0.0 108.622 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.13 -59.71 0.8 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 127.794 2.616 . . . . 0.0 114.395 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -142.86 0.89 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.792 2.037 . . . . 0.0 111.073 -174.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -124.76 144.64 50.14 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.8 p -68.35 175.58 3.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.034 0.834 . . . . 0.0 110.386 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.31 -38.43 74.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.671 169.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.22 -38.09 72.03 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.553 0.741 . . . . 0.0 111.502 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.4 4.7 7.5 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.827 1.203 . . . . 0.0 113.68 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -63.34 134.16 55.31 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -64.79 126.69 28.75 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.3 t -55.32 -42.44 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.476 1.111 . . . . 0.0 111.745 -170.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.67 -40.7 88.7 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.593 0.633 . . . . 0.0 110.311 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -69.95 -41.04 75.06 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.842 0.457 . . . . 0.0 110.034 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -59.33 -44.98 92.55 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.41 1.084 . . . . 0.0 110.875 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.17 -35.28 63.99 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.457 0.703 . . . . 0.0 110.629 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.67 -30.74 74.98 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.865 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -59.57 116.76 17.83 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.668 1.187 . . . . 0.0 110.149 177.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.498 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 74.2 Cg_endo -69.62 -15.66 37.74 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.896 1.731 . . . . 0.0 114.136 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.91 -14.26 52.14 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.439 1.018 . . . . 0.0 111.088 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -135.39 33.68 3.03 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.674 2.39 . . . . 0.0 108.828 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -62.4 -55.29 41.09 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.768 172.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.44 128.34 13.52 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 121.661 1.629 . . . . 0.0 109.41 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 m -147.93 164.69 5.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 123.551 0.74 . . . . 0.0 111.323 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -122.14 137.54 54.79 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.7 mt -137.76 133.94 45.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -107.13 138.01 44.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -145.22 168.6 20.02 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.748 1.219 . . . . 0.0 108.193 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.45 -174.18 44.48 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.0 mmm-85 -60.02 145.89 83.78 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.27 138.07 46.09 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.819 2.346 . . . . 0.0 112.841 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -143.87 162.87 35.0 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.311 -1.736 . . . . 0.0 106.311 169.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt -142.82 156.25 44.92 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.389 1.076 . . . . 0.0 108.436 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.4 p -68.58 164.18 21.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.554 1.142 . . . . 0.0 110.751 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.1 m -63.97 -15.61 59.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.498 1.119 . . . . 0.0 112.914 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 t30 . . . . . 0 C--O 1.247 0.932 0 C-N-CA 127.027 2.131 . . . . 0.0 106.592 175.37 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.2 177.15 48.29 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -143.44 148.97 36.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.1 1.36 . . . . 0.0 107.904 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.5 m80 54.91 -168.57 0.08 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.651 1.18 . . . . 0.0 111.23 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -64.57 152.28 42.42 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.429 -0.794 . . . . 0.0 109.587 173.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.97 169.73 17.51 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.994 1.718 . . . . 0.0 108.711 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -133.74 166.56 22.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.095 1.758 . . . . 0.0 107.746 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -147.74 168.28 22.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.91 1.284 . . . . 0.0 108.174 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.8 mt -67.77 157.41 34.79 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.132 0.573 . . . . 0.0 109.761 173.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.8 t70 54.81 -16.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 129.798 3.239 . . . . 0.0 118.867 169.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.4 p -61.54 -27.71 68.81 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.579 1.536 . . . . 0.0 113.216 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -77.02 -29.66 55.47 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.593 1.557 . . . . 0.0 112.537 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.64 -40.87 80.17 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -169.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.05 -34.43 77.6 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.805 2.336 . . . . 0.0 113.952 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -94.7 -47.17 6.61 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.026 0.83 . . . . 0.0 110.097 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.62 123.66 13.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.17 -28.55 67.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.09 171.41 17.54 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.135 0.974 . . . . 0.0 110.211 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -136.57 136.88 39.63 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 169.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -141.13 149.82 42.03 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.511 0.724 . . . . 0.0 109.541 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -82.2 143.22 31.54 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.899 1.28 . . . . 0.0 109.019 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -143.66 168.44 19.88 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.23 1.412 . . . . 0.0 109.81 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.7 m -142.66 175.25 9.95 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.07 2.548 . . . . 0.0 105.951 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -133.96 159.74 71.22 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 119.071 0.851 . . . . 0.0 110.193 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.66 155.08 27.54 Favored 'Cis proline' 0 C--N 1.351 0.678 0 CA-C-N 120.261 1.129 . . . . 0.0 112.826 -10.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.6 156.34 37.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.93 1.292 . . . . 0.0 107.562 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -67.26 -30.4 70.28 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.96 0.904 . . . . 0.0 112.361 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.0 tp -59.03 133.8 56.42 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.341 1.056 . . . . 0.0 109.223 173.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.2 tp -140.14 141.97 36.02 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.86 1.264 . . . . 0.0 107.822 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.6 mp -127.09 155.4 43.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.294 1.838 . . . . 0.0 107.882 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 152.45 45.29 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.531 0.732 . . . . 0.0 110.58 173.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.12 128.72 34.23 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -151.68 138.27 18.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.48 1.112 . . . . 0.0 108.369 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.8 t70 44.8 50.5 8.72 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.828 1.651 . . . . 0.0 112.558 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 56.5 16.43 2.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.986 2.114 . . . . 0.0 114.456 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -126.38 -169.7 2.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.131 2.172 . . . . 0.0 107.553 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.38 136.48 56.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.6 mt -127.45 156.23 42.45 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.894 1.278 . . . . 0.0 108.601 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.6 t -65.43 122.33 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.98 -38.35 19.38 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.4 1.08 . . . . 0.0 110.623 172.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -157.51 138.8 13.64 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.72 26.98 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.09 -0.839 . . . . 0.0 113.389 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.59 117.88 4.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.584 1.192 . . . . 0.0 108.44 -177.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 46' ' ' GLY . 4.0 tpp85 -157.81 118.58 3.48 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -173.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 64.44 -25.15 0.08 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.322 2.249 . . . . 0.0 114.0 -169.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 44' ' ' ARG . . . -164.82 175.06 40.83 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 127.343 2.402 . . . . 0.0 108.253 170.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.98 147.66 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 117.588 0.694 . . . . 0.0 109.322 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -136.1 -7.55 2.06 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.406 -0.807 . . . . 0.0 113.106 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.2 t -53.69 135.99 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 119.647 1.112 . . . . 0.0 108.897 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.85 -7.6 73.56 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.638 -1.09 . . . . 0.0 113.688 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -72.22 158.92 34.97 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.443 1.621 . . . . 0.0 108.028 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.86 141.03 47.15 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 123.203 0.601 . . . . 0.0 110.52 -169.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.11 134.28 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.92 -25.58 4.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.865 0.866 . . . . 0.0 109.921 -172.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.44 153.83 42.32 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.72 1.145 . . . . 0.0 109.446 168.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.6 mt -136.64 137.19 47.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 46.79 33.5 2.18 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.089 1.756 . . . . 0.0 112.418 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.06 11.27 79.09 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.733 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.6 mmt -120.18 121.77 39.48 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.849 1.325 . . . . 0.0 108.294 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.75 124.28 16.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.341 1.056 . . . . 0.0 109.283 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.4 m -73.24 140.82 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -79.87 61.6 3.84 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.176 1.39 . . . . 0.0 107.849 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.95 -112.1 3.58 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.103 1.335 . . . . 0.0 110.843 -172.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -72.32 -13.23 61.44 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.449 1.099 . . . . 0.0 111.959 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -112.03 155.43 23.82 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.394 0.678 . . . . 0.0 109.397 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.2 p -71.95 175.44 5.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.41 -0.806 . . . . 0.0 109.454 169.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.65 80.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.517 169.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.61 -36.34 68.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.427 0.691 . . . . 0.0 111.457 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.41 -1.22 7.03 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.554 -1.137 . . . . 0.0 114.96 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -67.43 147.77 52.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.925 1.863 . . . . 0.0 107.829 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -66.33 130.95 44.95 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 170.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 t -53.99 -41.75 51.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 125.192 1.397 . . . . 0.0 111.311 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.2 mt -66.98 -39.67 87.23 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.547 0.612 . . . . 0.0 110.546 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -71.5 -37.9 71.21 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.349 0.522 . . . . 0.0 110.226 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -60.97 -53.74 53.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.019 0.928 . . . . 0.0 109.929 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.26 -32.5 73.96 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.05 -0.406 . . . . 0.0 110.122 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.53 -9.67 78.43 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.236 -1.313 . . . . 0.0 114.187 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -83.33 112.51 39.61 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 119.979 1.89 . . . . 0.0 110.343 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.544 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 84.0 Cg_endo -72.23 -16.33 28.27 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.651 1.567 . . . . 0.0 114.669 -170.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.19 -11.9 24.23 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.06 0.845 . . . . 0.0 112.136 169.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.8 31.1 3.06 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.952 1.301 . . . . 0.0 111.829 173.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.544 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.1 m-30 -53.52 -40.51 80.83 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 116.136 -1.888 . . . . 0.0 115.519 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.68 122.08 9.01 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 CA-C-N 123.117 2.149 . . . . 0.0 109.206 172.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.23 169.66 7.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.998 1.319 . . . . 0.0 110.374 -172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -126.19 138.1 53.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.2 mm -128.87 140.77 48.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -174.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -130.08 127.04 39.05 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -144.55 163.29 34.32 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.121 0.968 . . . . 0.0 111.321 -169.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.69 -170.93 37.0 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.5 140.78 88.55 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 170.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -55.45 148.63 51.39 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.241 2.627 . . . . 0.0 112.331 -171.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.1 tpp85 -151.35 173.12 14.88 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.681 1.192 . . . . 0.0 108.916 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.2 tp -66.08 151.07 47.68 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.2 p -141.43 27.82 1.87 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.343 1.457 . . . . 0.0 110.031 -172.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 p -160.36 174.49 14.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.205 1.402 . . . . 0.0 108.9 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 . . . . . 0 C--O 1.249 1.064 0 C-N-CA 124.905 1.282 . . . . 0.0 108.21 175.477 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 ttm . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.09 58.48 4.58 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.732 1.158 . . . . 0.0 111.576 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -144.6 151.22 38.71 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.151 1.38 . . . . 0.0 107.964 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -60.12 143.9 51.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.358 0.663 . . . . 0.0 109.991 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -146.77 161.28 40.97 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.918 1.687 . . . . 0.0 108.073 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -128.76 -6.57 5.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.586 1.155 . . . . 0.0 112.23 -178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -138.5 150.0 45.97 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.188 1.795 . . . . 0.0 106.397 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -146.45 166.26 26.92 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.916 1.287 . . . . 0.0 108.769 -174.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 79.9 mt -138.08 153.28 49.31 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.635 1.574 . . . . 0.0 107.369 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.18 -0.37 7.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.83 1.252 . . . . 0.0 113.588 -174.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.5 m -52.14 -26.31 11.03 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.398 2.279 . . . . 0.0 114.871 -172.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -74.85 -20.96 59.53 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.729 0.812 . . . . 0.0 112.892 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.66 133.91 95.24 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.055 0.843 . . . . 0.0 109.269 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.28 -26.81 41.48 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.293 1.996 . . . . 0.0 112.685 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -71.18 -8.74 55.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.376 -0.821 . . . . 0.0 112.215 175.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.57 173.72 9.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.759 1.163 . . . . 0.0 110.638 -172.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -133.95 175.24 9.64 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.923 1.689 . . . . 0.0 108.347 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.33 162.66 14.44 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.784 0.833 . . . . 0.0 111.153 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -88.69 154.73 20.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.053 0.541 . . . . 0.0 109.741 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -143.09 166.75 23.79 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.59 1.556 . . . . 0.0 108.589 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 m -106.86 142.77 35.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.352 1.061 . . . . 0.0 108.346 -176.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -141.55 161.81 37.01 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.889 1.276 . . . . 0.0 109.695 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.4 m -155.96 170.9 21.07 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.522 1.929 . . . . 0.0 107.189 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -136.94 161.83 59.29 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.85 0.86 . . . . 0.0 109.521 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.92 141.76 61.27 Favored 'Cis proline' 0 CA--C 1.536 0.612 0 CA-C-N 119.966 1.023 . . . . 0.0 110.317 -10.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.1 tp -161.54 -58.02 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.606 1.162 . . . . 0.0 107.985 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.76 135.44 6.52 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.481 1.913 . . . . 0.0 106.636 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.6 tp -145.32 31.56 1.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.285 1.034 . . . . 0.0 109.163 171.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.56 68.93 2.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.461 1.104 . . . . 0.0 109.579 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.04 155.73 30.94 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.045 2.138 . . . . 0.0 106.996 172.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.25 154.01 49.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.541 0.609 . . . . 0.0 110.375 171.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tt -81.99 122.6 28.0 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -157.26 145.49 19.33 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.698 1.199 . . . . 0.0 107.964 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.1 t70 54.66 37.66 28.59 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.477 1.111 . . . . 0.0 111.716 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 52.93 25.28 3.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.244 1.817 . . . . 0.0 113.136 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -128.6 -177.3 4.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 127.547 2.339 . . . . 0.0 107.289 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.2 t -120.75 127.82 75.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 169.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.2 mt -123.19 157.45 32.98 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.7 1.2 . . . . 0.0 109.09 -171.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.26 120.18 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.391 1.077 . . . . 0.0 108.4 171.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.41 -29.27 20.36 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.903 0.881 . . . . 0.0 111.314 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -147.45 128.05 14.18 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.68 149.95 6.72 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -157.38 38.08 0.29 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.906 0.853 . . . . 0.0 110.726 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -123.75 160.48 27.2 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.879 1.271 . . . . 0.0 107.655 173.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -54.72 127.51 28.54 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.585 0.754 . . . . 0.0 110.882 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.14 -4.77 74.82 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.992 -0.893 . . . . 0.0 114.215 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.9 tp -144.25 26.53 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 118.815 1.307 . . . . 0.0 109.881 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -67.15 155.35 38.98 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.644 -1.285 . . . . 0.0 108.445 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.6 m -43.96 135.08 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.062 0.945 . . . . 0.0 110.945 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.49 -13.22 68.04 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.327 -1.263 . . . . 0.0 113.989 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -67.14 153.44 43.66 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.792 1.796 . . . . 0.0 107.764 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.61 146.5 44.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.281 1.432 . . . . 0.0 110.151 -170.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -68.21 138.15 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 169.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.8 mt -121.9 -29.09 4.35 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.47 1.108 . . . . 0.0 111.013 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.91 158.29 43.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 120.084 1.311 . . . . 0.0 110.558 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -140.38 135.12 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 50.46 27.9 3.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.774 1.63 . . . . 0.0 112.377 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.07 -11.0 63.86 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.845 1.212 . . . . 0.0 113.633 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.5 mtt -78.69 107.92 11.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.958 1.379 . . . . 0.0 108.518 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.34 121.77 12.26 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.6 m -76.44 137.0 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.718 0.77 . . . . 0.0 110.755 -169.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -79.31 67.04 4.94 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 169.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.41 -107.54 1.03 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.828 1.204 . . . . 0.0 111.302 -173.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -77.66 -10.55 59.58 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.61 1.164 . . . . 0.0 112.121 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -116.02 155.28 28.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.016 0.826 . . . . 0.0 109.54 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -71.14 177.65 3.69 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.26 -0.9 . . . . 0.0 109.703 169.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.68 82.19 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.346 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.6 -38.99 74.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.895 0.878 . . . . 0.0 111.412 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.08 -2.61 6.79 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.517 1.056 . . . . 0.0 114.161 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -60.51 135.36 57.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.05 1.425 . . . . 0.0 108.265 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -68.43 129.96 41.46 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 t -53.96 -43.57 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.185 1.394 . . . . 0.0 112.087 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.67 -39.76 88.31 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.859 0.754 . . . . 0.0 110.502 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -69.51 -41.16 76.42 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -59.7 -45.2 92.83 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.248 1.019 . . . . 0.0 110.801 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.53 -34.49 60.77 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.21 0.604 . . . . 0.0 110.895 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.39 -32.12 78.59 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.513 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -60.22 115.55 13.76 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.754 1.222 . . . . 0.0 110.179 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.5 Cg_endo -70.49 -15.03 34.32 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.844 1.696 . . . . 0.0 113.988 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.97 -14.72 56.08 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.412 1.006 . . . . 0.0 110.986 169.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -135.26 34.96 3.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.744 2.418 . . . . 0.0 108.607 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.488 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -64.72 -54.59 34.89 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 117.543 -1.217 . . . . 0.0 111.371 169.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.82 125.04 10.68 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.521 1.579 . . . . 0.0 109.133 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.3 m -149.97 170.9 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.165 0.986 . . . . 0.0 110.402 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.6 m -125.61 139.9 53.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.3 mt -137.27 145.1 30.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -120.19 140.33 51.3 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 171.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -124.55 172.81 8.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.459 1.504 . . . . 0.0 109.16 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.41 -154.82 13.7 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.27 149.99 39.43 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.79 135.89 50.32 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.736 2.291 . . . . 0.0 111.602 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -73.97 -15.15 61.12 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.517 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 30.3 tp 64.14 -36.58 0.18 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 129.032 2.933 . . . . 0.0 115.058 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.2 p 45.48 46.52 10.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.714 2.006 . . . . 0.0 112.642 174.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m -49.22 122.61 6.19 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.435 1.494 . . . . 0.0 110.749 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.9 p30 . . . . . 0 C--O 1.25 1.117 0 C-N-CA 126.133 1.773 . . . . 0.0 107.991 -177.801 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.8 -20.3 72.2 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 123.596 0.617 . . . . 0.0 113.338 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -146.77 160.41 42.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.388 1.875 . . . . 0.0 107.447 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -80.09 33.77 0.29 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.714 1.206 . . . . 0.0 112.53 -170.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -143.81 160.16 41.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.999 1.72 . . . . 0.0 108.592 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -63.46 -28.62 70.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.959 0.504 . . . . 0.0 112.073 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -156.79 171.75 19.85 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.95 1.7 . . . . 0.0 108.568 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.77 164.41 6.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.061 0.945 . . . . 0.0 111.189 174.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 tp 44.59 54.47 6.47 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.281 1.833 . . . . 0.0 112.375 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.04 7.46 7.96 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.468 1.507 . . . . 0.0 110.869 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 m -65.74 -12.57 54.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.09 1.756 . . . . 0.0 113.716 -177.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -59.44 155.35 15.11 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.402 1.081 . . . . 0.0 111.786 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' H ' ' CD ' ' A' ' 14' ' ' PRO . . . -148.23 -38.51 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 116.707 -1.616 . . . . 0.0 113.584 177.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.427 ' CD ' ' H ' ' A' ' 13' ' ' ALA . 74.5 Cg_exo -55.16 143.47 74.52 Favored 'Trans proline' 0 C--N 1.353 0.797 0 CA-C-N 122.173 1.812 . . . . 0.0 112.514 174.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.7 ttp85 -82.99 45.09 0.98 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.599 1.16 . . . . 0.0 108.983 174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.32 170.59 15.67 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.534 1.133 . . . . 0.0 112.799 -169.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -101.28 167.67 10.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.347 1.459 . . . . 0.0 109.8 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.39 155.0 36.76 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.437 0.695 . . . . 0.0 111.07 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.59 138.17 56.23 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 170.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -144.05 155.06 43.84 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.861 0.864 . . . . 0.0 108.941 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 p -78.88 142.88 36.44 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.594 1.158 . . . . 0.0 109.803 172.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.65 162.73 34.39 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.567 1.547 . . . . 0.0 109.29 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -159.0 175.18 13.86 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.59 2.756 . . . . 0.0 106.837 178.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -132.56 156.97 79.48 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.758 0.823 . . . . 0.0 109.569 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.5 156.38 81.87 Favored 'Cis proline' 0 CA--C 1.536 0.584 0 CA-C-N 119.729 0.939 . . . . 0.0 111.824 -5.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.33 167.68 29.57 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.37 1.468 . . . . 0.0 107.59 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.64 61.61 3.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.932 1.293 . . . . 0.0 110.056 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.5 mt -139.15 154.37 48.08 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.081 1.752 . . . . 0.0 108.683 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.3 tp -148.45 127.66 12.94 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -123.34 149.83 44.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.96 164.45 33.72 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.8 1.24 . . . . 0.0 110.114 -176.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.6 tp -86.73 133.98 33.62 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 171.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -150.18 129.43 12.82 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.84 1.256 . . . . 0.0 108.066 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 45.25 50.01 9.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.317 1.447 . . . . 0.0 112.367 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 62.35 18.45 10.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.704 1.602 . . . . 0.0 114.318 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 -127.72 143.51 51.14 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.75 -1.218 . . . . 0.0 109.179 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.28 127.74 39.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 169.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.43 145.37 48.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.641 1.576 . . . . 0.0 108.599 -176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.08 107.62 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.81 1.644 . . . . 0.0 106.861 171.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.89 -29.68 44.52 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.788 0.835 . . . . 0.0 111.826 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -147.95 143.18 27.15 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.1 4.4 0.1 OUTLIER Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.915 -174.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -136.11 46.54 2.29 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.319 1.447 . . . . 0.0 109.225 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.7 -19.28 10.29 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.17 -19.84 62.03 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.58 1.552 . . . . 0.0 112.594 172.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.88 -138.16 2.39 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.2 pt -128.68 20.74 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.92 1.288 . . . . 0.0 110.911 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -75.33 20.27 0.15 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.833 1.253 . . . . 0.0 113.247 -171.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.7 m -61.8 172.74 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 120.764 -1.21 . . . . 0.0 110.474 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.49 3.94 64.43 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.721 -1.044 . . . . 0.0 112.626 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -55.81 128.46 35.05 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.936 1.368 . . . . 0.0 108.096 169.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.02 141.13 30.52 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.36 140.59 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.6 mt -122.52 -32.31 3.62 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.616 -174.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.29 160.12 42.66 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.773 1.169 . . . . 0.0 110.672 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.0 mt -140.4 139.21 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 173.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.0 p30 47.27 21.58 0.2 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.102 2.161 . . . . 0.0 114.556 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.86 -27.84 18.46 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.484 1.516 . . . . 0.0 113.013 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 73.7 mtm -74.79 117.93 17.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.709 1.254 . . . . 0.0 109.675 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.72 135.54 55.22 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 169.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.4 m -97.87 126.9 50.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.596 0.712 . . . . 0.0 109.578 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -72.88 74.93 1.16 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.909 1.684 . . . . 0.0 107.874 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.34 -70.85 0.35 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 126.823 2.154 . . . . 0.0 113.12 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -134.21 12.84 3.89 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.936 1.295 . . . . 0.0 112.209 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -125.9 146.14 49.96 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.0 p -69.76 171.75 8.67 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.99 0.814 . . . . 0.0 109.924 172.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.03 75.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.56 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.06 -40.08 78.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 111.512 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.31 0.26 6.88 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.459 1.028 . . . . 0.0 114.378 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -59.69 136.24 57.93 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.375 1.587 . . . . 0.0 108.305 174.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.86 128.89 38.16 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.32 -41.74 88.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.283 1.033 . . . . 0.0 111.162 -171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.9 mt -66.66 -42.46 86.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.317 0.962 . . . . 0.0 110.295 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.52 -42.43 92.05 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -60.91 -53.14 60.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.845 0.858 . . . . 0.0 110.248 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.3 mt -66.27 -26.95 67.58 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.766 -0.584 . . . . 0.0 110.477 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.77 -15.31 77.99 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.421 -1.211 . . . . 0.0 113.778 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -84.39 112.99 45.9 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.787 1.793 . . . . 0.0 110.464 -177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.526 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 64.7 Cg_endo -68.24 -22.42 40.32 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.939 1.759 . . . . 0.0 114.117 -171.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.57 -10.99 21.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.761 0.71 . . . . 0.0 112.825 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.71 28.21 3.6 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.39 1.076 . . . . 0.0 111.956 173.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.526 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 6.4 m-30 -53.14 -47.57 95.35 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 116.643 -1.646 . . . . 0.0 112.633 169.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.22 104.82 1.6 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 122.102 1.787 . . . . 0.0 110.581 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.81 157.65 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.597 0.759 . . . . 0.0 109.961 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.6 m -84.27 146.25 27.86 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.0 mt -136.46 144.89 31.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -117.81 132.46 56.44 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 169.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -141.53 165.05 28.57 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.01 -174.16 37.99 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -173.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -68.09 158.72 83.11 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.789 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -49.94 157.34 2.78 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.525 2.817 . . . . 0.0 115.091 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -61.64 -10.02 7.46 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.935 1.694 . . . . 0.0 113.552 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -139.39 179.94 6.25 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.853 2.061 . . . . 0.0 108.881 -173.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -16.34 3.64 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.912 2.085 . . . . 0.0 115.383 -169.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.1 m -51.58 135.37 28.44 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.482 1.037 . . . . 0.0 110.559 173.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 . . . . . 0 C--O 1.249 1.04 0 C-N-CA 123.807 0.843 . . . . 0.0 111.794 -169.955 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.25 172.48 44.48 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -60.38 -29.8 69.18 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.282 0.541 . . . . 0.0 112.448 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -62.55 -46.98 85.87 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.812 -0.555 . . . . 0.0 110.443 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -69.12 -33.75 73.98 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.05 0.54 . . . . 0.0 110.244 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -62.57 -17.69 60.58 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.363 1.065 . . . . 0.0 111.838 172.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 66.9 m80 46.74 47.52 15.0 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.219 1.807 . . . . 0.0 110.762 -170.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -153.78 171.57 18.69 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.071 0.948 . . . . 0.0 109.942 -173.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -75.19 169.5 17.9 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -104.59 144.75 31.27 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.487 1.115 . . . . 0.0 108.407 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.3 p -149.3 158.72 44.41 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.641 0.776 . . . . 0.0 110.081 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -82.67 -24.25 33.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.652 1.181 . . . . 0.0 111.997 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.96 18.88 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -169.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.0 145.5 32.93 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.986 2.458 . . . . 0.0 113.163 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -152.32 151.62 31.1 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.748 1.219 . . . . 0.0 108.15 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.28 161.71 24.34 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 169.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 46.95 43.12 13.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.331 1.453 . . . . 0.0 112.357 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.48 145.14 41.64 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 169.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -143.16 137.64 29.2 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.265 0.938 . . . . 0.0 109.549 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -159.37 156.78 29.13 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.305 1.042 . . . . 0.0 109.32 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -79.44 142.46 35.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.936 1.695 . . . . 0.0 110.414 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.07 160.53 40.73 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.341 1.056 . . . . 0.0 110.296 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.3 m -150.87 175.13 12.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.271 2.228 . . . . 0.0 107.388 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -127.19 158.99 67.44 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 0.0 108.269 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.64 145.14 45.47 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 120.058 1.056 . . . . 0.0 111.404 -10.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.7 tp -160.38 158.44 29.57 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.551 1.541 . . . . 0.0 107.297 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.21 -22.56 61.99 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.64 127.3 31.33 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.7 mt -138.79 157.0 46.88 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 173.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.27 153.22 42.02 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.901 1.28 . . . . 0.0 108.211 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.01 164.99 28.58 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.777 1.231 . . . . 0.0 109.072 173.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.1 tp -108.03 127.05 53.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -150.78 140.83 22.07 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.432 1.093 . . . . 0.0 108.241 175.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 46.73 43.89 13.37 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.184 1.393 . . . . 0.0 112.606 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 58.87 24.78 12.85 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.911 1.684 . . . . 0.0 113.75 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -130.03 139.15 51.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 O-C-N 120.834 -1.166 . . . . 0.0 108.33 174.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.34 127.46 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 mt -126.44 155.75 41.73 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.617 1.567 . . . . 0.0 109.036 -172.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.16 117.94 3.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 124.693 1.197 . . . . 0.0 107.905 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.13 -41.86 14.37 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.592 1.157 . . . . 0.0 110.881 175.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -150.49 160.52 43.72 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.401 1.881 . . . . 0.0 107.546 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.36 -9.72 3.51 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.197 -0.78 . . . . 0.0 113.298 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.09 -35.24 78.1 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.324 1.562 . . . . 0.0 113.474 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -66.46 -29.68 69.85 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 118.893 -0.575 . . . . 0.0 112.13 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.52 -39.15 53.8 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.827 0.74 . . . . 0.0 109.855 170.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.59 -17.38 0.42 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.679 1.133 . . . . 0.0 113.774 169.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.6 mm -89.17 97.95 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.918 1.359 . . . . 0.0 108.221 -169.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -57.93 129.51 42.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.762 0.825 . . . . 0.0 111.173 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.5 t -54.76 149.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.18 1.392 . . . . 0.0 110.364 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.61 -7.98 74.16 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 119.037 -0.869 . . . . 0.0 114.177 171.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -70.89 151.17 45.01 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.942 1.371 . . . . 0.0 108.074 169.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.67 147.76 25.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.286 1.035 . . . . 0.0 109.786 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.39 137.86 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 169.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.63 -37.55 3.94 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.824 1.249 . . . . 0.0 109.486 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.47 160.49 43.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.238 0.926 . . . . 0.0 110.391 169.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 93.1 mt -135.59 133.28 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 48.23 31.21 2.5 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.008 1.723 . . . . 0.0 112.561 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.74 -12.75 66.25 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.974 1.273 . . . . 0.0 113.635 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.9 mtt -80.09 108.41 13.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.01 1.405 . . . . 0.0 108.755 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.65 124.33 17.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -82.05 133.54 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.685 0.755 . . . . 0.0 109.407 -173.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -78.6 70.69 4.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.71 -58.46 0.33 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 128.187 2.803 . . . . 0.0 114.828 174.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -134.84 -5.28 2.45 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.894 2.078 . . . . 0.0 111.529 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -120.2 155.57 32.88 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.9 p -71.08 177.08 3.94 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.405 1.002 . . . . 0.0 110.085 170.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.73 77.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.601 169.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.33 -36.85 71.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.649 0.78 . . . . 0.0 111.532 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.87 4.8 8.51 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.625 1.107 . . . . 0.0 113.727 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -63.17 134.47 56.03 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.67 128.7 37.25 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.8 t -58.51 -39.79 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.701 0.801 . . . . 0.0 111.263 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.6 mt -65.45 -42.74 92.02 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.738 0.699 . . . . 0.0 110.328 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.51 -41.71 83.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.017 0.527 . . . . 0.0 109.687 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -59.82 -52.43 65.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.137 0.975 . . . . 0.0 110.395 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.5 mt -67.0 -34.15 77.12 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.641 0.376 . . . . 0.0 109.998 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.92 -17.89 73.9 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.517 -1.157 . . . . 0.0 113.783 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -75.31 114.12 32.5 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 119.545 1.672 . . . . 0.0 110.596 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.463 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 61.4 Cg_endo -67.54 -21.09 46.68 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.34 2.027 . . . . 0.0 114.014 -171.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.86 -11.35 55.39 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 176.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.95 28.52 2.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.507 1.049 . . . . 0.0 112.756 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.463 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 6.4 m-30 -48.75 -48.68 69.54 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 116.438 -1.744 . . . . 0.0 115.015 175.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.49 120.61 7.41 Favored 'Trans proline' 0 C--N 1.35 0.635 0 CA-C-N 122.497 1.928 . . . . 0.0 109.948 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.9 m -146.38 171.6 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.519 1.528 . . . . 0.0 109.926 -175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -120.38 137.06 54.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.24 -2.134 . . . . 0.0 105.24 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.1 mt -132.35 138.5 52.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -107.93 136.04 48.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 170.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -123.13 160.47 26.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.248 1.819 . . . . 0.0 108.746 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.08 178.16 39.56 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -70.97 147.03 93.7 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.49 161.59 34.38 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.314 2.009 . . . . 0.0 111.148 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 55.9 -174.65 0.05 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.9 1.68 . . . . 0.0 112.101 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -154.45 173.36 16.36 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.981 1.712 . . . . 0.0 108.48 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.5 p -59.29 -22.09 60.68 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.861 1.265 . . . . 0.0 113.835 -174.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m -65.46 -14.57 61.25 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.845 1.258 . . . . 0.0 113.321 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 124.611 1.165 . . . . 0.0 110.15 175.462 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mtp . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.63 175.77 47.68 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -135.77 14.64 3.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.411 1.085 . . . . 0.0 111.515 -173.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -151.25 159.89 44.11 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.647 1.579 . . . . 0.0 108.478 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -144.07 160.76 40.33 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.693 1.597 . . . . 0.0 108.109 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -133.71 10.62 4.0 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.734 0.814 . . . . 0.0 112.003 -171.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.27 142.79 51.05 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.347 0.659 . . . . 0.0 109.45 169.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -159.24 173.53 16.19 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.58 1.152 . . . . 0.0 109.468 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -135.25 123.4 22.93 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -145.13 66.87 1.24 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.48 1.112 . . . . 0.0 109.166 -169.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -56.89 159.5 4.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.16 0.984 . . . . 0.0 111.005 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -69.8 179.3 2.26 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.976 0.51 . . . . 0.0 110.261 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.05 158.65 73.37 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.596 1.158 . . . . 0.0 109.753 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.22 140.19 20.33 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.406 2.737 . . . . 0.0 112.235 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -61.92 -35.43 78.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.962 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.47 -42.55 0.1 Allowed 'General case' 0 C--O 1.229 -0.024 0 C-N-CA 124.442 1.097 . . . . 0.0 109.599 170.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.75 161.09 34.64 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.222 1.409 . . . . 0.0 109.084 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.08 173.82 14.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.025 1.73 . . . . 0.0 108.783 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -145.95 143.71 29.68 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.787 0.835 . . . . 0.0 108.879 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -148.79 173.12 13.59 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.778 1.631 . . . . 0.0 109.29 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 m -131.57 141.16 49.63 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.235 1.414 . . . . 0.0 107.327 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -145.67 167.47 23.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.465 1.506 . . . . 0.0 109.941 -170.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.4 m -144.16 175.1 10.32 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.594 2.357 . . . . 0.0 106.304 169.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -134.78 162.21 59.1 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.517 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.01 149.42 28.87 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.373 1.169 . . . . 0.0 112.429 -10.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -157.9 150.58 22.68 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.403 1.481 . . . . 0.0 107.243 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.79 59.63 3.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.195 0.998 . . . . 0.0 110.414 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.9 tp -140.11 135.74 32.85 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.833 2.453 . . . . 0.0 105.524 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -145.92 145.21 30.6 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.5 mt -130.58 154.05 48.25 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.79 1.636 . . . . 0.0 107.432 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 156.26 45.6 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.558 0.617 . . . . 0.0 110.793 -178.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.5 tp -90.65 128.26 36.56 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.902 1.281 . . . . 0.0 108.137 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -156.91 145.23 19.6 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.587 1.155 . . . . 0.0 108.137 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.8 t70 51.81 37.79 21.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.175 0.99 . . . . 0.0 111.404 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 55.23 17.57 2.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.301 2.241 . . . . 0.0 114.414 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.08 161.92 20.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.84 1.256 . . . . 0.0 108.216 174.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.4 t -97.5 134.54 35.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.46 150.48 41.49 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.198 1.399 . . . . 0.0 107.623 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.52 117.37 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.15 -29.41 31.59 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.06 0.544 . . . . 0.0 111.497 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -154.78 138.51 16.15 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.014 1.325 . . . . 0.0 107.494 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.63 102.89 0.16 Allowed Glycine 0 CA--C 1.52 0.359 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 -177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -121.51 -17.84 7.41 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.507 0.723 . . . . 0.0 112.504 -171.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -81.79 146.66 29.8 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 62.74 -26.4 0.06 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.452 2.301 . . . . 0.0 114.074 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.49 167.88 38.1 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.55 1.547 . . . . 0.0 109.44 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 pt -73.61 64.2 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 122.436 1.113 . . . . 0.0 109.44 170.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -61.45 -23.03 65.57 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.589 1.156 . . . . 0.0 111.065 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -44.63 139.31 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 119.271 0.941 . . . . 0.0 110.639 169.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.34 -15.64 38.84 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.031 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -76.95 148.24 36.46 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.948 1.374 . . . . 0.0 108.649 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.54 141.84 29.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.39 1.076 . . . . 0.0 109.319 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.8 t -72.62 141.49 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.0 mt -128.97 -30.65 2.21 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.427 1.091 . . . . 0.0 111.139 -172.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.61 158.97 41.95 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.122 1.328 . . . . 0.0 110.089 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.0 mt -140.72 135.26 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 106.176 -1.786 . . . . 0.0 106.176 173.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 50.27 28.7 3.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.542 1.537 . . . . 0.0 112.093 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.33 -9.53 63.95 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.805 1.193 . . . . 0.0 113.68 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.4 mtt -77.72 108.61 11.06 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.088 1.444 . . . . 0.0 108.495 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.74 114.4 1.54 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.286 1.434 . . . . 0.0 109.68 169.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.53 142.52 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 124.198 0.999 . . . . 0.0 108.447 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -125.31 113.57 17.77 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.158 2.183 . . . . 0.0 105.355 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.61 -113.83 5.98 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -116.84 23.5 11.9 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.354 1.061 . . . . 0.0 110.672 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -126.65 140.08 52.68 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.1 p -67.39 176.85 2.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.541 1.064 . . . . 0.0 110.013 174.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.95 -39.27 74.25 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.85 169.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.32 -39.56 74.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.546 0.738 . . . . 0.0 111.098 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.53 -2.59 6.12 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.655 1.122 . . . . 0.0 113.736 171.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -61.11 133.43 56.0 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.007 1.404 . . . . 0.0 109.182 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -59.78 120.38 9.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.6 t -54.47 -44.53 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.95 1.3 . . . . 0.0 111.696 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.71 -38.17 83.27 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.375 0.534 . . . . 0.0 110.392 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.37 -38.01 63.29 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.301 0.5 . . . . 0.0 110.272 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -58.69 -44.62 90.34 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.473 1.109 . . . . 0.0 110.296 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.25 -34.99 61.46 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.66 0.784 . . . . 0.0 110.983 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.7 -33.5 87.41 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.368 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -60.29 114.93 11.25 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.659 1.184 . . . . 0.0 110.071 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.486 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 73.6 Cg_endo -70.73 -15.01 33.46 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.792 1.661 . . . . 0.0 113.912 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.53 -14.82 54.92 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.36 0.982 . . . . 0.0 110.899 169.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -134.28 33.91 3.31 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.826 2.45 . . . . 0.0 108.721 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -64.54 -53.24 46.54 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.186 -1.387 . . . . 0.0 111.289 169.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.97 123.76 9.56 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 121.717 1.649 . . . . 0.0 109.262 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -150.95 164.47 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 124.214 1.006 . . . . 0.0 110.873 -172.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -118.51 140.63 49.57 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.2 mt -136.55 139.49 45.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -171.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.7 ttt85 -115.55 135.95 53.57 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 172.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -146.85 164.09 33.98 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.943 1.297 . . . . 0.0 108.467 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.26 -169.0 40.56 Favored Glycine 0 C--N 1.33 0.21 0 O-C-N 121.518 -0.738 . . . . 0.0 112.135 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -58.85 143.83 82.42 Favored Pre-proline 0 C--O 1.239 0.511 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.232 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -48.49 160.64 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.871 3.047 . . . . 0.0 113.761 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.79 169.91 19.41 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.883 1.273 . . . . 0.0 108.31 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.37 151.53 46.74 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.8 p -139.67 157.61 45.48 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.897 1.279 . . . . 0.0 108.053 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.7 m -68.86 -27.4 65.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.444 0.698 . . . . 0.0 111.577 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 C--O 1.248 1.009 0 C-N-CA 125.415 1.486 . . . . 0.0 109.689 171.72 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 119.481 -0.295 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.97 179.33 48.8 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.8 t60 46.2 47.47 13.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.633 1.573 . . . . 0.0 111.821 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -61.17 157.65 15.6 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.617 0.767 . . . . 0.0 109.949 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -56.89 145.83 28.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.047 0.539 . . . . 0.0 109.78 171.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -154.94 167.14 31.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.494 1.517 . . . . 0.0 108.436 -174.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 153.42 14.49 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.977 0.911 . . . . 0.0 111.55 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -135.15 171.55 14.28 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.857 1.663 . . . . 0.0 107.644 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.3 tp -125.76 52.68 1.64 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.384 1.474 . . . . 0.0 108.637 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -63.59 -30.31 71.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.246 1.018 . . . . 0.0 112.411 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.0 p -152.69 161.87 42.01 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.833 1.653 . . . . 0.0 107.669 172.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -58.46 -47.43 84.06 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.773 -0.579 . . . . 0.0 111.869 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.517 ' H ' ' CD ' ' A' ' 14' ' ' PRO . . . -145.83 -21.92 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 116.542 -1.694 . . . . 0.0 115.326 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.517 ' CD ' ' H ' ' A' ' 13' ' ' ALA . 71.2 Cg_exo -55.97 -13.29 8.7 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.65 2.234 . . . . 0.0 115.725 172.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -50.96 125.96 14.94 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.38 1.072 . . . . 0.0 110.466 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.15 -82.53 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 169.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 35.84 51.62 0.74 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.924 2.089 . . . . 0.0 112.222 -175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.15 144.94 56.36 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -145.61 138.33 25.9 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -176.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.9 158.45 38.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.458 0.703 . . . . 0.0 110.334 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 p -78.3 143.05 37.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.024 1.73 . . . . 0.0 108.574 169.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -144.48 167.79 21.66 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.171 0.988 . . . . 0.0 110.048 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.4 m -137.71 166.66 23.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.369 1.868 . . . . 0.0 107.219 171.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.01 153.83 39.77 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.739 -175.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.8 133.69 15.75 Favored 'Cis proline' 0 C--N 1.35 0.638 0 CA-C-N 120.7 1.286 . . . . 0.0 110.155 -7.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.8 tp -66.59 123.86 21.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.682 0.793 . . . . 0.0 111.147 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -62.67 -42.63 99.73 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 111.485 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 tp -75.56 57.54 0.97 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.704 1.601 . . . . 0.0 109.113 170.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 46.1 tp -53.64 141.37 26.24 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.338 -0.851 . . . . 0.0 109.342 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.1 mt -125.27 155.99 39.29 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.249 1.019 . . . . 0.0 109.635 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.67 153.66 50.84 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 tt -92.65 123.98 36.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -150.95 136.46 17.88 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.718 1.207 . . . . 0.0 108.386 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.29 39.97 17.16 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.271 1.428 . . . . 0.0 111.819 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 59.44 0.43 0.21 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.411 2.285 . . . . 0.0 115.272 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -95.99 -177.72 4.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 120.67 1.577 . . . . 0.0 107.777 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.2 m -123.35 139.95 48.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 169.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.5 mt -133.13 151.45 51.99 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.113 0.965 . . . . 0.0 108.828 -175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.55 105.66 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.514 1.526 . . . . 0.0 107.651 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.26 60.06 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.678 1.591 . . . . 0.0 111.706 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -150.94 159.16 44.74 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.851 0.861 . . . . 0.0 109.327 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.3 -23.54 0.08 OUTLIER Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.542 1.068 . . . . 0.0 111.138 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -142.61 154.89 44.81 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.222 2.209 . . . . 0.0 105.046 169.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -57.75 -37.11 73.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.606 0.639 . . . . 0.0 110.593 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -161.87 125.01 3.06 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.74 169.89 31.83 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 118.424 0.556 . . . . 0.0 111.918 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 pt -63.02 -17.55 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.694 1.198 . . . . 0.0 114.095 -169.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -61.53 -37.61 84.38 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.957 1.253 . . . . 0.0 110.617 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.47 148.95 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.406 1.082 . . . . 0.0 108.884 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.32 0.75 86.56 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.26 -0.745 . . . . 0.0 114.271 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -72.1 162.82 28.91 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.599 1.2 . . . . 0.0 108.866 169.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.19 156.1 17.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.032 0.933 . . . . 0.0 109.131 170.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.42 144.61 11.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 169.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -114.35 -30.67 6.51 Favored 'General case' 0 CA--C 1.524 -0.034 0 CA-C-O 117.405 -1.283 . . . . 0.0 110.544 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.41 160.04 42.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.879 1.672 . . . . 0.0 111.793 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.9 mt -138.62 136.73 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 50.46 29.15 3.75 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.598 1.559 . . . . 0.0 112.272 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.21 -9.0 56.5 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.698 1.142 . . . . 0.0 113.65 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.4 mtt -80.37 111.97 17.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.091 1.445 . . . . 0.0 108.3 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -53.43 130.63 36.1 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 169.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -89.35 124.14 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.782 0.801 . . . . 0.0 109.496 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -76.48 80.24 3.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.018 1.327 . . . . 0.0 107.534 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.15 -58.73 1.08 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.91 2.195 . . . . 0.0 114.614 172.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -143.55 2.38 1.24 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.283 1.833 . . . . 0.0 111.874 176.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.79 151.75 38.33 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 119.424 1.011 . . . . 0.0 108.327 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 p -68.07 173.81 4.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.608 1.095 . . . . 0.0 109.528 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.82 -38.15 72.19 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.764 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.83 -37.84 76.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.582 0.753 . . . . 0.0 111.573 175.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.53 3.17 6.13 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.498 1.047 . . . . 0.0 114.112 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.23 129.68 40.65 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.044 1.422 . . . . 0.0 107.805 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.1 129.83 41.15 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 174.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 t -52.67 -44.19 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.396 1.478 . . . . 0.0 112.826 -169.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.2 mt -67.1 -42.48 84.5 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.978 0.808 . . . . 0.0 110.435 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -69.03 -40.84 78.37 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -59.88 -43.79 94.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.254 1.022 . . . . 0.0 111.158 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.87 -36.88 62.3 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.276 0.631 . . . . 0.0 110.476 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.04 -31.15 78.54 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.772 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -54.83 118.72 18.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.017 1.327 . . . . 0.0 110.157 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.475 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 60.0 Cg_endo -66.79 -17.67 52.31 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.365 2.043 . . . . 0.0 113.741 -176.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.45 -13.83 62.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.13 0.877 . . . . 0.0 112.356 170.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -135.18 37.01 3.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.922 1.689 . . . . 0.0 109.617 -171.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.475 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.0 m-30 -63.48 -57.36 20.27 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.359 -1.305 . . . . 0.0 111.348 169.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.23 126.96 11.51 Favored 'Trans proline' 0 C--N 1.352 0.719 0 CA-C-N 121.459 1.557 . . . . 0.0 109.101 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 m -150.31 171.42 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.378 1.071 . . . . 0.0 110.365 -172.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.2 m -125.83 139.55 53.4 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 168.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.5 mt -136.27 140.2 44.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -118.56 132.33 56.21 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 172.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -141.66 163.4 33.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.561 1.545 . . . . 0.0 109.312 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.31 -165.37 38.56 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -170.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.94 143.0 95.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.98 160.71 32.58 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.048 1.832 . . . . 0.0 112.225 -174.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -129.85 151.62 50.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.0 tp -61.52 144.48 54.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.123 0.487 . . . . 0.0 110.211 -175.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.99 165.69 35.46 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.289 1.836 . . . . 0.0 107.317 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.5 m -62.22 -38.04 87.68 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.767 0.827 . . . . 0.0 112.847 -171.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.992 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.9 tttm . . . . . 0 N--CA 1.462 0.149 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.5 p -72.09 145.41 48.2 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.838 1.255 . . . . 0.0 110.823 173.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -139.95 159.08 42.99 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.965 1.306 . . . . 0.0 108.723 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.0 m -158.87 174.89 14.3 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.307 2.243 . . . . 0.0 106.701 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -141.5 159.6 59.94 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.733 0.813 . . . . 0.0 109.233 -173.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -64.4 154.27 74.63 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 120.036 1.049 . . . . 0.0 110.976 -10.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 tp -157.36 155.94 31.44 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.242 1.417 . . . . 0.0 107.67 -173.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -76.01 58.93 1.24 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.71 1.204 . . . . 0.0 110.224 171.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -153.23 133.62 13.57 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.73 2.012 . . . . 0.0 106.048 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.7 tp -139.25 145.44 39.21 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.0 mt -125.21 155.57 39.85 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.996 1.318 . . . . 0.0 108.605 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 164.64 29.52 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.209 1.404 . . . . 0.0 109.757 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.2 tp -98.19 127.45 44.14 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.33 138.24 27.72 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.292 1.437 . . . . 0.0 107.514 169.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 44.8 48.45 9.02 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.598 1.559 . . . . 0.0 113.18 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 56.91 30.45 18.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.278 1.431 . . . . 0.0 113.252 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -134.8 148.85 50.29 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.742 1.217 . . . . 0.0 108.379 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -92.32 125.68 44.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 mp -123.61 152.97 41.34 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 125.961 1.704 . . . . 0.0 108.926 -173.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.72 121.04 14.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.34 -38.05 14.44 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.904 1.282 . . . . 0.0 111.306 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.5 t80 . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 124.815 1.246 . . . . 0.0 108.355 179.622 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.86 -11.09 60.7 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.537 -1.146 . . . . 0.0 113.647 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -66.96 155.62 38.07 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.595 1.698 . . . . 0.0 108.291 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.67 140.64 52.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.922 1.289 . . . . 0.0 110.156 -169.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.14 146.2 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.9 mt -130.12 -35.17 1.61 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.695 1.198 . . . . 0.0 110.595 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.07 159.98 43.55 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.461 1.028 . . . . 0.0 110.117 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.3 mt -134.96 131.82 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.5 p30 42.92 24.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.579 2.352 . . . . 0.0 115.139 -173.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.25 -14.27 58.3 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.112 1.339 . . . . 0.0 112.902 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.6 mtt -74.73 105.86 6.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.813 1.307 . . . . 0.0 108.603 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.35 122.38 12.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.6 m -77.68 132.17 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.491 0.662 . . . . 0.0 109.385 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -74.79 73.46 2.08 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.768 1.627 . . . . 0.0 107.146 169.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.02 -72.29 0.4 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.627 2.06 . . . . 0.0 112.808 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -133.74 11.02 4.01 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.878 1.671 . . . . 0.0 111.947 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -120.79 154.88 35.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.4 p -69.62 175.39 4.19 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.483 1.038 . . . . 0.0 109.911 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.85 -37.89 77.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.407 169.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.43 -37.25 74.37 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.717 0.807 . . . . 0.0 111.661 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 6.24 7.77 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.528 1.061 . . . . 0.0 114.099 172.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.71 136.04 54.93 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.066 1.433 . . . . 0.0 107.385 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.43 128.07 34.76 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.0 t -56.45 -39.95 64.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.669 1.188 . . . . 0.0 111.633 -170.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.5 -40.47 93.1 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.702 0.683 . . . . 0.0 110.585 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.55 -39.17 67.67 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.414 0.552 . . . . 0.0 110.029 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -59.58 -46.54 88.63 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.6 1.16 . . . . 0.0 110.518 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.56 -33.9 60.67 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.66 0.784 . . . . 0.0 110.749 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.62 -30.84 75.18 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.381 -0.677 . . . . 0.0 112.742 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -62.28 115.32 15.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.511 1.125 . . . . 0.0 109.861 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.453 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.6 Cg_endo -70.47 -16.1 34.52 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.67 1.58 . . . . 0.0 114.003 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.35 -14.86 54.55 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.335 0.97 . . . . 0.0 111.147 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -134.64 28.93 3.58 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.376 2.27 . . . . 0.0 109.251 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.2 m-30 -60.77 -54.41 54.78 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 117.158 -1.401 . . . . 0.0 111.815 170.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.59 122.17 8.02 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.629 1.617 . . . . 0.0 109.673 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 m -149.74 172.02 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.734 1.214 . . . . 0.0 109.778 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -125.75 139.93 53.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.2 mt -133.41 147.72 31.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -170.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -119.47 130.6 55.32 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -152.71 164.77 37.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.28 -165.22 33.89 Favored Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -170.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.7 tttt . . . . . 0 C--O 1.236 0.387 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -80.04 144.43 33.2 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.201 1.4 . . . . 0.0 107.351 168.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -142.21 171.2 14.38 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.377 1.071 . . . . 0.0 110.234 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.9 m -156.22 175.68 13.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.0 2.52 . . . . 0.0 106.455 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -123.87 153.9 67.32 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.552 0.741 . . . . 0.0 109.909 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.17 -39.19 1.34 Allowed 'Cis proline' 0 CA--C 1.537 0.627 0 CA-C-N 119.64 0.907 . . . . 0.0 112.038 -5.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.9 tp 48.04 -75.54 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.087 2.955 . . . . 0.0 114.548 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -166.65 -28.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.531 2.333 . . . . 0.0 109.313 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.0 tp -55.69 131.76 47.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.806 1.642 . . . . 0.0 112.315 -174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.11 128.72 11.48 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.98 154.96 33.75 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 161.74 40.48 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.958 0.903 . . . . 0.0 109.961 -177.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.9 tp -96.25 125.4 40.74 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -153.2 144.15 22.9 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.434 1.093 . . . . 0.0 108.752 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.4 t70 47.87 39.34 10.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.583 1.153 . . . . 0.0 111.804 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 64.96 6.09 3.24 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.036 2.135 . . . . 0.0 115.877 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -118.67 149.71 40.96 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.965 1.257 . . . . 0.0 109.403 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.417 HG11 HG21 ' A' ' 72' ' ' VAL . 11.8 p -76.26 135.09 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 76.1 mt -126.49 149.55 49.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.868 1.267 . . . . 0.0 108.187 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.4 t -68.88 139.78 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -120.63 -41.6 2.58 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.936 0.895 . . . . 0.0 110.647 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 C--N 1.331 -0.205 0 C-N-CA 125.983 1.713 . . . . 0.0 106.766 170.328 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 CA--C 1.546 0.82 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.71 0.43 86.06 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.28 -0.887 . . . . 0.0 113.258 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -75.57 154.89 36.47 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.152 0.976 . . . . 0.0 109.544 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.84 147.06 27.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.7 t -74.28 144.56 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 172.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -111.1 -33.39 6.49 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 124.986 1.314 . . . . 0.0 109.847 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.47 160.22 41.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.198 1.363 . . . . 0.0 111.738 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.1 mt -136.05 135.74 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 49.34 30.34 3.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 112.076 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.87 -9.14 57.7 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.823 1.201 . . . . 0.0 113.686 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.2 mmt -84.27 119.12 24.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.102 1.451 . . . . 0.0 107.922 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -49.02 142.8 6.25 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.516 1.127 . . . . 0.0 109.834 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.3 m -111.3 149.1 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.822 0.82 . . . . 0.0 110.026 172.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -125.21 101.64 7.09 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.116 2.167 . . . . 0.0 105.907 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.02 -80.29 0.19 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.19 1.376 . . . . 0.0 110.622 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.42 25.49 0.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.996 1.318 . . . . 0.0 111.116 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -127.79 143.54 51.12 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.6 p -70.13 172.5 7.92 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.009 0.822 . . . . 0.0 110.387 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.87 -38.66 67.8 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.997 0.919 . . . . 0.0 110.861 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.51 -38.07 71.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.494 0.717 . . . . 0.0 111.529 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.71 3.1 7.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.907 1.241 . . . . 0.0 113.737 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.93 133.65 53.64 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.809 1.304 . . . . 0.0 108.167 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.22 120.82 13.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.417 HG21 HG11 ' A' ' 37' ' ' VAL . 27.3 m -58.9 -40.16 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -169.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.13 -40.52 68.03 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.986 1.266 . . . . 0.0 109.758 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.29 -44.81 93.97 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.792 0.724 . . . . 0.0 110.11 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -58.49 -44.42 89.4 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.164 0.986 . . . . 0.0 111.209 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.08 -37.8 72.45 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.289 1.036 . . . . 0.0 110.786 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.5 -30.62 73.19 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.124 0.869 . . . . 0.0 112.333 -175.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -58.01 114.45 8.58 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.31 1.044 . . . . 0.0 109.629 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 72.0 Cg_endo -70.87 -13.73 32.08 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.558 1.505 . . . . 0.0 113.749 -175.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.27 -15.24 56.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.417 1.008 . . . . 0.0 110.612 169.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -132.59 34.22 3.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.309 2.644 . . . . 0.0 108.468 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.449 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -65.0 -52.52 48.63 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 117.18 -1.39 . . . . 0.0 111.498 169.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.36 125.41 11.27 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.667 1.631 . . . . 0.0 108.87 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.05 171.04 2.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.195 0.998 . . . . 0.0 110.524 -170.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.5 m -125.61 138.85 53.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 169.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.3 mt -136.48 139.58 44.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.6 mtp-105 -117.24 132.66 56.58 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -143.76 167.05 23.21 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.361 1.464 . . . . 0.0 109.185 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.52 -165.72 38.96 Favored Glycine 0 CA--C 1.52 0.399 0 O-C-N 121.543 -0.723 . . . . 0.0 111.656 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 117.983 -1.008 . . . . 0.0 108.301 170.959 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.2 tttp . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.6 m -91.31 142.2 27.96 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -139.09 162.77 34.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.064 1.345 . . . . 0.0 109.28 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.5 p -153.94 176.67 11.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.017 2.527 . . . . 0.0 107.402 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -135.22 156.29 78.21 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.243 1.017 . . . . 0.0 109.481 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.11 -23.88 9.07 Favored 'Cis proline' 0 C--N 1.351 0.675 0 CA-C-N 119.945 1.016 . . . . 0.0 113.518 -0.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tt 37.7 -91.39 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.603 2.761 . . . . 0.0 113.06 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -160.58 -38.79 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.471 1.508 . . . . 0.0 110.06 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.2 tp -57.51 130.57 46.94 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.961 0.904 . . . . 0.0 109.533 171.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.1 mt -142.54 153.17 43.34 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.337 1.455 . . . . 0.0 107.729 170.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.44 154.53 36.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.676 1.19 . . . . 0.0 108.902 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.14 154.89 46.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.441 1.096 . . . . 0.0 109.122 170.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.4 tp -92.52 132.48 36.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.532 1.133 . . . . 0.0 108.374 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -153.61 139.66 18.3 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.624 1.17 . . . . 0.0 107.958 169.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 t70 44.3 49.61 7.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.649 1.58 . . . . 0.0 112.672 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 59.08 22.87 11.0 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.637 1.575 . . . . 0.0 114.211 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -129.41 156.64 43.76 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 120.931 -1.106 . . . . 0.0 108.841 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.26 130.88 52.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.41 153.5 38.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.882 1.273 . . . . 0.0 108.39 -173.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.11 104.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 125.905 1.682 . . . . 0.0 107.339 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.31 -39.54 68.16 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.678 0.791 . . . . 0.0 109.814 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 175.762 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.9 t . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.95 -10.22 63.58 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.745 -1.031 . . . . 0.0 113.57 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -71.59 170.66 12.93 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.272 1.536 . . . . 0.0 108.674 169.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.57 143.65 50.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.208 1.003 . . . . 0.0 109.662 -172.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 p -70.27 140.82 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 169.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -116.77 -32.39 5.15 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.791 1.636 . . . . 0.0 109.867 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.51 158.61 40.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.091 0.859 . . . . 0.0 110.394 169.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.2 mt -131.65 130.17 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 p30 40.15 27.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.918 2.487 . . . . 0.0 115.314 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.33 -16.18 57.0 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.161 1.363 . . . . 0.0 112.789 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.65 109.29 11.5 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.645 1.223 . . . . 0.0 108.102 171.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -51.62 141.1 17.08 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.691 1.197 . . . . 0.0 108.881 169.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -103.87 116.33 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.387 1.089 . . . . 0.0 110.223 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -76.92 86.67 3.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.659 1.584 . . . . 0.0 108.041 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.02 -78.71 0.4 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.01 1.291 . . . . 0.0 111.963 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -135.84 13.63 3.39 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.927 1.291 . . . . 0.0 112.639 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -126.42 145.69 50.37 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.7 p -69.76 170.25 11.35 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.823 0.82 . . . . 0.0 110.155 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.5 -38.06 68.67 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.728 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.8 -37.09 73.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.657 0.783 . . . . 0.0 111.784 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.3 4.24 7.74 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.769 1.176 . . . . 0.0 113.944 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -67.93 137.69 55.39 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.903 1.352 . . . . 0.0 107.867 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -67.88 127.69 33.73 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.82 -40.56 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.536 0.734 . . . . 0.0 111.419 -170.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.7 mt -65.36 -36.8 85.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.072 0.851 . . . . 0.0 110.815 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -74.46 -40.61 61.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.455 0.57 . . . . 0.0 109.688 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -59.24 -51.05 71.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.775 0.83 . . . . 0.0 110.103 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.29 -30.0 64.39 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.601 0.76 . . . . 0.0 110.627 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.7 -38.06 95.65 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.517 -0.602 . . . . 0.0 111.812 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -63.93 117.08 32.25 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 117.738 0.769 . . . . 0.0 109.003 173.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 65.9 Cg_endo -67.34 -12.14 34.73 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.987 1.792 . . . . 0.0 114.009 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.57 -17.55 46.98 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.455 1.025 . . . . 0.0 111.211 169.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -120.67 21.05 11.64 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.703 1.601 . . . . 0.0 110.332 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 3.1 m-30 -61.06 -59.25 14.38 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 117.075 -1.441 . . . . 0.0 110.166 170.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.55 106.13 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.833 1.689 . . . . 0.0 109.603 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.02 156.45 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 123.197 0.599 . . . . 0.0 110.438 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -84.28 142.19 30.42 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 169.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.6 mt -139.73 147.04 24.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -121.3 138.13 54.38 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -133.28 151.77 51.91 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.299 1.84 . . . . 0.0 109.655 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.96 -168.93 22.61 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -73.75 145.72 44.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.951 1.3 . . . . 0.0 109.632 169.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -142.74 163.7 32.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.405 1.482 . . . . 0.0 109.599 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 p -158.47 175.47 13.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.025 2.13 . . . . 0.0 107.612 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -137.22 158.86 71.68 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 123.816 0.847 . . . . 0.0 110.167 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.96 156.95 79.49 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.759 0.949 . . . . 0.0 111.271 -9.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 tp -158.03 159.36 36.29 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.768 1.227 . . . . 0.0 108.579 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.0 -31.57 72.73 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.795 0.838 . . . . 0.0 112.18 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 tt -67.59 121.47 15.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.1 mt -133.58 156.22 48.22 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.084 1.754 . . . . 0.0 107.94 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -131.79 155.4 47.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.172 0.989 . . . . 0.0 111.215 -169.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.53 153.72 40.71 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.723 1.209 . . . . 0.0 110.112 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.3 tp -78.66 130.75 36.21 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -153.55 138.49 17.2 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.831 1.252 . . . . 0.0 107.932 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.1 t70 48.44 43.56 19.8 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.19 1.396 . . . . 0.0 113.091 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 58.25 25.41 12.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.823 1.649 . . . . 0.0 113.336 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -130.15 167.99 17.5 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.305 1.842 . . . . 0.0 108.167 173.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.5 t -112.91 116.03 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.02 152.13 26.3 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.146 1.378 . . . . 0.0 109.201 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.05 104.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.979 1.712 . . . . 0.0 107.561 172.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.94 -32.6 57.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.827 1.251 . . . . 0.0 110.874 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 175.391 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 120.974 0.416 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.83 -16.17 60.7 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.119 -0.823 . . . . 0.0 113.333 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -69.19 166.49 18.24 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.708 1.254 . . . . 0.0 108.255 169.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.45 152.29 51.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.269 0.628 . . . . 0.0 111.124 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 83.4 t -66.24 142.45 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -126.4 -30.11 2.9 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.605 1.162 . . . . 0.0 110.906 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.79 158.01 43.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.06 1.3 . . . . 0.0 110.551 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.4 mt -139.97 135.15 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 49.6 28.84 2.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.604 1.562 . . . . 0.0 112.229 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.35 -11.28 66.12 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.119 1.342 . . . . 0.0 113.734 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.3 mtt -82.81 111.96 19.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.938 1.369 . . . . 0.0 109.076 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.74 131.48 50.42 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.3 m -90.42 119.43 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -72.91 98.49 2.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.085 1.354 . . . . 0.0 107.949 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.2 -93.59 0.09 OUTLIER Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -175.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 ptt85 -124.78 14.32 8.63 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.755 1.622 . . . . 0.0 112.226 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -123.54 148.08 46.66 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.5 p -68.87 172.93 5.83 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.563 1.074 . . . . 0.0 110.355 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.61 -38.56 75.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.596 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.69 -39.14 77.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.818 0.847 . . . . 0.0 111.412 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.3 1.59 7.22 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.604 1.097 . . . . 0.0 113.988 172.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -61.29 140.92 57.88 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 119.092 1.446 . . . . 0.0 108.776 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.71 127.37 31.69 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.3 t -56.45 -43.38 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.61 0.764 . . . . 0.0 111.698 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.9 -36.7 82.87 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.351 0.523 . . . . 0.0 110.458 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.28 -42.92 68.12 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.293 0.497 . . . . 0.0 109.691 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -58.88 -46.53 87.6 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.718 1.207 . . . . 0.0 110.634 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.16 -33.67 59.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.492 0.717 . . . . 0.0 111.005 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.1 -32.02 79.31 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.308 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -61.18 114.17 9.93 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.154 . . . . 0.0 109.939 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 84.2 Cg_endo -71.06 -14.66 32.12 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.638 1.559 . . . . 0.0 113.789 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.23 -15.42 57.03 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.436 1.017 . . . . 0.0 110.869 169.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -133.36 32.83 3.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.884 2.474 . . . . 0.0 108.639 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.451 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -64.97 -53.78 39.53 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.189 -1.386 . . . . 0.0 110.398 169.585 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.02 124.36 10.49 Favored 'Trans proline' 0 C--N 1.352 0.756 0 CA-C-N 121.559 1.593 . . . . 0.0 109.369 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.1 m -150.66 172.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.251 1.42 . . . . 0.0 109.778 -172.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 m -121.46 138.22 54.38 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.5 mt -136.49 140.39 43.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -114.62 138.12 51.05 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.734 1.614 . . . . 0.0 106.852 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -125.54 169.47 12.41 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.899 1.28 . . . . 0.0 110.164 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.55 -160.92 25.51 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 170.016 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.0 tptt . . . . . 0 C--O 1.233 0.218 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -79.84 141.49 36.14 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -138.25 161.29 37.25 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.008 1.323 . . . . 0.0 109.024 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.0 p -156.63 175.32 14.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.319 2.248 . . . . 0.0 106.983 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -139.83 161.5 55.86 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 123.924 0.89 . . . . 0.0 109.125 -171.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.08 145.83 60.99 Favored 'Cis proline' 0 C--N 1.351 0.669 0 CA-C-N 120.261 1.129 . . . . 0.0 111.262 -6.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 tp -159.74 162.07 34.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.125 1.77 . . . . 0.0 107.009 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.57 -28.69 69.52 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.369 0.668 . . . . 0.0 112.502 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.7 tp -57.54 126.0 25.39 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.967 0.907 . . . . 0.0 110.101 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.9 tp -147.47 151.61 36.69 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.204 1.401 . . . . 0.0 107.535 172.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -121.31 156.04 33.43 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.633 1.173 . . . . 0.0 109.598 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.51 151.65 51.26 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.688 0.795 . . . . 0.0 109.321 169.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.19 124.43 28.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -152.82 142.45 21.87 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.489 1.115 . . . . 0.0 108.337 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.69 44.11 17.24 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.487 1.515 . . . . 0.0 112.126 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 59.36 6.86 0.83 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.718 2.007 . . . . 0.0 115.319 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -109.56 -178.75 3.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.464 1.906 . . . . 0.0 107.439 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.55 130.37 74.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 169.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.5 mt -127.93 154.87 45.06 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.402 1.081 . . . . 0.0 108.769 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.6 t -58.72 111.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.244 1.418 . . . . 0.0 108.094 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.07 -36.55 24.81 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.573 1.149 . . . . 0.0 110.463 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 174.517 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 121.063 0.459 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.06 -9.63 65.76 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.214 -1.326 . . . . 0.0 113.939 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -68.44 155.2 40.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.093 1.947 . . . . 0.0 109.278 169.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.23 146.48 30.26 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.924 0.889 . . . . 0.0 109.619 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -81.09 139.1 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 169.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.75 -37.44 3.93 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.437 1.495 . . . . 0.0 109.761 -174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.7 160.18 44.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.667 1.121 . . . . 0.0 110.676 170.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.5 mt -136.82 131.41 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.285 1.9 p-10 36.83 34.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 128.564 2.746 . . . . 0.0 114.817 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.84 -15.85 57.94 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.469 1.509 . . . . 0.0 113.15 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.4 mtt -82.94 108.75 16.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.497 1.149 . . . . 0.0 108.948 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.03 133.26 55.38 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 m -98.01 125.24 51.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -88.84 100.05 12.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.266 1.826 . . . . 0.0 107.53 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.78 -80.96 0.23 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.855 1.217 . . . . 0.0 110.781 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.23 23.16 1.5 Allowed 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.131 1.372 . . . . 0.0 111.767 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -126.23 146.72 49.87 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.9 p -68.54 173.58 4.91 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.795 0.807 . . . . 0.0 110.338 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.16 -38.41 73.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.666 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -70.05 -39.52 75.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.744 0.818 . . . . 0.0 111.406 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.6 -1.59 6.45 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.653 1.12 . . . . 0.0 114.089 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -61.9 134.29 56.5 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.095 1.447 . . . . 0.0 108.566 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.14 126.11 26.67 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.4 t -56.68 -38.31 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.367 1.067 . . . . 0.0 111.703 -169.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.12 -40.25 94.22 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.548 0.613 . . . . 0.0 110.33 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -74.43 -38.29 63.07 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.939 0.496 . . . . 0.0 110.136 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -59.32 -45.99 89.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.365 1.066 . . . . 0.0 110.454 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.5 mt -76.97 -31.49 56.58 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.462 0.705 . . . . 0.0 110.874 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.26 -33.64 87.35 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.404 -0.664 . . . . 0.0 112.502 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -63.2 114.47 12.83 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.562 1.145 . . . . 0.0 110.136 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 88.5 Cg_endo -71.64 -15.75 30.36 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.632 1.555 . . . . 0.0 113.905 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.97 -14.24 44.99 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.313 0.96 . . . . 0.0 111.201 169.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -132.1 22.49 4.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.026 2.13 . . . . 0.0 109.881 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.464 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.7 m-30 -59.37 -53.63 64.15 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 116.942 -1.504 . . . . 0.0 112.117 171.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.84 112.06 3.45 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.827 1.688 . . . . 0.0 109.681 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 m -148.42 152.22 12.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 123.889 0.875 . . . . 0.0 110.069 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.4 m -84.58 144.11 28.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.0 mt -134.0 135.94 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -103.6 121.9 43.88 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -106.99 176.09 5.29 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.55 1.14 . . . . 0.0 108.348 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.03 173.31 44.67 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 173.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? . . . . . 0 N--CA 1.464 0.273 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.5 p -78.7 145.32 34.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.3 1.04 . . . . 0.0 109.515 169.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -141.08 158.49 43.85 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.51 1.524 . . . . 0.0 110.009 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.8 m -146.67 175.15 10.82 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.608 2.763 . . . . 0.0 106.84 175.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -140.05 165.05 33.43 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.428 1.091 . . . . 0.0 109.108 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.96 -31.77 0.68 Allowed 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 120.591 1.247 . . . . 0.0 114.446 -7.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.7 tp 44.52 -123.59 0.95 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.565 1.546 . . . . 0.0 109.736 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.55 43.85 0.59 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.973 1.26 . . . . 0.0 110.625 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.45 161.55 39.43 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.046 1.338 . . . . 0.0 109.75 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.8 tp -154.44 152.49 30.21 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.874 1.27 . . . . 0.0 108.613 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.1 mt -121.76 155.37 35.42 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.807 1.243 . . . . 0.0 109.617 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.25 154.82 43.48 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.515 1.126 . . . . 0.0 109.451 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.88 126.85 33.38 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -155.67 144.76 20.71 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.044 1.338 . . . . 0.0 108.258 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 50.72 43.21 28.03 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.335 1.054 . . . . 0.0 111.823 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.282 10.5 pt-20 50.41 26.46 2.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.174 2.59 . . . . 0.0 115.298 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 mtp-105 -134.68 159.84 40.0 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.157 -0.965 . . . . 0.0 110.76 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 m -80.37 131.85 33.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 169.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.0 mt -120.07 154.06 35.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.63 1.172 . . . . 0.0 108.252 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.99 106.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.988 1.315 . . . . 0.0 107.476 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.05 -37.07 66.99 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.703 0.801 . . . . 0.0 110.022 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.9 t80 . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 107.697 177.197 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.93 -7.56 74.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.107 -1.385 . . . . 0.0 114.021 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -73.22 163.95 27.38 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.015 1.908 . . . . 0.0 108.613 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.09 155.66 21.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.52 1.128 . . . . 0.0 110.467 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.9 t -71.86 136.88 24.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 169.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -111.71 -36.75 5.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.669 1.188 . . . . 0.0 109.473 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.67 160.24 43.7 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.305 0.957 . . . . 0.0 111.094 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.1 mt -132.84 132.66 59.38 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 45.76 32.76 1.31 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.503 1.921 . . . . 0.0 112.118 -174.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.5 -9.46 73.38 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.0 1.286 . . . . 0.0 114.069 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.2 mtt -83.4 115.94 22.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.067 1.434 . . . . 0.0 108.808 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -49.66 124.73 10.13 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.755 1.222 . . . . 0.0 110.335 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.08 140.34 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 109.91 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -79.32 67.68 5.11 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.556 1.542 . . . . 0.0 108.535 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.74 -66.0 1.11 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.203 1.859 . . . . 0.0 113.974 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -136.74 9.14 3.08 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.892 1.677 . . . . 0.0 111.79 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -120.4 152.16 38.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.4 p -66.84 171.47 5.29 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.851 0.834 . . . . 0.0 109.427 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.08 76.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.599 169.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.28 -37.84 74.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.556 0.742 . . . . 0.0 111.578 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.76 1.94 6.32 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.359 -1.245 . . . . 0.0 115.878 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -69.11 144.52 53.88 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.315 2.058 . . . . 0.0 107.578 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.28 131.46 47.38 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.2 -37.39 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.345 1.058 . . . . 0.0 110.748 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.21 -40.22 95.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.082 0.401 . . . . 0.0 110.368 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -73.86 -41.79 61.72 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.391 0.541 . . . . 0.0 110.005 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -58.65 -51.1 71.34 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.251 0.62 . . . . 0.0 110.103 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.9 mt -76.76 -30.32 56.5 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.783 0.833 . . . . 0.0 110.848 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.3 -36.73 93.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.0 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -62.92 117.06 28.92 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 117.918 0.859 . . . . 0.0 109.067 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.472 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 68.4 Cg_endo -67.79 -11.8 33.3 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.875 1.717 . . . . 0.0 114.165 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.82 -17.47 49.89 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.42 1.009 . . . . 0.0 111.012 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -121.85 23.61 10.01 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.18 1.792 . . . . 0.0 110.099 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.8 m-30 -61.54 -57.62 23.82 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 117.087 -1.435 . . . . 0.0 110.501 169.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.88 107.15 2.41 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.903 1.736 . . . . 0.0 109.715 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.93 171.23 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.135 0.974 . . . . 0.0 109.829 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.5 m -105.9 143.12 34.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.2 mt -139.35 148.21 23.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -120.61 136.41 54.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -121.27 162.47 20.2 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.154 1.382 . . . . 0.0 107.938 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.69 -175.54 41.47 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.6 mmt-85 . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 117.796 -1.097 . . . . 0.0 108.467 175.594 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.7 tttt . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.4 m -126.09 142.72 51.4 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.395 1.078 . . . . 0.0 108.593 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -142.05 -178.79 5.87 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 127.006 2.122 . . . . 0.0 107.46 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.5 m -151.56 157.2 41.92 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.798 -1.189 . . . . 0.0 108.685 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -77.25 154.95 82.26 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -81.68 0.87 47.56 Favored 'Cis proline' 0 CA--C 1.544 1.011 0 CA-C-N 119.823 0.972 . . . . 0.0 111.909 -10.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -54.92 -38.89 68.21 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 124.662 1.185 . . . . 0.0 111.482 -172.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -144.22 142.4 30.48 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 121.215 0.531 . . . . 0.0 109.924 169.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -160.17 13.9 0.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.39 2.676 . . . . 0.0 110.024 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.9 mt -82.22 69.45 8.95 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.903 1.281 . . . . 0.0 110.635 -169.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.48 155.59 50.08 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.245 1.418 . . . . 0.0 108.744 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.6 150.84 46.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.385 0.674 . . . . 0.0 110.624 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tt -79.11 124.78 28.64 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -155.29 143.16 19.91 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.593 1.157 . . . . 0.0 108.298 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 47.91 41.94 15.48 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.522 1.529 . . . . 0.0 112.612 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 53.47 26.78 5.8 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.292 1.837 . . . . 0.0 113.35 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -126.17 -176.1 3.55 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.94 2.496 . . . . 0.0 106.203 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.33 132.49 71.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.0 mp -121.0 147.15 45.89 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.652 1.181 . . . . 0.0 108.734 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.9 t -60.18 111.24 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 170.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.42 -30.49 37.7 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.692 0.797 . . . . 0.0 111.252 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 69.4 t80 . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 125.336 1.454 . . . . 0.0 107.541 169.919 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.2 t . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.55 -6.28 77.94 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.547 -1.14 . . . . 0.0 114.139 169.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -62.51 135.27 57.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.476 1.638 . . . . 0.0 107.47 169.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.13 147.88 26.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.048 0.939 . . . . 0.0 108.511 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.2 t -74.0 136.48 25.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.31 -37.18 7.76 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.159 1.784 . . . . 0.0 108.942 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.1 159.51 44.45 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.219 0.918 . . . . 0.0 111.068 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.57 139.53 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.65 34.11 3.46 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.685 1.994 . . . . 0.0 112.444 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.36 13.84 82.83 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.018 -0.879 . . . . 0.0 113.534 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.3 mmt -118.56 121.61 40.64 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.19 1.396 . . . . 0.0 107.508 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -50.8 139.1 17.41 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.593 1.157 . . . . 0.0 110.011 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.3 m -102.21 122.17 54.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -73.17 85.28 1.37 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.566 1.546 . . . . 0.0 107.187 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.34 -100.92 0.39 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -106.75 8.61 31.0 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.195 1.398 . . . . 0.0 111.887 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -127.82 150.02 50.02 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 119.291 0.95 . . . . 0.0 109.17 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.1 p -69.77 175.45 4.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.624 0.726 . . . . 0.0 110.457 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.51 -38.81 72.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.437 0.695 . . . . 0.0 110.696 169.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.72 -39.89 69.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.769 0.828 . . . . 0.0 111.371 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.2 -0.67 7.07 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.502 1.048 . . . . 0.0 113.94 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -58.75 135.95 57.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.936 1.368 . . . . 0.0 108.008 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.99 131.14 45.53 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.29 -38.63 70.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.009 0.924 . . . . 0.0 113.251 -169.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.6 mt -69.35 -38.72 78.25 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.337 0.971 . . . . 0.0 110.692 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.0 -41.93 85.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -60.46 -46.22 90.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.18 0.992 . . . . 0.0 111.323 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.0 mt -70.78 -38.35 73.39 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.978 0.511 . . . . 0.0 109.927 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.68 -28.13 69.75 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.763 0.697 . . . . 0.0 112.929 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -53.45 118.14 13.8 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.27 1.428 . . . . 0.0 109.96 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.39 -14.36 39.88 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.0 1.8 . . . . 0.0 113.504 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.7 -12.69 61.05 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.375 0.989 . . . . 0.0 112.026 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -128.79 41.41 3.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.94 2.096 . . . . 0.0 108.599 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -47.1 96.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.486 -1.245 . . . . 0.0 113.398 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.27 138.91 18.28 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 121.527 1.581 . . . . 0.0 108.356 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.63 130.72 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -172.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.9 m -105.06 138.93 40.51 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 mt -140.55 139.47 35.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -115.23 133.2 56.25 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -148.5 160.78 42.74 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.523 1.129 . . . . 0.0 109.035 -169.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.38 -173.74 43.15 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.453 ' HD2' ' H ' ' A' ' 90' ' ' ARG . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.521 0 O-C-N 121.192 -1.181 . . . . 0.0 107.878 173.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HE2' ' CE2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.9 m -79.67 142.75 35.25 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.42 ' CE2' ' HE2' ' A' ' 20' ' ' LYS . 89.3 m-85 -116.27 165.12 13.54 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.313 1.845 . . . . 0.0 109.324 -174.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -146.98 167.45 23.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.05 1.74 . . . . 0.0 107.079 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -116.36 161.0 33.78 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.211 1.004 . . . . 0.0 109.499 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -62.08 160.92 51.46 Favored 'Cis proline' 0 C--N 1.35 0.633 0 CA-C-N 119.762 0.951 . . . . 0.0 110.93 -10.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.434 ' HG ' ' H ' ' A' ' 28' ' ' LEU . 51.8 tp -139.67 149.75 44.07 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.771 0.829 . . . . 0.0 110.417 -169.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.4 -31.9 72.95 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.903 1.281 . . . . 0.0 112.586 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 26' ' ' LEU . 55.2 mt -63.59 144.81 56.7 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.284 0.634 . . . . 0.0 110.146 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -140.41 132.36 27.72 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.9 mt -113.56 155.58 25.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.696 0.798 . . . . 0.0 110.209 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 145.74 50.97 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.573 1.149 . . . . 0.0 108.836 170.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tt -75.5 130.69 39.29 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -150.62 130.13 13.01 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.285 1.034 . . . . 0.0 108.234 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.2 t0 47.93 47.48 18.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.416 1.486 . . . . 0.0 112.188 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 61.12 10.79 3.09 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.566 1.946 . . . . 0.0 114.876 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.8 mtm-85 -110.36 179.37 4.1 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.447 1.499 . . . . 0.0 108.537 169.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.27 131.74 72.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.4 mp -120.23 143.36 48.32 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.833 1.253 . . . . 0.0 108.245 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.52 105.5 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 125.851 1.66 . . . . 0.0 107.534 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.95 -29.6 24.98 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 124.334 1.054 . . . . 0.0 111.26 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.0 t80 . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 173.322 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.17 -6.49 66.31 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.985 -0.897 . . . . 0.0 112.702 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -63.96 158.97 20.96 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.11 153.12 41.91 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.308 1.043 . . . . 0.0 109.103 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.15 137.4 24.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.31 -36.81 3.02 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.507 1.123 . . . . 0.0 110.058 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.98 157.73 43.71 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.734 0.697 . . . . 0.0 109.889 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 83.9 mt -136.48 139.53 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 170.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 42.33 38.95 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.515 2.326 . . . . 0.0 112.626 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 10.14 77.32 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.725 -1.042 . . . . 0.0 114.075 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 98.7 mmm -121.65 120.28 34.28 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.029 1.415 . . . . 0.0 108.485 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.62 129.05 37.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.601 1.161 . . . . 0.0 109.161 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.15 144.37 9.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.54 0.686 . . . . 0.0 111.369 -171.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -78.82 62.91 3.42 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.047 1.339 . . . . 0.0 107.603 169.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.78 -112.58 4.21 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.407 1.004 . . . . 0.0 110.978 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.05 2.09 28.65 Favored 'General case' 0 N--CA 1.46 0.062 0 C-N-CA 123.697 0.799 . . . . 0.0 112.023 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -119.68 147.99 43.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 119.091 0.86 . . . . 0.0 109.613 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.8 p -69.95 175.63 4.28 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.722 0.773 . . . . 0.0 110.038 172.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.99 -38.63 79.61 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.59 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.14 -37.11 69.5 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.793 0.837 . . . . 0.0 111.598 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.36 6.4 8.89 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.498 1.047 . . . . 0.0 114.072 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -63.13 140.28 58.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.292 1.546 . . . . 0.0 107.83 170.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.62 125.2 26.15 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 169.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.56 -33.18 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.049 0.54 . . . . 0.0 111.577 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.1 -42.02 97.05 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.326 0.512 . . . . 0.0 110.034 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -68.58 -46.1 70.29 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.08 -46.17 85.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.436 0.694 . . . . 0.0 111.375 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.6 mt -78.12 -33.98 50.24 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.105 0.962 . . . . 0.0 110.436 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.33 -31.31 68.72 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.509 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -53.97 116.46 10.31 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.171 1.389 . . . . 0.0 110.67 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.428 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 61.2 Cg_endo -68.37 -17.44 44.25 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.028 1.819 . . . . 0.0 113.543 -175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.24 -11.64 59.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.927 0.785 . . . . 0.0 112.497 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -129.67 31.96 4.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.573 1.549 . . . . 0.0 110.07 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.6 m-30 -53.53 -51.26 77.65 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 116.776 -1.583 . . . . 0.0 113.629 176.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.43 125.3 8.95 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 122.153 1.805 . . . . 0.0 109.513 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.1 135.63 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.748 0.819 . . . . 0.0 108.984 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 m -84.62 134.52 34.38 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.8 mt -140.56 147.35 23.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -124.65 140.71 52.68 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -120.73 153.83 36.44 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.91 -179.99 33.21 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.4 mmt-85 . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 169.963 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -76.41 142.45 41.09 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -143.0 153.41 42.95 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.609 0.764 . . . . 0.0 109.587 172.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -144.07 174.71 10.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.038 2.135 . . . . 0.0 106.235 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -137.05 160.18 67.08 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.881 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -64.96 155.37 76.45 Favored 'Cis proline' 0 C--N 1.351 0.68 0 CA-C-N 120.249 1.125 . . . . 0.0 111.903 -5.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -157.58 155.38 30.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.425 1.49 . . . . 0.0 107.995 -173.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.25 -31.82 72.43 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.292 0.637 . . . . 0.0 112.164 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.44 139.96 56.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.732 1.213 . . . . 0.0 109.657 173.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.8 tp -146.55 153.78 40.76 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.9 mt -122.49 155.6 35.86 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.317 1.447 . . . . 0.0 108.291 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.18 153.49 51.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.437 0.562 . . . . 0.0 110.387 170.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.9 tp -90.94 123.8 34.71 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.294 1.438 . . . . 0.0 107.168 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -149.16 137.13 20.61 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.729 1.212 . . . . 0.0 108.34 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.2 t70 45.82 43.1 9.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.521 1.529 . . . . 0.0 112.605 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 53.98 32.02 14.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.757 1.623 . . . . 0.0 113.991 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -130.29 164.2 25.13 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 125.779 1.631 . . . . 0.0 107.511 169.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.2 t -122.28 117.88 53.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -116.45 147.36 41.77 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.211 1.404 . . . . 0.0 108.061 -169.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.84 108.98 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 173.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.03 -40.95 21.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.747 1.219 . . . . 0.0 111.578 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 . . . . . 0 C--O 1.233 0.188 0 C-N-CA 124.685 1.194 . . . . 0.0 108.512 -176.353 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.08 -12.79 57.18 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.3 0.952 . . . . 0.0 113.911 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -79.68 174.75 11.27 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.851 1.325 . . . . 0.0 109.086 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.64 148.33 51.52 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.087 0.555 . . . . 0.0 111.398 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.2 t -61.85 137.25 24.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.8 mt -120.21 -33.1 3.99 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.896 1.279 . . . . 0.0 109.423 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.0 159.91 44.27 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.492 1.042 . . . . 0.0 110.9 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.3 mt -132.05 130.94 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.7 p30 41.69 26.25 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.559 2.343 . . . . 0.0 115.091 -174.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.63 -15.32 57.3 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.174 1.369 . . . . 0.0 113.151 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 76.7 mtm -75.32 106.93 7.1 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.836 1.318 . . . . 0.0 108.957 172.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.7 125.55 22.8 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.2 m -80.38 128.25 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -75.36 74.95 2.45 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.471 1.509 . . . . 0.0 107.918 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.17 -70.95 0.79 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 126.458 1.98 . . . . 0.0 112.157 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -129.35 -4.82 4.85 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.706 2.402 . . . . 0.0 111.522 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -117.94 156.18 28.93 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.2 p -70.61 175.65 4.72 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.277 -0.89 . . . . 0.0 109.629 169.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.14 79.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.141 169.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.29 -29.64 67.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.548 1.139 . . . . 0.0 111.992 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.66 3.88 19.96 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.075 1.321 . . . . 0.0 113.385 170.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -71.41 136.26 47.63 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.96 129.05 38.51 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 171.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 t -55.75 -41.96 67.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.987 0.915 . . . . 0.0 111.356 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.5 mt -66.55 -37.28 84.65 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.72 0.691 . . . . 0.0 110.927 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.68 -43.48 65.93 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -58.06 -46.78 84.83 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.619 1.168 . . . . 0.0 110.749 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.88 -32.83 59.86 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.65 0.78 . . . . 0.0 111.128 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.89 -32.1 76.82 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.427 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -60.19 114.69 10.57 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.204 1.001 . . . . 0.0 109.814 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.7 Cg_endo -71.06 -15.87 32.22 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.72 1.613 . . . . 0.0 113.838 -175.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.96 -14.54 48.55 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.222 0.919 . . . . 0.0 111.105 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -133.52 27.27 4.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.311 2.244 . . . . 0.0 109.438 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.449 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.4 m-30 -59.4 -53.15 68.87 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-O 117.046 -1.454 . . . . 0.0 112.264 170.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.16 119.44 6.17 Favored 'Trans proline' 0 C--N 1.351 0.691 0 CA-C-N 121.813 1.683 . . . . 0.0 109.755 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 m -147.44 174.05 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.642 1.577 . . . . 0.0 110.031 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.2 m -125.67 137.81 53.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 168.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.9 mt -131.33 137.72 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -173.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.1 ttp-105 -116.62 135.01 54.15 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -141.86 165.12 28.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.852 0.861 . . . . 0.0 110.45 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.74 -173.68 33.64 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 124.28 0.943 . . . . 0.0 111.038 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.489 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.774 0.321 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -83.58 142.99 30.44 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.834 1.253 . . . . 0.0 108.43 169.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -142.66 174.93 10.2 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.959 0.903 . . . . 0.0 110.343 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.9 m -151.22 175.53 12.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.905 2.482 . . . . 0.0 106.558 169.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.27 160.61 67.98 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.85 0.86 . . . . 0.0 110.24 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.25 -36.14 1.57 Allowed 'Cis proline' 0 C--N 1.351 0.704 0 CA-C-N 119.884 0.994 . . . . 0.0 111.425 -8.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 45.4 30.67 0.74 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.325 2.25 . . . . 0.0 114.156 169.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.7 t0 43.23 57.28 3.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.262 1.425 . . . . 0.0 112.192 -172.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.8 tp -144.28 140.7 29.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.932 1.693 . . . . 0.0 107.72 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.3 tp -146.95 142.01 27.09 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.657 0.783 . . . . 0.0 109.692 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -126.46 155.23 42.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.978 2.111 . . . . 0.0 107.165 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 153.43 41.17 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.053 0.842 . . . . 0.0 111.75 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.0 tp -73.55 127.67 33.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.891 1.676 . . . . 0.0 109.296 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -158.47 144.41 16.92 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.952 1.301 . . . . 0.0 108.406 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 51.36 39.81 25.04 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.935 1.294 . . . . 0.0 112.312 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 55.53 15.55 1.53 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.115 2.166 . . . . 0.0 114.658 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -118.71 -174.19 2.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.284 1.833 . . . . 0.0 107.102 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -123.26 142.09 41.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.4 mt -118.26 145.72 44.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.55 126.86 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 169.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -107.68 -38.05 5.98 Favored 'General case' 0 C--O 1.231 0.132 0 C-N-CA 123.483 0.713 . . . . 0.0 112.22 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.8 t80 . . . . . 0 C--O 1.233 0.231 0 C-N-CA 123.571 0.748 . . . . 0.0 108.995 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 121.057 0.456 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 1.21 38.8 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 117.846 -1.53 . . . . 0.0 113.634 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -60.95 136.68 58.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.281 2.04 . . . . 0.0 108.843 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.68 138.04 32.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.2 t -65.97 147.61 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 171.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.3 mt -126.37 -36.11 2.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.705 2.002 . . . . 0.0 109.488 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.7 159.48 44.08 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.005 0.82 . . . . 0.0 110.763 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 74.6 mt -136.08 136.0 49.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 45.78 32.67 1.3 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.918 2.087 . . . . 0.0 112.882 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.61 7.57 75.17 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.159 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.5 mmt -114.18 120.64 41.2 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.92 1.36 . . . . 0.0 107.894 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -53.43 133.87 40.47 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.275 1.03 . . . . 0.0 109.132 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.24 145.67 12.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.462 0.649 . . . . 0.0 110.133 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -78.06 62.59 2.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.762 1.625 . . . . 0.0 108.264 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.04 -107.79 1.07 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.876 1.227 . . . . 0.0 111.137 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -76.91 -6.88 54.25 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.339 1.056 . . . . 0.0 112.372 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -120.62 146.56 46.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 119.042 0.837 . . . . 0.0 109.247 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.6 p -69.17 177.32 2.79 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.66 0.743 . . . . 0.0 110.386 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.76 75.0 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.563 169.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.11 -38.2 63.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.753 0.821 . . . . 0.0 111.633 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.57 4.72 8.05 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.551 1.072 . . . . 0.0 113.92 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -61.8 140.66 58.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.198 1.499 . . . . 0.0 107.995 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -68.26 124.8 24.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.29 -32.9 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 122.93 0.492 . . . . 0.0 111.629 -170.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.89 -39.84 95.11 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.91 0.777 . . . . 0.0 110.662 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.22 -42.69 71.95 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -58.7 -44.69 90.4 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.8 0.84 . . . . 0.0 111.283 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.53 -32.17 53.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.482 1.113 . . . . 0.0 110.829 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.35 -28.31 73.33 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.94 0.781 . . . . 0.0 112.522 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -61.41 114.36 10.69 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.373 1.069 . . . . 0.0 109.279 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.465 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 94.4 Cg_endo -71.52 -13.05 30.0 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.347 1.365 . . . . 0.0 113.847 -175.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.66 -14.78 55.14 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.429 1.013 . . . . 0.0 110.66 169.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -132.91 33.43 3.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.297 2.639 . . . . 0.0 108.749 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -66.57 -53.49 28.97 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 117.099 -1.429 . . . . 0.0 111.562 169.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.7 125.84 12.07 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 121.786 1.673 . . . . 0.0 108.974 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 m -149.53 170.88 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.781 0.832 . . . . 0.0 111.302 -169.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.8 m -125.59 133.22 52.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.2 mm -128.93 137.47 57.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.3 ttt85 -112.29 133.41 54.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -144.69 166.41 25.27 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.773 1.229 . . . . 0.0 108.565 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.5 -173.22 37.59 Favored Glycine 0 N--CA 1.452 -0.28 0 O-C-N 121.813 -0.554 . . . . 0.0 111.805 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 118.507 -0.758 . . . . 0.0 109.093 -178.128 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -137.09 142.61 42.35 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -142.85 175.45 9.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.468 1.507 . . . . 0.0 110.529 -171.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.9 m -150.72 174.16 13.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.181 2.592 . . . . 0.0 106.197 169.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -132.78 159.59 71.93 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.524 -0.751 . . . . 0.0 109.922 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.62 155.96 82.55 Favored 'Cis proline' 0 CA--C 1.535 0.575 0 CA-C-N 120.009 1.039 . . . . 0.0 111.492 -6.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 tp -156.0 154.33 30.91 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.147 1.379 . . . . 0.0 108.267 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.6 56.46 1.45 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.16 1.384 . . . . 0.0 110.756 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.1 tp -142.91 135.98 28.15 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.924 2.09 . . . . 0.0 106.368 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.1 tp -145.84 143.65 29.76 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.0 mp -128.94 154.28 46.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.317 1.847 . . . . 0.0 107.365 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.91 152.69 42.33 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.041 0.837 . . . . 0.0 111.748 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.7 tp -71.82 129.26 38.19 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.906 1.282 . . . . 0.0 108.556 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -154.37 134.35 13.07 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.086 1.355 . . . . 0.0 108.087 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.3 t70 48.7 46.53 21.43 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.288 1.435 . . . . 0.0 112.578 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 55.69 16.1 1.84 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.41 1.884 . . . . 0.0 114.396 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.59 174.62 5.97 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 125.331 1.452 . . . . 0.0 107.387 169.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.65 133.8 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.0 mt -121.01 153.28 37.57 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.419 1.088 . . . . 0.0 108.313 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.8 122.35 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.75 -36.94 11.5 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.456 1.503 . . . . 0.0 111.235 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 t80 . . . . . 0 CA--C 1.529 0.145 0 C-N-CA 124.869 1.267 . . . . 0.0 107.935 173.454 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 120.884 0.373 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.82 -11.29 64.87 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.928 174.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -68.61 139.24 55.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.323 1.562 . . . . 0.0 107.478 169.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.36 143.4 27.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 p -76.02 135.38 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 168.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.62 -29.43 6.47 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.668 1.587 . . . . 0.0 110.071 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.39 160.25 43.85 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.573 1.079 . . . . 0.0 110.626 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.5 mt -138.71 134.54 42.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 44.8 36.08 1.71 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.328 1.851 . . . . 0.0 111.972 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.89 -16.3 57.19 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.449 1.499 . . . . 0.0 113.671 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.4 mmt -88.44 121.49 30.88 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.846 1.323 . . . . 0.0 109.014 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.42 135.98 32.38 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.337 1.055 . . . . 0.0 109.84 169.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 m -93.2 128.93 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.667 0.746 . . . . 0.0 109.029 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -73.81 76.93 1.6 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.849 1.66 . . . . 0.0 107.424 169.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.61 -79.06 0.25 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.68 1.61 . . . . 0.0 111.968 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -128.91 11.07 6.03 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.399 1.479 . . . . 0.0 112.048 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.51 152.15 42.05 Favored 'General case' 0 C--N 1.334 -0.077 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.2 p -71.64 174.69 6.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.36 0.982 . . . . 0.0 110.118 173.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.39 75.13 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.506 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.47 -37.61 71.31 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.784 0.834 . . . . 0.0 111.576 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.67 5.86 8.18 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.553 1.073 . . . . 0.0 114.088 173.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -63.28 137.81 58.32 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.171 1.486 . . . . 0.0 107.729 172.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -68.41 131.61 45.6 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 169.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -56.57 -41.42 73.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.576 1.15 . . . . 0.0 110.912 -174.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.4 mt -65.42 -37.65 87.55 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 118.091 0.405 . . . . 0.0 110.723 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.63 -45.32 68.76 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -60.14 -45.26 93.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.468 0.707 . . . . 0.0 111.405 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.49 -30.25 33.35 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.811 0.444 . . . . 0.0 111.156 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.43 -34.93 63.4 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.696 0.68 . . . . 0.0 112.0 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -60.39 117.66 26.53 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.353 1.061 . . . . 0.0 110.219 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.72 -31.57 32.19 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.771 1.647 . . . . 0.0 111.955 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.42 -3.56 1.46 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -169.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.41 45.18 2.84 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.14 1.376 . . . . 0.0 111.503 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -40.86 -55.15 4.87 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.36 117.97 5.39 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 122.264 1.844 . . . . 0.0 109.713 -172.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.52 131.13 34.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.7 m -98.8 139.02 35.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 mm -132.17 142.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -172.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 mtp-105 -119.79 139.88 51.64 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -128.35 170.41 13.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.229 1.412 . . . . 0.0 108.438 -173.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.85 -178.73 40.54 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.004 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 tttm . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -83.73 143.07 30.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.922 2.089 . . . . 0.0 110.62 172.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -140.1 162.71 34.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.461 1.104 . . . . 0.0 109.194 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.4 m -153.42 167.7 28.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.075 1.75 . . . . 0.0 107.044 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.63 175.87 3.32 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 117.392 -1.289 . . . . 0.0 109.73 -169.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.85 148.6 7.81 Favored 'Cis proline' 0 C--N 1.356 0.957 0 CA-C-N 122.614 1.969 . . . . 0.0 115.87 6.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.94 138.9 57.22 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.352 1.061 . . . . 0.0 111.014 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -136.12 20.48 3.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.622 1.569 . . . . 0.0 109.809 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 pp -148.15 169.36 20.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.234 3.014 . . . . 0.0 105.624 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.1 mt -143.21 145.82 33.12 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.9 mp -127.14 154.79 44.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.975 1.71 . . . . 0.0 107.178 174.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 154.08 43.79 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.738 0.815 . . . . 0.0 110.16 174.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.5 tp -76.29 121.86 23.57 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -153.25 144.2 22.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.288 1.435 . . . . 0.0 108.485 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 43.16 50.77 5.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.223 1.409 . . . . 0.0 111.753 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 60.05 7.76 1.28 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.821 2.048 . . . . 0.0 115.943 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -125.87 160.62 29.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.945 1.248 . . . . 0.0 109.851 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.31 124.41 40.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.4 mt -114.84 148.63 38.27 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.96 109.9 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.43 -38.11 71.4 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.8 1.24 . . . . 0.0 110.37 175.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.6 t80 . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 124.174 0.99 . . . . 0.0 109.146 171.96 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.4 0.55 70.05 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.733 -1.037 . . . . 0.0 114.013 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -65.89 136.38 56.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.235 1.517 . . . . 0.0 108.736 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.84 140.48 29.63 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.623 1.169 . . . . 0.0 108.988 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.99 142.62 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.2 mt -120.05 -32.57 4.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.313 1.045 . . . . 0.0 109.803 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.37 159.7 42.5 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.676 1.125 . . . . 0.0 110.75 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.433 ' CD1' HG13 ' A' ' 72' ' ' VAL . 96.9 mt -136.12 135.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 49.93 29.13 3.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.078 1.751 . . . . 0.0 112.122 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.63 -9.49 67.93 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.943 1.258 . . . . 0.0 113.795 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.3 mmt -85.62 115.16 23.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.973 1.387 . . . . 0.0 108.302 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -51.58 132.73 30.58 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.483 1.113 . . . . 0.0 109.559 169.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.71 133.97 32.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -78.15 71.77 4.64 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.325 1.45 . . . . 0.0 107.34 169.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.45 -59.6 0.29 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 128.032 2.729 . . . . 0.0 114.342 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -137.36 -4.61 1.86 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.003 2.121 . . . . 0.0 111.658 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -117.56 154.1 32.08 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.7 p -69.88 177.22 3.21 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.188 0.904 . . . . 0.0 110.113 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.32 -38.69 74.44 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.612 169.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.36 -37.93 68.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.672 0.789 . . . . 0.0 111.558 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.47 4.88 7.39 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.548 1.071 . . . . 0.0 113.874 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -64.22 136.93 57.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.785 1.292 . . . . 0.0 107.736 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.05 125.99 26.66 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.433 HG13 ' CD1' ' A' ' 56' ' ' ILE . 38.6 t -57.33 -37.39 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.191 0.596 . . . . 0.0 111.707 -170.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.47 -42.42 98.6 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.674 0.67 . . . . 0.0 110.09 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.66 -37.5 70.8 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.059 -0.401 . . . . 0.0 110.212 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -60.12 -43.62 95.48 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.801 0.84 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.62 -36.06 60.35 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.441 0.696 . . . . 0.0 110.575 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.13 -33.01 86.1 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.688 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -59.65 116.07 15.22 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.93 1.292 . . . . 0.0 110.453 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.6 Cg_endo -70.25 -14.6 34.7 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.92 1.746 . . . . 0.0 114.086 -177.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.51 -14.12 55.68 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.536 1.062 . . . . 0.0 110.901 169.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -135.58 34.74 2.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.764 2.426 . . . . 0.0 108.638 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.474 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -63.28 -55.4 36.48 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.669 -1.157 . . . . 0.0 111.583 171.413 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.32 127.99 13.24 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 121.382 1.529 . . . . 0.0 109.219 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.3 m -149.16 169.32 2.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 123.992 0.917 . . . . 0.0 110.852 -172.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.4 m -126.04 137.17 53.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 169.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.1 mt -132.73 143.59 39.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -123.55 130.81 53.22 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -138.47 172.2 13.25 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.054 0.942 . . . . 0.0 108.788 -176.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -176.46 39.41 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm . . . . . 0 C--O 1.236 0.354 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -73.17 145.06 46.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.67 1.188 . . . . 0.0 109.162 169.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -140.81 162.3 35.76 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.054 1.342 . . . . 0.0 108.849 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.1 m -148.34 175.64 10.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.384 2.274 . . . . 0.0 106.788 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -137.49 153.56 74.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.581 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.06 152.71 87.55 Favored 'Cis proline' 0 CA--C 1.538 0.691 0 CA-C-N 119.642 0.908 . . . . 0.0 110.412 -10.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.5 tp -160.66 170.88 19.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.222 1.409 . . . . 0.0 108.143 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.11 -33.21 68.88 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.286 1.035 . . . . 0.0 112.168 174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 tp -62.56 128.34 35.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.65 0.78 . . . . 0.0 109.841 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.6 tp -142.48 150.33 40.37 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.772 1.629 . . . . 0.0 107.2 172.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -132.59 155.54 48.51 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.507 1.123 . . . . 0.0 109.833 -170.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 155.42 44.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.788 0.835 . . . . 0.0 110.333 172.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.41 131.12 40.41 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.895 1.278 . . . . 0.0 107.83 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -152.72 138.76 18.19 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 t70 44.42 49.17 8.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.518 1.527 . . . . 0.0 112.839 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 60.22 14.54 4.64 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.991 1.716 . . . . 0.0 114.702 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 155.77 28.68 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 120.975 -1.078 . . . . 0.0 108.78 171.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.5 t -102.49 130.74 51.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.73 150.61 40.1 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.133 1.373 . . . . 0.0 107.967 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.56 108.01 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.74 -29.79 23.6 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.588 1.155 . . . . 0.0 111.759 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.794 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.99 -15.8 46.26 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.694 1.14 . . . . 0.0 114.03 173.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -72.33 158.6 35.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.095 1.447 . . . . 0.0 109.932 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.73 144.1 33.86 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.705 1.202 . . . . 0.0 109.271 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -63.61 152.04 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 174.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.6 mt -132.62 -41.5 0.95 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.645 1.178 . . . . 0.0 110.63 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.56 158.84 44.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.375 0.989 . . . . 0.0 110.368 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 78.4 mt -138.54 139.94 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 176.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 46.67 31.02 1.27 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.872 2.069 . . . . 0.0 112.745 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.66 18.48 65.81 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.709 -1.051 . . . . 0.0 113.816 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -125.29 133.05 52.78 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.036 1.418 . . . . 0.0 109.198 170.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -50.71 141.86 12.18 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.391 1.076 . . . . 0.0 109.579 169.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.4 m -115.13 128.74 72.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 122.146 0.975 . . . . 0.0 109.164 174.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -76.35 74.9 3.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.969 2.107 . . . . 0.0 108.967 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.93 -66.74 1.13 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.382 1.944 . . . . 0.0 112.943 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.59 9.47 2.43 Favored 'General case' 0 CA--C 1.526 0.051 0 C-N-CA 125.146 1.378 . . . . 0.0 112.457 175.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -121.51 143.68 49.13 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.7 p -71.64 174.01 7.32 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.257 0.935 . . . . 0.0 110.152 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.14 -38.18 76.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.469 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.67 -39.58 73.49 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.972 0.909 . . . . 0.0 111.406 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.78 -0.21 7.84 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.648 1.118 . . . . 0.0 114.187 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -61.48 143.69 55.49 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.181 1.49 . . . . 0.0 108.499 173.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -69.34 134.73 49.44 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 t -55.25 -45.7 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.771 1.228 . . . . 0.0 111.014 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.41 -36.41 81.22 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.478 0.581 . . . . 0.0 110.669 -176.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -70.63 -43.2 69.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.412 0.551 . . . . 0.0 109.746 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -60.28 -45.05 94.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.506 1.123 . . . . 0.0 110.703 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.39 -33.18 60.97 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.685 0.794 . . . . 0.0 111.001 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.43 -30.66 73.33 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.843 0.735 . . . . 0.0 112.456 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -60.49 114.56 10.46 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.285 1.034 . . . . 0.0 109.674 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 80.5 Cg_endo -70.87 -14.61 32.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.627 1.552 . . . . 0.0 113.832 -175.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.41 -15.04 56.41 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.393 0.997 . . . . 0.0 110.857 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -133.68 33.35 3.5 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.883 2.473 . . . . 0.0 108.648 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -65.24 -52.6 45.95 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 117.085 -1.436 . . . . 0.0 111.121 169.68 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.93 125.4 10.95 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.794 1.677 . . . . 0.0 109.251 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.1 m -150.45 171.83 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.188 1.395 . . . . 0.0 110.127 -170.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 m -125.74 138.72 53.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 169.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 mt -138.63 143.65 31.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -118.45 132.77 56.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -145.0 166.25 25.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.214 1.406 . . . . 0.0 107.317 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.74 -156.97 28.31 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.767 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -123.71 142.49 51.02 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.394 1.478 . . . . 0.0 108.086 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -141.73 167.18 22.77 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.607 0.718 . . . . 0.0 110.607 -173.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.8 m -155.07 174.47 15.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.719 2.008 . . . . 0.0 107.08 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -136.56 163.78 47.33 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.64 6.63 21.13 Favored 'Cis proline' 0 CA--C 1.541 0.856 0 CA-C-N 121.74 1.657 . . . . 0.0 114.562 5.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.1 tp -44.9 130.61 7.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.254 1.022 . . . . 0.0 110.023 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.59 123.88 17.79 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.251 1.02 . . . . 0.0 112.813 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.6 tp -161.27 153.41 19.87 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.763 2.425 . . . . 0.0 104.835 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 44.2 tp -147.05 137.21 23.37 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.642 1.11 . . . . 0.0 109.674 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.5 mp -131.06 150.62 52.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.433 2.293 . . . . 0.0 106.172 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 154.4 41.85 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.251 0.932 . . . . 0.0 111.196 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -77.4 124.61 28.11 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -154.73 144.72 21.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.235 1.414 . . . . 0.0 109.044 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 46.79 45.07 14.77 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.484 1.135 . . . . 0.0 111.655 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 62.5 0.92 0.68 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.378 2.271 . . . . 0.0 116.609 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -119.79 159.58 24.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 121.12 1.782 . . . . 0.0 109.97 173.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.84 131.76 33.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 169.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.9 mt -118.22 153.32 34.07 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.072 1.349 . . . . 0.0 107.572 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.43 121.77 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.07 -39.51 23.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.601 0.76 . . . . 0.0 110.409 171.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 61.7 t80 . . . . . 0 C--O 1.234 0.255 0 C-N-CA 124.154 0.982 . . . . 0.0 109.913 178.362 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.66 -8.76 67.59 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.809 -0.995 . . . . 0.0 113.719 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -77.93 143.98 37.22 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.302 1.551 . . . . 0.0 108.351 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.04 143.75 28.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.968 1.307 . . . . 0.0 109.724 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.04 143.53 15.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.95 -32.39 2.31 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.398 1.079 . . . . 0.0 110.583 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.61 158.83 44.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.902 1.228 . . . . 0.0 110.266 169.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -139.98 134.94 37.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 105.834 -1.914 . . . . 0.0 105.834 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 49.56 28.2 2.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.658 1.583 . . . . 0.0 112.46 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.17 -11.74 68.55 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.944 1.259 . . . . 0.0 113.799 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 78.8 mtm -80.35 112.63 17.87 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.303 1.551 . . . . 0.0 108.056 173.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.47 124.26 19.8 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.5 m -96.95 138.2 22.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 122.014 0.911 . . . . 0.0 110.865 -169.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -76.29 70.39 2.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.725 2.01 . . . . 0.0 108.622 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.13 -59.71 0.8 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 127.794 2.616 . . . . 0.0 114.395 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -142.86 0.89 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.792 2.037 . . . . 0.0 111.073 -174.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -124.76 144.64 50.14 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.8 p -68.35 175.58 3.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.034 0.834 . . . . 0.0 110.386 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.31 -38.43 74.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.671 169.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.22 -38.09 72.03 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.553 0.741 . . . . 0.0 111.502 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.4 4.7 7.5 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.827 1.203 . . . . 0.0 113.68 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -63.34 134.16 55.31 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -64.79 126.69 28.75 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.3 t -55.32 -42.44 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.476 1.111 . . . . 0.0 111.745 -170.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.67 -40.7 88.7 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.593 0.633 . . . . 0.0 110.311 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -69.95 -41.04 75.06 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.842 0.457 . . . . 0.0 110.034 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -59.33 -44.98 92.55 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.41 1.084 . . . . 0.0 110.875 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.17 -35.28 63.99 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.457 0.703 . . . . 0.0 110.629 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.67 -30.74 74.98 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.865 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -59.57 116.76 17.83 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.668 1.187 . . . . 0.0 110.149 177.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.47 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 74.2 Cg_endo -69.62 -15.66 37.74 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.896 1.731 . . . . 0.0 114.136 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.91 -14.26 52.14 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.439 1.018 . . . . 0.0 111.088 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -135.39 33.68 3.03 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.674 2.39 . . . . 0.0 108.828 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -62.4 -55.29 41.09 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.768 172.213 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.44 128.34 13.52 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 121.661 1.629 . . . . 0.0 109.41 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 m -147.93 164.69 5.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 123.551 0.74 . . . . 0.0 111.323 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -122.14 137.54 54.79 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.7 mt -137.76 133.94 45.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -107.13 138.01 44.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -145.22 168.6 20.02 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.748 1.219 . . . . 0.0 108.193 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.45 -174.18 44.48 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.0 mmm-85 . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.902 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -82.2 143.22 31.54 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.899 1.28 . . . . 0.0 109.019 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -143.66 168.44 19.88 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.23 1.412 . . . . 0.0 109.81 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.7 m -142.66 175.25 9.95 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.07 2.548 . . . . 0.0 105.951 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -133.96 159.74 71.22 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 119.071 0.851 . . . . 0.0 110.193 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.66 155.08 27.54 Favored 'Cis proline' 0 C--N 1.351 0.678 0 CA-C-N 120.261 1.129 . . . . 0.0 112.826 -10.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.454 HD13 ' H ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -153.6 156.34 37.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.93 1.292 . . . . 0.0 107.562 -176.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' H ' HD13 ' A' ' 26' ' ' LEU . 27.6 t70 -67.26 -30.4 70.28 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.96 0.904 . . . . 0.0 112.361 177.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.0 tp -59.03 133.8 56.42 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.341 1.056 . . . . 0.0 109.223 173.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.2 tp -140.14 141.97 36.02 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.86 1.264 . . . . 0.0 107.822 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.6 mp -127.09 155.4 43.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.294 1.838 . . . . 0.0 107.882 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 152.45 45.29 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.531 0.732 . . . . 0.0 110.58 173.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.12 128.72 34.23 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -151.68 138.27 18.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.48 1.112 . . . . 0.0 108.369 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.8 t70 44.8 50.5 8.72 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.828 1.651 . . . . 0.0 112.558 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 56.5 16.43 2.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.986 2.114 . . . . 0.0 114.456 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -126.38 -169.7 2.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.131 2.172 . . . . 0.0 107.553 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.38 136.48 56.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.6 mt -127.45 156.23 42.45 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.894 1.278 . . . . 0.0 108.601 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.6 t -65.43 122.33 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.98 -38.35 19.38 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.4 1.08 . . . . 0.0 110.623 172.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.9 t80 . . . . . 0 C--O 1.231 0.123 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.291 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.85 -7.6 73.56 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.638 -1.09 . . . . 0.0 113.688 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -72.22 158.92 34.97 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.443 1.621 . . . . 0.0 108.028 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.86 141.03 47.15 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 123.203 0.601 . . . . 0.0 110.52 -169.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.11 134.28 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.92 -25.58 4.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.865 0.866 . . . . 0.0 109.921 -172.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.44 153.83 42.32 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.72 1.145 . . . . 0.0 109.446 168.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.6 mt -136.64 137.19 47.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 46.79 33.5 2.18 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.089 1.756 . . . . 0.0 112.418 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.06 11.27 79.09 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.733 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.6 mmt -120.18 121.77 39.48 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.849 1.325 . . . . 0.0 108.294 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.75 124.28 16.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.341 1.056 . . . . 0.0 109.283 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.4 m -73.24 140.82 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -79.87 61.6 3.84 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.176 1.39 . . . . 0.0 107.849 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.95 -112.1 3.58 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.103 1.335 . . . . 0.0 110.843 -172.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -72.32 -13.23 61.44 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.449 1.099 . . . . 0.0 111.959 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -112.03 155.43 23.82 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.394 0.678 . . . . 0.0 109.397 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.2 p -71.95 175.44 5.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.41 -0.806 . . . . 0.0 109.454 169.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.65 80.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.517 169.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.61 -36.34 68.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.427 0.691 . . . . 0.0 111.457 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.41 -1.22 7.03 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.554 -1.137 . . . . 0.0 114.96 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -67.43 147.77 52.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.925 1.863 . . . . 0.0 107.829 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -66.33 130.95 44.95 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 170.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 t -53.99 -41.75 51.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 125.192 1.397 . . . . 0.0 111.311 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.2 mt -66.98 -39.67 87.23 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.547 0.612 . . . . 0.0 110.546 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -71.5 -37.9 71.21 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.349 0.522 . . . . 0.0 110.226 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -60.97 -53.74 53.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.019 0.928 . . . . 0.0 109.929 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.26 -32.5 73.96 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.05 -0.406 . . . . 0.0 110.122 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.53 -9.67 78.43 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.236 -1.313 . . . . 0.0 114.187 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -83.33 112.51 39.61 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 119.979 1.89 . . . . 0.0 110.343 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.515 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 84.0 Cg_endo -72.23 -16.33 28.27 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.651 1.567 . . . . 0.0 114.669 -170.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.19 -11.9 24.23 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.06 0.845 . . . . 0.0 112.136 169.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.8 31.1 3.06 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.952 1.301 . . . . 0.0 111.829 173.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.515 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.1 m-30 -53.52 -40.51 80.83 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 116.136 -1.888 . . . . 0.0 115.519 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.68 122.08 9.01 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 CA-C-N 123.117 2.149 . . . . 0.0 109.206 172.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.23 169.66 7.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.998 1.319 . . . . 0.0 110.374 -172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -126.19 138.1 53.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.2 mm -128.87 140.77 48.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -174.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -130.08 127.04 39.05 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -144.55 163.29 34.32 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.121 0.968 . . . . 0.0 111.321 -169.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.69 -170.93 37.0 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 170.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 m -106.86 142.77 35.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.352 1.061 . . . . 0.0 108.346 -176.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -141.55 161.81 37.01 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.889 1.276 . . . . 0.0 109.695 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.4 m -155.96 170.9 21.07 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.522 1.929 . . . . 0.0 107.189 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -136.94 161.83 59.29 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.85 0.86 . . . . 0.0 109.521 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.92 141.76 61.27 Favored 'Cis proline' 0 CA--C 1.536 0.612 0 CA-C-N 119.966 1.023 . . . . 0.0 110.317 -10.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.1 tp -161.54 -58.02 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.606 1.162 . . . . 0.0 107.985 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.76 135.44 6.52 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.481 1.913 . . . . 0.0 106.636 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.6 tp -145.32 31.56 1.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.285 1.034 . . . . 0.0 109.163 171.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.56 68.93 2.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.461 1.104 . . . . 0.0 109.579 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.04 155.73 30.94 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.045 2.138 . . . . 0.0 106.996 172.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.25 154.01 49.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.541 0.609 . . . . 0.0 110.375 171.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tt -81.99 122.6 28.0 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -157.26 145.49 19.33 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.698 1.199 . . . . 0.0 107.964 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.1 t70 54.66 37.66 28.59 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.477 1.111 . . . . 0.0 111.716 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 52.93 25.28 3.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.244 1.817 . . . . 0.0 113.136 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -128.6 -177.3 4.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 127.547 2.339 . . . . 0.0 107.289 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.2 t -120.75 127.82 75.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 169.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.2 mt -123.19 157.45 32.98 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.7 1.2 . . . . 0.0 109.09 -171.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.26 120.18 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.391 1.077 . . . . 0.0 108.4 171.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.41 -29.27 20.36 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.903 0.881 . . . . 0.0 111.314 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.7 t80 . . . . . 0 C--O 1.232 0.154 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 171.18 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.6 m . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.34 0.114 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.49 -13.22 68.04 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.327 -1.263 . . . . 0.0 113.989 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -67.14 153.44 43.66 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.792 1.796 . . . . 0.0 107.764 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.61 146.5 44.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.281 1.432 . . . . 0.0 110.151 -170.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -68.21 138.15 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 169.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.8 mt -121.9 -29.09 4.35 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.47 1.108 . . . . 0.0 111.013 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.91 158.29 43.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 120.084 1.311 . . . . 0.0 110.558 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -140.38 135.12 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 50.46 27.9 3.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.774 1.63 . . . . 0.0 112.377 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.07 -11.0 63.86 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.845 1.212 . . . . 0.0 113.633 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.5 mtt -78.69 107.92 11.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.958 1.379 . . . . 0.0 108.518 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.34 121.77 12.26 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.6 m -76.44 137.0 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.718 0.77 . . . . 0.0 110.755 -169.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -79.31 67.04 4.94 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 169.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.41 -107.54 1.03 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.828 1.204 . . . . 0.0 111.302 -173.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -77.66 -10.55 59.58 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.61 1.164 . . . . 0.0 112.121 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -116.02 155.28 28.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.016 0.826 . . . . 0.0 109.54 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -71.14 177.65 3.69 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.26 -0.9 . . . . 0.0 109.703 169.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.68 82.19 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.346 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.6 -38.99 74.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.895 0.878 . . . . 0.0 111.412 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.08 -2.61 6.79 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.517 1.056 . . . . 0.0 114.161 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -60.51 135.36 57.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.05 1.425 . . . . 0.0 108.265 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -68.43 129.96 41.46 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 t -53.96 -43.57 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.185 1.394 . . . . 0.0 112.087 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.67 -39.76 88.31 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.859 0.754 . . . . 0.0 110.502 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -69.51 -41.16 76.42 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -59.7 -45.2 92.83 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.248 1.019 . . . . 0.0 110.801 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.53 -34.49 60.77 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.21 0.604 . . . . 0.0 110.895 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.39 -32.12 78.59 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.513 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -60.22 115.55 13.76 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.754 1.222 . . . . 0.0 110.179 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.5 Cg_endo -70.49 -15.03 34.32 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.844 1.696 . . . . 0.0 113.988 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.97 -14.72 56.08 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.412 1.006 . . . . 0.0 110.986 169.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -135.26 34.96 3.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.744 2.418 . . . . 0.0 108.607 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.462 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -64.72 -54.59 34.89 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 117.543 -1.217 . . . . 0.0 111.371 169.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.82 125.04 10.68 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.521 1.579 . . . . 0.0 109.133 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.3 m -149.97 170.9 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.165 0.986 . . . . 0.0 110.402 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.6 m -125.61 139.9 53.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.3 mt -137.27 145.1 30.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -120.19 140.33 51.3 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 171.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -124.55 172.81 8.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.459 1.504 . . . . 0.0 109.16 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.41 -154.82 13.7 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.509 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 p -78.88 142.88 36.44 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.594 1.158 . . . . 0.0 109.803 172.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.65 162.73 34.39 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.567 1.547 . . . . 0.0 109.29 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -159.0 175.18 13.86 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.59 2.756 . . . . 0.0 106.837 178.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -132.56 156.97 79.48 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.758 0.823 . . . . 0.0 109.569 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.5 156.38 81.87 Favored 'Cis proline' 0 CA--C 1.536 0.584 0 CA-C-N 119.729 0.939 . . . . 0.0 111.824 -5.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.33 167.68 29.57 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.37 1.468 . . . . 0.0 107.59 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.64 61.61 3.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.932 1.293 . . . . 0.0 110.056 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.5 mt -139.15 154.37 48.08 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.081 1.752 . . . . 0.0 108.683 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.3 tp -148.45 127.66 12.94 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -123.34 149.83 44.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.96 164.45 33.72 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.8 1.24 . . . . 0.0 110.114 -176.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.6 tp -86.73 133.98 33.62 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 171.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -150.18 129.43 12.82 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.84 1.256 . . . . 0.0 108.066 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 45.25 50.01 9.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.317 1.447 . . . . 0.0 112.367 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 62.35 18.45 10.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.704 1.602 . . . . 0.0 114.318 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 -127.72 143.51 51.14 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.75 -1.218 . . . . 0.0 109.179 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.28 127.74 39.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 169.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.43 145.37 48.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.641 1.576 . . . . 0.0 108.599 -176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.08 107.62 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.81 1.644 . . . . 0.0 106.861 171.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.89 -29.68 44.52 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.788 0.835 . . . . 0.0 111.826 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.0 t80 . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.735 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.788 0.804 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.49 3.94 64.43 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.721 -1.044 . . . . 0.0 112.626 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -55.81 128.46 35.05 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.936 1.368 . . . . 0.0 108.096 169.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.02 141.13 30.52 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.36 140.59 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.6 mt -122.52 -32.31 3.62 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.616 -174.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.29 160.12 42.66 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.773 1.169 . . . . 0.0 110.672 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.0 mt -140.4 139.21 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 173.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.0 p30 47.27 21.58 0.2 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.102 2.161 . . . . 0.0 114.556 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.86 -27.84 18.46 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.484 1.516 . . . . 0.0 113.013 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 73.7 mtm -74.79 117.93 17.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.709 1.254 . . . . 0.0 109.675 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.72 135.54 55.22 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 169.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.4 m -97.87 126.9 50.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.596 0.712 . . . . 0.0 109.578 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -72.88 74.93 1.16 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.909 1.684 . . . . 0.0 107.874 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.34 -70.85 0.35 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 126.823 2.154 . . . . 0.0 113.12 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -134.21 12.84 3.89 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.936 1.295 . . . . 0.0 112.209 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -125.9 146.14 49.96 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.0 p -69.76 171.75 8.67 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.99 0.814 . . . . 0.0 109.924 172.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.03 75.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.56 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.06 -40.08 78.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 111.512 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.31 0.26 6.88 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.459 1.028 . . . . 0.0 114.378 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -59.69 136.24 57.93 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.375 1.587 . . . . 0.0 108.305 174.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.86 128.89 38.16 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.32 -41.74 88.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.283 1.033 . . . . 0.0 111.162 -171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.9 mt -66.66 -42.46 86.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.317 0.962 . . . . 0.0 110.295 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.52 -42.43 92.05 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -60.91 -53.14 60.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.845 0.858 . . . . 0.0 110.248 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.3 mt -66.27 -26.95 67.58 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.766 -0.584 . . . . 0.0 110.477 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.77 -15.31 77.99 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.421 -1.211 . . . . 0.0 113.778 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -84.39 112.99 45.9 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.787 1.793 . . . . 0.0 110.464 -177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.513 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 64.7 Cg_endo -68.24 -22.42 40.32 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.939 1.759 . . . . 0.0 114.117 -171.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.57 -10.99 21.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.761 0.71 . . . . 0.0 112.825 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.71 28.21 3.6 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.39 1.076 . . . . 0.0 111.956 173.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.513 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 6.4 m-30 -53.14 -47.57 95.35 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 116.643 -1.646 . . . . 0.0 112.633 169.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.22 104.82 1.6 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 122.102 1.787 . . . . 0.0 110.581 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.81 157.65 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.597 0.759 . . . . 0.0 109.961 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.6 m -84.27 146.25 27.86 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.0 mt -136.46 144.89 31.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -117.81 132.46 56.44 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 169.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -141.53 165.05 28.57 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.01 -174.16 37.99 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -173.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.789 171.946 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptp . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -79.44 142.46 35.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.936 1.695 . . . . 0.0 110.414 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.07 160.53 40.73 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.341 1.056 . . . . 0.0 110.296 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.3 m -150.87 175.13 12.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.271 2.228 . . . . 0.0 107.388 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -127.19 158.99 67.44 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 0.0 108.269 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.64 145.14 45.47 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 120.058 1.056 . . . . 0.0 111.404 -10.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.7 tp -160.38 158.44 29.57 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.551 1.541 . . . . 0.0 107.297 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.21 -22.56 61.99 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.64 127.3 31.33 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.7 mt -138.79 157.0 46.88 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 173.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.27 153.22 42.02 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.901 1.28 . . . . 0.0 108.211 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.01 164.99 28.58 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.777 1.231 . . . . 0.0 109.072 173.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.1 tp -108.03 127.05 53.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -150.78 140.83 22.07 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.432 1.093 . . . . 0.0 108.241 175.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 46.73 43.89 13.37 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.184 1.393 . . . . 0.0 112.606 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 58.87 24.78 12.85 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.911 1.684 . . . . 0.0 113.75 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -130.03 139.15 51.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 O-C-N 120.834 -1.166 . . . . 0.0 108.33 174.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.34 127.46 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 mt -126.44 155.75 41.73 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.617 1.567 . . . . 0.0 109.036 -172.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.16 117.94 3.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 124.693 1.197 . . . . 0.0 107.905 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.13 -41.86 14.37 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.592 1.157 . . . . 0.0 110.881 175.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--O 1.233 0.222 0 C-N-CA 126.401 1.881 . . . . 0.0 107.546 -178.133 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 CA--C 1.538 0.497 0 CA-C-O 120.822 0.344 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.61 -7.98 74.16 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 119.037 -0.869 . . . . 0.0 114.177 171.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -70.89 151.17 45.01 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.942 1.371 . . . . 0.0 108.074 169.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.67 147.76 25.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.286 1.035 . . . . 0.0 109.786 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.39 137.86 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 169.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.63 -37.55 3.94 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.824 1.249 . . . . 0.0 109.486 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.47 160.49 43.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.238 0.926 . . . . 0.0 110.391 169.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 93.1 mt -135.59 133.28 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.597 HD21 HG12 ' A' ' 84' ' ' VAL . 80.8 m-20 48.23 31.21 2.5 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.008 1.723 . . . . 0.0 112.561 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.74 -12.75 66.25 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.974 1.273 . . . . 0.0 113.635 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.9 mtt -80.09 108.41 13.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.01 1.405 . . . . 0.0 108.755 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.65 124.33 17.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -82.05 133.54 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.685 0.755 . . . . 0.0 109.407 -173.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -78.6 70.69 4.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.71 -58.46 0.33 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 128.187 2.803 . . . . 0.0 114.828 174.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -134.84 -5.28 2.45 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.894 2.078 . . . . 0.0 111.529 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -120.2 155.57 32.88 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.9 p -71.08 177.08 3.94 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.405 1.002 . . . . 0.0 110.085 170.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.73 77.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.601 169.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.33 -36.85 71.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.649 0.78 . . . . 0.0 111.532 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.87 4.8 8.51 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.625 1.107 . . . . 0.0 113.727 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -63.17 134.47 56.03 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.67 128.7 37.25 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.8 t -58.51 -39.79 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.701 0.801 . . . . 0.0 111.263 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.6 mt -65.45 -42.74 92.02 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.738 0.699 . . . . 0.0 110.328 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.51 -41.71 83.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.017 0.527 . . . . 0.0 109.687 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -59.82 -52.43 65.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.137 0.975 . . . . 0.0 110.395 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.5 mt -67.0 -34.15 77.12 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.641 0.376 . . . . 0.0 109.998 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.92 -17.89 73.9 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.517 -1.157 . . . . 0.0 113.783 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -75.31 114.12 32.5 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 119.545 1.672 . . . . 0.0 110.596 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.481 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 61.4 Cg_endo -67.54 -21.09 46.68 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.34 2.027 . . . . 0.0 114.014 -171.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.86 -11.35 55.39 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 176.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.95 28.52 2.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.507 1.049 . . . . 0.0 112.756 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.481 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 6.4 m-30 -48.75 -48.68 69.54 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 116.438 -1.744 . . . . 0.0 115.015 175.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.49 120.61 7.41 Favored 'Trans proline' 0 C--N 1.35 0.635 0 CA-C-N 122.497 1.928 . . . . 0.0 109.948 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.597 HG12 HD21 ' A' ' 57' ' ' ASN . 28.9 m -146.38 171.6 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.519 1.528 . . . . 0.0 109.926 -175.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -120.38 137.06 54.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.24 -2.134 . . . . 0.0 105.24 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.1 mt -132.35 138.5 52.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -107.93 136.04 48.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 170.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -123.13 160.47 26.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.248 1.819 . . . . 0.0 108.746 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.08 178.16 39.56 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.826 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 m -131.57 141.16 49.63 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.235 1.414 . . . . 0.0 107.327 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -145.67 167.47 23.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.465 1.506 . . . . 0.0 109.941 -170.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.4 m -144.16 175.1 10.32 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.594 2.357 . . . . 0.0 106.304 169.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -134.78 162.21 59.1 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.517 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.01 149.42 28.87 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.373 1.169 . . . . 0.0 112.429 -10.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -157.9 150.58 22.68 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.403 1.481 . . . . 0.0 107.243 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.79 59.63 3.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.195 0.998 . . . . 0.0 110.414 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.9 tp -140.11 135.74 32.85 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.833 2.453 . . . . 0.0 105.524 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -145.92 145.21 30.6 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.5 mt -130.58 154.05 48.25 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.79 1.636 . . . . 0.0 107.432 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 156.26 45.6 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.558 0.617 . . . . 0.0 110.793 -178.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.5 tp -90.65 128.26 36.56 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.902 1.281 . . . . 0.0 108.137 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -156.91 145.23 19.6 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.587 1.155 . . . . 0.0 108.137 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.8 t70 51.81 37.79 21.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.175 0.99 . . . . 0.0 111.404 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 55.23 17.57 2.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.301 2.241 . . . . 0.0 114.414 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.08 161.92 20.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.84 1.256 . . . . 0.0 108.216 174.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.4 t -97.5 134.54 35.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.46 150.48 41.49 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.198 1.399 . . . . 0.0 107.623 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.52 117.37 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.15 -29.41 31.59 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.06 0.544 . . . . 0.0 111.497 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 C--O 1.232 0.184 0 C-N-CA 125.014 1.325 . . . . 0.0 107.494 174.923 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 121.32 0.581 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.34 -15.64 38.84 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.031 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -76.95 148.24 36.46 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.948 1.374 . . . . 0.0 108.649 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.54 141.84 29.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.39 1.076 . . . . 0.0 109.319 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.8 t -72.62 141.49 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.0 mt -128.97 -30.65 2.21 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.427 1.091 . . . . 0.0 111.139 -172.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.61 158.97 41.95 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.122 1.328 . . . . 0.0 110.089 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.0 mt -140.72 135.26 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 106.176 -1.786 . . . . 0.0 106.176 173.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 50.27 28.7 3.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.542 1.537 . . . . 0.0 112.093 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.33 -9.53 63.95 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.805 1.193 . . . . 0.0 113.68 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.4 mtt -77.72 108.61 11.06 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.088 1.444 . . . . 0.0 108.495 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.74 114.4 1.54 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.286 1.434 . . . . 0.0 109.68 169.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.53 142.52 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 124.198 0.999 . . . . 0.0 108.447 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -125.31 113.57 17.77 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.158 2.183 . . . . 0.0 105.355 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.61 -113.83 5.98 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -116.84 23.5 11.9 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.354 1.061 . . . . 0.0 110.672 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -126.65 140.08 52.68 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.1 p -67.39 176.85 2.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.541 1.064 . . . . 0.0 110.013 174.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.95 -39.27 74.25 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.85 169.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.32 -39.56 74.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.546 0.738 . . . . 0.0 111.098 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.53 -2.59 6.12 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.655 1.122 . . . . 0.0 113.736 171.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -61.11 133.43 56.0 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.007 1.404 . . . . 0.0 109.182 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -59.78 120.38 9.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.6 t -54.47 -44.53 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.95 1.3 . . . . 0.0 111.696 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.71 -38.17 83.27 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.375 0.534 . . . . 0.0 110.392 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.37 -38.01 63.29 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.301 0.5 . . . . 0.0 110.272 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -58.69 -44.62 90.34 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.473 1.109 . . . . 0.0 110.296 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.25 -34.99 61.46 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.66 0.784 . . . . 0.0 110.983 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.7 -33.5 87.41 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.368 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -60.29 114.93 11.25 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.659 1.184 . . . . 0.0 110.071 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 73.6 Cg_endo -70.73 -15.01 33.46 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.792 1.661 . . . . 0.0 113.912 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.53 -14.82 54.92 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.36 0.982 . . . . 0.0 110.899 169.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -134.28 33.91 3.31 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.826 2.45 . . . . 0.0 108.721 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.458 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -64.54 -53.24 46.54 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.186 -1.387 . . . . 0.0 111.289 169.804 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.97 123.76 9.56 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 121.717 1.649 . . . . 0.0 109.262 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -150.95 164.47 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 124.214 1.006 . . . . 0.0 110.873 -172.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -118.51 140.63 49.57 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.2 mt -136.55 139.49 45.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -171.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.7 ttt85 -115.55 135.95 53.57 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 172.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -146.85 164.09 33.98 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.943 1.297 . . . . 0.0 108.467 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.26 -169.0 40.56 Favored Glycine 0 C--N 1.33 0.21 0 O-C-N 121.518 -0.738 . . . . 0.0 112.135 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 . . . . . 0 C--O 1.239 0.511 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.232 172.015 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 121.022 0.439 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 p -78.3 143.05 37.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.024 1.73 . . . . 0.0 108.574 169.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -144.48 167.79 21.66 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.171 0.988 . . . . 0.0 110.048 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.4 m -137.71 166.66 23.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.369 1.868 . . . . 0.0 107.219 171.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.01 153.83 39.77 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.739 -175.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.8 133.69 15.75 Favored 'Cis proline' 0 C--N 1.35 0.638 0 CA-C-N 120.7 1.286 . . . . 0.0 110.155 -7.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.8 tp -66.59 123.86 21.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.682 0.793 . . . . 0.0 111.147 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -62.67 -42.63 99.73 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 111.485 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 tp -75.56 57.54 0.97 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.704 1.601 . . . . 0.0 109.113 170.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 46.1 tp -53.64 141.37 26.24 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.338 -0.851 . . . . 0.0 109.342 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.1 mt -125.27 155.99 39.29 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.249 1.019 . . . . 0.0 109.635 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.67 153.66 50.84 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 tt -92.65 123.98 36.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -150.95 136.46 17.88 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.718 1.207 . . . . 0.0 108.386 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.29 39.97 17.16 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.271 1.428 . . . . 0.0 111.819 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 59.44 0.43 0.21 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.411 2.285 . . . . 0.0 115.272 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -95.99 -177.72 4.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 120.67 1.577 . . . . 0.0 107.777 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.2 m -123.35 139.95 48.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 169.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.5 mt -133.13 151.45 51.99 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.113 0.965 . . . . 0.0 108.828 -175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.55 105.66 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.514 1.526 . . . . 0.0 107.651 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.26 60.06 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.678 1.591 . . . . 0.0 111.706 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 t80 . . . . . 0 C--O 1.232 0.137 0 C-N-CA 123.851 0.861 . . . . 0.0 109.327 179.845 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.6 t . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.32 0.75 86.56 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.26 -0.745 . . . . 0.0 114.271 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -72.1 162.82 28.91 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.599 1.2 . . . . 0.0 108.866 169.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.19 156.1 17.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.032 0.933 . . . . 0.0 109.131 170.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.42 144.61 11.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 169.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -114.35 -30.67 6.51 Favored 'General case' 0 CA--C 1.524 -0.034 0 CA-C-O 117.405 -1.283 . . . . 0.0 110.544 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.41 160.04 42.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.879 1.672 . . . . 0.0 111.793 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.9 mt -138.62 136.73 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 50.46 29.15 3.75 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.598 1.559 . . . . 0.0 112.272 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.21 -9.0 56.5 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.698 1.142 . . . . 0.0 113.65 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.4 mtt -80.37 111.97 17.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.091 1.445 . . . . 0.0 108.3 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -53.43 130.63 36.1 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 169.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -89.35 124.14 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.782 0.801 . . . . 0.0 109.496 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -76.48 80.24 3.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.018 1.327 . . . . 0.0 107.534 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.15 -58.73 1.08 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.91 2.195 . . . . 0.0 114.614 172.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -143.55 2.38 1.24 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.283 1.833 . . . . 0.0 111.874 176.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.79 151.75 38.33 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 119.424 1.011 . . . . 0.0 108.327 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 p -68.07 173.81 4.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.608 1.095 . . . . 0.0 109.528 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.82 -38.15 72.19 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.764 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.83 -37.84 76.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.582 0.753 . . . . 0.0 111.573 175.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.53 3.17 6.13 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.498 1.047 . . . . 0.0 114.112 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.23 129.68 40.65 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.044 1.422 . . . . 0.0 107.805 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.1 129.83 41.15 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 174.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 t -52.67 -44.19 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.396 1.478 . . . . 0.0 112.826 -169.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.2 mt -67.1 -42.48 84.5 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.978 0.808 . . . . 0.0 110.435 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -69.03 -40.84 78.37 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -59.88 -43.79 94.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.254 1.022 . . . . 0.0 111.158 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.87 -36.88 62.3 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.276 0.631 . . . . 0.0 110.476 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.04 -31.15 78.54 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.772 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -54.83 118.72 18.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.017 1.327 . . . . 0.0 110.157 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 60.0 Cg_endo -66.79 -17.67 52.31 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.365 2.043 . . . . 0.0 113.741 -176.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.45 -13.83 62.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.13 0.877 . . . . 0.0 112.356 170.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -135.18 37.01 3.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.922 1.689 . . . . 0.0 109.617 -171.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.0 m-30 -63.48 -57.36 20.27 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.359 -1.305 . . . . 0.0 111.348 169.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.23 126.96 11.51 Favored 'Trans proline' 0 C--N 1.352 0.719 0 CA-C-N 121.459 1.557 . . . . 0.0 109.101 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 m -150.31 171.42 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.378 1.071 . . . . 0.0 110.365 -172.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.2 m -125.83 139.55 53.4 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 168.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.5 mt -136.27 140.2 44.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -118.56 132.33 56.21 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 172.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -141.66 163.4 33.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.561 1.545 . . . . 0.0 109.312 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.31 -165.37 38.56 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -170.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HD2' ' H ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.375 0.131 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.22 -61.43 4.39 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.779 1.181 . . . . 0.0 112.068 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 47.05 38.78 6.87 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.163 1.785 . . . . 0.0 112.302 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -64.07 155.49 31.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.168 0.987 . . . . 0.0 110.595 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -152.71 159.52 43.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.023 1.329 . . . . 0.0 108.336 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -152.94 155.38 36.88 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.69 1.596 . . . . 0.0 107.693 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -153.44 163.8 39.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.704 1.202 . . . . 0.0 109.582 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -66.21 172.68 3.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.579 1.151 . . . . 0.0 110.327 172.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 tp -46.52 122.44 4.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.024 1.33 . . . . 0.0 110.162 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -55.32 -32.79 62.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.52 1.528 . . . . 0.0 113.11 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -64.37 -22.64 67.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.52 1.128 . . . . 0.0 113.353 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.14 164.12 12.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -169.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -162.55 159.24 20.15 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.953 2.501 . . . . 0.0 106.862 169.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.21 150.69 7.16 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.761 2.974 . . . . 0.0 113.356 172.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -55.03 158.51 2.81 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.733 1.213 . . . . 0.0 113.085 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.22 158.08 27.15 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.748 0.819 . . . . 0.0 110.845 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -86.43 167.77 14.4 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 171.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.36 160.43 16.07 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.478 0.711 . . . . 0.0 111.187 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -61.28 142.34 56.91 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.259 0.624 . . . . 0.0 109.463 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -142.41 142.22 32.36 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.267 1.027 . . . . 0.0 108.4 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.5 p -72.09 145.41 48.2 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.838 1.255 . . . . 0.0 110.823 173.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -139.95 159.08 42.99 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.965 1.306 . . . . 0.0 108.723 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.0 m -158.87 174.89 14.3 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.307 2.243 . . . . 0.0 106.701 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -141.5 159.6 59.94 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.733 0.813 . . . . 0.0 109.233 -173.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -64.4 154.27 74.63 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 120.036 1.049 . . . . 0.0 110.976 -10.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 tp -157.36 155.94 31.44 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.242 1.417 . . . . 0.0 107.67 -173.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -76.01 58.93 1.24 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.71 1.204 . . . . 0.0 110.224 171.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -153.23 133.62 13.57 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.73 2.012 . . . . 0.0 106.048 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.7 tp -139.25 145.44 39.21 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.0 mt -125.21 155.57 39.85 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.996 1.318 . . . . 0.0 108.605 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 164.64 29.52 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.209 1.404 . . . . 0.0 109.757 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.2 tp -98.19 127.45 44.14 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.33 138.24 27.72 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.292 1.437 . . . . 0.0 107.514 169.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 44.8 48.45 9.02 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.598 1.559 . . . . 0.0 113.18 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 56.91 30.45 18.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.278 1.431 . . . . 0.0 113.252 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -134.8 148.85 50.29 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.742 1.217 . . . . 0.0 108.379 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -92.32 125.68 44.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 mp -123.61 152.97 41.34 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 125.961 1.704 . . . . 0.0 108.926 -173.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.72 121.04 14.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.34 -38.05 14.44 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.904 1.282 . . . . 0.0 111.306 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -160.78 157.04 26.15 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.815 1.246 . . . . 0.0 108.355 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.57 -3.34 2.91 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.781 1.182 . . . . 0.0 112.55 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -57.93 141.82 48.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.242 1.817 . . . . 0.0 111.998 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -72.49 -30.01 64.13 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.5 169.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.3 -38.82 0.11 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.877 0.871 . . . . 0.0 111.793 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.42 -31.51 0.06 OUTLIER Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.421 -0.655 . . . . 0.0 114.047 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 pt -70.29 31.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 126.159 1.783 . . . . 0.0 115.185 -172.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 -42.24 0.6 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.236 -1.54 . . . . 0.0 111.979 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 m -58.35 143.57 12.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 119.675 1.125 . . . . 0.0 109.809 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.86 -11.09 60.7 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.537 -1.146 . . . . 0.0 113.647 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -66.96 155.62 38.07 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.595 1.698 . . . . 0.0 108.291 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.67 140.64 52.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.922 1.289 . . . . 0.0 110.156 -169.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.14 146.2 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.9 mt -130.12 -35.17 1.61 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.695 1.198 . . . . 0.0 110.595 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.07 159.98 43.55 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.461 1.028 . . . . 0.0 110.117 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.3 mt -134.96 131.82 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.5 p30 42.92 24.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.579 2.352 . . . . 0.0 115.139 -173.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.25 -14.27 58.3 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.112 1.339 . . . . 0.0 112.902 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.6 mtt -74.73 105.86 6.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.813 1.307 . . . . 0.0 108.603 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.35 122.38 12.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.6 m -77.68 132.17 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.491 0.662 . . . . 0.0 109.385 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -74.79 73.46 2.08 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.768 1.627 . . . . 0.0 107.146 169.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.02 -72.29 0.4 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.627 2.06 . . . . 0.0 112.808 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -133.74 11.02 4.01 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.878 1.671 . . . . 0.0 111.947 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -120.79 154.88 35.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.4 p -69.62 175.39 4.19 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.483 1.038 . . . . 0.0 109.911 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.85 -37.89 77.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.407 169.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.43 -37.25 74.37 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.717 0.807 . . . . 0.0 111.661 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 6.24 7.77 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.528 1.061 . . . . 0.0 114.099 172.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.71 136.04 54.93 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.066 1.433 . . . . 0.0 107.385 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.43 128.07 34.76 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.0 t -56.45 -39.95 64.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.669 1.188 . . . . 0.0 111.633 -170.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.5 -40.47 93.1 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.702 0.683 . . . . 0.0 110.585 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.55 -39.17 67.67 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.414 0.552 . . . . 0.0 110.029 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -59.58 -46.54 88.63 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.6 1.16 . . . . 0.0 110.518 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.56 -33.9 60.67 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.66 0.784 . . . . 0.0 110.749 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.62 -30.84 75.18 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.381 -0.677 . . . . 0.0 112.742 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -62.28 115.32 15.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.511 1.125 . . . . 0.0 109.861 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.453 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.6 Cg_endo -70.47 -16.1 34.52 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.67 1.58 . . . . 0.0 114.003 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.35 -14.86 54.55 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.335 0.97 . . . . 0.0 111.147 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -134.64 28.93 3.58 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.376 2.27 . . . . 0.0 109.251 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.2 m-30 -60.77 -54.41 54.78 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 117.158 -1.401 . . . . 0.0 111.815 170.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.59 122.17 8.02 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.629 1.617 . . . . 0.0 109.673 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 m -149.74 172.02 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.734 1.214 . . . . 0.0 109.778 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -125.75 139.93 53.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.2 mt -133.41 147.72 31.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -170.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -119.47 130.6 55.32 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -152.71 164.77 37.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.28 -165.22 33.89 Favored Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -170.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.08 142.23 98.56 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.36 167.26 17.06 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.417 2.078 . . . . 0.0 110.082 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 51.93 40.19 27.59 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.554 1.142 . . . . 0.0 111.686 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.3 tp -54.2 -37.47 64.58 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.543 -0.723 . . . . 0.0 110.038 170.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.6 m -153.49 155.69 36.72 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.9 m -63.92 -19.08 64.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 . . . . . 0 C--O 1.249 1.063 0 C-N-CA 125.433 1.493 . . . . 0.0 107.913 177.445 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 145.93 -179.02 23.27 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.783 1.174 . . . . 0.0 110.924 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -62.08 -11.2 12.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.671 1.188 . . . . 0.0 113.169 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -59.0 -25.15 63.38 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.727 1.211 . . . . 0.0 111.993 169.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.8 m80 54.17 17.56 1.5 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.238 1.815 . . . . 0.0 114.138 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -148.06 161.25 41.78 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.364 1.465 . . . . 0.0 108.306 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -144.11 167.91 21.28 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.435 1.494 . . . . 0.0 107.583 170.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -60.44 130.42 46.49 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.3 mt -84.4 62.47 7.24 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -76.57 64.84 2.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.382 1.473 . . . . 0.0 109.969 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 p -155.23 158.78 39.39 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.12 1.368 . . . . 0.0 110.01 -171.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -84.95 -13.63 50.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.715 0.806 . . . . 0.0 111.874 172.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 144.79 90.87 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.925 0.89 . . . . 0.0 111.239 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.59 -0.67 0.81 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.644 3.563 . . . . 0.0 116.862 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -56.81 -9.53 0.82 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -169.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.73 -14.59 53.76 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.514 1.052 . . . . 0.0 111.398 169.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -134.18 163.57 29.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.365 1.866 . . . . 0.0 108.668 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.7 167.08 30.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.47 1.908 . . . . 0.0 108.146 172.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.45 155.58 33.77 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.393 0.677 . . . . 0.0 110.233 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -162.83 164.08 26.26 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.739 0.816 . . . . 0.0 109.663 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -80.04 144.43 33.2 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.201 1.4 . . . . 0.0 107.351 168.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -142.21 171.2 14.38 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.377 1.071 . . . . 0.0 110.234 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.9 m -156.22 175.68 13.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.0 2.52 . . . . 0.0 106.455 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -123.87 153.9 67.32 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.552 0.741 . . . . 0.0 109.909 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.17 -39.19 1.34 Allowed 'Cis proline' 0 CA--C 1.537 0.627 0 CA-C-N 119.64 0.907 . . . . 0.0 112.038 -5.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.9 tp 48.04 -75.54 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.087 2.955 . . . . 0.0 114.548 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -166.65 -28.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.531 2.333 . . . . 0.0 109.313 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.0 tp -55.69 131.76 47.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.806 1.642 . . . . 0.0 112.315 -174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.11 128.72 11.48 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.98 154.96 33.75 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 161.74 40.48 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.958 0.903 . . . . 0.0 109.961 -177.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.9 tp -96.25 125.4 40.74 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -153.2 144.15 22.9 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.434 1.093 . . . . 0.0 108.752 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.4 t70 47.87 39.34 10.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.583 1.153 . . . . 0.0 111.804 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 64.96 6.09 3.24 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.036 2.135 . . . . 0.0 115.877 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -118.67 149.71 40.96 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.965 1.257 . . . . 0.0 109.403 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.417 HG11 HG21 ' A' ' 72' ' ' VAL . 11.8 p -76.26 135.09 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 76.1 mt -126.49 149.55 49.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.868 1.267 . . . . 0.0 108.187 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.4 t -68.88 139.78 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -120.63 -41.6 2.58 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.936 0.895 . . . . 0.0 110.647 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -139.4 165.53 26.97 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.983 1.713 . . . . 0.0 106.766 170.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.79 -20.73 5.1 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.696 1.141 . . . . 0.0 111.338 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -139.84 36.6 1.98 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.594 1.558 . . . . 0.0 109.602 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -58.18 -11.34 2.54 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -53.4 -23.02 8.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.792 1.637 . . . . 0.0 111.775 169.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.19 -171.58 19.35 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.506 1.05 . . . . 0.0 110.952 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.6 pt -81.4 0.97 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.672 0.789 . . . . 0.0 112.385 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -70.71 6.53 1.43 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -169.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 m -69.51 168.31 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 120.1 1.318 . . . . 0.0 108.646 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.71 0.43 86.06 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.28 -0.887 . . . . 0.0 113.258 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -75.57 154.89 36.47 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.152 0.976 . . . . 0.0 109.544 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.84 147.06 27.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.7 t -74.28 144.56 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 172.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -111.1 -33.39 6.49 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 124.986 1.314 . . . . 0.0 109.847 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.47 160.22 41.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.198 1.363 . . . . 0.0 111.738 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.1 mt -136.05 135.74 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 49.34 30.34 3.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 112.076 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.87 -9.14 57.7 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.823 1.201 . . . . 0.0 113.686 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.2 mmt -84.27 119.12 24.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.102 1.451 . . . . 0.0 107.922 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -49.02 142.8 6.25 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.516 1.127 . . . . 0.0 109.834 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.3 m -111.3 149.1 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.822 0.82 . . . . 0.0 110.026 172.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -125.21 101.64 7.09 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.116 2.167 . . . . 0.0 105.907 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.02 -80.29 0.19 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.19 1.376 . . . . 0.0 110.622 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.42 25.49 0.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.996 1.318 . . . . 0.0 111.116 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -127.79 143.54 51.12 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.6 p -70.13 172.5 7.92 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.009 0.822 . . . . 0.0 110.387 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.87 -38.66 67.8 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.997 0.919 . . . . 0.0 110.861 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.51 -38.07 71.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.494 0.717 . . . . 0.0 111.529 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.71 3.1 7.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.907 1.241 . . . . 0.0 113.737 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.93 133.65 53.64 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.809 1.304 . . . . 0.0 108.167 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.22 120.82 13.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.417 HG21 HG11 ' A' ' 37' ' ' VAL . 27.3 m -58.9 -40.16 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -169.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.13 -40.52 68.03 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.986 1.266 . . . . 0.0 109.758 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.29 -44.81 93.97 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.792 0.724 . . . . 0.0 110.11 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -58.49 -44.42 89.4 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.164 0.986 . . . . 0.0 111.209 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.08 -37.8 72.45 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.289 1.036 . . . . 0.0 110.786 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.5 -30.62 73.19 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.124 0.869 . . . . 0.0 112.333 -175.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -58.01 114.45 8.58 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.31 1.044 . . . . 0.0 109.629 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 72.0 Cg_endo -70.87 -13.73 32.08 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.558 1.505 . . . . 0.0 113.749 -175.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.27 -15.24 56.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.417 1.008 . . . . 0.0 110.612 169.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -132.59 34.22 3.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.309 2.644 . . . . 0.0 108.468 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.449 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -65.0 -52.52 48.63 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 117.18 -1.39 . . . . 0.0 111.498 169.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.36 125.41 11.27 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.667 1.631 . . . . 0.0 108.87 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.05 171.04 2.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.195 0.998 . . . . 0.0 110.524 -170.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.5 m -125.61 138.85 53.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 169.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.3 mt -136.48 139.58 44.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.6 mtp-105 -117.24 132.66 56.58 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -143.76 167.05 23.21 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.361 1.464 . . . . 0.0 109.185 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.52 -165.72 38.96 Favored Glycine 0 CA--C 1.52 0.399 0 O-C-N 121.543 -0.723 . . . . 0.0 111.656 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -59.15 142.4 85.91 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 117.983 -1.008 . . . . 0.0 108.301 170.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.64 -42.25 29.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.415 2.743 . . . . 0.0 113.037 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -150.32 165.89 31.67 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.408 1.883 . . . . 0.0 105.954 169.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 46.9 tp -59.27 -30.54 68.37 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.318 -0.864 . . . . 0.0 111.923 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.2 p -68.51 -19.07 64.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.029 0.931 . . . . 0.0 112.669 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.1 m -78.67 36.64 0.27 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.611 1.564 . . . . 0.0 111.805 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 . . . . . 0 C--O 1.249 1.055 0 C-N-CA 125.928 1.691 . . . . 0.0 107.789 179.815 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -167.67 168.16 40.45 Favored Glycine 0 C--N 1.334 0.463 0 O-C-N 121.493 -0.754 . . . . 0.0 111.687 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -140.63 112.41 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.6 t60 65.79 -37.39 0.25 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.633 2.373 . . . . 0.0 113.295 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -149.1 169.24 21.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.417 1.887 . . . . 0.0 107.795 169.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -52.47 139.23 25.68 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.868 1.267 . . . . 0.0 110.73 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -68.95 151.44 46.53 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -155.5 161.1 40.99 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.042 1.337 . . . . 0.0 108.246 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.99 147.61 42.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.698 0.799 . . . . 0.0 109.366 170.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -139.06 155.4 47.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.01 1.324 . . . . 0.0 108.88 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.2 m -63.25 155.47 28.35 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.937 1.295 . . . . 0.0 112.147 -174.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -67.55 166.47 14.79 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.852 0.861 . . . . 0.0 109.972 169.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.53 150.34 37.55 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 124.031 0.932 . . . . 0.0 109.062 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.53 135.15 33.38 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.426 2.75 . . . . 0.0 111.214 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -69.96 141.74 52.98 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.48 173.29 16.85 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.839 1.655 . . . . 0.0 107.813 -171.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -139.29 -0.52 1.81 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.22 147.73 29.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.58 141.32 18.01 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -167.49 174.07 8.18 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.909 0.884 . . . . 0.0 109.648 -174.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.6 m -91.31 142.2 27.96 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -139.09 162.77 34.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.064 1.345 . . . . 0.0 109.28 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.5 p -153.94 176.67 11.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.017 2.527 . . . . 0.0 107.402 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -135.22 156.29 78.21 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.243 1.017 . . . . 0.0 109.481 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.11 -23.88 9.07 Favored 'Cis proline' 0 C--N 1.351 0.675 0 CA-C-N 119.945 1.016 . . . . 0.0 113.518 -0.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tt 37.7 -91.39 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.603 2.761 . . . . 0.0 113.06 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -160.58 -38.79 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.471 1.508 . . . . 0.0 110.06 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.2 tp -57.51 130.57 46.94 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.961 0.904 . . . . 0.0 109.533 171.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.1 mt -142.54 153.17 43.34 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.337 1.455 . . . . 0.0 107.729 170.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.44 154.53 36.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.676 1.19 . . . . 0.0 108.902 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.14 154.89 46.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.441 1.096 . . . . 0.0 109.122 170.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.4 tp -92.52 132.48 36.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.532 1.133 . . . . 0.0 108.374 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -153.61 139.66 18.3 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.624 1.17 . . . . 0.0 107.958 169.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 t70 44.3 49.61 7.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.649 1.58 . . . . 0.0 112.672 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 59.08 22.87 11.0 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.637 1.575 . . . . 0.0 114.211 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -129.41 156.64 43.76 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 120.931 -1.106 . . . . 0.0 108.841 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.26 130.88 52.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.41 153.5 38.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.882 1.273 . . . . 0.0 108.39 -173.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.11 104.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 125.905 1.682 . . . . 0.0 107.339 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.31 -39.54 68.16 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.678 0.791 . . . . 0.0 109.814 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -146.29 138.18 24.92 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.1 144.61 4.1 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -151.88 157.84 42.39 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.383 1.073 . . . . 0.0 110.302 -172.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.4 mmp_? 62.28 168.49 0.12 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.248 2.619 . . . . 0.0 113.517 174.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t0 43.85 42.58 4.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.307 1.843 . . . . 0.0 112.674 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.11 -18.35 28.03 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.911 1.243 . . . . 0.0 113.959 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.2 mm -70.75 129.61 34.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 173.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -146.64 149.7 34.01 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.9 t -59.11 141.33 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.95 -10.22 63.58 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.745 -1.031 . . . . 0.0 113.57 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -71.59 170.66 12.93 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.272 1.536 . . . . 0.0 108.674 169.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.57 143.65 50.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.208 1.003 . . . . 0.0 109.662 -172.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 p -70.27 140.82 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 169.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -116.77 -32.39 5.15 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.791 1.636 . . . . 0.0 109.867 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.51 158.61 40.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.091 0.859 . . . . 0.0 110.394 169.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.2 mt -131.65 130.17 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 p30 40.15 27.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.918 2.487 . . . . 0.0 115.314 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.33 -16.18 57.0 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.161 1.363 . . . . 0.0 112.789 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.65 109.29 11.5 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.645 1.223 . . . . 0.0 108.102 171.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -51.62 141.1 17.08 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.691 1.197 . . . . 0.0 108.881 169.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -103.87 116.33 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.387 1.089 . . . . 0.0 110.223 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -76.92 86.67 3.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.659 1.584 . . . . 0.0 108.041 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.02 -78.71 0.4 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.01 1.291 . . . . 0.0 111.963 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -135.84 13.63 3.39 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.927 1.291 . . . . 0.0 112.639 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -126.42 145.69 50.37 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.7 p -69.76 170.25 11.35 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.823 0.82 . . . . 0.0 110.155 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.5 -38.06 68.67 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.728 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.8 -37.09 73.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.657 0.783 . . . . 0.0 111.784 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.3 4.24 7.74 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.769 1.176 . . . . 0.0 113.944 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -67.93 137.69 55.39 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.903 1.352 . . . . 0.0 107.867 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -67.88 127.69 33.73 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.82 -40.56 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.536 0.734 . . . . 0.0 111.419 -170.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.7 mt -65.36 -36.8 85.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.072 0.851 . . . . 0.0 110.815 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -74.46 -40.61 61.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.455 0.57 . . . . 0.0 109.688 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -59.24 -51.05 71.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.775 0.83 . . . . 0.0 110.103 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.29 -30.0 64.39 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.601 0.76 . . . . 0.0 110.627 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.7 -38.06 95.65 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.517 -0.602 . . . . 0.0 111.812 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -63.93 117.08 32.25 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 117.738 0.769 . . . . 0.0 109.003 173.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 65.9 Cg_endo -67.34 -12.14 34.73 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.987 1.792 . . . . 0.0 114.009 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.57 -17.55 46.98 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.455 1.025 . . . . 0.0 111.211 169.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -120.67 21.05 11.64 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.703 1.601 . . . . 0.0 110.332 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 3.1 m-30 -61.06 -59.25 14.38 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 117.075 -1.441 . . . . 0.0 110.166 170.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.55 106.13 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.833 1.689 . . . . 0.0 109.603 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.02 156.45 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 123.197 0.599 . . . . 0.0 110.438 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -84.28 142.19 30.42 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 169.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.6 mt -139.73 147.04 24.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -121.3 138.13 54.38 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -133.28 151.77 51.91 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.299 1.84 . . . . 0.0 109.655 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.96 -168.93 22.61 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 165.53 22.69 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.67 156.42 4.44 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.66 1.574 . . . . 0.0 110.691 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -28.97 10.93 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 54.7 tp -51.71 -28.2 14.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.684 1.193 . . . . 0.0 112.858 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -129.82 23.63 5.36 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.77 1.228 . . . . 0.0 110.226 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.9 m -148.75 76.36 1.34 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.361 1.464 . . . . 0.0 107.891 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.049 175.608 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.14 -43.7 0.23 Allowed Glycine 0 C--N 1.34 0.765 0 O-C-N 121.971 -0.455 . . . . 0.0 112.455 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -62.86 -9.82 11.04 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -171.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -64.96 -25.44 67.87 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.908 0.776 . . . . 0.0 112.21 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -68.09 161.26 27.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.227 0.611 . . . . 0.0 111.033 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -148.73 160.18 43.43 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.806 1.642 . . . . 0.0 107.385 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -60.14 147.22 40.4 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.899 0.48 . . . . 0.0 109.997 172.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -154.03 164.68 38.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.539 1.536 . . . . 0.0 108.264 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.3 tp -62.54 136.72 58.03 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -145.71 152.86 40.28 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.154 1.382 . . . . 0.0 107.365 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.8 m -62.79 -30.5 71.51 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.71 1.204 . . . . 0.0 112.005 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -157.02 177.36 11.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.184 1.794 . . . . 0.0 107.894 172.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.58 146.31 55.04 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.393 1.077 . . . . 0.0 108.165 173.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.66 163.41 35.24 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.93 2.42 . . . . 0.0 111.419 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -74.8 17.73 0.2 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.984 0.914 . . . . 0.0 112.071 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.66 132.78 54.87 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.28 11.1 pt-20 45.47 36.5 2.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.403 1.881 . . . . 0.0 112.499 -174.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.81 176.18 9.64 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.783 2.033 . . . . 0.0 108.442 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.87 155.75 38.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.719 0.808 . . . . 0.0 110.718 -172.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -158.82 166.96 30.71 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.749 1.22 . . . . 0.0 108.832 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -73.75 145.72 44.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.951 1.3 . . . . 0.0 109.632 169.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -142.74 163.7 32.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.405 1.482 . . . . 0.0 109.599 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 p -158.47 175.47 13.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.025 2.13 . . . . 0.0 107.612 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -137.22 158.86 71.68 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 123.816 0.847 . . . . 0.0 110.167 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.96 156.95 79.49 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.759 0.949 . . . . 0.0 111.271 -9.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 tp -158.03 159.36 36.29 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.768 1.227 . . . . 0.0 108.579 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.0 -31.57 72.73 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.795 0.838 . . . . 0.0 112.18 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 tt -67.59 121.47 15.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.1 mt -133.58 156.22 48.22 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.084 1.754 . . . . 0.0 107.94 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -131.79 155.4 47.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.172 0.989 . . . . 0.0 111.215 -169.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.53 153.72 40.71 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.723 1.209 . . . . 0.0 110.112 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.3 tp -78.66 130.75 36.21 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -153.55 138.49 17.2 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.831 1.252 . . . . 0.0 107.932 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.1 t70 48.44 43.56 19.8 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.19 1.396 . . . . 0.0 113.091 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 58.25 25.41 12.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.823 1.649 . . . . 0.0 113.336 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -130.15 167.99 17.5 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.305 1.842 . . . . 0.0 108.167 173.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.5 t -112.91 116.03 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.02 152.13 26.3 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.146 1.378 . . . . 0.0 109.201 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.05 104.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.979 1.712 . . . . 0.0 107.561 172.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.94 -32.6 57.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.827 1.251 . . . . 0.0 110.874 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -155.34 156.07 34.8 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.46 8.11 0.03 OUTLIER Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.181 0.896 . . . . 0.0 113.31 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -64.11 -13.13 45.59 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.729 1.211 . . . . 0.0 113.126 -170.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -112.23 -27.43 8.34 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.708 1.14 . . . . 0.0 110.58 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.11 -46.43 89.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.064 0.847 . . . . 0.0 109.128 169.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.22 33.29 0.54 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.526 1.06 . . . . 0.0 112.76 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.9 tt -142.74 120.11 6.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 CA-C-N 119.348 1.574 . . . . 0.0 108.298 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -75.72 149.81 37.98 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m -62.35 154.61 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.892 0.877 . . . . 0.0 110.958 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.83 -16.17 60.7 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.119 -0.823 . . . . 0.0 113.333 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -69.19 166.49 18.24 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.708 1.254 . . . . 0.0 108.255 169.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.45 152.29 51.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.269 0.628 . . . . 0.0 111.124 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 83.4 t -66.24 142.45 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -126.4 -30.11 2.9 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.605 1.162 . . . . 0.0 110.906 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.79 158.01 43.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.06 1.3 . . . . 0.0 110.551 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.4 mt -139.97 135.15 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 49.6 28.84 2.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.604 1.562 . . . . 0.0 112.229 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.35 -11.28 66.12 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.119 1.342 . . . . 0.0 113.734 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.3 mtt -82.81 111.96 19.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.938 1.369 . . . . 0.0 109.076 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.74 131.48 50.42 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.3 m -90.42 119.43 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -72.91 98.49 2.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.085 1.354 . . . . 0.0 107.949 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.2 -93.59 0.09 OUTLIER Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -175.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 ptt85 -124.78 14.32 8.63 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.755 1.622 . . . . 0.0 112.226 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -123.54 148.08 46.66 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.5 p -68.87 172.93 5.83 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.563 1.074 . . . . 0.0 110.355 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.61 -38.56 75.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.596 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.69 -39.14 77.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.818 0.847 . . . . 0.0 111.412 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.3 1.59 7.22 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.604 1.097 . . . . 0.0 113.988 172.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -61.29 140.92 57.88 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 119.092 1.446 . . . . 0.0 108.776 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.71 127.37 31.69 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.3 t -56.45 -43.38 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.61 0.764 . . . . 0.0 111.698 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.9 -36.7 82.87 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.351 0.523 . . . . 0.0 110.458 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.28 -42.92 68.12 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.293 0.497 . . . . 0.0 109.691 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -58.88 -46.53 87.6 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.718 1.207 . . . . 0.0 110.634 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.16 -33.67 59.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.492 0.717 . . . . 0.0 111.005 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.1 -32.02 79.31 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.308 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -61.18 114.17 9.93 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.154 . . . . 0.0 109.939 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 84.2 Cg_endo -71.06 -14.66 32.12 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.638 1.559 . . . . 0.0 113.789 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.23 -15.42 57.03 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.436 1.017 . . . . 0.0 110.869 169.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -133.36 32.83 3.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.884 2.474 . . . . 0.0 108.639 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.451 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -64.97 -53.78 39.53 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.189 -1.386 . . . . 0.0 110.398 169.585 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.02 124.36 10.49 Favored 'Trans proline' 0 C--N 1.352 0.756 0 CA-C-N 121.559 1.593 . . . . 0.0 109.369 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.1 m -150.66 172.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.251 1.42 . . . . 0.0 109.778 -172.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 m -121.46 138.22 54.38 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.5 mt -136.49 140.39 43.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -114.62 138.12 51.05 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.734 1.614 . . . . 0.0 106.852 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -125.54 169.47 12.41 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.899 1.28 . . . . 0.0 110.164 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.55 -160.92 25.51 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -67.27 152.97 95.58 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 170.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.04 -45.11 30.48 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.296 2.664 . . . . 0.0 113.357 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -147.03 161.94 39.8 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.977 1.711 . . . . 0.0 106.489 171.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 38.5 tp -149.55 152.92 36.34 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 p -65.72 -39.43 91.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.287 1.035 . . . . 0.0 111.172 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.4 m 49.48 36.16 9.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.007 1.723 . . . . 0.0 112.692 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 123.71 0.804 . . . . 0.0 110.087 176.673 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 159.08 -35.39 0.49 Allowed Glycine 0 C--N 1.34 0.77 0 C-N-CA 123.086 0.374 . . . . 0.0 112.76 172.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -62.76 -20.65 65.17 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.298 1.049 . . . . 0.0 112.641 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -62.88 -12.89 28.0 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.112 -0.993 . . . . 0.0 112.977 171.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -131.55 -23.45 2.34 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.827 1.251 . . . . 0.0 112.436 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -140.6 -167.81 2.43 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.507 1.049 . . . . 0.0 111.834 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -54.43 166.19 0.46 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.197 2.199 . . . . 0.0 112.517 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -49.74 -40.99 42.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.88 1.272 . . . . 0.0 114.165 -169.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.8 mt -144.59 154.72 43.14 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.238 1.415 . . . . 0.0 108.955 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -146.97 -21.82 0.41 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.747 1.619 . . . . 0.0 111.613 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 m -65.32 164.04 14.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.571 1.948 . . . . 0.0 112.599 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -65.87 -16.95 64.31 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.01 146.5 77.04 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.478 0.711 . . . . 0.0 111.217 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.41 143.16 35.89 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.504 2.803 . . . . 0.0 112.617 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -83.66 -13.35 54.37 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.55 159.53 18.53 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.439 0.638 . . . . 0.0 110.538 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -129.35 166.26 19.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.478 1.911 . . . . 0.0 108.049 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.63 149.13 31.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.262 0.625 . . . . 0.0 111.713 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mp0 -63.04 153.04 35.25 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.009 0.924 . . . . 0.0 110.662 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -147.21 143.23 28.03 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -79.84 141.49 36.14 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -138.25 161.29 37.25 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.008 1.323 . . . . 0.0 109.024 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.0 p -156.63 175.32 14.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.319 2.248 . . . . 0.0 106.983 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -139.83 161.5 55.86 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 123.924 0.89 . . . . 0.0 109.125 -171.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.08 145.83 60.99 Favored 'Cis proline' 0 C--N 1.351 0.669 0 CA-C-N 120.261 1.129 . . . . 0.0 111.262 -6.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 tp -159.74 162.07 34.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.125 1.77 . . . . 0.0 107.009 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.57 -28.69 69.52 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.369 0.668 . . . . 0.0 112.502 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.7 tp -57.54 126.0 25.39 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.967 0.907 . . . . 0.0 110.101 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.9 tp -147.47 151.61 36.69 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.204 1.401 . . . . 0.0 107.535 172.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -121.31 156.04 33.43 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.633 1.173 . . . . 0.0 109.598 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.51 151.65 51.26 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.688 0.795 . . . . 0.0 109.321 169.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.19 124.43 28.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -152.82 142.45 21.87 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.489 1.115 . . . . 0.0 108.337 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.69 44.11 17.24 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.487 1.515 . . . . 0.0 112.126 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 59.36 6.86 0.83 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.718 2.007 . . . . 0.0 115.319 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -109.56 -178.75 3.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.464 1.906 . . . . 0.0 107.439 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.55 130.37 74.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 169.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.5 mt -127.93 154.87 45.06 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.402 1.081 . . . . 0.0 108.769 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.6 t -58.72 111.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.244 1.418 . . . . 0.0 108.094 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.07 -36.55 24.81 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.573 1.149 . . . . 0.0 110.463 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -145.16 135.12 23.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.79 125.17 1.24 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.52 172.82 16.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.847 1.259 . . . . 0.0 109.205 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? 64.31 -33.54 0.14 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 128.671 2.788 . . . . 0.0 115.377 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.31 -36.57 78.22 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.796 1.18 . . . . 0.0 111.569 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.09 -46.27 0.51 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.4 pt -65.22 162.28 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 123.7 0.8 . . . . 0.0 109.251 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -141.81 163.15 33.69 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.9 m -51.41 143.32 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.063 0.459 . . . . 0.0 110.846 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.06 -9.63 65.76 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.214 -1.326 . . . . 0.0 113.939 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -68.44 155.2 40.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.093 1.947 . . . . 0.0 109.278 169.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.23 146.48 30.26 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.924 0.889 . . . . 0.0 109.619 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -81.09 139.1 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 169.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.75 -37.44 3.93 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.437 1.495 . . . . 0.0 109.761 -174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.7 160.18 44.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.667 1.121 . . . . 0.0 110.676 170.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.5 mt -136.82 131.41 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.285 1.9 p-10 36.83 34.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 128.564 2.746 . . . . 0.0 114.817 -176.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.84 -15.85 57.94 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.469 1.509 . . . . 0.0 113.15 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.4 mtt -82.94 108.75 16.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.497 1.149 . . . . 0.0 108.948 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.03 133.26 55.38 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 m -98.01 125.24 51.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -88.84 100.05 12.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.266 1.826 . . . . 0.0 107.53 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.78 -80.96 0.23 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.855 1.217 . . . . 0.0 110.781 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.23 23.16 1.5 Allowed 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.131 1.372 . . . . 0.0 111.767 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -126.23 146.72 49.87 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.9 p -68.54 173.58 4.91 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.795 0.807 . . . . 0.0 110.338 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.16 -38.41 73.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.666 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -70.05 -39.52 75.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.744 0.818 . . . . 0.0 111.406 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.6 -1.59 6.45 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.653 1.12 . . . . 0.0 114.089 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -61.9 134.29 56.5 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.095 1.447 . . . . 0.0 108.566 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.14 126.11 26.67 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.4 t -56.68 -38.31 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.367 1.067 . . . . 0.0 111.703 -169.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.12 -40.25 94.22 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.548 0.613 . . . . 0.0 110.33 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -74.43 -38.29 63.07 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.939 0.496 . . . . 0.0 110.136 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -59.32 -45.99 89.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.365 1.066 . . . . 0.0 110.454 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.5 mt -76.97 -31.49 56.58 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.462 0.705 . . . . 0.0 110.874 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.26 -33.64 87.35 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.404 -0.664 . . . . 0.0 112.502 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -63.2 114.47 12.83 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.562 1.145 . . . . 0.0 110.136 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 88.5 Cg_endo -71.64 -15.75 30.36 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.632 1.555 . . . . 0.0 113.905 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.97 -14.24 44.99 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.313 0.96 . . . . 0.0 111.201 169.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -132.1 22.49 4.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.026 2.13 . . . . 0.0 109.881 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.464 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.7 m-30 -59.37 -53.63 64.15 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 116.942 -1.504 . . . . 0.0 112.117 171.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.84 112.06 3.45 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.827 1.688 . . . . 0.0 109.681 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 m -148.42 152.22 12.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 123.889 0.875 . . . . 0.0 110.069 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.4 m -84.58 144.11 28.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.0 mt -134.0 135.94 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -103.6 121.9 43.88 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -106.99 176.09 5.29 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.55 1.14 . . . . 0.0 108.348 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.03 173.31 44.67 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 173.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.31 140.63 92.98 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.11 151.47 50.53 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.803 1.668 . . . . 0.0 110.71 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -63.85 150.42 44.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 169.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.4 tp -134.15 -173.75 3.35 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.933 1.693 . . . . 0.0 107.284 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.4 p -56.08 -53.29 58.84 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.977 -1.077 . . . . 0.0 109.31 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.3 m -58.4 153.1 16.35 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.374 1.07 . . . . 0.0 111.5 171.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.839 0 CA-C-O 117.886 -1.054 . . . . 0.0 108.25 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ttt . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.61 -50.57 0.02 OUTLIER Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -61.89 152.85 30.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 66.87 -46.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.478 2.311 . . . . 0.0 111.906 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -69.93 -42.35 73.39 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.952 0.901 . . . . 0.0 110.833 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -66.77 126.74 29.98 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -157.56 166.86 31.79 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.881 1.673 . . . . 0.0 106.956 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -151.07 174.42 13.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.435 1.094 . . . . 0.0 109.494 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 tp -56.28 145.44 26.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.883 0.873 . . . . 0.0 110.148 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -53.34 -34.55 57.96 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.611 1.564 . . . . 0.0 113.629 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -64.2 174.31 1.64 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.907 2.083 . . . . 0.0 113.037 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -63.23 164.23 9.09 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.367 0.604 . . . . 0.0 110.194 169.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.06 169.28 9.9 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.881 1.673 . . . . 0.0 107.808 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -51.01 -20.46 7.24 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.799 3.0 . . . . 0.0 116.519 -176.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -134.36 15.72 3.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.085 0.857 . . . . 0.0 113.003 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.14 139.5 41.23 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.786 1.175 . . . . 0.0 110.117 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -99.62 26.77 5.86 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.507 1.523 . . . . 0.0 112.204 -169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 72.82 166.64 0.3 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.743 2.417 . . . . 0.0 113.961 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -84.16 137.18 33.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.187 0.995 . . . . 0.0 109.887 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -138.58 157.47 46.08 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 169.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.5 p -78.7 145.32 34.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.3 1.04 . . . . 0.0 109.515 169.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -141.08 158.49 43.85 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.51 1.524 . . . . 0.0 110.009 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.8 m -146.67 175.15 10.82 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.608 2.763 . . . . 0.0 106.84 175.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -140.05 165.05 33.43 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.428 1.091 . . . . 0.0 109.108 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.96 -31.77 0.68 Allowed 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 120.591 1.247 . . . . 0.0 114.446 -7.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.7 tp 44.52 -123.59 0.95 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.565 1.546 . . . . 0.0 109.736 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.55 43.85 0.59 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.973 1.26 . . . . 0.0 110.625 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.45 161.55 39.43 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.046 1.338 . . . . 0.0 109.75 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.8 tp -154.44 152.49 30.21 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.874 1.27 . . . . 0.0 108.613 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.1 mt -121.76 155.37 35.42 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.807 1.243 . . . . 0.0 109.617 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.25 154.82 43.48 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.515 1.126 . . . . 0.0 109.451 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.88 126.85 33.38 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -155.67 144.76 20.71 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.044 1.338 . . . . 0.0 108.258 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 50.72 43.21 28.03 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.335 1.054 . . . . 0.0 111.823 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.282 10.5 pt-20 50.41 26.46 2.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.174 2.59 . . . . 0.0 115.298 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 mtp-105 -134.68 159.84 40.0 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.157 -0.965 . . . . 0.0 110.76 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 m -80.37 131.85 33.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 169.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.0 mt -120.07 154.06 35.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.63 1.172 . . . . 0.0 108.252 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.99 106.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.988 1.315 . . . . 0.0 107.476 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.05 -37.07 66.99 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.703 0.801 . . . . 0.0 110.022 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -154.13 150.03 27.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 107.697 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.52 -44.79 0.18 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 42.19 38.63 1.17 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.126 2.57 . . . . 0.0 115.134 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -139.61 158.2 44.51 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -54.76 123.17 12.47 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.31 -16.9 56.45 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 117.916 -1.491 . . . . 0.0 113.531 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.7 pt -141.83 54.89 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.74 2.016 . . . . 0.0 108.244 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -62.79 134.76 56.75 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -59.86 136.45 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.93 -7.56 74.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.107 -1.385 . . . . 0.0 114.021 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -73.22 163.95 27.38 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.015 1.908 . . . . 0.0 108.613 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.09 155.66 21.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.52 1.128 . . . . 0.0 110.467 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.9 t -71.86 136.88 24.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 169.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -111.71 -36.75 5.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.669 1.188 . . . . 0.0 109.473 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.67 160.24 43.7 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.305 0.957 . . . . 0.0 111.094 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.1 mt -132.84 132.66 59.38 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 45.76 32.76 1.31 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.503 1.921 . . . . 0.0 112.118 -174.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.5 -9.46 73.38 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.0 1.286 . . . . 0.0 114.069 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.2 mtt -83.4 115.94 22.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.067 1.434 . . . . 0.0 108.808 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -49.66 124.73 10.13 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.755 1.222 . . . . 0.0 110.335 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.08 140.34 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 109.91 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -79.32 67.68 5.11 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.556 1.542 . . . . 0.0 108.535 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.74 -66.0 1.11 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.203 1.859 . . . . 0.0 113.974 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -136.74 9.14 3.08 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.892 1.677 . . . . 0.0 111.79 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -120.4 152.16 38.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.4 p -66.84 171.47 5.29 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.851 0.834 . . . . 0.0 109.427 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.08 76.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.599 169.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.28 -37.84 74.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.556 0.742 . . . . 0.0 111.578 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.76 1.94 6.32 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.359 -1.245 . . . . 0.0 115.878 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -69.11 144.52 53.88 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.315 2.058 . . . . 0.0 107.578 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.28 131.46 47.38 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.2 -37.39 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.345 1.058 . . . . 0.0 110.748 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.21 -40.22 95.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.082 0.401 . . . . 0.0 110.368 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -73.86 -41.79 61.72 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.391 0.541 . . . . 0.0 110.005 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -58.65 -51.1 71.34 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.251 0.62 . . . . 0.0 110.103 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.9 mt -76.76 -30.32 56.5 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.783 0.833 . . . . 0.0 110.848 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.3 -36.73 93.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.0 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -62.92 117.06 28.92 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 117.918 0.859 . . . . 0.0 109.067 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.472 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 68.4 Cg_endo -67.79 -11.8 33.3 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.875 1.717 . . . . 0.0 114.165 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.82 -17.47 49.89 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.42 1.009 . . . . 0.0 111.012 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -121.85 23.61 10.01 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.18 1.792 . . . . 0.0 110.099 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.8 m-30 -61.54 -57.62 23.82 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 117.087 -1.435 . . . . 0.0 110.501 169.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.88 107.15 2.41 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.903 1.736 . . . . 0.0 109.715 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.93 171.23 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.135 0.974 . . . . 0.0 109.829 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.5 m -105.9 143.12 34.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.2 mt -139.35 148.21 23.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -120.61 136.41 54.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -121.27 162.47 20.2 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.154 1.382 . . . . 0.0 107.938 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.69 -175.54 41.47 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.6 mmt-85 -64.02 143.77 98.21 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.796 -1.097 . . . . 0.0 108.467 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.24 -170.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 124.576 3.518 . . . . 0.0 114.787 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp-105 -51.98 -38.26 56.02 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.292 -0.88 . . . . 0.0 111.225 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.22 133.11 36.75 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 169.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.9 m -70.66 -25.45 63.01 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.749 0.42 . . . . 0.0 111.935 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 p -64.61 135.95 56.49 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.536 0.734 . . . . 0.0 109.234 169.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 123.715 0.806 . . . . 0.0 109.801 -178.634 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.88 46.4 0.29 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -63.27 -26.19 68.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.96 0.904 . . . . 0.0 112.092 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -150.74 174.74 12.68 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.464 1.906 . . . . 0.0 107.691 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -143.86 139.44 29.26 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 171.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -140.99 156.2 46.09 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.183 1.793 . . . . 0.0 106.753 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -57.94 123.88 17.35 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.84 124.75 25.51 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -171.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.5 tp -58.05 142.56 46.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.261 1.025 . . . . 0.0 108.318 169.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -63.13 137.61 58.29 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -169.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.6 p -124.82 -18.2 5.64 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.501 2.32 . . . . 0.0 112.981 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -158.36 -13.97 0.07 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.7 144.04 97.93 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 120.928 1.694 . . . . 0.0 111.345 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.42 169.31 20.05 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.041 2.494 . . . . 0.0 112.017 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 56.82 112.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.422 2.689 . . . . 0.0 114.441 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.4 76.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.497 169.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -155.29 158.14 38.32 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.789 1.236 . . . . 0.0 109.042 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.76 170.05 20.72 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.058 1.743 . . . . 0.0 108.951 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -142.44 137.13 30.13 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -156.79 166.02 34.57 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.838 0.855 . . . . 0.0 109.081 -175.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.4 m -126.09 142.72 51.4 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.395 1.078 . . . . 0.0 108.593 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -142.05 -178.79 5.87 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 127.006 2.122 . . . . 0.0 107.46 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.5 m -151.56 157.2 41.92 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.798 -1.189 . . . . 0.0 108.685 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -77.25 154.95 82.26 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -81.68 0.87 47.56 Favored 'Cis proline' 0 CA--C 1.544 1.011 0 CA-C-N 119.823 0.972 . . . . 0.0 111.909 -10.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -54.92 -38.89 68.21 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 124.662 1.185 . . . . 0.0 111.482 -172.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -144.22 142.4 30.48 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 121.215 0.531 . . . . 0.0 109.924 169.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -160.17 13.9 0.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.39 2.676 . . . . 0.0 110.024 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.9 mt -82.22 69.45 8.95 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.903 1.281 . . . . 0.0 110.635 -169.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.48 155.59 50.08 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.245 1.418 . . . . 0.0 108.744 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.6 150.84 46.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.385 0.674 . . . . 0.0 110.624 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tt -79.11 124.78 28.64 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -155.29 143.16 19.91 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.593 1.157 . . . . 0.0 108.298 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 47.91 41.94 15.48 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.522 1.529 . . . . 0.0 112.612 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 53.47 26.78 5.8 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.292 1.837 . . . . 0.0 113.35 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -126.17 -176.1 3.55 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.94 2.496 . . . . 0.0 106.203 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.33 132.49 71.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.0 mp -121.0 147.15 45.89 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.652 1.181 . . . . 0.0 108.734 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.9 t -60.18 111.24 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 170.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.42 -30.49 37.7 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.692 0.797 . . . . 0.0 111.252 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -155.75 157.68 36.95 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.336 1.454 . . . . 0.0 107.541 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.36 0.79 0.03 OUTLIER Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.491 -1.172 . . . . 0.0 114.956 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -62.39 -35.61 79.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.955 1.878 . . . . 0.0 111.287 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -65.3 -40.65 94.09 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.067 0.547 . . . . 0.0 110.521 177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.21 -39.15 75.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.805 0.442 . . . . 0.0 110.912 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.55 25.36 1.44 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.89 1.233 . . . . 0.0 113.146 173.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.5 pt -130.27 151.8 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 119.251 1.525 . . . . 0.0 109.838 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -69.0 141.53 54.87 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.2 t -68.47 155.98 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.55 -6.28 77.94 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.547 -1.14 . . . . 0.0 114.139 169.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -62.51 135.27 57.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.476 1.638 . . . . 0.0 107.47 169.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.13 147.88 26.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.048 0.939 . . . . 0.0 108.511 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.2 t -74.0 136.48 25.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.31 -37.18 7.76 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.159 1.784 . . . . 0.0 108.942 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.1 159.51 44.45 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.219 0.918 . . . . 0.0 111.068 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.57 139.53 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.65 34.11 3.46 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.685 1.994 . . . . 0.0 112.444 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.36 13.84 82.83 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.018 -0.879 . . . . 0.0 113.534 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.3 mmt -118.56 121.61 40.64 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.19 1.396 . . . . 0.0 107.508 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -50.8 139.1 17.41 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.593 1.157 . . . . 0.0 110.011 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.3 m -102.21 122.17 54.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -73.17 85.28 1.37 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.566 1.546 . . . . 0.0 107.187 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.34 -100.92 0.39 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -106.75 8.61 31.0 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.195 1.398 . . . . 0.0 111.887 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -127.82 150.02 50.02 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 119.291 0.95 . . . . 0.0 109.17 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.1 p -69.77 175.45 4.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.624 0.726 . . . . 0.0 110.457 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.51 -38.81 72.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.437 0.695 . . . . 0.0 110.696 169.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.72 -39.89 69.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.769 0.828 . . . . 0.0 111.371 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.2 -0.67 7.07 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.502 1.048 . . . . 0.0 113.94 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -58.75 135.95 57.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.936 1.368 . . . . 0.0 108.008 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.99 131.14 45.53 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.29 -38.63 70.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.009 0.924 . . . . 0.0 113.251 -169.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.6 mt -69.35 -38.72 78.25 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.337 0.971 . . . . 0.0 110.692 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.0 -41.93 85.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -60.46 -46.22 90.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.18 0.992 . . . . 0.0 111.323 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.0 mt -70.78 -38.35 73.39 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.978 0.511 . . . . 0.0 109.927 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.68 -28.13 69.75 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.763 0.697 . . . . 0.0 112.929 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -53.45 118.14 13.8 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.27 1.428 . . . . 0.0 109.96 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.39 -14.36 39.88 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.0 1.8 . . . . 0.0 113.504 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.7 -12.69 61.05 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.375 0.989 . . . . 0.0 112.026 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -128.79 41.41 3.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.94 2.096 . . . . 0.0 108.599 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -47.1 96.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.486 -1.245 . . . . 0.0 113.398 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.27 138.91 18.28 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 121.527 1.581 . . . . 0.0 108.356 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.63 130.72 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -172.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.9 m -105.06 138.93 40.51 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 mt -140.55 139.47 35.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -115.23 133.2 56.25 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -148.5 160.78 42.74 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.523 1.129 . . . . 0.0 109.035 -169.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.38 -173.74 43.15 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.453 ' HD2' ' H ' ' A' ' 90' ' ' ARG . 0.7 OUTLIER -68.27 142.34 94.65 Favored Pre-proline 0 CA--C 1.539 0.521 0 O-C-N 121.192 -1.181 . . . . 0.0 107.878 173.67 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.47 -27.83 62.23 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.487 2.124 . . . . 0.0 112.059 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -139.2 143.09 37.93 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 169.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -61.02 122.37 14.77 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 122.127 0.965 . . . . 0.0 108.799 -174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 m -155.08 136.72 14.32 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 126.892 2.077 . . . . 0.0 106.161 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.4 p -158.16 10.16 0.16 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.261 0.625 . . . . 0.0 112.498 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.1 t30 . . . . . 0 C--O 1.247 0.952 0 C-N-CA 125.645 1.578 . . . . 0.0 108.176 -175.463 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.53 -176.22 47.78 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -130.33 10.43 5.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.227 1.011 . . . . 0.0 111.989 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 49.47 37.54 12.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.674 1.59 . . . . 0.0 112.305 -177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -151.6 160.26 43.73 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.757 1.623 . . . . 0.0 108.153 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -152.75 162.01 41.83 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.48 1.512 . . . . 0.0 108.124 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -58.98 124.45 19.94 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -81.64 -8.86 59.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.88 0.472 . . . . 0.0 111.61 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tt -74.21 65.09 1.14 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.319 1.448 . . . . 0.0 108.437 171.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -146.22 -31.87 0.35 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.355 1.862 . . . . 0.0 111.063 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -62.82 158.62 18.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.686 1.194 . . . . 0.0 111.532 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -144.63 -47.05 0.25 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.557 1.143 . . . . 0.0 110.177 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.1 -31.35 5.28 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -66.29 -10.82 28.89 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.629 2.219 . . . . 0.0 115.921 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.7 tpt85 -51.39 120.82 5.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.928 1.24 . . . . 0.0 111.067 -171.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.94 159.76 43.16 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.05 1.34 . . . . 0.0 108.834 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -74.76 167.78 21.15 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.056 0.943 . . . . 0.0 108.466 169.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.71 82.6 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.404 -0.81 . . . . 0.0 111.391 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 47.98 -155.8 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.85 1.66 . . . . 0.0 112.949 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HE2' ' CE2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -158.12 174.07 15.77 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.828 2.051 . . . . 0.0 108.797 -169.362 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.9 m -79.67 142.75 35.25 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.42 ' CE2' ' HE2' ' A' ' 20' ' ' LYS . 89.3 m-85 -116.27 165.12 13.54 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.313 1.845 . . . . 0.0 109.324 -174.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -146.98 167.45 23.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.05 1.74 . . . . 0.0 107.079 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -116.36 161.0 33.78 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.211 1.004 . . . . 0.0 109.499 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -62.08 160.92 51.46 Favored 'Cis proline' 0 C--N 1.35 0.633 0 CA-C-N 119.762 0.951 . . . . 0.0 110.93 -10.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.434 ' HG ' ' H ' ' A' ' 28' ' ' LEU . 51.8 tp -139.67 149.75 44.07 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.771 0.829 . . . . 0.0 110.417 -169.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.4 -31.9 72.95 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.903 1.281 . . . . 0.0 112.586 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 26' ' ' LEU . 55.2 mt -63.59 144.81 56.7 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.284 0.634 . . . . 0.0 110.146 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -140.41 132.36 27.72 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.9 mt -113.56 155.58 25.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.696 0.798 . . . . 0.0 110.209 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 145.74 50.97 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.573 1.149 . . . . 0.0 108.836 170.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tt -75.5 130.69 39.29 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -150.62 130.13 13.01 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.285 1.034 . . . . 0.0 108.234 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.2 t0 47.93 47.48 18.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.416 1.486 . . . . 0.0 112.188 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 61.12 10.79 3.09 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.566 1.946 . . . . 0.0 114.876 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.8 mtm-85 -110.36 179.37 4.1 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.447 1.499 . . . . 0.0 108.537 169.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.27 131.74 72.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.4 mp -120.23 143.36 48.32 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.833 1.253 . . . . 0.0 108.245 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.52 105.5 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 125.851 1.66 . . . . 0.0 107.534 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.95 -29.6 24.98 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 124.334 1.054 . . . . 0.0 111.26 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -149.57 152.61 35.79 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.17 40.03 0.04 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -70.02 -4.13 19.48 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -116.24 -37.41 3.8 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.473 1.488 . . . . 0.0 110.177 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.63 -26.39 62.54 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.936 0.789 . . . . 0.0 111.405 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.58 -150.0 5.7 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.233 1.873 . . . . 0.0 109.158 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 tp -153.04 -38.12 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 117.451 0.625 . . . . 0.0 112.145 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -77.73 82.95 4.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.925 0.784 . . . . 0.0 110.363 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.9 m -56.97 158.69 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.467 0.707 . . . . 0.0 109.135 169.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.17 -6.49 66.31 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.985 -0.897 . . . . 0.0 112.702 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -63.96 158.97 20.96 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.11 153.12 41.91 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.308 1.043 . . . . 0.0 109.103 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.15 137.4 24.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.31 -36.81 3.02 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.507 1.123 . . . . 0.0 110.058 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.98 157.73 43.71 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.734 0.697 . . . . 0.0 109.889 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 83.9 mt -136.48 139.53 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 170.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 42.33 38.95 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.515 2.326 . . . . 0.0 112.626 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 10.14 77.32 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.725 -1.042 . . . . 0.0 114.075 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 98.7 mmm -121.65 120.28 34.28 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.029 1.415 . . . . 0.0 108.485 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.62 129.05 37.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.601 1.161 . . . . 0.0 109.161 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.15 144.37 9.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.54 0.686 . . . . 0.0 111.369 -171.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -78.82 62.91 3.42 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.047 1.339 . . . . 0.0 107.603 169.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.78 -112.58 4.21 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.407 1.004 . . . . 0.0 110.978 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.05 2.09 28.65 Favored 'General case' 0 N--CA 1.46 0.062 0 C-N-CA 123.697 0.799 . . . . 0.0 112.023 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -119.68 147.99 43.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 119.091 0.86 . . . . 0.0 109.613 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.8 p -69.95 175.63 4.28 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.722 0.773 . . . . 0.0 110.038 172.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.99 -38.63 79.61 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.59 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.14 -37.11 69.5 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.793 0.837 . . . . 0.0 111.598 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.36 6.4 8.89 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.498 1.047 . . . . 0.0 114.072 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -63.13 140.28 58.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.292 1.546 . . . . 0.0 107.83 170.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.62 125.2 26.15 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 169.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.56 -33.18 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.049 0.54 . . . . 0.0 111.577 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.1 -42.02 97.05 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.326 0.512 . . . . 0.0 110.034 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -68.58 -46.1 70.29 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.08 -46.17 85.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.436 0.694 . . . . 0.0 111.375 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.6 mt -78.12 -33.98 50.24 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.105 0.962 . . . . 0.0 110.436 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.33 -31.31 68.72 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.509 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -53.97 116.46 10.31 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.171 1.389 . . . . 0.0 110.67 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.428 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 61.2 Cg_endo -68.37 -17.44 44.25 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.028 1.819 . . . . 0.0 113.543 -175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.24 -11.64 59.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.927 0.785 . . . . 0.0 112.497 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -129.67 31.96 4.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.573 1.549 . . . . 0.0 110.07 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.6 m-30 -53.53 -51.26 77.65 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 116.776 -1.583 . . . . 0.0 113.629 176.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.43 125.3 8.95 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 122.153 1.805 . . . . 0.0 109.513 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.1 135.63 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.748 0.819 . . . . 0.0 108.984 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 m -84.62 134.52 34.38 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.8 mt -140.56 147.35 23.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -124.65 140.71 52.68 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -120.73 153.83 36.44 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.91 -179.99 33.21 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.4 mmt-85 -68.24 158.46 84.34 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.8 162.31 3.83 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.578 1.519 . . . . 0.0 109.561 168.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -58.87 -18.04 29.34 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 43.9 tp -56.23 -17.0 6.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.3 1.44 . . . . 0.0 112.662 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 m 64.58 46.39 3.24 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.263 1.425 . . . . 0.0 110.197 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m -71.03 58.3 0.22 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.202 2.201 . . . . 0.0 111.832 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.4 t30 . . . . . 0 C--O 1.249 1.073 0 C-N-CA 124.978 1.311 . . . . 0.0 111.731 -174.21 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.13 -176.37 40.25 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 121.705 -0.622 . . . . 0.0 111.95 -174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -59.41 -19.78 49.81 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.727 1.611 . . . . 0.0 114.1 -169.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -128.01 13.29 6.76 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.938 0.895 . . . . 0.0 110.901 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -138.63 51.97 1.82 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 127.01 2.124 . . . . 0.0 106.241 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -68.29 90.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -57.95 161.8 3.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.394 1.078 . . . . 0.0 110.896 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -66.78 12.57 0.07 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.18 2.592 . . . . 0.0 114.636 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.1 tp -55.48 153.71 7.25 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.89 2.076 . . . . 0.0 111.369 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -58.99 -6.22 0.77 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.683 1.993 . . . . 0.0 114.354 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -51.93 -21.51 3.08 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.909 1.684 . . . . 0.0 113.225 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -141.63 166.42 24.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.504 1.121 . . . . 0.0 109.153 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.619 ' H ' ' CD ' ' A' ' 14' ' ' PRO . . . -143.0 -25.35 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 116.45 -1.738 . . . . 0.0 114.922 -177.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.619 ' CD ' ' H ' ' A' ' 13' ' ' ALA . 80.0 Cg_exo -51.69 156.79 6.08 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.56 2.173 . . . . 0.0 114.163 175.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.24 -5.21 1.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.81 0.844 . . . . 0.0 113.095 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.06 154.29 43.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.807 1.243 . . . . 0.0 107.799 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 50.75 45.03 27.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.651 1.18 . . . . 0.0 109.826 -171.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.36 160.65 38.96 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.537 1.535 . . . . 0.0 108.674 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -141.12 142.71 34.07 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.439 1.096 . . . . 0.0 108.975 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -146.18 147.48 31.53 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.573 1.149 . . . . 0.0 110.075 -173.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -76.41 142.45 41.09 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -143.0 153.41 42.95 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.609 0.764 . . . . 0.0 109.587 172.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -144.07 174.71 10.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.038 2.135 . . . . 0.0 106.235 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -137.05 160.18 67.08 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.881 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -64.96 155.37 76.45 Favored 'Cis proline' 0 C--N 1.351 0.68 0 CA-C-N 120.249 1.125 . . . . 0.0 111.903 -5.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -157.58 155.38 30.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.425 1.49 . . . . 0.0 107.995 -173.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.25 -31.82 72.43 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.292 0.637 . . . . 0.0 112.164 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.44 139.96 56.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.732 1.213 . . . . 0.0 109.657 173.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.8 tp -146.55 153.78 40.76 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.9 mt -122.49 155.6 35.86 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.317 1.447 . . . . 0.0 108.291 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.18 153.49 51.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.437 0.562 . . . . 0.0 110.387 170.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.9 tp -90.94 123.8 34.71 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.294 1.438 . . . . 0.0 107.168 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -149.16 137.13 20.61 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.729 1.212 . . . . 0.0 108.34 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.2 t70 45.82 43.1 9.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.521 1.529 . . . . 0.0 112.605 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 53.98 32.02 14.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.757 1.623 . . . . 0.0 113.991 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -130.29 164.2 25.13 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 125.779 1.631 . . . . 0.0 107.511 169.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.2 t -122.28 117.88 53.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -116.45 147.36 41.77 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.211 1.404 . . . . 0.0 108.061 -169.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.84 108.98 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 173.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.03 -40.95 21.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.747 1.219 . . . . 0.0 111.578 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -147.8 159.54 43.72 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.685 1.194 . . . . 0.0 108.512 -176.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.06 50.96 0.02 OUTLIER Glycine 0 CA--C 1.52 0.403 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -63.32 -30.52 71.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.627 0.713 . . . . 0.0 110.875 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -65.82 -30.02 70.59 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.011 0.524 . . . . 0.0 110.939 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -82.31 -57.16 3.49 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.381 0.672 . . . . 0.0 110.721 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.39 -16.73 58.69 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 117.35 -1.806 . . . . 0.0 115.165 170.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.0 tt -146.31 -25.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 121.013 2.407 . . . . 0.0 114.62 -170.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -17.96 64.24 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.715 -1.241 . . . . 0.0 111.723 173.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -54.76 145.17 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.765 1.166 . . . . 0.0 109.825 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.08 -12.79 57.18 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.3 0.952 . . . . 0.0 113.911 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -79.68 174.75 11.27 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.851 1.325 . . . . 0.0 109.086 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.64 148.33 51.52 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.087 0.555 . . . . 0.0 111.398 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.2 t -61.85 137.25 24.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.8 mt -120.21 -33.1 3.99 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.896 1.279 . . . . 0.0 109.423 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.0 159.91 44.27 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.492 1.042 . . . . 0.0 110.9 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.3 mt -132.05 130.94 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.7 p30 41.69 26.25 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.559 2.343 . . . . 0.0 115.091 -174.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.63 -15.32 57.3 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.174 1.369 . . . . 0.0 113.151 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 76.7 mtm -75.32 106.93 7.1 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.836 1.318 . . . . 0.0 108.957 172.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.7 125.55 22.8 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.2 m -80.38 128.25 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -75.36 74.95 2.45 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.471 1.509 . . . . 0.0 107.918 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.17 -70.95 0.79 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 126.458 1.98 . . . . 0.0 112.157 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -129.35 -4.82 4.85 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.706 2.402 . . . . 0.0 111.522 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -117.94 156.18 28.93 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.2 p -70.61 175.65 4.72 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.277 -0.89 . . . . 0.0 109.629 169.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.14 79.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.141 169.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.29 -29.64 67.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.548 1.139 . . . . 0.0 111.992 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.66 3.88 19.96 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.075 1.321 . . . . 0.0 113.385 170.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -71.41 136.26 47.63 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.96 129.05 38.51 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 171.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 t -55.75 -41.96 67.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.987 0.915 . . . . 0.0 111.356 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.5 mt -66.55 -37.28 84.65 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.72 0.691 . . . . 0.0 110.927 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.68 -43.48 65.93 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -58.06 -46.78 84.83 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.619 1.168 . . . . 0.0 110.749 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.88 -32.83 59.86 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.65 0.78 . . . . 0.0 111.128 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.89 -32.1 76.82 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.427 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -60.19 114.69 10.57 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.204 1.001 . . . . 0.0 109.814 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.7 Cg_endo -71.06 -15.87 32.22 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.72 1.613 . . . . 0.0 113.838 -175.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.96 -14.54 48.55 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.222 0.919 . . . . 0.0 111.105 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -133.52 27.27 4.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.311 2.244 . . . . 0.0 109.438 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.449 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.4 m-30 -59.4 -53.15 68.87 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-O 117.046 -1.454 . . . . 0.0 112.264 170.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.16 119.44 6.17 Favored 'Trans proline' 0 C--N 1.351 0.691 0 CA-C-N 121.813 1.683 . . . . 0.0 109.755 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 m -147.44 174.05 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.642 1.577 . . . . 0.0 110.031 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.2 m -125.67 137.81 53.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 168.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.9 mt -131.33 137.72 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -173.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.1 ttp-105 -116.62 135.01 54.15 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -141.86 165.12 28.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.852 0.861 . . . . 0.0 110.45 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.74 -173.68 33.64 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 124.28 0.943 . . . . 0.0 111.038 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -63.79 129.06 93.56 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.81 166.96 24.51 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 121.446 1.431 . . . . 0.0 110.703 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -64.52 145.54 55.97 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -52.93 -40.89 63.96 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.948 0.899 . . . . 0.0 112.12 -170.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.6 -23.79 29.48 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.705 1.602 . . . . 0.0 113.138 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -68.07 -18.99 64.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.613 0.765 . . . . 0.0 112.894 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.2 t30 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 124.36 1.064 . . . . 0.0 111.032 -179.581 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.8 mtm . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.6 168.92 38.61 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -74.92 35.51 0.11 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.481 1.912 . . . . 0.0 111.954 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -59.72 -32.04 70.16 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 120.934 -1.104 . . . . 0.0 111.209 173.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -138.35 146.2 42.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.867 2.067 . . . . 0.0 106.075 173.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -63.77 -34.35 77.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.758 0.423 . . . . 0.0 110.868 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -83.0 46.55 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.039 1.336 . . . . 0.0 110.988 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -153.54 -53.13 0.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.763 1.625 . . . . 0.0 108.449 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 tp -149.79 144.18 25.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.924 2.09 . . . . 0.0 106.336 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.45 -33.84 0.97 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.513 0.725 . . . . 0.0 111.644 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.5 m -163.28 169.73 18.71 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.141 2.177 . . . . 0.0 107.729 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.05 101.8 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.002 2.121 . . . . 0.0 114.38 169.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.15 148.51 38.43 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.149 1.379 . . . . 0.0 107.721 169.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.2 143.81 24.74 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.655 2.903 . . . . 0.0 112.885 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -148.69 46.28 1.02 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.293 1.037 . . . . 0.0 110.474 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.82 -15.07 57.91 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.85 157.96 43.88 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.295 1.438 . . . . 0.0 108.593 175.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.05 169.93 21.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.369 1.868 . . . . 0.0 108.604 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.31 135.71 24.14 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.888 0.875 . . . . 0.0 108.662 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -147.68 153.0 38.77 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.778 0.831 . . . . 0.0 110.334 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -83.58 142.99 30.44 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.834 1.253 . . . . 0.0 108.43 169.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -142.66 174.93 10.2 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.959 0.903 . . . . 0.0 110.343 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.9 m -151.22 175.53 12.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.905 2.482 . . . . 0.0 106.558 169.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.27 160.61 67.98 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.85 0.86 . . . . 0.0 110.24 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.25 -36.14 1.57 Allowed 'Cis proline' 0 C--N 1.351 0.704 0 CA-C-N 119.884 0.994 . . . . 0.0 111.425 -8.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 45.4 30.67 0.74 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.325 2.25 . . . . 0.0 114.156 169.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.7 t0 43.23 57.28 3.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.262 1.425 . . . . 0.0 112.192 -172.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.8 tp -144.28 140.7 29.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.932 1.693 . . . . 0.0 107.72 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.3 tp -146.95 142.01 27.09 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.657 0.783 . . . . 0.0 109.692 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -126.46 155.23 42.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.978 2.111 . . . . 0.0 107.165 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 153.43 41.17 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.053 0.842 . . . . 0.0 111.75 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.0 tp -73.55 127.67 33.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.891 1.676 . . . . 0.0 109.296 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -158.47 144.41 16.92 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.952 1.301 . . . . 0.0 108.406 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 51.36 39.81 25.04 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.935 1.294 . . . . 0.0 112.312 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 55.53 15.55 1.53 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.115 2.166 . . . . 0.0 114.658 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -118.71 -174.19 2.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.284 1.833 . . . . 0.0 107.102 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -123.26 142.09 41.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.4 mt -118.26 145.72 44.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.55 126.86 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 169.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -107.68 -38.05 5.98 Favored 'General case' 0 C--O 1.231 0.132 0 C-N-CA 123.483 0.713 . . . . 0.0 112.22 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -156.89 154.67 30.16 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.571 0.748 . . . . 0.0 108.995 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.46 15.84 79.08 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.145 -0.809 . . . . 0.0 113.461 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -63.26 102.72 0.42 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.665 1.233 . . . . 0.0 109.962 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -65.61 -26.32 67.78 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.053 -0.405 . . . . 0.0 111.555 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.69 -31.06 71.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.172 0.989 . . . . 0.0 112.793 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.4 165.98 21.47 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -21.01 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -171.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -77.54 74.12 4.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.271 0.942 . . . . 0.0 110.046 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 m -53.68 164.79 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.185 0.994 . . . . 0.0 109.847 169.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 1.21 38.8 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 117.846 -1.53 . . . . 0.0 113.634 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -60.95 136.68 58.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.281 2.04 . . . . 0.0 108.843 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.68 138.04 32.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.2 t -65.97 147.61 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 171.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.3 mt -126.37 -36.11 2.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.705 2.002 . . . . 0.0 109.488 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.7 159.48 44.08 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.005 0.82 . . . . 0.0 110.763 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 74.6 mt -136.08 136.0 49.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 45.78 32.67 1.3 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.918 2.087 . . . . 0.0 112.882 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.61 7.57 75.17 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.159 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.5 mmt -114.18 120.64 41.2 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.92 1.36 . . . . 0.0 107.894 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -53.43 133.87 40.47 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.275 1.03 . . . . 0.0 109.132 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.24 145.67 12.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.462 0.649 . . . . 0.0 110.133 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -78.06 62.59 2.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.762 1.625 . . . . 0.0 108.264 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.04 -107.79 1.07 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.876 1.227 . . . . 0.0 111.137 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -76.91 -6.88 54.25 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.339 1.056 . . . . 0.0 112.372 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -120.62 146.56 46.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 119.042 0.837 . . . . 0.0 109.247 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.6 p -69.17 177.32 2.79 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.66 0.743 . . . . 0.0 110.386 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.76 75.0 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.563 169.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.11 -38.2 63.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.753 0.821 . . . . 0.0 111.633 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.57 4.72 8.05 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.551 1.072 . . . . 0.0 113.92 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -61.8 140.66 58.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.198 1.499 . . . . 0.0 107.995 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -68.26 124.8 24.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.29 -32.9 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 122.93 0.492 . . . . 0.0 111.629 -170.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.89 -39.84 95.11 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.91 0.777 . . . . 0.0 110.662 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.22 -42.69 71.95 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -58.7 -44.69 90.4 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.8 0.84 . . . . 0.0 111.283 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.53 -32.17 53.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.482 1.113 . . . . 0.0 110.829 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.35 -28.31 73.33 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.94 0.781 . . . . 0.0 112.522 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -61.41 114.36 10.69 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.373 1.069 . . . . 0.0 109.279 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.465 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 94.4 Cg_endo -71.52 -13.05 30.0 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.347 1.365 . . . . 0.0 113.847 -175.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.66 -14.78 55.14 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.429 1.013 . . . . 0.0 110.66 169.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -132.91 33.43 3.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.297 2.639 . . . . 0.0 108.749 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -66.57 -53.49 28.97 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 117.099 -1.429 . . . . 0.0 111.562 169.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.7 125.84 12.07 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 121.786 1.673 . . . . 0.0 108.974 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 m -149.53 170.88 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.781 0.832 . . . . 0.0 111.302 -169.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.8 m -125.59 133.22 52.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.2 mm -128.93 137.47 57.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.3 ttt85 -112.29 133.41 54.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -144.69 166.41 25.27 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.773 1.229 . . . . 0.0 108.565 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.5 -173.22 37.59 Favored Glycine 0 N--CA 1.452 -0.28 0 O-C-N 121.813 -0.554 . . . . 0.0 111.805 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -60.41 132.6 90.74 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.507 -0.758 . . . . 0.0 109.093 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.81 -15.53 50.74 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.903 2.402 . . . . 0.0 113.858 169.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -129.24 157.86 40.65 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.584 2.353 . . . . 0.0 107.415 -169.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.07 -49.18 78.85 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.685 0.675 . . . . 0.0 110.301 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -69.1 140.38 54.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.984 1.314 . . . . 0.0 109.187 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -68.97 -21.54 64.17 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 174.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 117.98 -1.009 . . . . 0.0 108.766 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.5 mtm . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.27 46.17 0.22 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -60.28 -22.9 63.68 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -66.5 -40.13 89.09 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.699 0.681 . . . . 0.0 111.432 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -72.76 -35.38 67.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.35 0.66 . . . . 0.0 109.945 171.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 67.11 172.11 0.26 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.208 2.203 . . . . 0.0 111.476 -172.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -70.48 -174.9 0.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.963 1.705 . . . . 0.0 111.254 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -57.06 -34.43 68.24 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.943 0.897 . . . . 0.0 111.914 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.54 127.71 32.98 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.91 -29.71 69.75 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -146.21 170.27 17.07 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.722 2.009 . . . . 0.0 107.661 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -62.88 158.32 19.3 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 169.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.48 134.38 7.9 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -52.19 -18.41 7.47 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.364 3.376 . . . . 0.0 116.752 -172.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -61.38 -22.96 65.45 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.226 -0.921 . . . . 0.0 112.109 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.85 -37.92 0.48 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.944 0.898 . . . . 0.0 113.296 -175.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -146.84 158.32 43.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.243 1.017 . . . . 0.0 111.101 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.23 166.38 28.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.649 1.179 . . . . 0.0 109.079 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -152.55 131.71 12.71 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -150.56 170.93 17.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.3 1.44 . . . . 0.0 109.483 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -137.09 142.61 42.35 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -142.85 175.45 9.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.468 1.507 . . . . 0.0 110.529 -171.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.9 m -150.72 174.16 13.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.181 2.592 . . . . 0.0 106.197 169.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -132.78 159.59 71.93 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.524 -0.751 . . . . 0.0 109.922 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.62 155.96 82.55 Favored 'Cis proline' 0 CA--C 1.535 0.575 0 CA-C-N 120.009 1.039 . . . . 0.0 111.492 -6.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 tp -156.0 154.33 30.91 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.147 1.379 . . . . 0.0 108.267 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.6 56.46 1.45 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.16 1.384 . . . . 0.0 110.756 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.1 tp -142.91 135.98 28.15 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.924 2.09 . . . . 0.0 106.368 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.1 tp -145.84 143.65 29.76 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.0 mp -128.94 154.28 46.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.317 1.847 . . . . 0.0 107.365 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.91 152.69 42.33 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.041 0.837 . . . . 0.0 111.748 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.7 tp -71.82 129.26 38.19 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.906 1.282 . . . . 0.0 108.556 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -154.37 134.35 13.07 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.086 1.355 . . . . 0.0 108.087 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.3 t70 48.7 46.53 21.43 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.288 1.435 . . . . 0.0 112.578 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 55.69 16.1 1.84 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.41 1.884 . . . . 0.0 114.396 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.59 174.62 5.97 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 125.331 1.452 . . . . 0.0 107.387 169.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.65 133.8 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.0 mt -121.01 153.28 37.57 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.419 1.088 . . . . 0.0 108.313 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.8 122.35 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.75 -36.94 11.5 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.456 1.503 . . . . 0.0 111.235 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -154.14 151.22 28.99 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.869 1.267 . . . . 0.0 107.935 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.5 -5.91 1.2 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.364 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -60.17 157.54 13.04 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.925 1.362 . . . . 0.0 111.487 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 56.45 25.57 9.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.33 1.452 . . . . 0.0 112.592 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -153.2 -37.99 0.1 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.875 1.27 . . . . 0.0 110.08 172.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.66 -158.45 7.54 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.686 2.088 . . . . 0.0 109.461 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.0 mm -55.28 140.3 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.465 1.106 . . . . 0.0 109.766 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -67.64 151.71 46.84 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 122.26 -0.275 . . . . 0.0 110.427 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m -51.99 150.5 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.406 1.082 . . . . 0.0 111.578 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.82 -11.29 64.87 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.928 174.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -68.61 139.24 55.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.323 1.562 . . . . 0.0 107.478 169.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.36 143.4 27.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 p -76.02 135.38 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 168.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.62 -29.43 6.47 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.668 1.587 . . . . 0.0 110.071 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.39 160.25 43.85 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.573 1.079 . . . . 0.0 110.626 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.5 mt -138.71 134.54 42.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 44.8 36.08 1.71 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.328 1.851 . . . . 0.0 111.972 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.89 -16.3 57.19 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.449 1.499 . . . . 0.0 113.671 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.4 mmt -88.44 121.49 30.88 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.846 1.323 . . . . 0.0 109.014 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.42 135.98 32.38 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.337 1.055 . . . . 0.0 109.84 169.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 m -93.2 128.93 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.667 0.746 . . . . 0.0 109.029 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -73.81 76.93 1.6 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.849 1.66 . . . . 0.0 107.424 169.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.61 -79.06 0.25 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.68 1.61 . . . . 0.0 111.968 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -128.91 11.07 6.03 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.399 1.479 . . . . 0.0 112.048 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.51 152.15 42.05 Favored 'General case' 0 C--N 1.334 -0.077 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.2 p -71.64 174.69 6.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.36 0.982 . . . . 0.0 110.118 173.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.39 75.13 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.506 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.47 -37.61 71.31 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.784 0.834 . . . . 0.0 111.576 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.67 5.86 8.18 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.553 1.073 . . . . 0.0 114.088 173.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -63.28 137.81 58.32 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.171 1.486 . . . . 0.0 107.729 172.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -68.41 131.61 45.6 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 169.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -56.57 -41.42 73.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.576 1.15 . . . . 0.0 110.912 -174.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.4 mt -65.42 -37.65 87.55 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 118.091 0.405 . . . . 0.0 110.723 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.63 -45.32 68.76 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -60.14 -45.26 93.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.468 0.707 . . . . 0.0 111.405 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.49 -30.25 33.35 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.811 0.444 . . . . 0.0 111.156 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.43 -34.93 63.4 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.696 0.68 . . . . 0.0 112.0 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -60.39 117.66 26.53 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.353 1.061 . . . . 0.0 110.219 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.72 -31.57 32.19 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.771 1.647 . . . . 0.0 111.955 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.42 -3.56 1.46 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -169.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.41 45.18 2.84 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.14 1.376 . . . . 0.0 111.503 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -40.86 -55.15 4.87 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.36 117.97 5.39 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 122.264 1.844 . . . . 0.0 109.713 -172.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.52 131.13 34.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.7 m -98.8 139.02 35.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 mm -132.17 142.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -172.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 mtp-105 -119.79 139.88 51.64 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -128.35 170.41 13.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.229 1.412 . . . . 0.0 108.438 -173.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.85 -178.73 40.54 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -66.76 149.34 98.37 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.4 -19.11 49.73 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.448 2.098 . . . . 0.0 113.214 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -138.08 151.02 47.42 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.044 1.338 . . . . 0.0 107.503 169.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.1 152.03 49.99 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 175.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.1 p -60.88 123.46 17.61 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.797 0.839 . . . . 0.0 109.885 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.0 m 52.1 28.99 5.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.533 1.533 . . . . 0.0 113.821 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 C--O 1.25 1.117 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -178.096 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.55 -178.83 48.76 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -141.51 161.73 37.2 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.53 1.532 . . . . 0.0 108.301 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -143.01 161.75 37.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.918 1.287 . . . . 0.0 108.993 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -136.74 166.56 23.3 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.373 1.869 . . . . 0.0 107.221 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -137.87 142.83 40.7 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.497 1.119 . . . . 0.0 108.263 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -146.84 159.33 43.65 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.503 1.521 . . . . 0.0 107.736 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -138.94 -169.19 2.58 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.892 1.677 . . . . 0.0 108.099 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.8 tp -51.33 117.72 2.8 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.275 1.03 . . . . 0.0 109.958 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.0 t0 42.77 34.51 0.59 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.723 2.409 . . . . 0.0 115.343 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.3 m -65.61 169.81 5.8 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.565 -0.709 . . . . 0.0 110.938 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -59.0 160.92 5.47 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 169.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.42 166.71 15.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.883 1.273 . . . . 0.0 108.982 -174.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.41 -6.01 1.31 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.264 3.309 . . . . 0.0 116.716 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -110.07 11.32 23.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.022 1.329 . . . . 0.0 111.546 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.41 172.35 3.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.745 0.702 . . . . 0.0 110.104 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.7 -176.8 4.52 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.698 0.799 . . . . 0.0 110.374 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.41 165.82 4.44 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.774 1.273 . . . . 0.0 113.314 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -135.89 120.42 18.18 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 102.474 -3.158 . . . . 0.0 102.474 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -152.64 154.44 35.34 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.247 0.93 . . . . 0.0 112.345 -169.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -83.73 143.07 30.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.922 2.089 . . . . 0.0 110.62 172.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -140.1 162.71 34.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.461 1.104 . . . . 0.0 109.194 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.4 m -153.42 167.7 28.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.075 1.75 . . . . 0.0 107.044 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.63 175.87 3.32 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 117.392 -1.289 . . . . 0.0 109.73 -169.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.85 148.6 7.81 Favored 'Cis proline' 0 C--N 1.356 0.957 0 CA-C-N 122.614 1.969 . . . . 0.0 115.87 6.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.94 138.9 57.22 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.352 1.061 . . . . 0.0 111.014 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -136.12 20.48 3.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.622 1.569 . . . . 0.0 109.809 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 pp -148.15 169.36 20.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.234 3.014 . . . . 0.0 105.624 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.1 mt -143.21 145.82 33.12 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.9 mp -127.14 154.79 44.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.975 1.71 . . . . 0.0 107.178 174.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 154.08 43.79 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.738 0.815 . . . . 0.0 110.16 174.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.5 tp -76.29 121.86 23.57 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -153.25 144.2 22.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.288 1.435 . . . . 0.0 108.485 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 43.16 50.77 5.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.223 1.409 . . . . 0.0 111.753 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 60.05 7.76 1.28 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.821 2.048 . . . . 0.0 115.943 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -125.87 160.62 29.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.945 1.248 . . . . 0.0 109.851 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.31 124.41 40.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.4 mt -114.84 148.63 38.27 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.96 109.9 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.43 -38.11 71.4 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.8 1.24 . . . . 0.0 110.37 175.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -158.83 142.23 14.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.174 0.99 . . . . 0.0 109.146 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.3 22.77 0.09 OUTLIER Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.468 1.033 . . . . 0.0 110.6 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -69.59 -25.96 64.23 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.05 0.925 . . . . 0.0 112.539 -169.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -68.73 -36.66 78.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.07 0.85 . . . . 0.0 111.214 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.14 -41.7 85.64 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 170.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.64 -11.34 2.18 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.676 1.608 . . . . 0.0 112.376 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.8 mt -71.38 120.98 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.52 1.128 . . . . 0.0 109.369 -169.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -61.56 137.39 58.24 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 169.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.88 144.1 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.698 0.799 . . . . 0.0 109.069 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.4 0.55 70.05 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.733 -1.037 . . . . 0.0 114.013 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -65.89 136.38 56.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.235 1.517 . . . . 0.0 108.736 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.84 140.48 29.63 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.623 1.169 . . . . 0.0 108.988 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.99 142.62 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.2 mt -120.05 -32.57 4.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.313 1.045 . . . . 0.0 109.803 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.37 159.7 42.5 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.676 1.125 . . . . 0.0 110.75 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.433 ' CD1' HG13 ' A' ' 72' ' ' VAL . 96.9 mt -136.12 135.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 49.93 29.13 3.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.078 1.751 . . . . 0.0 112.122 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.63 -9.49 67.93 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.943 1.258 . . . . 0.0 113.795 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.3 mmt -85.62 115.16 23.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.973 1.387 . . . . 0.0 108.302 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -51.58 132.73 30.58 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.483 1.113 . . . . 0.0 109.559 169.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.71 133.97 32.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -78.15 71.77 4.64 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.325 1.45 . . . . 0.0 107.34 169.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.45 -59.6 0.29 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 128.032 2.729 . . . . 0.0 114.342 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -137.36 -4.61 1.86 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.003 2.121 . . . . 0.0 111.658 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -117.56 154.1 32.08 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.7 p -69.88 177.22 3.21 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.188 0.904 . . . . 0.0 110.113 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.32 -38.69 74.44 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.612 169.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.36 -37.93 68.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.672 0.789 . . . . 0.0 111.558 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.47 4.88 7.39 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.548 1.071 . . . . 0.0 113.874 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -64.22 136.93 57.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.785 1.292 . . . . 0.0 107.736 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.05 125.99 26.66 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.433 HG13 ' CD1' ' A' ' 56' ' ' ILE . 38.6 t -57.33 -37.39 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.191 0.596 . . . . 0.0 111.707 -170.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.47 -42.42 98.6 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.674 0.67 . . . . 0.0 110.09 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.66 -37.5 70.8 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.059 -0.401 . . . . 0.0 110.212 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -60.12 -43.62 95.48 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.801 0.84 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.62 -36.06 60.35 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.441 0.696 . . . . 0.0 110.575 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.13 -33.01 86.1 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.688 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -59.65 116.07 15.22 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.93 1.292 . . . . 0.0 110.453 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.6 Cg_endo -70.25 -14.6 34.7 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.92 1.746 . . . . 0.0 114.086 -177.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.51 -14.12 55.68 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.536 1.062 . . . . 0.0 110.901 169.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -135.58 34.74 2.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.764 2.426 . . . . 0.0 108.638 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.474 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -63.28 -55.4 36.48 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.669 -1.157 . . . . 0.0 111.583 171.413 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.32 127.99 13.24 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 121.382 1.529 . . . . 0.0 109.219 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.3 m -149.16 169.32 2.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 123.992 0.917 . . . . 0.0 110.852 -172.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.4 m -126.04 137.17 53.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 169.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.1 mt -132.73 143.59 39.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -123.55 130.81 53.22 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -138.47 172.2 13.25 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.054 0.942 . . . . 0.0 108.788 -176.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -176.46 39.41 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.34 147.28 98.91 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 169.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.96 -20.18 70.89 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.972 2.448 . . . . 0.0 112.642 175.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -126.67 95.93 4.5 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 101.817 -3.401 . . . . 0.0 101.817 169.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.0 tp -45.14 -44.89 11.01 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -169.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 p -81.55 2.07 30.78 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.591 1.157 . . . . 0.0 113.577 -172.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 69.4 p -67.9 -8.63 38.31 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.444 1.02 . . . . 0.0 113.224 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.915 0 C-N-CA 126.088 1.755 . . . . 0.0 106.38 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.77 6.9 0.65 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.567 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -68.78 -3.64 13.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.08 1.44 . . . . 0.0 113.24 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -61.63 -28.81 69.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.734 0.814 . . . . 0.0 111.709 172.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -65.68 137.34 57.24 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.451 0.569 . . . . 0.0 109.957 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -144.87 163.96 32.53 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.182 1.793 . . . . 0.0 107.816 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -59.27 139.16 57.25 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.907 0.483 . . . . 0.0 109.715 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -157.0 -32.86 0.08 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.41 1.084 . . . . 0.0 111.628 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.88 141.71 54.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.326 1.05 . . . . 0.0 109.315 173.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.45 -30.29 69.97 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.453 0.701 . . . . 0.0 112.796 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 m -59.7 155.6 15.49 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.336 1.454 . . . . 0.0 111.895 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -64.59 168.06 6.43 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.31 0.576 . . . . 0.0 110.739 172.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.08 163.01 40.32 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.601 1.56 . . . . 0.0 108.366 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.56 149.11 4.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.422 2.748 . . . . 0.0 112.667 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -109.14 41.65 1.59 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.164 0.986 . . . . 0.0 109.512 -172.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.2 153.34 18.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.411 0.684 . . . . 0.0 110.275 175.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -131.54 -5.29 3.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.307 1.443 . . . . 0.0 110.854 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.99 154.03 36.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.767 1.227 . . . . 0.0 109.564 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -153.95 101.53 2.44 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 169.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -155.07 154.93 33.19 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -171.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -73.17 145.06 46.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.67 1.188 . . . . 0.0 109.162 169.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -140.81 162.3 35.76 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.054 1.342 . . . . 0.0 108.849 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.1 m -148.34 175.64 10.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.384 2.274 . . . . 0.0 106.788 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -137.49 153.56 74.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.581 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.06 152.71 87.55 Favored 'Cis proline' 0 CA--C 1.538 0.691 0 CA-C-N 119.642 0.908 . . . . 0.0 110.412 -10.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.5 tp -160.66 170.88 19.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.222 1.409 . . . . 0.0 108.143 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.11 -33.21 68.88 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.286 1.035 . . . . 0.0 112.168 174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 tp -62.56 128.34 35.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.65 0.78 . . . . 0.0 109.841 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.6 tp -142.48 150.33 40.37 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.772 1.629 . . . . 0.0 107.2 172.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -132.59 155.54 48.51 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.507 1.123 . . . . 0.0 109.833 -170.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 155.42 44.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.788 0.835 . . . . 0.0 110.333 172.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.41 131.12 40.41 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.895 1.278 . . . . 0.0 107.83 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -152.72 138.76 18.19 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 t70 44.42 49.17 8.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.518 1.527 . . . . 0.0 112.839 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 60.22 14.54 4.64 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.991 1.716 . . . . 0.0 114.702 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 155.77 28.68 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 120.975 -1.078 . . . . 0.0 108.78 171.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.5 t -102.49 130.74 51.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.73 150.61 40.1 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.133 1.373 . . . . 0.0 107.967 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.56 108.01 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.74 -29.79 23.6 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.588 1.155 . . . . 0.0 111.759 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -146.64 144.54 29.57 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.03 93.91 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 106.283 -2.727 . . . . 0.0 106.283 -169.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -145.21 174.99 10.6 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.003 0.921 . . . . 0.0 110.527 -170.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 67.09 -47.13 0.48 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.236 2.614 . . . . 0.0 113.523 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.79 -35.72 80.78 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.051 0.841 . . . . 0.0 110.58 172.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.18 178.6 48.4 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.6 pt -76.67 54.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.258 1.023 . . . . 0.0 110.339 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -66.14 -30.61 71.12 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.928 -1.107 . . . . 0.0 111.748 -169.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -44.66 141.46 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.323 1.049 . . . . 0.0 112.65 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.99 -15.8 46.26 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.694 1.14 . . . . 0.0 114.03 173.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -72.33 158.6 35.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.095 1.447 . . . . 0.0 109.932 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.73 144.1 33.86 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.705 1.202 . . . . 0.0 109.271 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -63.61 152.04 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 174.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.6 mt -132.62 -41.5 0.95 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.645 1.178 . . . . 0.0 110.63 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.56 158.84 44.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.375 0.989 . . . . 0.0 110.368 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 78.4 mt -138.54 139.94 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 176.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 46.67 31.02 1.27 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.872 2.069 . . . . 0.0 112.745 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.66 18.48 65.81 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.709 -1.051 . . . . 0.0 113.816 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -125.29 133.05 52.78 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.036 1.418 . . . . 0.0 109.198 170.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -50.71 141.86 12.18 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.391 1.076 . . . . 0.0 109.579 169.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.4 m -115.13 128.74 72.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 122.146 0.975 . . . . 0.0 109.164 174.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -76.35 74.9 3.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.969 2.107 . . . . 0.0 108.967 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.93 -66.74 1.13 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.382 1.944 . . . . 0.0 112.943 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.59 9.47 2.43 Favored 'General case' 0 CA--C 1.526 0.051 0 C-N-CA 125.146 1.378 . . . . 0.0 112.457 175.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -121.51 143.68 49.13 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.7 p -71.64 174.01 7.32 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.257 0.935 . . . . 0.0 110.152 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.14 -38.18 76.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.469 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.67 -39.58 73.49 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.972 0.909 . . . . 0.0 111.406 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.78 -0.21 7.84 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.648 1.118 . . . . 0.0 114.187 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -61.48 143.69 55.49 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.181 1.49 . . . . 0.0 108.499 173.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -69.34 134.73 49.44 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 t -55.25 -45.7 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.771 1.228 . . . . 0.0 111.014 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.41 -36.41 81.22 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.478 0.581 . . . . 0.0 110.669 -176.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -70.63 -43.2 69.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.412 0.551 . . . . 0.0 109.746 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -60.28 -45.05 94.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.506 1.123 . . . . 0.0 110.703 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.39 -33.18 60.97 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.685 0.794 . . . . 0.0 111.001 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.43 -30.66 73.33 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.843 0.735 . . . . 0.0 112.456 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -60.49 114.56 10.46 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.285 1.034 . . . . 0.0 109.674 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 80.5 Cg_endo -70.87 -14.61 32.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.627 1.552 . . . . 0.0 113.832 -175.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.41 -15.04 56.41 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.393 0.997 . . . . 0.0 110.857 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -133.68 33.35 3.5 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.883 2.473 . . . . 0.0 108.648 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -65.24 -52.6 45.95 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 117.085 -1.436 . . . . 0.0 111.121 169.68 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.93 125.4 10.95 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.794 1.677 . . . . 0.0 109.251 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.1 m -150.45 171.83 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.188 1.395 . . . . 0.0 110.127 -170.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 m -125.74 138.72 53.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 169.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 mt -138.63 143.65 31.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -118.45 132.77 56.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -145.0 166.25 25.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.214 1.406 . . . . 0.0 107.317 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.74 -156.97 28.31 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -68.94 158.3 86.68 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.31 154.91 43.62 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.906 1.737 . . . . 0.0 110.435 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -72.61 -7.35 49.82 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.0 tp -137.83 161.1 37.5 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.287 1.835 . . . . 0.0 107.228 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.3 p -62.2 -23.11 66.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.583 1.153 . . . . 0.0 113.315 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 m -56.65 126.91 28.85 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.607 1.163 . . . . 0.0 110.078 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.027 179.504 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.88 -168.57 39.15 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -56.66 -19.49 16.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.566 1.147 . . . . 0.0 113.999 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.555 ' HD1' ' CG ' ' A' ' 6' ' ' HIS . 9.6 p80 -61.49 -22.87 65.48 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.173 0.989 . . . . 0.0 112.918 174.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.3 m80 41.61 51.03 3.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.523 1.929 . . . . 0.0 114.253 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.555 ' CG ' ' HD1' ' A' ' 4' ' ' HIS . 62.2 m170 -69.13 -10.13 56.13 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.44 -0.788 . . . . 0.0 111.416 169.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -140.24 164.11 30.96 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.671 1.989 . . . . 0.0 107.482 171.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.98 144.7 56.88 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 122.825 0.45 . . . . 0.0 109.911 173.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.8 tp -81.81 69.66 8.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.91 152.38 16.25 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.665 0.786 . . . . 0.0 110.697 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.5 m -64.65 -33.46 75.99 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.88 139.62 50.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -162.16 154.99 16.92 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.268 2.227 . . . . 0.0 106.363 169.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.29 -33.98 57.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.895 3.063 . . . . 0.0 113.54 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -141.61 133.78 27.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.46 19.74 1.53 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.793 1.237 . . . . 0.0 110.378 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -130.82 157.86 41.74 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.689 1.596 . . . . 0.0 110.176 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.0 174.08 15.14 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.38 1.872 . . . . 0.0 108.608 173.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -142.64 146.89 34.94 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.136 0.974 . . . . 0.0 108.62 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -153.96 172.74 16.96 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.663 1.185 . . . . 0.0 108.877 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -123.71 142.49 51.02 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.394 1.478 . . . . 0.0 108.086 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -141.73 167.18 22.77 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.607 0.718 . . . . 0.0 110.607 -173.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.8 m -155.07 174.47 15.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.719 2.008 . . . . 0.0 107.08 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -136.56 163.78 47.33 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.64 6.63 21.13 Favored 'Cis proline' 0 CA--C 1.541 0.856 0 CA-C-N 121.74 1.657 . . . . 0.0 114.562 5.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.1 tp -44.9 130.61 7.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.254 1.022 . . . . 0.0 110.023 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.59 123.88 17.79 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.251 1.02 . . . . 0.0 112.813 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.6 tp -161.27 153.41 19.87 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.763 2.425 . . . . 0.0 104.835 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 44.2 tp -147.05 137.21 23.37 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.642 1.11 . . . . 0.0 109.674 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.5 mp -131.06 150.62 52.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.433 2.293 . . . . 0.0 106.172 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 154.4 41.85 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.251 0.932 . . . . 0.0 111.196 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -77.4 124.61 28.11 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -154.73 144.72 21.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.235 1.414 . . . . 0.0 109.044 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 46.79 45.07 14.77 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.484 1.135 . . . . 0.0 111.655 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 62.5 0.92 0.68 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.378 2.271 . . . . 0.0 116.609 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -119.79 159.58 24.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 121.12 1.782 . . . . 0.0 109.97 173.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.84 131.76 33.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 169.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.9 mt -118.22 153.32 34.07 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.072 1.349 . . . . 0.0 107.572 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.43 121.77 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.07 -39.51 23.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.601 0.76 . . . . 0.0 110.409 171.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -150.71 132.67 15.16 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.154 0.982 . . . . 0.0 109.913 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.98 26.83 0.25 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.612 1.577 . . . . 0.0 110.954 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.45 -27.15 67.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.803 0.841 . . . . 0.0 112.595 -169.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.5 ptt85 -60.19 -29.19 68.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 118.796 -0.621 . . . . 0.0 112.323 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -91.31 -41.25 11.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.769 0.713 . . . . 0.0 110.578 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.8 -164.77 37.17 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 pt -70.59 33.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 125.9 1.68 . . . . 0.0 113.73 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -25.66 63.54 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.582 -1.324 . . . . 0.0 112.395 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.6 t -46.01 129.42 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.272 1.029 . . . . 0.0 110.066 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.66 -8.76 67.59 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.809 -0.995 . . . . 0.0 113.719 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -77.93 143.98 37.22 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.302 1.551 . . . . 0.0 108.351 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.04 143.75 28.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.968 1.307 . . . . 0.0 109.724 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.04 143.53 15.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.95 -32.39 2.31 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.398 1.079 . . . . 0.0 110.583 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.61 158.83 44.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.902 1.228 . . . . 0.0 110.266 169.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -139.98 134.94 37.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 105.834 -1.914 . . . . 0.0 105.834 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 49.56 28.2 2.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.658 1.583 . . . . 0.0 112.46 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.17 -11.74 68.55 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.944 1.259 . . . . 0.0 113.799 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 78.8 mtm -80.35 112.63 17.87 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.303 1.551 . . . . 0.0 108.056 173.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.47 124.26 19.8 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.5 m -96.95 138.2 22.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 122.014 0.911 . . . . 0.0 110.865 -169.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -76.29 70.39 2.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.725 2.01 . . . . 0.0 108.622 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.13 -59.71 0.8 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 127.794 2.616 . . . . 0.0 114.395 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -142.86 0.89 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.792 2.037 . . . . 0.0 111.073 -174.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -124.76 144.64 50.14 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.8 p -68.35 175.58 3.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.034 0.834 . . . . 0.0 110.386 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.31 -38.43 74.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.671 169.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.22 -38.09 72.03 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.553 0.741 . . . . 0.0 111.502 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.4 4.7 7.5 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.827 1.203 . . . . 0.0 113.68 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -63.34 134.16 55.31 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -64.79 126.69 28.75 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.3 t -55.32 -42.44 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.476 1.111 . . . . 0.0 111.745 -170.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.67 -40.7 88.7 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.593 0.633 . . . . 0.0 110.311 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -69.95 -41.04 75.06 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.842 0.457 . . . . 0.0 110.034 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -59.33 -44.98 92.55 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.41 1.084 . . . . 0.0 110.875 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.17 -35.28 63.99 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.457 0.703 . . . . 0.0 110.629 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.67 -30.74 74.98 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.865 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -59.57 116.76 17.83 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.668 1.187 . . . . 0.0 110.149 177.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.47 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 74.2 Cg_endo -69.62 -15.66 37.74 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.896 1.731 . . . . 0.0 114.136 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.91 -14.26 52.14 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.439 1.018 . . . . 0.0 111.088 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -135.39 33.68 3.03 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.674 2.39 . . . . 0.0 108.828 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -62.4 -55.29 41.09 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.768 172.213 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.44 128.34 13.52 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 121.661 1.629 . . . . 0.0 109.41 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 m -147.93 164.69 5.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 123.551 0.74 . . . . 0.0 111.323 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -122.14 137.54 54.79 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.7 mt -137.76 133.94 45.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -107.13 138.01 44.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -145.22 168.6 20.02 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.748 1.219 . . . . 0.0 108.193 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.45 -174.18 44.48 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.0 mmm-85 -60.02 145.89 83.78 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.27 138.07 46.09 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.819 2.346 . . . . 0.0 112.841 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -143.87 162.87 35.0 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.311 -1.736 . . . . 0.0 106.311 169.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt -142.82 156.25 44.92 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.389 1.076 . . . . 0.0 108.436 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.4 p -68.58 164.18 21.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.554 1.142 . . . . 0.0 110.751 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.1 m -63.97 -15.61 59.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.498 1.119 . . . . 0.0 112.914 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 t30 . . . . . 0 C--O 1.247 0.932 0 C-N-CA 127.027 2.131 . . . . 0.0 106.592 175.37 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.2 177.15 48.29 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -143.44 148.97 36.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.1 1.36 . . . . 0.0 107.904 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.5 m80 54.91 -168.57 0.08 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.651 1.18 . . . . 0.0 111.23 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -64.57 152.28 42.42 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.429 -0.794 . . . . 0.0 109.587 173.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.97 169.73 17.51 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.994 1.718 . . . . 0.0 108.711 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -133.74 166.56 22.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.095 1.758 . . . . 0.0 107.746 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -147.74 168.28 22.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.91 1.284 . . . . 0.0 108.174 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.8 mt -67.77 157.41 34.79 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.132 0.573 . . . . 0.0 109.761 173.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.8 t70 54.81 -16.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 129.798 3.239 . . . . 0.0 118.867 169.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.4 p -61.54 -27.71 68.81 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.579 1.536 . . . . 0.0 113.216 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -77.02 -29.66 55.47 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.593 1.557 . . . . 0.0 112.537 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.64 -40.87 80.17 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -169.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.05 -34.43 77.6 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.805 2.336 . . . . 0.0 113.952 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -94.7 -47.17 6.61 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.026 0.83 . . . . 0.0 110.097 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.62 123.66 13.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.17 -28.55 67.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.09 171.41 17.54 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.135 0.974 . . . . 0.0 110.211 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -136.57 136.88 39.63 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 169.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -141.13 149.82 42.03 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.511 0.724 . . . . 0.0 109.541 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -82.2 143.22 31.54 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.899 1.28 . . . . 0.0 109.019 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -143.66 168.44 19.88 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.23 1.412 . . . . 0.0 109.81 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.7 m -142.66 175.25 9.95 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.07 2.548 . . . . 0.0 105.951 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -133.96 159.74 71.22 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 119.071 0.851 . . . . 0.0 110.193 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.66 155.08 27.54 Favored 'Cis proline' 0 C--N 1.351 0.678 0 CA-C-N 120.261 1.129 . . . . 0.0 112.826 -10.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.454 HD13 ' H ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -153.6 156.34 37.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.93 1.292 . . . . 0.0 107.562 -176.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' H ' HD13 ' A' ' 26' ' ' LEU . 27.6 t70 -67.26 -30.4 70.28 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.96 0.904 . . . . 0.0 112.361 177.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.0 tp -59.03 133.8 56.42 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.341 1.056 . . . . 0.0 109.223 173.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.2 tp -140.14 141.97 36.02 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.86 1.264 . . . . 0.0 107.822 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.6 mp -127.09 155.4 43.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.294 1.838 . . . . 0.0 107.882 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 152.45 45.29 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.531 0.732 . . . . 0.0 110.58 173.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.12 128.72 34.23 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -151.68 138.27 18.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.48 1.112 . . . . 0.0 108.369 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.8 t70 44.8 50.5 8.72 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.828 1.651 . . . . 0.0 112.558 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 56.5 16.43 2.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.986 2.114 . . . . 0.0 114.456 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -126.38 -169.7 2.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.131 2.172 . . . . 0.0 107.553 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.38 136.48 56.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.6 mt -127.45 156.23 42.45 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.894 1.278 . . . . 0.0 108.601 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.6 t -65.43 122.33 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.98 -38.35 19.38 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.4 1.08 . . . . 0.0 110.623 172.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -157.51 138.8 13.64 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.72 26.98 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.09 -0.839 . . . . 0.0 113.389 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.59 117.88 4.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.584 1.192 . . . . 0.0 108.44 -177.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.0 tpp85 -157.81 118.58 3.48 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 64.44 -25.15 0.08 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.322 2.249 . . . . 0.0 114.0 -169.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.82 175.06 40.83 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 127.343 2.402 . . . . 0.0 108.253 170.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.98 147.66 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 117.588 0.694 . . . . 0.0 109.322 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -136.1 -7.55 2.06 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.406 -0.807 . . . . 0.0 113.106 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.2 t -53.69 135.99 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 119.647 1.112 . . . . 0.0 108.897 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.85 -7.6 73.56 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.638 -1.09 . . . . 0.0 113.688 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -72.22 158.92 34.97 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.443 1.621 . . . . 0.0 108.028 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.86 141.03 47.15 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 123.203 0.601 . . . . 0.0 110.52 -169.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.11 134.28 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.92 -25.58 4.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.865 0.866 . . . . 0.0 109.921 -172.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.44 153.83 42.32 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.72 1.145 . . . . 0.0 109.446 168.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.6 mt -136.64 137.19 47.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 46.79 33.5 2.18 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.089 1.756 . . . . 0.0 112.418 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.06 11.27 79.09 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.733 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.6 mmt -120.18 121.77 39.48 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.849 1.325 . . . . 0.0 108.294 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.75 124.28 16.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.341 1.056 . . . . 0.0 109.283 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.4 m -73.24 140.82 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -79.87 61.6 3.84 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.176 1.39 . . . . 0.0 107.849 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 94' ' ' THR . . . 57.95 -112.1 3.58 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.103 1.335 . . . . 0.0 110.843 -172.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -72.32 -13.23 61.44 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.449 1.099 . . . . 0.0 111.959 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -112.03 155.43 23.82 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.394 0.678 . . . . 0.0 109.397 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.2 p -71.95 175.44 5.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.41 -0.806 . . . . 0.0 109.454 169.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.65 80.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.517 169.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.61 -36.34 68.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.427 0.691 . . . . 0.0 111.457 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.41 -1.22 7.03 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.554 -1.137 . . . . 0.0 114.96 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -67.43 147.77 52.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.925 1.863 . . . . 0.0 107.829 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -66.33 130.95 44.95 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 170.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 t -53.99 -41.75 51.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 125.192 1.397 . . . . 0.0 111.311 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.2 mt -66.98 -39.67 87.23 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.547 0.612 . . . . 0.0 110.546 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -71.5 -37.9 71.21 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.349 0.522 . . . . 0.0 110.226 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -60.97 -53.74 53.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.019 0.928 . . . . 0.0 109.929 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.26 -32.5 73.96 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.05 -0.406 . . . . 0.0 110.122 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.53 -9.67 78.43 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.236 -1.313 . . . . 0.0 114.187 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -83.33 112.51 39.61 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 119.979 1.89 . . . . 0.0 110.343 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.515 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 84.0 Cg_endo -72.23 -16.33 28.27 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.651 1.567 . . . . 0.0 114.669 -170.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.19 -11.9 24.23 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.06 0.845 . . . . 0.0 112.136 169.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.8 31.1 3.06 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.952 1.301 . . . . 0.0 111.829 173.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.515 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.1 m-30 -53.52 -40.51 80.83 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 116.136 -1.888 . . . . 0.0 115.519 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.68 122.08 9.01 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 CA-C-N 123.117 2.149 . . . . 0.0 109.206 172.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.23 169.66 7.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.998 1.319 . . . . 0.0 110.374 -172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -126.19 138.1 53.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.2 mm -128.87 140.77 48.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -174.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -130.08 127.04 39.05 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -144.55 163.29 34.32 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.121 0.968 . . . . 0.0 111.321 -169.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.69 -170.93 37.0 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.5 140.78 88.55 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 170.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -55.45 148.63 51.39 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.241 2.627 . . . . 0.0 112.331 -171.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.1 tpp85 -151.35 173.12 14.88 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.681 1.192 . . . . 0.0 108.916 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.2 tp -66.08 151.07 47.68 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 63' ' ' GLY . 10.2 p -141.43 27.82 1.87 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.343 1.457 . . . . 0.0 110.031 -172.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 p -160.36 174.49 14.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.205 1.402 . . . . 0.0 108.9 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 . . . . . 0 C--O 1.249 1.064 0 C-N-CA 124.905 1.282 . . . . 0.0 108.21 175.477 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 ttm . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.09 58.48 4.58 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.732 1.158 . . . . 0.0 111.576 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -144.6 151.22 38.71 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.151 1.38 . . . . 0.0 107.964 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -60.12 143.9 51.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.358 0.663 . . . . 0.0 109.991 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -146.77 161.28 40.97 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.918 1.687 . . . . 0.0 108.073 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -128.76 -6.57 5.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.586 1.155 . . . . 0.0 112.23 -178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -138.5 150.0 45.97 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.188 1.795 . . . . 0.0 106.397 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -146.45 166.26 26.92 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.916 1.287 . . . . 0.0 108.769 -174.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 79.9 mt -138.08 153.28 49.31 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.635 1.574 . . . . 0.0 107.369 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.18 -0.37 7.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.83 1.252 . . . . 0.0 113.588 -174.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.5 m -52.14 -26.31 11.03 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.398 2.279 . . . . 0.0 114.871 -172.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -74.85 -20.96 59.53 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.729 0.812 . . . . 0.0 112.892 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.66 133.91 95.24 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.055 0.843 . . . . 0.0 109.269 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.28 -26.81 41.48 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.293 1.996 . . . . 0.0 112.685 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -71.18 -8.74 55.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.376 -0.821 . . . . 0.0 112.215 175.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.57 173.72 9.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.759 1.163 . . . . 0.0 110.638 -172.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -133.95 175.24 9.64 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.923 1.689 . . . . 0.0 108.347 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.33 162.66 14.44 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.784 0.833 . . . . 0.0 111.153 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -88.69 154.73 20.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.053 0.541 . . . . 0.0 109.741 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -143.09 166.75 23.79 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.59 1.556 . . . . 0.0 108.589 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 m -106.86 142.77 35.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.352 1.061 . . . . 0.0 108.346 -176.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -141.55 161.81 37.01 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.889 1.276 . . . . 0.0 109.695 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.4 m -155.96 170.9 21.07 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.522 1.929 . . . . 0.0 107.189 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -136.94 161.83 59.29 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.85 0.86 . . . . 0.0 109.521 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.92 141.76 61.27 Favored 'Cis proline' 0 CA--C 1.536 0.612 0 CA-C-N 119.966 1.023 . . . . 0.0 110.317 -10.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.1 tp -161.54 -58.02 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.606 1.162 . . . . 0.0 107.985 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.76 135.44 6.52 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.481 1.913 . . . . 0.0 106.636 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.6 tp -145.32 31.56 1.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.285 1.034 . . . . 0.0 109.163 171.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.56 68.93 2.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.461 1.104 . . . . 0.0 109.579 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.04 155.73 30.94 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.045 2.138 . . . . 0.0 106.996 172.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.25 154.01 49.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.541 0.609 . . . . 0.0 110.375 171.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tt -81.99 122.6 28.0 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -157.26 145.49 19.33 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.698 1.199 . . . . 0.0 107.964 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.1 t70 54.66 37.66 28.59 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.477 1.111 . . . . 0.0 111.716 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 52.93 25.28 3.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.244 1.817 . . . . 0.0 113.136 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -128.6 -177.3 4.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 127.547 2.339 . . . . 0.0 107.289 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.2 t -120.75 127.82 75.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 169.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.2 mt -123.19 157.45 32.98 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.7 1.2 . . . . 0.0 109.09 -171.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.26 120.18 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.391 1.077 . . . . 0.0 108.4 171.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.41 -29.27 20.36 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.903 0.881 . . . . 0.0 111.314 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -147.45 128.05 14.18 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.68 149.95 6.72 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -157.38 38.08 0.29 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.906 0.853 . . . . 0.0 110.726 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -123.75 160.48 27.2 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.879 1.271 . . . . 0.0 107.655 173.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -54.72 127.51 28.54 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.585 0.754 . . . . 0.0 110.882 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.14 -4.77 74.82 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.992 -0.893 . . . . 0.0 114.215 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.9 tp -144.25 26.53 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 118.815 1.307 . . . . 0.0 109.881 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -67.15 155.35 38.98 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.644 -1.285 . . . . 0.0 108.445 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.6 m -43.96 135.08 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.062 0.945 . . . . 0.0 110.945 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.49 -13.22 68.04 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.327 -1.263 . . . . 0.0 113.989 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -67.14 153.44 43.66 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.792 1.796 . . . . 0.0 107.764 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.61 146.5 44.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.281 1.432 . . . . 0.0 110.151 -170.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -68.21 138.15 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 169.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.8 mt -121.9 -29.09 4.35 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.47 1.108 . . . . 0.0 111.013 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.91 158.29 43.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 120.084 1.311 . . . . 0.0 110.558 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -140.38 135.12 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 50.46 27.9 3.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.774 1.63 . . . . 0.0 112.377 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.07 -11.0 63.86 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.845 1.212 . . . . 0.0 113.633 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.5 mtt -78.69 107.92 11.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.958 1.379 . . . . 0.0 108.518 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.34 121.77 12.26 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.6 m -76.44 137.0 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.718 0.77 . . . . 0.0 110.755 -169.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -79.31 67.04 4.94 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 169.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.41 -107.54 1.03 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.828 1.204 . . . . 0.0 111.302 -173.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -77.66 -10.55 59.58 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.61 1.164 . . . . 0.0 112.121 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -116.02 155.28 28.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.016 0.826 . . . . 0.0 109.54 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -71.14 177.65 3.69 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.26 -0.9 . . . . 0.0 109.703 169.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.68 82.19 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.346 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.6 -38.99 74.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.895 0.878 . . . . 0.0 111.412 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.08 -2.61 6.79 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.517 1.056 . . . . 0.0 114.161 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -60.51 135.36 57.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.05 1.425 . . . . 0.0 108.265 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -68.43 129.96 41.46 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 t -53.96 -43.57 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.185 1.394 . . . . 0.0 112.087 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.67 -39.76 88.31 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.859 0.754 . . . . 0.0 110.502 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -69.51 -41.16 76.42 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -59.7 -45.2 92.83 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.248 1.019 . . . . 0.0 110.801 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.53 -34.49 60.77 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.21 0.604 . . . . 0.0 110.895 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.39 -32.12 78.59 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.513 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -60.22 115.55 13.76 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.754 1.222 . . . . 0.0 110.179 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.5 Cg_endo -70.49 -15.03 34.32 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.844 1.696 . . . . 0.0 113.988 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.97 -14.72 56.08 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.412 1.006 . . . . 0.0 110.986 169.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -135.26 34.96 3.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.744 2.418 . . . . 0.0 108.607 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.462 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -64.72 -54.59 34.89 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 117.543 -1.217 . . . . 0.0 111.371 169.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.82 125.04 10.68 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.521 1.579 . . . . 0.0 109.133 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.3 m -149.97 170.9 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.165 0.986 . . . . 0.0 110.402 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.6 m -125.61 139.9 53.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.3 mt -137.27 145.1 30.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -120.19 140.33 51.3 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 171.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -124.55 172.81 8.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.459 1.504 . . . . 0.0 109.16 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.41 -154.82 13.7 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.27 149.99 39.43 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.79 135.89 50.32 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.736 2.291 . . . . 0.0 111.602 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -73.97 -15.15 61.12 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.517 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 30.3 tp 64.14 -36.58 0.18 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 129.032 2.933 . . . . 0.0 115.058 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.2 p 45.48 46.52 10.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.714 2.006 . . . . 0.0 112.642 174.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m -49.22 122.61 6.19 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.435 1.494 . . . . 0.0 110.749 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.9 p30 . . . . . 0 C--O 1.25 1.117 0 C-N-CA 126.133 1.773 . . . . 0.0 107.991 -177.801 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.8 -20.3 72.2 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 123.596 0.617 . . . . 0.0 113.338 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -146.77 160.41 42.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.388 1.875 . . . . 0.0 107.447 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -80.09 33.77 0.29 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.714 1.206 . . . . 0.0 112.53 -170.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -143.81 160.16 41.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.999 1.72 . . . . 0.0 108.592 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -63.46 -28.62 70.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.959 0.504 . . . . 0.0 112.073 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -156.79 171.75 19.85 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.95 1.7 . . . . 0.0 108.568 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.77 164.41 6.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.061 0.945 . . . . 0.0 111.189 174.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 tp 44.59 54.47 6.47 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.281 1.833 . . . . 0.0 112.375 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.04 7.46 7.96 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.468 1.507 . . . . 0.0 110.869 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 m -65.74 -12.57 54.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.09 1.756 . . . . 0.0 113.716 -177.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -59.44 155.35 15.11 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.402 1.081 . . . . 0.0 111.786 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.5 ' H ' ' CD ' ' A' ' 14' ' ' PRO . . . -148.23 -38.51 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 116.707 -1.616 . . . . 0.0 113.584 177.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.5 ' CD ' ' H ' ' A' ' 13' ' ' ALA . 74.5 Cg_exo -55.16 143.47 74.52 Favored 'Trans proline' 0 C--N 1.353 0.797 0 CA-C-N 122.173 1.812 . . . . 0.0 112.514 174.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.7 ttp85 -82.99 45.09 0.98 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.599 1.16 . . . . 0.0 108.983 174.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.32 170.59 15.67 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.534 1.133 . . . . 0.0 112.799 -169.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -101.28 167.67 10.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.347 1.459 . . . . 0.0 109.8 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.39 155.0 36.76 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.437 0.695 . . . . 0.0 111.07 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.59 138.17 56.23 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 170.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -144.05 155.06 43.84 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.861 0.864 . . . . 0.0 108.941 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 p -78.88 142.88 36.44 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.594 1.158 . . . . 0.0 109.803 172.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.65 162.73 34.39 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.567 1.547 . . . . 0.0 109.29 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -159.0 175.18 13.86 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.59 2.756 . . . . 0.0 106.837 178.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -132.56 156.97 79.48 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.758 0.823 . . . . 0.0 109.569 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.5 156.38 81.87 Favored 'Cis proline' 0 CA--C 1.536 0.584 0 CA-C-N 119.729 0.939 . . . . 0.0 111.824 -5.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.33 167.68 29.57 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.37 1.468 . . . . 0.0 107.59 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.64 61.61 3.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.932 1.293 . . . . 0.0 110.056 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.5 mt -139.15 154.37 48.08 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.081 1.752 . . . . 0.0 108.683 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.3 tp -148.45 127.66 12.94 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -123.34 149.83 44.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.96 164.45 33.72 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.8 1.24 . . . . 0.0 110.114 -176.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.6 tp -86.73 133.98 33.62 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 171.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -150.18 129.43 12.82 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.84 1.256 . . . . 0.0 108.066 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 45.25 50.01 9.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.317 1.447 . . . . 0.0 112.367 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 62.35 18.45 10.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.704 1.602 . . . . 0.0 114.318 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 -127.72 143.51 51.14 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.75 -1.218 . . . . 0.0 109.179 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.28 127.74 39.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 169.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.43 145.37 48.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.641 1.576 . . . . 0.0 108.599 -176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.08 107.62 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.81 1.644 . . . . 0.0 106.861 171.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.89 -29.68 44.52 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.788 0.835 . . . . 0.0 111.826 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -147.95 143.18 27.15 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.1 4.4 0.1 OUTLIER Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.915 -174.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -136.11 46.54 2.29 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.319 1.447 . . . . 0.0 109.225 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.7 -19.28 10.29 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.17 -19.84 62.03 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.58 1.552 . . . . 0.0 112.594 172.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.88 -138.16 2.39 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.2 pt -128.68 20.74 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.92 1.288 . . . . 0.0 110.911 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -75.33 20.27 0.15 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.833 1.253 . . . . 0.0 113.247 -171.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.7 m -61.8 172.74 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 120.764 -1.21 . . . . 0.0 110.474 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.49 3.94 64.43 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.721 -1.044 . . . . 0.0 112.626 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -55.81 128.46 35.05 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.936 1.368 . . . . 0.0 108.096 169.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.02 141.13 30.52 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.36 140.59 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.6 mt -122.52 -32.31 3.62 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.616 -174.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.29 160.12 42.66 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.773 1.169 . . . . 0.0 110.672 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.0 mt -140.4 139.21 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 173.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.0 p30 47.27 21.58 0.2 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.102 2.161 . . . . 0.0 114.556 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.86 -27.84 18.46 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.484 1.516 . . . . 0.0 113.013 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 73.7 mtm -74.79 117.93 17.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.709 1.254 . . . . 0.0 109.675 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.72 135.54 55.22 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 169.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.4 m -97.87 126.9 50.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.596 0.712 . . . . 0.0 109.578 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -72.88 74.93 1.16 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.909 1.684 . . . . 0.0 107.874 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.34 -70.85 0.35 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 126.823 2.154 . . . . 0.0 113.12 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -134.21 12.84 3.89 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.936 1.295 . . . . 0.0 112.209 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -125.9 146.14 49.96 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.0 p -69.76 171.75 8.67 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.99 0.814 . . . . 0.0 109.924 172.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.03 75.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.56 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.06 -40.08 78.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 111.512 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.31 0.26 6.88 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.459 1.028 . . . . 0.0 114.378 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -59.69 136.24 57.93 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.375 1.587 . . . . 0.0 108.305 174.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.86 128.89 38.16 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.32 -41.74 88.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.283 1.033 . . . . 0.0 111.162 -171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.9 mt -66.66 -42.46 86.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.317 0.962 . . . . 0.0 110.295 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.52 -42.43 92.05 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -60.91 -53.14 60.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.845 0.858 . . . . 0.0 110.248 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.3 mt -66.27 -26.95 67.58 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.766 -0.584 . . . . 0.0 110.477 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.77 -15.31 77.99 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.421 -1.211 . . . . 0.0 113.778 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -84.39 112.99 45.9 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.787 1.793 . . . . 0.0 110.464 -177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.513 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 64.7 Cg_endo -68.24 -22.42 40.32 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.939 1.759 . . . . 0.0 114.117 -171.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.57 -10.99 21.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.761 0.71 . . . . 0.0 112.825 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.71 28.21 3.6 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.39 1.076 . . . . 0.0 111.956 173.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.513 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 6.4 m-30 -53.14 -47.57 95.35 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 116.643 -1.646 . . . . 0.0 112.633 169.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.22 104.82 1.6 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 122.102 1.787 . . . . 0.0 110.581 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.81 157.65 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.597 0.759 . . . . 0.0 109.961 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.6 m -84.27 146.25 27.86 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.0 mt -136.46 144.89 31.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -117.81 132.46 56.44 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 169.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -141.53 165.05 28.57 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.01 -174.16 37.99 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -173.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -68.09 158.72 83.11 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.789 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -49.94 157.34 2.78 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.525 2.817 . . . . 0.0 115.091 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -61.64 -10.02 7.46 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.935 1.694 . . . . 0.0 113.552 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -139.39 179.94 6.25 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.853 2.061 . . . . 0.0 108.881 -173.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -16.34 3.64 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.912 2.085 . . . . 0.0 115.383 -169.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.1 m -51.58 135.37 28.44 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.482 1.037 . . . . 0.0 110.559 173.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 . . . . . 0 C--O 1.249 1.04 0 C-N-CA 123.807 0.843 . . . . 0.0 111.794 -169.955 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.25 172.48 44.48 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -60.38 -29.8 69.18 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.282 0.541 . . . . 0.0 112.448 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -62.55 -46.98 85.87 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.812 -0.555 . . . . 0.0 110.443 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -69.12 -33.75 73.98 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.05 0.54 . . . . 0.0 110.244 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -62.57 -17.69 60.58 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.363 1.065 . . . . 0.0 111.838 172.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 66.9 m80 46.74 47.52 15.0 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.219 1.807 . . . . 0.0 110.762 -170.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -153.78 171.57 18.69 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.071 0.948 . . . . 0.0 109.942 -173.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -75.19 169.5 17.9 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -104.59 144.75 31.27 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.487 1.115 . . . . 0.0 108.407 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.3 p -149.3 158.72 44.41 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.641 0.776 . . . . 0.0 110.081 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -82.67 -24.25 33.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.652 1.181 . . . . 0.0 111.997 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.96 18.88 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -169.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.0 145.5 32.93 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.986 2.458 . . . . 0.0 113.163 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -152.32 151.62 31.1 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.748 1.219 . . . . 0.0 108.15 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.28 161.71 24.34 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 169.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 46.95 43.12 13.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.331 1.453 . . . . 0.0 112.357 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.48 145.14 41.64 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 169.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -143.16 137.64 29.2 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.265 0.938 . . . . 0.0 109.549 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -159.37 156.78 29.13 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.305 1.042 . . . . 0.0 109.32 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -79.44 142.46 35.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.936 1.695 . . . . 0.0 110.414 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.07 160.53 40.73 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.341 1.056 . . . . 0.0 110.296 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.3 m -150.87 175.13 12.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.271 2.228 . . . . 0.0 107.388 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -127.19 158.99 67.44 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 0.0 108.269 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.64 145.14 45.47 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 120.058 1.056 . . . . 0.0 111.404 -10.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.7 tp -160.38 158.44 29.57 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.551 1.541 . . . . 0.0 107.297 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.21 -22.56 61.99 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.64 127.3 31.33 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.7 mt -138.79 157.0 46.88 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 173.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.27 153.22 42.02 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.901 1.28 . . . . 0.0 108.211 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.01 164.99 28.58 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.777 1.231 . . . . 0.0 109.072 173.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.1 tp -108.03 127.05 53.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -150.78 140.83 22.07 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.432 1.093 . . . . 0.0 108.241 175.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 46.73 43.89 13.37 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.184 1.393 . . . . 0.0 112.606 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 58.87 24.78 12.85 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.911 1.684 . . . . 0.0 113.75 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -130.03 139.15 51.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 O-C-N 120.834 -1.166 . . . . 0.0 108.33 174.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.34 127.46 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 mt -126.44 155.75 41.73 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.617 1.567 . . . . 0.0 109.036 -172.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.16 117.94 3.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 124.693 1.197 . . . . 0.0 107.905 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.13 -41.86 14.37 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.592 1.157 . . . . 0.0 110.881 175.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -150.49 160.52 43.72 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.401 1.881 . . . . 0.0 107.546 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.36 -9.72 3.51 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.197 -0.78 . . . . 0.0 113.298 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.09 -35.24 78.1 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.324 1.562 . . . . 0.0 113.474 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -66.46 -29.68 69.85 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 118.893 -0.575 . . . . 0.0 112.13 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.52 -39.15 53.8 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.827 0.74 . . . . 0.0 109.855 170.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.59 -17.38 0.42 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.679 1.133 . . . . 0.0 113.774 169.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.6 mm -89.17 97.95 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.918 1.359 . . . . 0.0 108.221 -169.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -57.93 129.51 42.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.762 0.825 . . . . 0.0 111.173 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.5 t -54.76 149.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.18 1.392 . . . . 0.0 110.364 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.61 -7.98 74.16 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 119.037 -0.869 . . . . 0.0 114.177 171.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -70.89 151.17 45.01 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.942 1.371 . . . . 0.0 108.074 169.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.67 147.76 25.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.286 1.035 . . . . 0.0 109.786 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.39 137.86 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 169.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.63 -37.55 3.94 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.824 1.249 . . . . 0.0 109.486 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.47 160.49 43.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.238 0.926 . . . . 0.0 110.391 169.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 93.1 mt -135.59 133.28 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.597 HD21 HG12 ' A' ' 84' ' ' VAL . 80.8 m-20 48.23 31.21 2.5 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.008 1.723 . . . . 0.0 112.561 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.74 -12.75 66.25 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.974 1.273 . . . . 0.0 113.635 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.9 mtt -80.09 108.41 13.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.01 1.405 . . . . 0.0 108.755 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.65 124.33 17.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -82.05 133.54 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.685 0.755 . . . . 0.0 109.407 -173.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -78.6 70.69 4.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.71 -58.46 0.33 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 128.187 2.803 . . . . 0.0 114.828 174.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -134.84 -5.28 2.45 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.894 2.078 . . . . 0.0 111.529 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -120.2 155.57 32.88 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.9 p -71.08 177.08 3.94 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.405 1.002 . . . . 0.0 110.085 170.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.73 77.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.601 169.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.33 -36.85 71.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.649 0.78 . . . . 0.0 111.532 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.87 4.8 8.51 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.625 1.107 . . . . 0.0 113.727 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -63.17 134.47 56.03 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.67 128.7 37.25 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.8 t -58.51 -39.79 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.701 0.801 . . . . 0.0 111.263 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.6 mt -65.45 -42.74 92.02 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.738 0.699 . . . . 0.0 110.328 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.51 -41.71 83.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.017 0.527 . . . . 0.0 109.687 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -59.82 -52.43 65.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.137 0.975 . . . . 0.0 110.395 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.5 mt -67.0 -34.15 77.12 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.641 0.376 . . . . 0.0 109.998 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.92 -17.89 73.9 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.517 -1.157 . . . . 0.0 113.783 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -75.31 114.12 32.5 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 119.545 1.672 . . . . 0.0 110.596 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.481 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 61.4 Cg_endo -67.54 -21.09 46.68 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.34 2.027 . . . . 0.0 114.014 -171.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.86 -11.35 55.39 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 176.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.95 28.52 2.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.507 1.049 . . . . 0.0 112.756 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.481 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 6.4 m-30 -48.75 -48.68 69.54 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 116.438 -1.744 . . . . 0.0 115.015 175.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.49 120.61 7.41 Favored 'Trans proline' 0 C--N 1.35 0.635 0 CA-C-N 122.497 1.928 . . . . 0.0 109.948 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.597 HG12 HD21 ' A' ' 57' ' ' ASN . 28.9 m -146.38 171.6 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.519 1.528 . . . . 0.0 109.926 -175.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -120.38 137.06 54.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.24 -2.134 . . . . 0.0 105.24 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.1 mt -132.35 138.5 52.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -107.93 136.04 48.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 170.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -123.13 160.47 26.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.248 1.819 . . . . 0.0 108.746 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.08 178.16 39.56 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -70.97 147.03 93.7 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.49 161.59 34.38 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.314 2.009 . . . . 0.0 111.148 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 55.9 -174.65 0.05 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.9 1.68 . . . . 0.0 112.101 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -154.45 173.36 16.36 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.981 1.712 . . . . 0.0 108.48 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.5 p -59.29 -22.09 60.68 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.861 1.265 . . . . 0.0 113.835 -174.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m -65.46 -14.57 61.25 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.845 1.258 . . . . 0.0 113.321 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 124.611 1.165 . . . . 0.0 110.15 175.462 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mtp . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.63 175.77 47.68 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -135.77 14.64 3.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.411 1.085 . . . . 0.0 111.515 -173.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -151.25 159.89 44.11 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.647 1.579 . . . . 0.0 108.478 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -144.07 160.76 40.33 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.693 1.597 . . . . 0.0 108.109 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -133.71 10.62 4.0 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.734 0.814 . . . . 0.0 112.003 -171.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.27 142.79 51.05 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.347 0.659 . . . . 0.0 109.45 169.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -159.24 173.53 16.19 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.58 1.152 . . . . 0.0 109.468 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -135.25 123.4 22.93 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -145.13 66.87 1.24 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.48 1.112 . . . . 0.0 109.166 -169.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -56.89 159.5 4.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.16 0.984 . . . . 0.0 111.005 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -69.8 179.3 2.26 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.976 0.51 . . . . 0.0 110.261 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.05 158.65 73.37 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.596 1.158 . . . . 0.0 109.753 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.22 140.19 20.33 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.406 2.737 . . . . 0.0 112.235 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -61.92 -35.43 78.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.962 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.47 -42.55 0.1 Allowed 'General case' 0 C--O 1.229 -0.024 0 C-N-CA 124.442 1.097 . . . . 0.0 109.599 170.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.75 161.09 34.64 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.222 1.409 . . . . 0.0 109.084 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.08 173.82 14.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.025 1.73 . . . . 0.0 108.783 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -145.95 143.71 29.68 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.787 0.835 . . . . 0.0 108.879 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -148.79 173.12 13.59 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.778 1.631 . . . . 0.0 109.29 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 m -131.57 141.16 49.63 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.235 1.414 . . . . 0.0 107.327 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -145.67 167.47 23.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.465 1.506 . . . . 0.0 109.941 -170.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.4 m -144.16 175.1 10.32 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.594 2.357 . . . . 0.0 106.304 169.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -134.78 162.21 59.1 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.517 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.01 149.42 28.87 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.373 1.169 . . . . 0.0 112.429 -10.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -157.9 150.58 22.68 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.403 1.481 . . . . 0.0 107.243 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.79 59.63 3.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.195 0.998 . . . . 0.0 110.414 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.9 tp -140.11 135.74 32.85 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.833 2.453 . . . . 0.0 105.524 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -145.92 145.21 30.6 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.5 mt -130.58 154.05 48.25 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.79 1.636 . . . . 0.0 107.432 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 156.26 45.6 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.558 0.617 . . . . 0.0 110.793 -178.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.5 tp -90.65 128.26 36.56 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.902 1.281 . . . . 0.0 108.137 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -156.91 145.23 19.6 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.587 1.155 . . . . 0.0 108.137 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.8 t70 51.81 37.79 21.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.175 0.99 . . . . 0.0 111.404 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 55.23 17.57 2.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.301 2.241 . . . . 0.0 114.414 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.08 161.92 20.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.84 1.256 . . . . 0.0 108.216 174.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.4 t -97.5 134.54 35.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.46 150.48 41.49 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.198 1.399 . . . . 0.0 107.623 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.52 117.37 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.15 -29.41 31.59 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.06 0.544 . . . . 0.0 111.497 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -154.78 138.51 16.15 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.014 1.325 . . . . 0.0 107.494 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.63 102.89 0.16 Allowed Glycine 0 CA--C 1.52 0.359 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 -177.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -121.51 -17.84 7.41 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.507 0.723 . . . . 0.0 112.504 -171.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -81.79 146.66 29.8 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 62.74 -26.4 0.06 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.452 2.301 . . . . 0.0 114.074 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.49 167.88 38.1 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.55 1.547 . . . . 0.0 109.44 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 pt -73.61 64.2 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 122.436 1.113 . . . . 0.0 109.44 170.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -61.45 -23.03 65.57 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.589 1.156 . . . . 0.0 111.065 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -44.63 139.31 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 119.271 0.941 . . . . 0.0 110.639 169.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.34 -15.64 38.84 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.031 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -76.95 148.24 36.46 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.948 1.374 . . . . 0.0 108.649 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.54 141.84 29.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.39 1.076 . . . . 0.0 109.319 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.8 t -72.62 141.49 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.0 mt -128.97 -30.65 2.21 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.427 1.091 . . . . 0.0 111.139 -172.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.61 158.97 41.95 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.122 1.328 . . . . 0.0 110.089 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.0 mt -140.72 135.26 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 106.176 -1.786 . . . . 0.0 106.176 173.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 50.27 28.7 3.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.542 1.537 . . . . 0.0 112.093 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.33 -9.53 63.95 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.805 1.193 . . . . 0.0 113.68 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.4 mtt -77.72 108.61 11.06 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.088 1.444 . . . . 0.0 108.495 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.74 114.4 1.54 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.286 1.434 . . . . 0.0 109.68 169.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.53 142.52 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 124.198 0.999 . . . . 0.0 108.447 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -125.31 113.57 17.77 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.158 2.183 . . . . 0.0 105.355 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.61 -113.83 5.98 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -116.84 23.5 11.9 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.354 1.061 . . . . 0.0 110.672 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -126.65 140.08 52.68 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.1 p -67.39 176.85 2.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.541 1.064 . . . . 0.0 110.013 174.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.95 -39.27 74.25 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.85 169.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.32 -39.56 74.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.546 0.738 . . . . 0.0 111.098 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.53 -2.59 6.12 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.655 1.122 . . . . 0.0 113.736 171.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -61.11 133.43 56.0 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.007 1.404 . . . . 0.0 109.182 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -59.78 120.38 9.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.6 t -54.47 -44.53 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.95 1.3 . . . . 0.0 111.696 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.71 -38.17 83.27 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.375 0.534 . . . . 0.0 110.392 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.37 -38.01 63.29 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.301 0.5 . . . . 0.0 110.272 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -58.69 -44.62 90.34 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.473 1.109 . . . . 0.0 110.296 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.25 -34.99 61.46 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.66 0.784 . . . . 0.0 110.983 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.7 -33.5 87.41 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.368 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -60.29 114.93 11.25 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.659 1.184 . . . . 0.0 110.071 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 73.6 Cg_endo -70.73 -15.01 33.46 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.792 1.661 . . . . 0.0 113.912 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.53 -14.82 54.92 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.36 0.982 . . . . 0.0 110.899 169.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -134.28 33.91 3.31 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.826 2.45 . . . . 0.0 108.721 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.458 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -64.54 -53.24 46.54 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.186 -1.387 . . . . 0.0 111.289 169.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.97 123.76 9.56 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 121.717 1.649 . . . . 0.0 109.262 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -150.95 164.47 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 124.214 1.006 . . . . 0.0 110.873 -172.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -118.51 140.63 49.57 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.2 mt -136.55 139.49 45.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -171.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.7 ttt85 -115.55 135.95 53.57 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 172.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -146.85 164.09 33.98 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.943 1.297 . . . . 0.0 108.467 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.26 -169.0 40.56 Favored Glycine 0 C--N 1.33 0.21 0 O-C-N 121.518 -0.738 . . . . 0.0 112.135 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -58.85 143.83 82.42 Favored Pre-proline 0 C--O 1.239 0.511 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.232 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -48.49 160.64 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.871 3.047 . . . . 0.0 113.761 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.79 169.91 19.41 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.883 1.273 . . . . 0.0 108.31 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.37 151.53 46.74 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.8 p -139.67 157.61 45.48 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.897 1.279 . . . . 0.0 108.053 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.7 m -68.86 -27.4 65.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.444 0.698 . . . . 0.0 111.577 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 C--O 1.248 1.009 0 C-N-CA 125.415 1.486 . . . . 0.0 109.689 171.72 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 119.481 -0.295 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.97 179.33 48.8 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.8 t60 46.2 47.47 13.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.633 1.573 . . . . 0.0 111.821 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -61.17 157.65 15.6 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.617 0.767 . . . . 0.0 109.949 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -56.89 145.83 28.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.047 0.539 . . . . 0.0 109.78 171.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -154.94 167.14 31.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.494 1.517 . . . . 0.0 108.436 -174.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 153.42 14.49 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.977 0.911 . . . . 0.0 111.55 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -135.15 171.55 14.28 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.857 1.663 . . . . 0.0 107.644 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.3 tp -125.76 52.68 1.64 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.384 1.474 . . . . 0.0 108.637 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -63.59 -30.31 71.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.246 1.018 . . . . 0.0 112.411 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.0 p -152.69 161.87 42.01 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.833 1.653 . . . . 0.0 107.669 172.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -58.46 -47.43 84.06 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.773 -0.579 . . . . 0.0 111.869 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.595 ' H ' ' CD ' ' A' ' 14' ' ' PRO . . . -145.83 -21.92 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 116.542 -1.694 . . . . 0.0 115.326 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.595 ' CD ' ' H ' ' A' ' 13' ' ' ALA . 71.2 Cg_exo -55.97 -13.29 8.7 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.65 2.234 . . . . 0.0 115.725 172.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -50.96 125.96 14.94 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.38 1.072 . . . . 0.0 110.466 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.15 -82.53 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 169.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 35.84 51.62 0.74 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.924 2.089 . . . . 0.0 112.222 -175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.15 144.94 56.36 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -145.61 138.33 25.9 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -176.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.9 158.45 38.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.458 0.703 . . . . 0.0 110.334 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 p -78.3 143.05 37.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.024 1.73 . . . . 0.0 108.574 169.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -144.48 167.79 21.66 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.171 0.988 . . . . 0.0 110.048 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.4 m -137.71 166.66 23.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.369 1.868 . . . . 0.0 107.219 171.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.01 153.83 39.77 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.739 -175.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.8 133.69 15.75 Favored 'Cis proline' 0 C--N 1.35 0.638 0 CA-C-N 120.7 1.286 . . . . 0.0 110.155 -7.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.8 tp -66.59 123.86 21.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.682 0.793 . . . . 0.0 111.147 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -62.67 -42.63 99.73 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 111.485 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 tp -75.56 57.54 0.97 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.704 1.601 . . . . 0.0 109.113 170.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 46.1 tp -53.64 141.37 26.24 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.338 -0.851 . . . . 0.0 109.342 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.1 mt -125.27 155.99 39.29 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.249 1.019 . . . . 0.0 109.635 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.67 153.66 50.84 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 tt -92.65 123.98 36.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -150.95 136.46 17.88 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.718 1.207 . . . . 0.0 108.386 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.29 39.97 17.16 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.271 1.428 . . . . 0.0 111.819 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 59.44 0.43 0.21 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.411 2.285 . . . . 0.0 115.272 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -95.99 -177.72 4.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 120.67 1.577 . . . . 0.0 107.777 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.2 m -123.35 139.95 48.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 169.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.5 mt -133.13 151.45 51.99 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.113 0.965 . . . . 0.0 108.828 -175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.55 105.66 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.514 1.526 . . . . 0.0 107.651 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.26 60.06 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.678 1.591 . . . . 0.0 111.706 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -150.94 159.16 44.74 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.851 0.861 . . . . 0.0 109.327 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.3 -23.54 0.08 OUTLIER Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.542 1.068 . . . . 0.0 111.138 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -142.61 154.89 44.81 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.222 2.209 . . . . 0.0 105.046 169.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -57.75 -37.11 73.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.606 0.639 . . . . 0.0 110.593 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -161.87 125.01 3.06 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.74 169.89 31.83 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 118.424 0.556 . . . . 0.0 111.918 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 pt -63.02 -17.55 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.694 1.198 . . . . 0.0 114.095 -169.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -61.53 -37.61 84.38 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.957 1.253 . . . . 0.0 110.617 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.47 148.95 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.406 1.082 . . . . 0.0 108.884 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.32 0.75 86.56 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.26 -0.745 . . . . 0.0 114.271 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -72.1 162.82 28.91 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.599 1.2 . . . . 0.0 108.866 169.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.19 156.1 17.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.032 0.933 . . . . 0.0 109.131 170.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.42 144.61 11.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 169.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -114.35 -30.67 6.51 Favored 'General case' 0 CA--C 1.524 -0.034 0 CA-C-O 117.405 -1.283 . . . . 0.0 110.544 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.41 160.04 42.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.879 1.672 . . . . 0.0 111.793 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.9 mt -138.62 136.73 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 50.46 29.15 3.75 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.598 1.559 . . . . 0.0 112.272 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.21 -9.0 56.5 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.698 1.142 . . . . 0.0 113.65 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.4 mtt -80.37 111.97 17.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.091 1.445 . . . . 0.0 108.3 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -53.43 130.63 36.1 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 169.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -89.35 124.14 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.782 0.801 . . . . 0.0 109.496 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -76.48 80.24 3.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.018 1.327 . . . . 0.0 107.534 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.15 -58.73 1.08 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.91 2.195 . . . . 0.0 114.614 172.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -143.55 2.38 1.24 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.283 1.833 . . . . 0.0 111.874 176.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.79 151.75 38.33 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 119.424 1.011 . . . . 0.0 108.327 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 p -68.07 173.81 4.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.608 1.095 . . . . 0.0 109.528 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.82 -38.15 72.19 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.764 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.83 -37.84 76.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.582 0.753 . . . . 0.0 111.573 175.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.53 3.17 6.13 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.498 1.047 . . . . 0.0 114.112 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.23 129.68 40.65 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.044 1.422 . . . . 0.0 107.805 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.1 129.83 41.15 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 174.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 t -52.67 -44.19 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.396 1.478 . . . . 0.0 112.826 -169.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.2 mt -67.1 -42.48 84.5 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.978 0.808 . . . . 0.0 110.435 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -69.03 -40.84 78.37 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -59.88 -43.79 94.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.254 1.022 . . . . 0.0 111.158 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.87 -36.88 62.3 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.276 0.631 . . . . 0.0 110.476 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.04 -31.15 78.54 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.772 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -54.83 118.72 18.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.017 1.327 . . . . 0.0 110.157 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 60.0 Cg_endo -66.79 -17.67 52.31 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.365 2.043 . . . . 0.0 113.741 -176.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.45 -13.83 62.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.13 0.877 . . . . 0.0 112.356 170.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -135.18 37.01 3.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.922 1.689 . . . . 0.0 109.617 -171.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.0 m-30 -63.48 -57.36 20.27 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.359 -1.305 . . . . 0.0 111.348 169.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.23 126.96 11.51 Favored 'Trans proline' 0 C--N 1.352 0.719 0 CA-C-N 121.459 1.557 . . . . 0.0 109.101 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 m -150.31 171.42 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.378 1.071 . . . . 0.0 110.365 -172.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.2 m -125.83 139.55 53.4 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 168.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.5 mt -136.27 140.2 44.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -118.56 132.33 56.21 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 172.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -141.66 163.4 33.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.561 1.545 . . . . 0.0 109.312 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.31 -165.37 38.56 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -170.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HD2' ' H ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -67.94 143.0 95.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.605 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.98 160.71 32.58 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.048 1.832 . . . . 0.0 112.225 -174.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -129.85 151.62 50.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.0 tp -61.52 144.48 54.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.123 0.487 . . . . 0.0 110.211 -175.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.99 165.69 35.46 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.289 1.836 . . . . 0.0 107.317 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.5 m -62.22 -38.04 87.68 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.767 0.827 . . . . 0.0 112.847 -171.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.992 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.9 tttm . . . . . 0 N--CA 1.462 0.149 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.5 p -72.09 145.41 48.2 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.838 1.255 . . . . 0.0 110.823 173.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -139.95 159.08 42.99 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.965 1.306 . . . . 0.0 108.723 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.0 m -158.87 174.89 14.3 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.307 2.243 . . . . 0.0 106.701 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -141.5 159.6 59.94 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.733 0.813 . . . . 0.0 109.233 -173.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -64.4 154.27 74.63 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 120.036 1.049 . . . . 0.0 110.976 -10.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 tp -157.36 155.94 31.44 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.242 1.417 . . . . 0.0 107.67 -173.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -76.01 58.93 1.24 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.71 1.204 . . . . 0.0 110.224 171.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -153.23 133.62 13.57 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.73 2.012 . . . . 0.0 106.048 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.7 tp -139.25 145.44 39.21 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.0 mt -125.21 155.57 39.85 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.996 1.318 . . . . 0.0 108.605 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 164.64 29.52 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.209 1.404 . . . . 0.0 109.757 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.2 tp -98.19 127.45 44.14 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.33 138.24 27.72 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.292 1.437 . . . . 0.0 107.514 169.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 44.8 48.45 9.02 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.598 1.559 . . . . 0.0 113.18 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 56.91 30.45 18.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.278 1.431 . . . . 0.0 113.252 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -134.8 148.85 50.29 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.742 1.217 . . . . 0.0 108.379 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -92.32 125.68 44.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 mp -123.61 152.97 41.34 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 125.961 1.704 . . . . 0.0 108.926 -173.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.72 121.04 14.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.34 -38.05 14.44 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.904 1.282 . . . . 0.0 111.306 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.5 t80 . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 124.815 1.246 . . . . 0.0 108.355 179.622 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.235 0.294 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.86 -11.09 60.7 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.537 -1.146 . . . . 0.0 113.647 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -66.96 155.62 38.07 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.595 1.698 . . . . 0.0 108.291 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.67 140.64 52.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.922 1.289 . . . . 0.0 110.156 -169.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.14 146.2 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.9 mt -130.12 -35.17 1.61 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.695 1.198 . . . . 0.0 110.595 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.07 159.98 43.55 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.461 1.028 . . . . 0.0 110.117 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.3 mt -134.96 131.82 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.5 p30 42.92 24.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.579 2.352 . . . . 0.0 115.139 -173.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.25 -14.27 58.3 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.112 1.339 . . . . 0.0 112.902 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.6 mtt -74.73 105.86 6.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.813 1.307 . . . . 0.0 108.603 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.35 122.38 12.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.6 m -77.68 132.17 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.491 0.662 . . . . 0.0 109.385 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -74.79 73.46 2.08 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.768 1.627 . . . . 0.0 107.146 169.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.02 -72.29 0.4 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.627 2.06 . . . . 0.0 112.808 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -133.74 11.02 4.01 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.878 1.671 . . . . 0.0 111.947 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -120.79 154.88 35.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.4 p -69.62 175.39 4.19 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.483 1.038 . . . . 0.0 109.911 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.85 -37.89 77.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.407 169.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.43 -37.25 74.37 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.717 0.807 . . . . 0.0 111.661 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 6.24 7.77 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.528 1.061 . . . . 0.0 114.099 172.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.71 136.04 54.93 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.066 1.433 . . . . 0.0 107.385 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.43 128.07 34.76 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.0 t -56.45 -39.95 64.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.669 1.188 . . . . 0.0 111.633 -170.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.5 -40.47 93.1 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.702 0.683 . . . . 0.0 110.585 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.55 -39.17 67.67 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.414 0.552 . . . . 0.0 110.029 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -59.58 -46.54 88.63 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.6 1.16 . . . . 0.0 110.518 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.56 -33.9 60.67 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.66 0.784 . . . . 0.0 110.749 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.62 -30.84 75.18 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.381 -0.677 . . . . 0.0 112.742 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -62.28 115.32 15.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.511 1.125 . . . . 0.0 109.861 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.453 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.6 Cg_endo -70.47 -16.1 34.52 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.67 1.58 . . . . 0.0 114.003 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.35 -14.86 54.55 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.335 0.97 . . . . 0.0 111.147 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -134.64 28.93 3.58 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.376 2.27 . . . . 0.0 109.251 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.2 m-30 -60.77 -54.41 54.78 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 117.158 -1.401 . . . . 0.0 111.815 170.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.59 122.17 8.02 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.629 1.617 . . . . 0.0 109.673 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 m -149.74 172.02 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.734 1.214 . . . . 0.0 109.778 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -125.75 139.93 53.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.2 mt -133.41 147.72 31.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -170.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -119.47 130.6 55.32 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -152.71 164.77 37.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.28 -165.22 33.89 Favored Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -170.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.7 tttt . . . . . 0 C--O 1.236 0.387 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -80.04 144.43 33.2 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.201 1.4 . . . . 0.0 107.351 168.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -142.21 171.2 14.38 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.377 1.071 . . . . 0.0 110.234 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.9 m -156.22 175.68 13.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.0 2.52 . . . . 0.0 106.455 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -123.87 153.9 67.32 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.552 0.741 . . . . 0.0 109.909 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.17 -39.19 1.34 Allowed 'Cis proline' 0 CA--C 1.537 0.627 0 CA-C-N 119.64 0.907 . . . . 0.0 112.038 -5.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.9 tp 48.04 -75.54 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.087 2.955 . . . . 0.0 114.548 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -166.65 -28.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.531 2.333 . . . . 0.0 109.313 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.0 tp -55.69 131.76 47.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.806 1.642 . . . . 0.0 112.315 -174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.11 128.72 11.48 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.98 154.96 33.75 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 161.74 40.48 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.958 0.903 . . . . 0.0 109.961 -177.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.9 tp -96.25 125.4 40.74 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -153.2 144.15 22.9 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.434 1.093 . . . . 0.0 108.752 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.4 t70 47.87 39.34 10.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.583 1.153 . . . . 0.0 111.804 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 64.96 6.09 3.24 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.036 2.135 . . . . 0.0 115.877 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -118.67 149.71 40.96 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.965 1.257 . . . . 0.0 109.403 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.417 HG11 HG21 ' A' ' 72' ' ' VAL . 11.8 p -76.26 135.09 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 76.1 mt -126.49 149.55 49.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.868 1.267 . . . . 0.0 108.187 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.4 t -68.88 139.78 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -120.63 -41.6 2.58 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.936 0.895 . . . . 0.0 110.647 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 C--N 1.331 -0.205 0 C-N-CA 125.983 1.713 . . . . 0.0 106.766 170.328 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 CA--C 1.546 0.82 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.71 0.43 86.06 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.28 -0.887 . . . . 0.0 113.258 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -75.57 154.89 36.47 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.152 0.976 . . . . 0.0 109.544 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.84 147.06 27.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.7 t -74.28 144.56 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 172.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -111.1 -33.39 6.49 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 124.986 1.314 . . . . 0.0 109.847 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.47 160.22 41.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.198 1.363 . . . . 0.0 111.738 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.1 mt -136.05 135.74 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 49.34 30.34 3.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 112.076 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.87 -9.14 57.7 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.823 1.201 . . . . 0.0 113.686 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.2 mmt -84.27 119.12 24.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.102 1.451 . . . . 0.0 107.922 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -49.02 142.8 6.25 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.516 1.127 . . . . 0.0 109.834 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.3 m -111.3 149.1 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.822 0.82 . . . . 0.0 110.026 172.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -125.21 101.64 7.09 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.116 2.167 . . . . 0.0 105.907 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.02 -80.29 0.19 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.19 1.376 . . . . 0.0 110.622 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.42 25.49 0.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.996 1.318 . . . . 0.0 111.116 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -127.79 143.54 51.12 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.6 p -70.13 172.5 7.92 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.009 0.822 . . . . 0.0 110.387 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.87 -38.66 67.8 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.997 0.919 . . . . 0.0 110.861 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.51 -38.07 71.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.494 0.717 . . . . 0.0 111.529 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.71 3.1 7.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.907 1.241 . . . . 0.0 113.737 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.93 133.65 53.64 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.809 1.304 . . . . 0.0 108.167 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.22 120.82 13.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.417 HG21 HG11 ' A' ' 37' ' ' VAL . 27.3 m -58.9 -40.16 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -169.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.13 -40.52 68.03 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.986 1.266 . . . . 0.0 109.758 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.29 -44.81 93.97 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.792 0.724 . . . . 0.0 110.11 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -58.49 -44.42 89.4 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.164 0.986 . . . . 0.0 111.209 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.08 -37.8 72.45 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.289 1.036 . . . . 0.0 110.786 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.5 -30.62 73.19 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.124 0.869 . . . . 0.0 112.333 -175.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -58.01 114.45 8.58 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.31 1.044 . . . . 0.0 109.629 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 72.0 Cg_endo -70.87 -13.73 32.08 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.558 1.505 . . . . 0.0 113.749 -175.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.27 -15.24 56.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.417 1.008 . . . . 0.0 110.612 169.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -132.59 34.22 3.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.309 2.644 . . . . 0.0 108.468 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.449 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -65.0 -52.52 48.63 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 117.18 -1.39 . . . . 0.0 111.498 169.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.36 125.41 11.27 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.667 1.631 . . . . 0.0 108.87 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.05 171.04 2.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.195 0.998 . . . . 0.0 110.524 -170.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.5 m -125.61 138.85 53.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 169.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.3 mt -136.48 139.58 44.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.6 mtp-105 -117.24 132.66 56.58 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -143.76 167.05 23.21 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.361 1.464 . . . . 0.0 109.185 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.52 -165.72 38.96 Favored Glycine 0 CA--C 1.52 0.399 0 O-C-N 121.543 -0.723 . . . . 0.0 111.656 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 117.983 -1.008 . . . . 0.0 108.301 170.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.2 tttp . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.6 m -91.31 142.2 27.96 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -139.09 162.77 34.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.064 1.345 . . . . 0.0 109.28 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.5 p -153.94 176.67 11.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.017 2.527 . . . . 0.0 107.402 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -135.22 156.29 78.21 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.243 1.017 . . . . 0.0 109.481 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.11 -23.88 9.07 Favored 'Cis proline' 0 C--N 1.351 0.675 0 CA-C-N 119.945 1.016 . . . . 0.0 113.518 -0.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tt 37.7 -91.39 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.603 2.761 . . . . 0.0 113.06 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -160.58 -38.79 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.471 1.508 . . . . 0.0 110.06 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.2 tp -57.51 130.57 46.94 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.961 0.904 . . . . 0.0 109.533 171.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.1 mt -142.54 153.17 43.34 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.337 1.455 . . . . 0.0 107.729 170.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.44 154.53 36.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.676 1.19 . . . . 0.0 108.902 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.14 154.89 46.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.441 1.096 . . . . 0.0 109.122 170.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.4 tp -92.52 132.48 36.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.532 1.133 . . . . 0.0 108.374 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -153.61 139.66 18.3 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.624 1.17 . . . . 0.0 107.958 169.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 t70 44.3 49.61 7.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.649 1.58 . . . . 0.0 112.672 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 59.08 22.87 11.0 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.637 1.575 . . . . 0.0 114.211 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -129.41 156.64 43.76 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 120.931 -1.106 . . . . 0.0 108.841 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.26 130.88 52.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.41 153.5 38.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.882 1.273 . . . . 0.0 108.39 -173.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.11 104.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 125.905 1.682 . . . . 0.0 107.339 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.31 -39.54 68.16 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.678 0.791 . . . . 0.0 109.814 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.232 0.151 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 175.762 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.9 t . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.95 -10.22 63.58 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.745 -1.031 . . . . 0.0 113.57 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -71.59 170.66 12.93 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.272 1.536 . . . . 0.0 108.674 169.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.57 143.65 50.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.208 1.003 . . . . 0.0 109.662 -172.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 p -70.27 140.82 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 169.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -116.77 -32.39 5.15 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.791 1.636 . . . . 0.0 109.867 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.51 158.61 40.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.091 0.859 . . . . 0.0 110.394 169.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.2 mt -131.65 130.17 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 p30 40.15 27.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.918 2.487 . . . . 0.0 115.314 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.33 -16.18 57.0 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.161 1.363 . . . . 0.0 112.789 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.65 109.29 11.5 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.645 1.223 . . . . 0.0 108.102 171.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -51.62 141.1 17.08 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.691 1.197 . . . . 0.0 108.881 169.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -103.87 116.33 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.387 1.089 . . . . 0.0 110.223 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -76.92 86.67 3.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.659 1.584 . . . . 0.0 108.041 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.02 -78.71 0.4 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.01 1.291 . . . . 0.0 111.963 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -135.84 13.63 3.39 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.927 1.291 . . . . 0.0 112.639 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -126.42 145.69 50.37 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.7 p -69.76 170.25 11.35 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.823 0.82 . . . . 0.0 110.155 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.5 -38.06 68.67 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.728 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.8 -37.09 73.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.657 0.783 . . . . 0.0 111.784 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.3 4.24 7.74 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.769 1.176 . . . . 0.0 113.944 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -67.93 137.69 55.39 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.903 1.352 . . . . 0.0 107.867 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -67.88 127.69 33.73 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.82 -40.56 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.536 0.734 . . . . 0.0 111.419 -170.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.7 mt -65.36 -36.8 85.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.072 0.851 . . . . 0.0 110.815 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -74.46 -40.61 61.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.455 0.57 . . . . 0.0 109.688 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -59.24 -51.05 71.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.775 0.83 . . . . 0.0 110.103 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.29 -30.0 64.39 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.601 0.76 . . . . 0.0 110.627 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.7 -38.06 95.65 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.517 -0.602 . . . . 0.0 111.812 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -63.93 117.08 32.25 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 117.738 0.769 . . . . 0.0 109.003 173.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 65.9 Cg_endo -67.34 -12.14 34.73 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.987 1.792 . . . . 0.0 114.009 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.57 -17.55 46.98 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.455 1.025 . . . . 0.0 111.211 169.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -120.67 21.05 11.64 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.703 1.601 . . . . 0.0 110.332 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 3.1 m-30 -61.06 -59.25 14.38 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 117.075 -1.441 . . . . 0.0 110.166 170.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.55 106.13 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.833 1.689 . . . . 0.0 109.603 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.02 156.45 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 123.197 0.599 . . . . 0.0 110.438 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -84.28 142.19 30.42 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 169.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.6 mt -139.73 147.04 24.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -121.3 138.13 54.38 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -133.28 151.77 51.91 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.299 1.84 . . . . 0.0 109.655 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.96 -168.93 22.61 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 169.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -73.75 145.72 44.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.951 1.3 . . . . 0.0 109.632 169.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -142.74 163.7 32.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.405 1.482 . . . . 0.0 109.599 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 p -158.47 175.47 13.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.025 2.13 . . . . 0.0 107.612 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -137.22 158.86 71.68 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 123.816 0.847 . . . . 0.0 110.167 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.96 156.95 79.49 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.759 0.949 . . . . 0.0 111.271 -9.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 tp -158.03 159.36 36.29 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.768 1.227 . . . . 0.0 108.579 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.0 -31.57 72.73 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.795 0.838 . . . . 0.0 112.18 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 tt -67.59 121.47 15.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.1 mt -133.58 156.22 48.22 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.084 1.754 . . . . 0.0 107.94 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -131.79 155.4 47.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.172 0.989 . . . . 0.0 111.215 -169.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.53 153.72 40.71 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.723 1.209 . . . . 0.0 110.112 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.3 tp -78.66 130.75 36.21 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -153.55 138.49 17.2 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.831 1.252 . . . . 0.0 107.932 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.1 t70 48.44 43.56 19.8 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.19 1.396 . . . . 0.0 113.091 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 58.25 25.41 12.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.823 1.649 . . . . 0.0 113.336 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -130.15 167.99 17.5 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.305 1.842 . . . . 0.0 108.167 173.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.5 t -112.91 116.03 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.02 152.13 26.3 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.146 1.378 . . . . 0.0 109.201 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.05 104.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.979 1.712 . . . . 0.0 107.561 172.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.94 -32.6 57.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.827 1.251 . . . . 0.0 110.874 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 CA--C 1.531 0.226 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 175.391 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 120.974 0.416 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.83 -16.17 60.7 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.119 -0.823 . . . . 0.0 113.333 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -69.19 166.49 18.24 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.708 1.254 . . . . 0.0 108.255 169.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.45 152.29 51.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.269 0.628 . . . . 0.0 111.124 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 83.4 t -66.24 142.45 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -126.4 -30.11 2.9 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.605 1.162 . . . . 0.0 110.906 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.79 158.01 43.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.06 1.3 . . . . 0.0 110.551 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.4 mt -139.97 135.15 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 49.6 28.84 2.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.604 1.562 . . . . 0.0 112.229 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.35 -11.28 66.12 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.119 1.342 . . . . 0.0 113.734 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.3 mtt -82.81 111.96 19.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.938 1.369 . . . . 0.0 109.076 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.74 131.48 50.42 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.3 m -90.42 119.43 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -72.91 98.49 2.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.085 1.354 . . . . 0.0 107.949 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.2 -93.59 0.09 OUTLIER Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -175.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 ptt85 -124.78 14.32 8.63 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.755 1.622 . . . . 0.0 112.226 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -123.54 148.08 46.66 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.5 p -68.87 172.93 5.83 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.563 1.074 . . . . 0.0 110.355 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.61 -38.56 75.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.596 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.69 -39.14 77.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.818 0.847 . . . . 0.0 111.412 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.3 1.59 7.22 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.604 1.097 . . . . 0.0 113.988 172.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -61.29 140.92 57.88 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 119.092 1.446 . . . . 0.0 108.776 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.71 127.37 31.69 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.3 t -56.45 -43.38 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.61 0.764 . . . . 0.0 111.698 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.9 -36.7 82.87 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.351 0.523 . . . . 0.0 110.458 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.28 -42.92 68.12 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.293 0.497 . . . . 0.0 109.691 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -58.88 -46.53 87.6 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.718 1.207 . . . . 0.0 110.634 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.16 -33.67 59.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.492 0.717 . . . . 0.0 111.005 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.1 -32.02 79.31 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.308 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -61.18 114.17 9.93 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.154 . . . . 0.0 109.939 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 84.2 Cg_endo -71.06 -14.66 32.12 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.638 1.559 . . . . 0.0 113.789 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.23 -15.42 57.03 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.436 1.017 . . . . 0.0 110.869 169.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -133.36 32.83 3.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.884 2.474 . . . . 0.0 108.639 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.451 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -64.97 -53.78 39.53 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.189 -1.386 . . . . 0.0 110.398 169.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.02 124.36 10.49 Favored 'Trans proline' 0 C--N 1.352 0.756 0 CA-C-N 121.559 1.593 . . . . 0.0 109.369 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.1 m -150.66 172.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.251 1.42 . . . . 0.0 109.778 -172.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 m -121.46 138.22 54.38 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.5 mt -136.49 140.39 43.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -114.62 138.12 51.05 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.734 1.614 . . . . 0.0 106.852 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -125.54 169.47 12.41 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.899 1.28 . . . . 0.0 110.164 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.55 -160.92 25.51 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 170.016 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.0 tptt . . . . . 0 C--O 1.233 0.218 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -79.84 141.49 36.14 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -138.25 161.29 37.25 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.008 1.323 . . . . 0.0 109.024 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.0 p -156.63 175.32 14.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.319 2.248 . . . . 0.0 106.983 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -139.83 161.5 55.86 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 123.924 0.89 . . . . 0.0 109.125 -171.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.08 145.83 60.99 Favored 'Cis proline' 0 C--N 1.351 0.669 0 CA-C-N 120.261 1.129 . . . . 0.0 111.262 -6.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 tp -159.74 162.07 34.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.125 1.77 . . . . 0.0 107.009 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.57 -28.69 69.52 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.369 0.668 . . . . 0.0 112.502 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.7 tp -57.54 126.0 25.39 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.967 0.907 . . . . 0.0 110.101 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.9 tp -147.47 151.61 36.69 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.204 1.401 . . . . 0.0 107.535 172.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -121.31 156.04 33.43 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.633 1.173 . . . . 0.0 109.598 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.51 151.65 51.26 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.688 0.795 . . . . 0.0 109.321 169.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.19 124.43 28.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -152.82 142.45 21.87 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.489 1.115 . . . . 0.0 108.337 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.69 44.11 17.24 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.487 1.515 . . . . 0.0 112.126 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 59.36 6.86 0.83 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.718 2.007 . . . . 0.0 115.319 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -109.56 -178.75 3.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.464 1.906 . . . . 0.0 107.439 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.55 130.37 74.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 169.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.5 mt -127.93 154.87 45.06 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.402 1.081 . . . . 0.0 108.769 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.6 t -58.72 111.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.244 1.418 . . . . 0.0 108.094 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.07 -36.55 24.81 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.573 1.149 . . . . 0.0 110.463 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 174.517 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 121.063 0.459 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.06 -9.63 65.76 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.214 -1.326 . . . . 0.0 113.939 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -68.44 155.2 40.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.093 1.947 . . . . 0.0 109.278 169.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.23 146.48 30.26 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.924 0.889 . . . . 0.0 109.619 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -81.09 139.1 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 169.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.75 -37.44 3.93 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.437 1.495 . . . . 0.0 109.761 -174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.7 160.18 44.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.667 1.121 . . . . 0.0 110.676 170.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.5 mt -136.82 131.41 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.285 0.0 OUTLIER 36.83 34.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 128.564 2.746 . . . . 0.0 114.817 -176.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.84 -15.85 57.94 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.469 1.509 . . . . 0.0 113.15 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.4 mtt -82.94 108.75 16.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.497 1.149 . . . . 0.0 108.948 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.03 133.26 55.38 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 m -98.01 125.24 51.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -88.84 100.05 12.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.266 1.826 . . . . 0.0 107.53 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.78 -80.96 0.23 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.855 1.217 . . . . 0.0 110.781 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.23 23.16 1.5 Allowed 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.131 1.372 . . . . 0.0 111.767 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -126.23 146.72 49.87 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.9 p -68.54 173.58 4.91 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.795 0.807 . . . . 0.0 110.338 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.16 -38.41 73.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.666 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -70.05 -39.52 75.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.744 0.818 . . . . 0.0 111.406 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.6 -1.59 6.45 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.653 1.12 . . . . 0.0 114.089 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -61.9 134.29 56.5 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.095 1.447 . . . . 0.0 108.566 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.14 126.11 26.67 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.4 t -56.68 -38.31 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.367 1.067 . . . . 0.0 111.703 -169.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.12 -40.25 94.22 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.548 0.613 . . . . 0.0 110.33 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -74.43 -38.29 63.07 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.939 0.496 . . . . 0.0 110.136 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -59.32 -45.99 89.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.365 1.066 . . . . 0.0 110.454 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.5 mt -76.97 -31.49 56.58 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.462 0.705 . . . . 0.0 110.874 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.26 -33.64 87.35 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.404 -0.664 . . . . 0.0 112.502 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -63.2 114.47 12.83 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.562 1.145 . . . . 0.0 110.136 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 88.5 Cg_endo -71.64 -15.75 30.36 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.632 1.555 . . . . 0.0 113.905 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.97 -14.24 44.99 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.313 0.96 . . . . 0.0 111.201 169.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -132.1 22.49 4.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.026 2.13 . . . . 0.0 109.881 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.464 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.7 m-30 -59.37 -53.63 64.15 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 116.942 -1.504 . . . . 0.0 112.117 171.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.84 112.06 3.45 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.827 1.688 . . . . 0.0 109.681 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 m -148.42 152.22 12.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 123.889 0.875 . . . . 0.0 110.069 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.4 m -84.58 144.11 28.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.0 mt -134.0 135.94 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -103.6 121.9 43.88 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -106.99 176.09 5.29 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.55 1.14 . . . . 0.0 108.348 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.03 173.31 44.67 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 173.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? . . . . . 0 N--CA 1.464 0.273 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.5 p -78.7 145.32 34.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.3 1.04 . . . . 0.0 109.515 169.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -141.08 158.49 43.85 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.51 1.524 . . . . 0.0 110.009 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.8 m -146.67 175.15 10.82 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.608 2.763 . . . . 0.0 106.84 175.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -140.05 165.05 33.43 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.428 1.091 . . . . 0.0 109.108 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.96 -31.77 0.68 Allowed 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 120.591 1.247 . . . . 0.0 114.446 -7.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.7 tp 44.52 -123.59 0.95 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.565 1.546 . . . . 0.0 109.736 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.55 43.85 0.59 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.973 1.26 . . . . 0.0 110.625 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.45 161.55 39.43 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.046 1.338 . . . . 0.0 109.75 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.8 tp -154.44 152.49 30.21 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.874 1.27 . . . . 0.0 108.613 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.1 mt -121.76 155.37 35.42 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.807 1.243 . . . . 0.0 109.617 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.25 154.82 43.48 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.515 1.126 . . . . 0.0 109.451 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.88 126.85 33.38 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -155.67 144.76 20.71 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.044 1.338 . . . . 0.0 108.258 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 50.72 43.21 28.03 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.335 1.054 . . . . 0.0 111.823 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.282 10.5 pt-20 50.41 26.46 2.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.174 2.59 . . . . 0.0 115.298 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 mtp-105 -134.68 159.84 40.0 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.157 -0.965 . . . . 0.0 110.76 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 m -80.37 131.85 33.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 169.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.0 mt -120.07 154.06 35.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.63 1.172 . . . . 0.0 108.252 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.99 106.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.988 1.315 . . . . 0.0 107.476 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.05 -37.07 66.99 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.703 0.801 . . . . 0.0 110.022 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.9 t80 . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 107.697 177.197 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t . . . . . 0 CA--C 1.537 0.447 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.93 -7.56 74.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.107 -1.385 . . . . 0.0 114.021 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -73.22 163.95 27.38 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.015 1.908 . . . . 0.0 108.613 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.09 155.66 21.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.52 1.128 . . . . 0.0 110.467 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.9 t -71.86 136.88 24.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 169.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -111.71 -36.75 5.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.669 1.188 . . . . 0.0 109.473 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.67 160.24 43.7 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.305 0.957 . . . . 0.0 111.094 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.1 mt -132.84 132.66 59.38 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 45.76 32.76 1.31 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.503 1.921 . . . . 0.0 112.118 -174.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.5 -9.46 73.38 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.0 1.286 . . . . 0.0 114.069 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.2 mtt -83.4 115.94 22.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.067 1.434 . . . . 0.0 108.808 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -49.66 124.73 10.13 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.755 1.222 . . . . 0.0 110.335 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.08 140.34 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 109.91 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -79.32 67.68 5.11 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.556 1.542 . . . . 0.0 108.535 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.74 -66.0 1.11 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.203 1.859 . . . . 0.0 113.974 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -136.74 9.14 3.08 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.892 1.677 . . . . 0.0 111.79 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -120.4 152.16 38.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.4 p -66.84 171.47 5.29 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.851 0.834 . . . . 0.0 109.427 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.08 76.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.599 169.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.28 -37.84 74.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.556 0.742 . . . . 0.0 111.578 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.76 1.94 6.32 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.359 -1.245 . . . . 0.0 115.878 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -69.11 144.52 53.88 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.315 2.058 . . . . 0.0 107.578 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.28 131.46 47.38 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.2 -37.39 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.345 1.058 . . . . 0.0 110.748 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.21 -40.22 95.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.082 0.401 . . . . 0.0 110.368 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -73.86 -41.79 61.72 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.391 0.541 . . . . 0.0 110.005 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -58.65 -51.1 71.34 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.251 0.62 . . . . 0.0 110.103 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.9 mt -76.76 -30.32 56.5 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.783 0.833 . . . . 0.0 110.848 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.3 -36.73 93.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.0 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -62.92 117.06 28.92 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 117.918 0.859 . . . . 0.0 109.067 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.472 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 68.4 Cg_endo -67.79 -11.8 33.3 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.875 1.717 . . . . 0.0 114.165 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.82 -17.47 49.89 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.42 1.009 . . . . 0.0 111.012 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -121.85 23.61 10.01 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.18 1.792 . . . . 0.0 110.099 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.8 m-30 -61.54 -57.62 23.82 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 117.087 -1.435 . . . . 0.0 110.501 169.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.88 107.15 2.41 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.903 1.736 . . . . 0.0 109.715 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.93 171.23 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.135 0.974 . . . . 0.0 109.829 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.5 m -105.9 143.12 34.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.2 mt -139.35 148.21 23.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -120.61 136.41 54.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -121.27 162.47 20.2 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.154 1.382 . . . . 0.0 107.938 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.69 -175.54 41.47 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.6 mmt-85 . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 117.796 -1.097 . . . . 0.0 108.467 175.594 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.7 tttt . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.4 m -126.09 142.72 51.4 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.395 1.078 . . . . 0.0 108.593 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -142.05 -178.79 5.87 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 127.006 2.122 . . . . 0.0 107.46 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.5 m -151.56 157.2 41.92 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.798 -1.189 . . . . 0.0 108.685 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -77.25 154.95 82.26 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -81.68 0.87 47.56 Favored 'Cis proline' 0 CA--C 1.544 1.011 0 CA-C-N 119.823 0.972 . . . . 0.0 111.909 -10.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -54.92 -38.89 68.21 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 124.662 1.185 . . . . 0.0 111.482 -172.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -144.22 142.4 30.48 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 121.215 0.531 . . . . 0.0 109.924 169.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -160.17 13.9 0.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.39 2.676 . . . . 0.0 110.024 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.9 mt -82.22 69.45 8.95 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.903 1.281 . . . . 0.0 110.635 -169.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.48 155.59 50.08 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.245 1.418 . . . . 0.0 108.744 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.6 150.84 46.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.385 0.674 . . . . 0.0 110.624 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tt -79.11 124.78 28.64 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -155.29 143.16 19.91 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.593 1.157 . . . . 0.0 108.298 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 47.91 41.94 15.48 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.522 1.529 . . . . 0.0 112.612 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 53.47 26.78 5.8 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.292 1.837 . . . . 0.0 113.35 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -126.17 -176.1 3.55 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.94 2.496 . . . . 0.0 106.203 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.33 132.49 71.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.0 mp -121.0 147.15 45.89 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.652 1.181 . . . . 0.0 108.734 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.9 t -60.18 111.24 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 170.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.42 -30.49 37.7 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.692 0.797 . . . . 0.0 111.252 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 69.4 t80 . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 125.336 1.454 . . . . 0.0 107.541 169.919 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.2 t . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.55 -6.28 77.94 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.547 -1.14 . . . . 0.0 114.139 169.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -62.51 135.27 57.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.476 1.638 . . . . 0.0 107.47 169.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.13 147.88 26.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.048 0.939 . . . . 0.0 108.511 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.2 t -74.0 136.48 25.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.31 -37.18 7.76 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.159 1.784 . . . . 0.0 108.942 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.1 159.51 44.45 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.219 0.918 . . . . 0.0 111.068 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.57 139.53 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.65 34.11 3.46 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.685 1.994 . . . . 0.0 112.444 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.36 13.84 82.83 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.018 -0.879 . . . . 0.0 113.534 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.3 mmt -118.56 121.61 40.64 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.19 1.396 . . . . 0.0 107.508 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -50.8 139.1 17.41 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.593 1.157 . . . . 0.0 110.011 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.3 m -102.21 122.17 54.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -73.17 85.28 1.37 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.566 1.546 . . . . 0.0 107.187 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.34 -100.92 0.39 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -106.75 8.61 31.0 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.195 1.398 . . . . 0.0 111.887 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -127.82 150.02 50.02 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 119.291 0.95 . . . . 0.0 109.17 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.1 p -69.77 175.45 4.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.624 0.726 . . . . 0.0 110.457 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.51 -38.81 72.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.437 0.695 . . . . 0.0 110.696 169.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.72 -39.89 69.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.769 0.828 . . . . 0.0 111.371 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.2 -0.67 7.07 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.502 1.048 . . . . 0.0 113.94 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -58.75 135.95 57.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.936 1.368 . . . . 0.0 108.008 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.99 131.14 45.53 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.29 -38.63 70.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.009 0.924 . . . . 0.0 113.251 -169.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.6 mt -69.35 -38.72 78.25 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.337 0.971 . . . . 0.0 110.692 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.0 -41.93 85.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -60.46 -46.22 90.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.18 0.992 . . . . 0.0 111.323 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.0 mt -70.78 -38.35 73.39 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.978 0.511 . . . . 0.0 109.927 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.68 -28.13 69.75 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.763 0.697 . . . . 0.0 112.929 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -53.45 118.14 13.8 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.27 1.428 . . . . 0.0 109.96 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.39 -14.36 39.88 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.0 1.8 . . . . 0.0 113.504 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.7 -12.69 61.05 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.375 0.989 . . . . 0.0 112.026 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -128.79 41.41 3.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.94 2.096 . . . . 0.0 108.599 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -47.1 96.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.486 -1.245 . . . . 0.0 113.398 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.27 138.91 18.28 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 121.527 1.581 . . . . 0.0 108.356 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.63 130.72 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -172.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.9 m -105.06 138.93 40.51 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 mt -140.55 139.47 35.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -115.23 133.2 56.25 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -148.5 160.78 42.74 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.523 1.129 . . . . 0.0 109.035 -169.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.38 -173.74 43.15 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.453 ' H ' ' HD2' ' A' ' 90' ' ' ARG . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.521 0 O-C-N 121.192 -1.181 . . . . 0.0 107.878 173.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HE2' ' CE2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.9 m -79.67 142.75 35.25 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.42 ' CE2' ' HE2' ' A' ' 20' ' ' LYS . 89.3 m-85 -116.27 165.12 13.54 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.313 1.845 . . . . 0.0 109.324 -174.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -146.98 167.45 23.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.05 1.74 . . . . 0.0 107.079 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -116.36 161.0 33.78 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.211 1.004 . . . . 0.0 109.499 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -62.08 160.92 51.46 Favored 'Cis proline' 0 C--N 1.35 0.633 0 CA-C-N 119.762 0.951 . . . . 0.0 110.93 -10.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.434 ' HG ' ' H ' ' A' ' 28' ' ' LEU . 51.8 tp -139.67 149.75 44.07 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.771 0.829 . . . . 0.0 110.417 -169.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.4 -31.9 72.95 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.903 1.281 . . . . 0.0 112.586 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 26' ' ' LEU . 55.2 mt -63.59 144.81 56.7 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.284 0.634 . . . . 0.0 110.146 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -140.41 132.36 27.72 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.9 mt -113.56 155.58 25.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.696 0.798 . . . . 0.0 110.209 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 145.74 50.97 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.573 1.149 . . . . 0.0 108.836 170.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tt -75.5 130.69 39.29 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -150.62 130.13 13.01 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.285 1.034 . . . . 0.0 108.234 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.2 t0 47.93 47.48 18.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.416 1.486 . . . . 0.0 112.188 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 61.12 10.79 3.09 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.566 1.946 . . . . 0.0 114.876 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.8 mtm-85 -110.36 179.37 4.1 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.447 1.499 . . . . 0.0 108.537 169.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.27 131.74 72.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.4 mp -120.23 143.36 48.32 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.833 1.253 . . . . 0.0 108.245 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.52 105.5 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 125.851 1.66 . . . . 0.0 107.534 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.95 -29.6 24.98 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 124.334 1.054 . . . . 0.0 111.26 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.0 t80 . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 173.322 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.17 -6.49 66.31 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.985 -0.897 . . . . 0.0 112.702 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -63.96 158.97 20.96 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.11 153.12 41.91 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.308 1.043 . . . . 0.0 109.103 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.15 137.4 24.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.31 -36.81 3.02 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.507 1.123 . . . . 0.0 110.058 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.98 157.73 43.71 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.734 0.697 . . . . 0.0 109.889 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 83.9 mt -136.48 139.53 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 170.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 42.33 38.95 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.515 2.326 . . . . 0.0 112.626 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 10.14 77.32 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.725 -1.042 . . . . 0.0 114.075 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 98.7 mmm -121.65 120.28 34.28 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.029 1.415 . . . . 0.0 108.485 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.62 129.05 37.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.601 1.161 . . . . 0.0 109.161 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.15 144.37 9.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.54 0.686 . . . . 0.0 111.369 -171.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -78.82 62.91 3.42 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.047 1.339 . . . . 0.0 107.603 169.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.78 -112.58 4.21 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.407 1.004 . . . . 0.0 110.978 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.05 2.09 28.65 Favored 'General case' 0 N--CA 1.46 0.062 0 C-N-CA 123.697 0.799 . . . . 0.0 112.023 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -119.68 147.99 43.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 119.091 0.86 . . . . 0.0 109.613 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.8 p -69.95 175.63 4.28 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.722 0.773 . . . . 0.0 110.038 172.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.99 -38.63 79.61 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.59 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.14 -37.11 69.5 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.793 0.837 . . . . 0.0 111.598 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.36 6.4 8.89 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.498 1.047 . . . . 0.0 114.072 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -63.13 140.28 58.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.292 1.546 . . . . 0.0 107.83 170.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.62 125.2 26.15 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 169.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.56 -33.18 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.049 0.54 . . . . 0.0 111.577 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.1 -42.02 97.05 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.326 0.512 . . . . 0.0 110.034 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -68.58 -46.1 70.29 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.08 -46.17 85.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.436 0.694 . . . . 0.0 111.375 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.6 mt -78.12 -33.98 50.24 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.105 0.962 . . . . 0.0 110.436 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.33 -31.31 68.72 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.509 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -53.97 116.46 10.31 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.171 1.389 . . . . 0.0 110.67 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.428 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 61.2 Cg_endo -68.37 -17.44 44.25 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.028 1.819 . . . . 0.0 113.543 -175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.24 -11.64 59.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.927 0.785 . . . . 0.0 112.497 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -129.67 31.96 4.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.573 1.549 . . . . 0.0 110.07 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.6 m-30 -53.53 -51.26 77.65 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 116.776 -1.583 . . . . 0.0 113.629 176.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.43 125.3 8.95 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 122.153 1.805 . . . . 0.0 109.513 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.1 135.63 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.748 0.819 . . . . 0.0 108.984 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 m -84.62 134.52 34.38 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.8 mt -140.56 147.35 23.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -124.65 140.71 52.68 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -120.73 153.83 36.44 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.91 -179.99 33.21 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.4 mmt-85 . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 169.963 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -76.41 142.45 41.09 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -143.0 153.41 42.95 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.609 0.764 . . . . 0.0 109.587 172.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -144.07 174.71 10.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.038 2.135 . . . . 0.0 106.235 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -137.05 160.18 67.08 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.881 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -64.96 155.37 76.45 Favored 'Cis proline' 0 C--N 1.351 0.68 0 CA-C-N 120.249 1.125 . . . . 0.0 111.903 -5.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -157.58 155.38 30.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.425 1.49 . . . . 0.0 107.995 -173.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.25 -31.82 72.43 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.292 0.637 . . . . 0.0 112.164 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.44 139.96 56.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.732 1.213 . . . . 0.0 109.657 173.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.8 tp -146.55 153.78 40.76 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.9 mt -122.49 155.6 35.86 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.317 1.447 . . . . 0.0 108.291 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.18 153.49 51.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.437 0.562 . . . . 0.0 110.387 170.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.9 tp -90.94 123.8 34.71 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.294 1.438 . . . . 0.0 107.168 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -149.16 137.13 20.61 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.729 1.212 . . . . 0.0 108.34 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.2 t70 45.82 43.1 9.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.521 1.529 . . . . 0.0 112.605 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 53.98 32.02 14.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.757 1.623 . . . . 0.0 113.991 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -130.29 164.2 25.13 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 125.779 1.631 . . . . 0.0 107.511 169.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.2 t -122.28 117.88 53.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -116.45 147.36 41.77 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.211 1.404 . . . . 0.0 108.061 -169.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.84 108.98 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 173.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.03 -40.95 21.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.747 1.219 . . . . 0.0 111.578 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 . . . . . 0 C--O 1.233 0.188 0 C-N-CA 124.685 1.194 . . . . 0.0 108.512 -176.353 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.08 -12.79 57.18 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.3 0.952 . . . . 0.0 113.911 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -79.68 174.75 11.27 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.851 1.325 . . . . 0.0 109.086 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.64 148.33 51.52 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.087 0.555 . . . . 0.0 111.398 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.2 t -61.85 137.25 24.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.8 mt -120.21 -33.1 3.99 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.896 1.279 . . . . 0.0 109.423 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.0 159.91 44.27 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.492 1.042 . . . . 0.0 110.9 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.3 mt -132.05 130.94 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.7 p30 41.69 26.25 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.559 2.343 . . . . 0.0 115.091 -174.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.63 -15.32 57.3 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.174 1.369 . . . . 0.0 113.151 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 76.7 mtm -75.32 106.93 7.1 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.836 1.318 . . . . 0.0 108.957 172.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.7 125.55 22.8 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.2 m -80.38 128.25 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -75.36 74.95 2.45 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.471 1.509 . . . . 0.0 107.918 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.17 -70.95 0.79 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 126.458 1.98 . . . . 0.0 112.157 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -129.35 -4.82 4.85 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.706 2.402 . . . . 0.0 111.522 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -117.94 156.18 28.93 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.2 p -70.61 175.65 4.72 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.277 -0.89 . . . . 0.0 109.629 169.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.14 79.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.141 169.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.29 -29.64 67.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.548 1.139 . . . . 0.0 111.992 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.66 3.88 19.96 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.075 1.321 . . . . 0.0 113.385 170.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -71.41 136.26 47.63 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.96 129.05 38.51 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 171.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 t -55.75 -41.96 67.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.987 0.915 . . . . 0.0 111.356 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.5 mt -66.55 -37.28 84.65 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.72 0.691 . . . . 0.0 110.927 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.68 -43.48 65.93 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -58.06 -46.78 84.83 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.619 1.168 . . . . 0.0 110.749 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.88 -32.83 59.86 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.65 0.78 . . . . 0.0 111.128 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.89 -32.1 76.82 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.427 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -60.19 114.69 10.57 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.204 1.001 . . . . 0.0 109.814 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.7 Cg_endo -71.06 -15.87 32.22 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.72 1.613 . . . . 0.0 113.838 -175.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.96 -14.54 48.55 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.222 0.919 . . . . 0.0 111.105 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -133.52 27.27 4.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.311 2.244 . . . . 0.0 109.438 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.449 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.4 m-30 -59.4 -53.15 68.87 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-O 117.046 -1.454 . . . . 0.0 112.264 170.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.16 119.44 6.17 Favored 'Trans proline' 0 C--N 1.351 0.691 0 CA-C-N 121.813 1.683 . . . . 0.0 109.755 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 m -147.44 174.05 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.642 1.577 . . . . 0.0 110.031 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.2 m -125.67 137.81 53.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 168.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.9 mt -131.33 137.72 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -173.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.1 ttp-105 -116.62 135.01 54.15 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -141.86 165.12 28.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.852 0.861 . . . . 0.0 110.45 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.74 -173.68 33.64 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 124.28 0.943 . . . . 0.0 111.038 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.489 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 N--CA 1.466 0.334 0 CA-C-O 120.774 0.321 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -83.58 142.99 30.44 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.834 1.253 . . . . 0.0 108.43 169.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -142.66 174.93 10.2 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.959 0.903 . . . . 0.0 110.343 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.9 m -151.22 175.53 12.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.905 2.482 . . . . 0.0 106.558 169.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.27 160.61 67.98 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.85 0.86 . . . . 0.0 110.24 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.25 -36.14 1.57 Allowed 'Cis proline' 0 C--N 1.351 0.704 0 CA-C-N 119.884 0.994 . . . . 0.0 111.425 -8.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 45.4 30.67 0.74 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.325 2.25 . . . . 0.0 114.156 169.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.7 t0 43.23 57.28 3.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.262 1.425 . . . . 0.0 112.192 -172.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.8 tp -144.28 140.7 29.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.932 1.693 . . . . 0.0 107.72 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.3 tp -146.95 142.01 27.09 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.657 0.783 . . . . 0.0 109.692 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -126.46 155.23 42.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.978 2.111 . . . . 0.0 107.165 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 153.43 41.17 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.053 0.842 . . . . 0.0 111.75 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.0 tp -73.55 127.67 33.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.891 1.676 . . . . 0.0 109.296 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -158.47 144.41 16.92 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.952 1.301 . . . . 0.0 108.406 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 51.36 39.81 25.04 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.935 1.294 . . . . 0.0 112.312 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 55.53 15.55 1.53 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.115 2.166 . . . . 0.0 114.658 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -118.71 -174.19 2.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.284 1.833 . . . . 0.0 107.102 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -123.26 142.09 41.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.4 mt -118.26 145.72 44.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.55 126.86 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 169.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -107.68 -38.05 5.98 Favored 'General case' 0 C--O 1.231 0.132 0 C-N-CA 123.483 0.713 . . . . 0.0 112.22 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.8 t80 . . . . . 0 C--O 1.233 0.231 0 C-N-CA 123.571 0.748 . . . . 0.0 108.995 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 CA--C 1.54 0.576 0 CA-C-O 121.057 0.456 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 1.21 38.8 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 117.846 -1.53 . . . . 0.0 113.634 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -60.95 136.68 58.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.281 2.04 . . . . 0.0 108.843 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.68 138.04 32.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.2 t -65.97 147.61 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 171.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.3 mt -126.37 -36.11 2.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.705 2.002 . . . . 0.0 109.488 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.7 159.48 44.08 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.005 0.82 . . . . 0.0 110.763 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 74.6 mt -136.08 136.0 49.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 45.78 32.67 1.3 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.918 2.087 . . . . 0.0 112.882 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.61 7.57 75.17 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.159 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.5 mmt -114.18 120.64 41.2 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.92 1.36 . . . . 0.0 107.894 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -53.43 133.87 40.47 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.275 1.03 . . . . 0.0 109.132 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.24 145.67 12.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.462 0.649 . . . . 0.0 110.133 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -78.06 62.59 2.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.762 1.625 . . . . 0.0 108.264 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.04 -107.79 1.07 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.876 1.227 . . . . 0.0 111.137 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -76.91 -6.88 54.25 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.339 1.056 . . . . 0.0 112.372 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -120.62 146.56 46.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 119.042 0.837 . . . . 0.0 109.247 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.6 p -69.17 177.32 2.79 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.66 0.743 . . . . 0.0 110.386 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.76 75.0 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.563 169.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.11 -38.2 63.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.753 0.821 . . . . 0.0 111.633 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.57 4.72 8.05 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.551 1.072 . . . . 0.0 113.92 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -61.8 140.66 58.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.198 1.499 . . . . 0.0 107.995 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -68.26 124.8 24.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.29 -32.9 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 122.93 0.492 . . . . 0.0 111.629 -170.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.89 -39.84 95.11 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.91 0.777 . . . . 0.0 110.662 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.22 -42.69 71.95 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -58.7 -44.69 90.4 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.8 0.84 . . . . 0.0 111.283 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.53 -32.17 53.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.482 1.113 . . . . 0.0 110.829 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.35 -28.31 73.33 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.94 0.781 . . . . 0.0 112.522 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -61.41 114.36 10.69 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.373 1.069 . . . . 0.0 109.279 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.465 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 94.4 Cg_endo -71.52 -13.05 30.0 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.347 1.365 . . . . 0.0 113.847 -175.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.66 -14.78 55.14 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.429 1.013 . . . . 0.0 110.66 169.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -132.91 33.43 3.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.297 2.639 . . . . 0.0 108.749 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -66.57 -53.49 28.97 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 117.099 -1.429 . . . . 0.0 111.562 169.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.7 125.84 12.07 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 121.786 1.673 . . . . 0.0 108.974 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 m -149.53 170.88 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.781 0.832 . . . . 0.0 111.302 -169.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.8 m -125.59 133.22 52.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.2 mm -128.93 137.47 57.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.3 ttt85 -112.29 133.41 54.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -144.69 166.41 25.27 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.773 1.229 . . . . 0.0 108.565 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.5 -173.22 37.59 Favored Glycine 0 N--CA 1.452 -0.28 0 O-C-N 121.813 -0.554 . . . . 0.0 111.805 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 118.507 -0.758 . . . . 0.0 109.093 -178.128 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -137.09 142.61 42.35 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -142.85 175.45 9.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.468 1.507 . . . . 0.0 110.529 -171.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.9 m -150.72 174.16 13.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.181 2.592 . . . . 0.0 106.197 169.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -132.78 159.59 71.93 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.524 -0.751 . . . . 0.0 109.922 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.62 155.96 82.55 Favored 'Cis proline' 0 CA--C 1.535 0.575 0 CA-C-N 120.009 1.039 . . . . 0.0 111.492 -6.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 tp -156.0 154.33 30.91 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.147 1.379 . . . . 0.0 108.267 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.6 56.46 1.45 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.16 1.384 . . . . 0.0 110.756 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.1 tp -142.91 135.98 28.15 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.924 2.09 . . . . 0.0 106.368 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.1 tp -145.84 143.65 29.76 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.0 mp -128.94 154.28 46.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.317 1.847 . . . . 0.0 107.365 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.91 152.69 42.33 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.041 0.837 . . . . 0.0 111.748 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.7 tp -71.82 129.26 38.19 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.906 1.282 . . . . 0.0 108.556 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -154.37 134.35 13.07 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.086 1.355 . . . . 0.0 108.087 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.3 t70 48.7 46.53 21.43 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.288 1.435 . . . . 0.0 112.578 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 55.69 16.1 1.84 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.41 1.884 . . . . 0.0 114.396 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.59 174.62 5.97 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 125.331 1.452 . . . . 0.0 107.387 169.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.65 133.8 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.0 mt -121.01 153.28 37.57 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.419 1.088 . . . . 0.0 108.313 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.8 122.35 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.75 -36.94 11.5 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.456 1.503 . . . . 0.0 111.235 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 t80 . . . . . 0 CA--C 1.529 0.145 0 C-N-CA 124.869 1.267 . . . . 0.0 107.935 173.454 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 120.884 0.373 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.82 -11.29 64.87 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.928 174.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -68.61 139.24 55.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.323 1.562 . . . . 0.0 107.478 169.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.36 143.4 27.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 p -76.02 135.38 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 168.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.62 -29.43 6.47 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.668 1.587 . . . . 0.0 110.071 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.39 160.25 43.85 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.573 1.079 . . . . 0.0 110.626 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.5 mt -138.71 134.54 42.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 44.8 36.08 1.71 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.328 1.851 . . . . 0.0 111.972 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.89 -16.3 57.19 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.449 1.499 . . . . 0.0 113.671 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.4 mmt -88.44 121.49 30.88 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.846 1.323 . . . . 0.0 109.014 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.42 135.98 32.38 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.337 1.055 . . . . 0.0 109.84 169.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 m -93.2 128.93 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.667 0.746 . . . . 0.0 109.029 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -73.81 76.93 1.6 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.849 1.66 . . . . 0.0 107.424 169.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.61 -79.06 0.25 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.68 1.61 . . . . 0.0 111.968 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -128.91 11.07 6.03 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.399 1.479 . . . . 0.0 112.048 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.51 152.15 42.05 Favored 'General case' 0 C--N 1.334 -0.077 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.2 p -71.64 174.69 6.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.36 0.982 . . . . 0.0 110.118 173.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.39 75.13 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.506 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.47 -37.61 71.31 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.784 0.834 . . . . 0.0 111.576 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.67 5.86 8.18 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.553 1.073 . . . . 0.0 114.088 173.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -63.28 137.81 58.32 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.171 1.486 . . . . 0.0 107.729 172.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -68.41 131.61 45.6 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 169.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -56.57 -41.42 73.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.576 1.15 . . . . 0.0 110.912 -174.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.4 mt -65.42 -37.65 87.55 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 118.091 0.405 . . . . 0.0 110.723 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.63 -45.32 68.76 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -60.14 -45.26 93.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.468 0.707 . . . . 0.0 111.405 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.49 -30.25 33.35 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.811 0.444 . . . . 0.0 111.156 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.43 -34.93 63.4 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.696 0.68 . . . . 0.0 112.0 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -60.39 117.66 26.53 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.353 1.061 . . . . 0.0 110.219 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.72 -31.57 32.19 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.771 1.647 . . . . 0.0 111.955 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.42 -3.56 1.46 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -169.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.41 45.18 2.84 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.14 1.376 . . . . 0.0 111.503 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -40.86 -55.15 4.87 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.36 117.97 5.39 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 122.264 1.844 . . . . 0.0 109.713 -172.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.52 131.13 34.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.7 m -98.8 139.02 35.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 mm -132.17 142.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -172.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 mtp-105 -119.79 139.88 51.64 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -128.35 170.41 13.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.229 1.412 . . . . 0.0 108.438 -173.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.85 -178.73 40.54 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.004 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 tttm . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -83.73 143.07 30.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.922 2.089 . . . . 0.0 110.62 172.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -140.1 162.71 34.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.461 1.104 . . . . 0.0 109.194 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.4 m -153.42 167.7 28.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.075 1.75 . . . . 0.0 107.044 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.63 175.87 3.32 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 117.392 -1.289 . . . . 0.0 109.73 -169.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.85 148.6 7.81 Favored 'Cis proline' 0 C--N 1.356 0.957 0 CA-C-N 122.614 1.969 . . . . 0.0 115.87 6.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.94 138.9 57.22 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.352 1.061 . . . . 0.0 111.014 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -136.12 20.48 3.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.622 1.569 . . . . 0.0 109.809 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 pp -148.15 169.36 20.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.234 3.014 . . . . 0.0 105.624 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.1 mt -143.21 145.82 33.12 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.9 mp -127.14 154.79 44.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.975 1.71 . . . . 0.0 107.178 174.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 154.08 43.79 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.738 0.815 . . . . 0.0 110.16 174.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.5 tp -76.29 121.86 23.57 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -153.25 144.2 22.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.288 1.435 . . . . 0.0 108.485 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 43.16 50.77 5.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.223 1.409 . . . . 0.0 111.753 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 60.05 7.76 1.28 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.821 2.048 . . . . 0.0 115.943 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -125.87 160.62 29.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.945 1.248 . . . . 0.0 109.851 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.31 124.41 40.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.4 mt -114.84 148.63 38.27 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.96 109.9 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.43 -38.11 71.4 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.8 1.24 . . . . 0.0 110.37 175.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.6 t80 . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 124.174 0.99 . . . . 0.0 109.146 171.96 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.4 0.55 70.05 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.733 -1.037 . . . . 0.0 114.013 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -65.89 136.38 56.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.235 1.517 . . . . 0.0 108.736 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.84 140.48 29.63 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.623 1.169 . . . . 0.0 108.988 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.99 142.62 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.2 mt -120.05 -32.57 4.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.313 1.045 . . . . 0.0 109.803 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.37 159.7 42.5 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.676 1.125 . . . . 0.0 110.75 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.433 ' CD1' HG13 ' A' ' 72' ' ' VAL . 96.9 mt -136.12 135.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 49.93 29.13 3.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.078 1.751 . . . . 0.0 112.122 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.63 -9.49 67.93 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.943 1.258 . . . . 0.0 113.795 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.3 mmt -85.62 115.16 23.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.973 1.387 . . . . 0.0 108.302 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -51.58 132.73 30.58 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.483 1.113 . . . . 0.0 109.559 169.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.71 133.97 32.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -78.15 71.77 4.64 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.325 1.45 . . . . 0.0 107.34 169.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.45 -59.6 0.29 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 128.032 2.729 . . . . 0.0 114.342 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -137.36 -4.61 1.86 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.003 2.121 . . . . 0.0 111.658 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -117.56 154.1 32.08 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.7 p -69.88 177.22 3.21 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.188 0.904 . . . . 0.0 110.113 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.32 -38.69 74.44 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.612 169.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.36 -37.93 68.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.672 0.789 . . . . 0.0 111.558 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.47 4.88 7.39 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.548 1.071 . . . . 0.0 113.874 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -64.22 136.93 57.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.785 1.292 . . . . 0.0 107.736 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.05 125.99 26.66 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.433 HG13 ' CD1' ' A' ' 56' ' ' ILE . 38.6 t -57.33 -37.39 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.191 0.596 . . . . 0.0 111.707 -170.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.47 -42.42 98.6 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.674 0.67 . . . . 0.0 110.09 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.66 -37.5 70.8 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.059 -0.401 . . . . 0.0 110.212 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -60.12 -43.62 95.48 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.801 0.84 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.62 -36.06 60.35 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.441 0.696 . . . . 0.0 110.575 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.13 -33.01 86.1 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.688 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -59.65 116.07 15.22 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.93 1.292 . . . . 0.0 110.453 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.6 Cg_endo -70.25 -14.6 34.7 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.92 1.746 . . . . 0.0 114.086 -177.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.51 -14.12 55.68 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.536 1.062 . . . . 0.0 110.901 169.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -135.58 34.74 2.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.764 2.426 . . . . 0.0 108.638 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.474 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -63.28 -55.4 36.48 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.669 -1.157 . . . . 0.0 111.583 171.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.32 127.99 13.24 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 121.382 1.529 . . . . 0.0 109.219 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.3 m -149.16 169.32 2.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 123.992 0.917 . . . . 0.0 110.852 -172.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.4 m -126.04 137.17 53.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 169.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.1 mt -132.73 143.59 39.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -123.55 130.81 53.22 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -138.47 172.2 13.25 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.054 0.942 . . . . 0.0 108.788 -176.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -176.46 39.41 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm . . . . . 0 C--O 1.236 0.354 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -73.17 145.06 46.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.67 1.188 . . . . 0.0 109.162 169.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -140.81 162.3 35.76 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.054 1.342 . . . . 0.0 108.849 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.1 m -148.34 175.64 10.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.384 2.274 . . . . 0.0 106.788 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -137.49 153.56 74.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.581 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.06 152.71 87.55 Favored 'Cis proline' 0 CA--C 1.538 0.691 0 CA-C-N 119.642 0.908 . . . . 0.0 110.412 -10.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.5 tp -160.66 170.88 19.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.222 1.409 . . . . 0.0 108.143 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.11 -33.21 68.88 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.286 1.035 . . . . 0.0 112.168 174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 tp -62.56 128.34 35.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.65 0.78 . . . . 0.0 109.841 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.6 tp -142.48 150.33 40.37 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.772 1.629 . . . . 0.0 107.2 172.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -132.59 155.54 48.51 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.507 1.123 . . . . 0.0 109.833 -170.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 155.42 44.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.788 0.835 . . . . 0.0 110.333 172.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.41 131.12 40.41 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.895 1.278 . . . . 0.0 107.83 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -152.72 138.76 18.19 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 t70 44.42 49.17 8.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.518 1.527 . . . . 0.0 112.839 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 60.22 14.54 4.64 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.991 1.716 . . . . 0.0 114.702 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 155.77 28.68 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 120.975 -1.078 . . . . 0.0 108.78 171.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.5 t -102.49 130.74 51.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.73 150.61 40.1 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.133 1.373 . . . . 0.0 107.967 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.56 108.01 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.74 -29.79 23.6 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.588 1.155 . . . . 0.0 111.759 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.794 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.99 -15.8 46.26 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.694 1.14 . . . . 0.0 114.03 173.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -72.33 158.6 35.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.095 1.447 . . . . 0.0 109.932 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.73 144.1 33.86 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.705 1.202 . . . . 0.0 109.271 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -63.61 152.04 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 174.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.6 mt -132.62 -41.5 0.95 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.645 1.178 . . . . 0.0 110.63 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.56 158.84 44.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.375 0.989 . . . . 0.0 110.368 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 78.4 mt -138.54 139.94 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 176.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 46.67 31.02 1.27 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.872 2.069 . . . . 0.0 112.745 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.66 18.48 65.81 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.709 -1.051 . . . . 0.0 113.816 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -125.29 133.05 52.78 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.036 1.418 . . . . 0.0 109.198 170.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -50.71 141.86 12.18 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.391 1.076 . . . . 0.0 109.579 169.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.4 m -115.13 128.74 72.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 122.146 0.975 . . . . 0.0 109.164 174.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -76.35 74.9 3.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.969 2.107 . . . . 0.0 108.967 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.93 -66.74 1.13 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.382 1.944 . . . . 0.0 112.943 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.59 9.47 2.43 Favored 'General case' 0 CA--C 1.526 0.051 0 C-N-CA 125.146 1.378 . . . . 0.0 112.457 175.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -121.51 143.68 49.13 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.7 p -71.64 174.01 7.32 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.257 0.935 . . . . 0.0 110.152 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.14 -38.18 76.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.469 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.67 -39.58 73.49 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.972 0.909 . . . . 0.0 111.406 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.78 -0.21 7.84 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.648 1.118 . . . . 0.0 114.187 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -61.48 143.69 55.49 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.181 1.49 . . . . 0.0 108.499 173.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -69.34 134.73 49.44 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 t -55.25 -45.7 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.771 1.228 . . . . 0.0 111.014 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.41 -36.41 81.22 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.478 0.581 . . . . 0.0 110.669 -176.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -70.63 -43.2 69.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.412 0.551 . . . . 0.0 109.746 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -60.28 -45.05 94.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.506 1.123 . . . . 0.0 110.703 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.39 -33.18 60.97 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.685 0.794 . . . . 0.0 111.001 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.43 -30.66 73.33 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.843 0.735 . . . . 0.0 112.456 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -60.49 114.56 10.46 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.285 1.034 . . . . 0.0 109.674 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 80.5 Cg_endo -70.87 -14.61 32.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.627 1.552 . . . . 0.0 113.832 -175.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.41 -15.04 56.41 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.393 0.997 . . . . 0.0 110.857 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -133.68 33.35 3.5 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.883 2.473 . . . . 0.0 108.648 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -65.24 -52.6 45.95 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 117.085 -1.436 . . . . 0.0 111.121 169.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.93 125.4 10.95 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.794 1.677 . . . . 0.0 109.251 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.1 m -150.45 171.83 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.188 1.395 . . . . 0.0 110.127 -170.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 m -125.74 138.72 53.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 169.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 mt -138.63 143.65 31.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -118.45 132.77 56.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -145.0 166.25 25.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.214 1.406 . . . . 0.0 107.317 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.74 -156.97 28.31 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.767 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -123.71 142.49 51.02 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.394 1.478 . . . . 0.0 108.086 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -141.73 167.18 22.77 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.607 0.718 . . . . 0.0 110.607 -173.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.8 m -155.07 174.47 15.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.719 2.008 . . . . 0.0 107.08 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -136.56 163.78 47.33 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.64 6.63 21.13 Favored 'Cis proline' 0 CA--C 1.541 0.856 0 CA-C-N 121.74 1.657 . . . . 0.0 114.562 5.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.1 tp -44.9 130.61 7.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.254 1.022 . . . . 0.0 110.023 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.59 123.88 17.79 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.251 1.02 . . . . 0.0 112.813 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.6 tp -161.27 153.41 19.87 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.763 2.425 . . . . 0.0 104.835 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 44.2 tp -147.05 137.21 23.37 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.642 1.11 . . . . 0.0 109.674 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.5 mp -131.06 150.62 52.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.433 2.293 . . . . 0.0 106.172 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 154.4 41.85 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.251 0.932 . . . . 0.0 111.196 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -77.4 124.61 28.11 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -154.73 144.72 21.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.235 1.414 . . . . 0.0 109.044 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 46.79 45.07 14.77 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.484 1.135 . . . . 0.0 111.655 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 62.5 0.92 0.68 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.378 2.271 . . . . 0.0 116.609 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -119.79 159.58 24.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 121.12 1.782 . . . . 0.0 109.97 173.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.84 131.76 33.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 169.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.9 mt -118.22 153.32 34.07 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.072 1.349 . . . . 0.0 107.572 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.43 121.77 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.07 -39.51 23.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.601 0.76 . . . . 0.0 110.409 171.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 61.7 t80 . . . . . 0 C--O 1.234 0.255 0 C-N-CA 124.154 0.982 . . . . 0.0 109.913 178.362 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.66 -8.76 67.59 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.809 -0.995 . . . . 0.0 113.719 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -77.93 143.98 37.22 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.302 1.551 . . . . 0.0 108.351 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.04 143.75 28.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.968 1.307 . . . . 0.0 109.724 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.04 143.53 15.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.95 -32.39 2.31 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.398 1.079 . . . . 0.0 110.583 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.61 158.83 44.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.902 1.228 . . . . 0.0 110.266 169.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -139.98 134.94 37.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 105.834 -1.914 . . . . 0.0 105.834 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 49.56 28.2 2.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.658 1.583 . . . . 0.0 112.46 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.17 -11.74 68.55 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.944 1.259 . . . . 0.0 113.799 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 78.8 mtm -80.35 112.63 17.87 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.303 1.551 . . . . 0.0 108.056 173.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.47 124.26 19.8 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.5 m -96.95 138.2 22.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 122.014 0.911 . . . . 0.0 110.865 -169.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -76.29 70.39 2.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.725 2.01 . . . . 0.0 108.622 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.13 -59.71 0.8 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 127.794 2.616 . . . . 0.0 114.395 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -142.86 0.89 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.792 2.037 . . . . 0.0 111.073 -174.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -124.76 144.64 50.14 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.8 p -68.35 175.58 3.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.034 0.834 . . . . 0.0 110.386 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.31 -38.43 74.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.671 169.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.22 -38.09 72.03 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.553 0.741 . . . . 0.0 111.502 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.4 4.7 7.5 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.827 1.203 . . . . 0.0 113.68 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -63.34 134.16 55.31 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -64.79 126.69 28.75 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.3 t -55.32 -42.44 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.476 1.111 . . . . 0.0 111.745 -170.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.67 -40.7 88.7 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.593 0.633 . . . . 0.0 110.311 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -69.95 -41.04 75.06 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.842 0.457 . . . . 0.0 110.034 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -59.33 -44.98 92.55 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.41 1.084 . . . . 0.0 110.875 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.17 -35.28 63.99 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.457 0.703 . . . . 0.0 110.629 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.67 -30.74 74.98 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.865 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -59.57 116.76 17.83 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.668 1.187 . . . . 0.0 110.149 177.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.47 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 74.2 Cg_endo -69.62 -15.66 37.74 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.896 1.731 . . . . 0.0 114.136 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.91 -14.26 52.14 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.439 1.018 . . . . 0.0 111.088 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -135.39 33.68 3.03 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.674 2.39 . . . . 0.0 108.828 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -62.4 -55.29 41.09 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.768 172.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.44 128.34 13.52 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 121.661 1.629 . . . . 0.0 109.41 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 m -147.93 164.69 5.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 123.551 0.74 . . . . 0.0 111.323 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -122.14 137.54 54.79 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.7 mt -137.76 133.94 45.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -107.13 138.01 44.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -145.22 168.6 20.02 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.748 1.219 . . . . 0.0 108.193 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.45 -174.18 44.48 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.0 mmm-85 . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.902 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -82.2 143.22 31.54 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.899 1.28 . . . . 0.0 109.019 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -143.66 168.44 19.88 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.23 1.412 . . . . 0.0 109.81 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.7 m -142.66 175.25 9.95 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.07 2.548 . . . . 0.0 105.951 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -133.96 159.74 71.22 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 119.071 0.851 . . . . 0.0 110.193 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.66 155.08 27.54 Favored 'Cis proline' 0 C--N 1.351 0.678 0 CA-C-N 120.261 1.129 . . . . 0.0 112.826 -10.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.454 HD13 ' H ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -153.6 156.34 37.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.93 1.292 . . . . 0.0 107.562 -176.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' H ' HD13 ' A' ' 26' ' ' LEU . 27.6 t70 -67.26 -30.4 70.28 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.96 0.904 . . . . 0.0 112.361 177.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.0 tp -59.03 133.8 56.42 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.341 1.056 . . . . 0.0 109.223 173.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.2 tp -140.14 141.97 36.02 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.86 1.264 . . . . 0.0 107.822 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.6 mp -127.09 155.4 43.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.294 1.838 . . . . 0.0 107.882 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 152.45 45.29 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.531 0.732 . . . . 0.0 110.58 173.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.12 128.72 34.23 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -151.68 138.27 18.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.48 1.112 . . . . 0.0 108.369 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.8 t70 44.8 50.5 8.72 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.828 1.651 . . . . 0.0 112.558 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 56.5 16.43 2.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.986 2.114 . . . . 0.0 114.456 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -126.38 -169.7 2.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.131 2.172 . . . . 0.0 107.553 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.38 136.48 56.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.6 mt -127.45 156.23 42.45 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.894 1.278 . . . . 0.0 108.601 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.6 t -65.43 122.33 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.98 -38.35 19.38 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.4 1.08 . . . . 0.0 110.623 172.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.9 t80 . . . . . 0 C--O 1.231 0.123 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.291 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.85 -7.6 73.56 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.638 -1.09 . . . . 0.0 113.688 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -72.22 158.92 34.97 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.443 1.621 . . . . 0.0 108.028 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.86 141.03 47.15 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 123.203 0.601 . . . . 0.0 110.52 -169.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.11 134.28 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.92 -25.58 4.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.865 0.866 . . . . 0.0 109.921 -172.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.44 153.83 42.32 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.72 1.145 . . . . 0.0 109.446 168.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.6 mt -136.64 137.19 47.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 46.79 33.5 2.18 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.089 1.756 . . . . 0.0 112.418 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.06 11.27 79.09 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.733 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.6 mmt -120.18 121.77 39.48 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.849 1.325 . . . . 0.0 108.294 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.75 124.28 16.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.341 1.056 . . . . 0.0 109.283 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.4 m -73.24 140.82 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -79.87 61.6 3.84 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.176 1.39 . . . . 0.0 107.849 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.95 -112.1 3.58 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.103 1.335 . . . . 0.0 110.843 -172.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -72.32 -13.23 61.44 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.449 1.099 . . . . 0.0 111.959 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -112.03 155.43 23.82 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.394 0.678 . . . . 0.0 109.397 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.2 p -71.95 175.44 5.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.41 -0.806 . . . . 0.0 109.454 169.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.65 80.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.517 169.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.61 -36.34 68.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.427 0.691 . . . . 0.0 111.457 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.41 -1.22 7.03 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.554 -1.137 . . . . 0.0 114.96 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -67.43 147.77 52.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.925 1.863 . . . . 0.0 107.829 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -66.33 130.95 44.95 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 170.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 t -53.99 -41.75 51.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 125.192 1.397 . . . . 0.0 111.311 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.2 mt -66.98 -39.67 87.23 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.547 0.612 . . . . 0.0 110.546 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -71.5 -37.9 71.21 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.349 0.522 . . . . 0.0 110.226 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -60.97 -53.74 53.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.019 0.928 . . . . 0.0 109.929 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.26 -32.5 73.96 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.05 -0.406 . . . . 0.0 110.122 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.53 -9.67 78.43 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.236 -1.313 . . . . 0.0 114.187 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -83.33 112.51 39.61 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 119.979 1.89 . . . . 0.0 110.343 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.515 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 84.0 Cg_endo -72.23 -16.33 28.27 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.651 1.567 . . . . 0.0 114.669 -170.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.19 -11.9 24.23 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.06 0.845 . . . . 0.0 112.136 169.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.8 31.1 3.06 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.952 1.301 . . . . 0.0 111.829 173.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.515 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.1 m-30 -53.52 -40.51 80.83 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 116.136 -1.888 . . . . 0.0 115.519 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.68 122.08 9.01 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 CA-C-N 123.117 2.149 . . . . 0.0 109.206 172.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.23 169.66 7.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.998 1.319 . . . . 0.0 110.374 -172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -126.19 138.1 53.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.2 mm -128.87 140.77 48.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -174.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -130.08 127.04 39.05 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -144.55 163.29 34.32 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.121 0.968 . . . . 0.0 111.321 -169.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.69 -170.93 37.0 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 170.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 m -106.86 142.77 35.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.352 1.061 . . . . 0.0 108.346 -176.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -141.55 161.81 37.01 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.889 1.276 . . . . 0.0 109.695 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.4 m -155.96 170.9 21.07 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.522 1.929 . . . . 0.0 107.189 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -136.94 161.83 59.29 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.85 0.86 . . . . 0.0 109.521 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.92 141.76 61.27 Favored 'Cis proline' 0 CA--C 1.536 0.612 0 CA-C-N 119.966 1.023 . . . . 0.0 110.317 -10.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.1 tp -161.54 -58.02 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.606 1.162 . . . . 0.0 107.985 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.76 135.44 6.52 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.481 1.913 . . . . 0.0 106.636 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.6 tp -145.32 31.56 1.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.285 1.034 . . . . 0.0 109.163 171.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.56 68.93 2.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.461 1.104 . . . . 0.0 109.579 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.04 155.73 30.94 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.045 2.138 . . . . 0.0 106.996 172.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.25 154.01 49.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.541 0.609 . . . . 0.0 110.375 171.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tt -81.99 122.6 28.0 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -157.26 145.49 19.33 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.698 1.199 . . . . 0.0 107.964 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.1 t70 54.66 37.66 28.59 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.477 1.111 . . . . 0.0 111.716 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 52.93 25.28 3.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.244 1.817 . . . . 0.0 113.136 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -128.6 -177.3 4.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 127.547 2.339 . . . . 0.0 107.289 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.2 t -120.75 127.82 75.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 169.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.2 mt -123.19 157.45 32.98 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.7 1.2 . . . . 0.0 109.09 -171.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.26 120.18 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.391 1.077 . . . . 0.0 108.4 171.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.41 -29.27 20.36 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.903 0.881 . . . . 0.0 111.314 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.7 t80 . . . . . 0 C--O 1.232 0.154 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 171.18 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.6 m . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.34 0.114 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.49 -13.22 68.04 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.327 -1.263 . . . . 0.0 113.989 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -67.14 153.44 43.66 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.792 1.796 . . . . 0.0 107.764 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.61 146.5 44.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.281 1.432 . . . . 0.0 110.151 -170.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -68.21 138.15 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 169.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.8 mt -121.9 -29.09 4.35 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.47 1.108 . . . . 0.0 111.013 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.91 158.29 43.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 120.084 1.311 . . . . 0.0 110.558 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -140.38 135.12 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 50.46 27.9 3.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.774 1.63 . . . . 0.0 112.377 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.07 -11.0 63.86 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.845 1.212 . . . . 0.0 113.633 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.5 mtt -78.69 107.92 11.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.958 1.379 . . . . 0.0 108.518 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.34 121.77 12.26 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.6 m -76.44 137.0 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.718 0.77 . . . . 0.0 110.755 -169.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -79.31 67.04 4.94 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 169.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.41 -107.54 1.03 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.828 1.204 . . . . 0.0 111.302 -173.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -77.66 -10.55 59.58 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.61 1.164 . . . . 0.0 112.121 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -116.02 155.28 28.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.016 0.826 . . . . 0.0 109.54 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -71.14 177.65 3.69 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.26 -0.9 . . . . 0.0 109.703 169.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.68 82.19 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.346 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.6 -38.99 74.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.895 0.878 . . . . 0.0 111.412 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.08 -2.61 6.79 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.517 1.056 . . . . 0.0 114.161 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -60.51 135.36 57.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.05 1.425 . . . . 0.0 108.265 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -68.43 129.96 41.46 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 t -53.96 -43.57 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.185 1.394 . . . . 0.0 112.087 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.67 -39.76 88.31 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.859 0.754 . . . . 0.0 110.502 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -69.51 -41.16 76.42 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -59.7 -45.2 92.83 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.248 1.019 . . . . 0.0 110.801 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.53 -34.49 60.77 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.21 0.604 . . . . 0.0 110.895 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.39 -32.12 78.59 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.513 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -60.22 115.55 13.76 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.754 1.222 . . . . 0.0 110.179 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.5 Cg_endo -70.49 -15.03 34.32 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.844 1.696 . . . . 0.0 113.988 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.97 -14.72 56.08 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.412 1.006 . . . . 0.0 110.986 169.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -135.26 34.96 3.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.744 2.418 . . . . 0.0 108.607 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.462 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -64.72 -54.59 34.89 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 117.543 -1.217 . . . . 0.0 111.371 169.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.82 125.04 10.68 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.521 1.579 . . . . 0.0 109.133 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.3 m -149.97 170.9 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.165 0.986 . . . . 0.0 110.402 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.6 m -125.61 139.9 53.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.3 mt -137.27 145.1 30.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -120.19 140.33 51.3 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 171.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -124.55 172.81 8.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.459 1.504 . . . . 0.0 109.16 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.41 -154.82 13.7 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.324 -0.509 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 p -78.88 142.88 36.44 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.594 1.158 . . . . 0.0 109.803 172.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.65 162.73 34.39 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.567 1.547 . . . . 0.0 109.29 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -159.0 175.18 13.86 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.59 2.756 . . . . 0.0 106.837 178.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -132.56 156.97 79.48 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.758 0.823 . . . . 0.0 109.569 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.5 156.38 81.87 Favored 'Cis proline' 0 CA--C 1.536 0.584 0 CA-C-N 119.729 0.939 . . . . 0.0 111.824 -5.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.33 167.68 29.57 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.37 1.468 . . . . 0.0 107.59 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.64 61.61 3.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.932 1.293 . . . . 0.0 110.056 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.5 mt -139.15 154.37 48.08 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.081 1.752 . . . . 0.0 108.683 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.3 tp -148.45 127.66 12.94 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -123.34 149.83 44.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.96 164.45 33.72 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.8 1.24 . . . . 0.0 110.114 -176.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.6 tp -86.73 133.98 33.62 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 171.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -150.18 129.43 12.82 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.84 1.256 . . . . 0.0 108.066 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 45.25 50.01 9.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.317 1.447 . . . . 0.0 112.367 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 62.35 18.45 10.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.704 1.602 . . . . 0.0 114.318 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 -127.72 143.51 51.14 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.75 -1.218 . . . . 0.0 109.179 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.28 127.74 39.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 169.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.43 145.37 48.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.641 1.576 . . . . 0.0 108.599 -176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.08 107.62 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.81 1.644 . . . . 0.0 106.861 171.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.89 -29.68 44.52 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.788 0.835 . . . . 0.0 111.826 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.0 t80 . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.735 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.788 0.804 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.49 3.94 64.43 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.721 -1.044 . . . . 0.0 112.626 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -55.81 128.46 35.05 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.936 1.368 . . . . 0.0 108.096 169.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.02 141.13 30.52 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.36 140.59 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.6 mt -122.52 -32.31 3.62 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.616 -174.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.29 160.12 42.66 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.773 1.169 . . . . 0.0 110.672 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.0 mt -140.4 139.21 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 173.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.0 p30 47.27 21.58 0.2 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.102 2.161 . . . . 0.0 114.556 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.86 -27.84 18.46 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.484 1.516 . . . . 0.0 113.013 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 73.7 mtm -74.79 117.93 17.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.709 1.254 . . . . 0.0 109.675 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.72 135.54 55.22 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 169.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.4 m -97.87 126.9 50.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.596 0.712 . . . . 0.0 109.578 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -72.88 74.93 1.16 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.909 1.684 . . . . 0.0 107.874 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.34 -70.85 0.35 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 126.823 2.154 . . . . 0.0 113.12 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -134.21 12.84 3.89 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.936 1.295 . . . . 0.0 112.209 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -125.9 146.14 49.96 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.0 p -69.76 171.75 8.67 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.99 0.814 . . . . 0.0 109.924 172.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.03 75.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.56 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.06 -40.08 78.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 111.512 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.31 0.26 6.88 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.459 1.028 . . . . 0.0 114.378 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -59.69 136.24 57.93 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.375 1.587 . . . . 0.0 108.305 174.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.86 128.89 38.16 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.32 -41.74 88.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.283 1.033 . . . . 0.0 111.162 -171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.9 mt -66.66 -42.46 86.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.317 0.962 . . . . 0.0 110.295 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.52 -42.43 92.05 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -60.91 -53.14 60.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.845 0.858 . . . . 0.0 110.248 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.3 mt -66.27 -26.95 67.58 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.766 -0.584 . . . . 0.0 110.477 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.77 -15.31 77.99 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.421 -1.211 . . . . 0.0 113.778 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -84.39 112.99 45.9 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.787 1.793 . . . . 0.0 110.464 -177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.513 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 64.7 Cg_endo -68.24 -22.42 40.32 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.939 1.759 . . . . 0.0 114.117 -171.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.57 -10.99 21.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.761 0.71 . . . . 0.0 112.825 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.71 28.21 3.6 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.39 1.076 . . . . 0.0 111.956 173.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.513 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 6.4 m-30 -53.14 -47.57 95.35 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 116.643 -1.646 . . . . 0.0 112.633 169.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.22 104.82 1.6 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 122.102 1.787 . . . . 0.0 110.581 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.81 157.65 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.597 0.759 . . . . 0.0 109.961 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.6 m -84.27 146.25 27.86 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.0 mt -136.46 144.89 31.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -117.81 132.46 56.44 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 169.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -141.53 165.05 28.57 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.01 -174.16 37.99 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -173.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.789 171.946 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptp . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -79.44 142.46 35.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.936 1.695 . . . . 0.0 110.414 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.07 160.53 40.73 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.341 1.056 . . . . 0.0 110.296 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.3 m -150.87 175.13 12.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.271 2.228 . . . . 0.0 107.388 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -127.19 158.99 67.44 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 0.0 108.269 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.64 145.14 45.47 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 120.058 1.056 . . . . 0.0 111.404 -10.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.7 tp -160.38 158.44 29.57 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.551 1.541 . . . . 0.0 107.297 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.21 -22.56 61.99 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.64 127.3 31.33 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.7 mt -138.79 157.0 46.88 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 173.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.27 153.22 42.02 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.901 1.28 . . . . 0.0 108.211 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.01 164.99 28.58 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.777 1.231 . . . . 0.0 109.072 173.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.1 tp -108.03 127.05 53.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -150.78 140.83 22.07 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.432 1.093 . . . . 0.0 108.241 175.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 46.73 43.89 13.37 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.184 1.393 . . . . 0.0 112.606 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 58.87 24.78 12.85 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.911 1.684 . . . . 0.0 113.75 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -130.03 139.15 51.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 O-C-N 120.834 -1.166 . . . . 0.0 108.33 174.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.34 127.46 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 mt -126.44 155.75 41.73 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.617 1.567 . . . . 0.0 109.036 -172.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.16 117.94 3.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 124.693 1.197 . . . . 0.0 107.905 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.13 -41.86 14.37 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.592 1.157 . . . . 0.0 110.881 175.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 C--O 1.233 0.222 0 C-N-CA 126.401 1.881 . . . . 0.0 107.546 -178.133 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 CA--C 1.538 0.497 0 CA-C-O 120.822 0.344 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.61 -7.98 74.16 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 119.037 -0.869 . . . . 0.0 114.177 171.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -70.89 151.17 45.01 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.942 1.371 . . . . 0.0 108.074 169.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.67 147.76 25.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.286 1.035 . . . . 0.0 109.786 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.39 137.86 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 169.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.63 -37.55 3.94 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.824 1.249 . . . . 0.0 109.486 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.47 160.49 43.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.238 0.926 . . . . 0.0 110.391 169.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 93.1 mt -135.59 133.28 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.597 HD21 HG12 ' A' ' 84' ' ' VAL . 80.8 m-20 48.23 31.21 2.5 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.008 1.723 . . . . 0.0 112.561 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.74 -12.75 66.25 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.974 1.273 . . . . 0.0 113.635 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.9 mtt -80.09 108.41 13.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.01 1.405 . . . . 0.0 108.755 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.65 124.33 17.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -82.05 133.54 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.685 0.755 . . . . 0.0 109.407 -173.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -78.6 70.69 4.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.71 -58.46 0.33 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 128.187 2.803 . . . . 0.0 114.828 174.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -134.84 -5.28 2.45 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.894 2.078 . . . . 0.0 111.529 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -120.2 155.57 32.88 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.9 p -71.08 177.08 3.94 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.405 1.002 . . . . 0.0 110.085 170.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.73 77.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.601 169.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.33 -36.85 71.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.649 0.78 . . . . 0.0 111.532 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.87 4.8 8.51 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.625 1.107 . . . . 0.0 113.727 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -63.17 134.47 56.03 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.67 128.7 37.25 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.8 t -58.51 -39.79 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.701 0.801 . . . . 0.0 111.263 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.6 mt -65.45 -42.74 92.02 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.738 0.699 . . . . 0.0 110.328 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.51 -41.71 83.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.017 0.527 . . . . 0.0 109.687 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -59.82 -52.43 65.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.137 0.975 . . . . 0.0 110.395 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.5 mt -67.0 -34.15 77.12 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.641 0.376 . . . . 0.0 109.998 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.92 -17.89 73.9 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.517 -1.157 . . . . 0.0 113.783 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -75.31 114.12 32.5 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 119.545 1.672 . . . . 0.0 110.596 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.481 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 61.4 Cg_endo -67.54 -21.09 46.68 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.34 2.027 . . . . 0.0 114.014 -171.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.86 -11.35 55.39 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 176.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.95 28.52 2.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.507 1.049 . . . . 0.0 112.756 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.481 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 6.4 m-30 -48.75 -48.68 69.54 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 116.438 -1.744 . . . . 0.0 115.015 175.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.49 120.61 7.41 Favored 'Trans proline' 0 C--N 1.35 0.635 0 CA-C-N 122.497 1.928 . . . . 0.0 109.948 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.597 HG12 HD21 ' A' ' 57' ' ' ASN . 28.9 m -146.38 171.6 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.519 1.528 . . . . 0.0 109.926 -175.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -120.38 137.06 54.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.24 -2.134 . . . . 0.0 105.24 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.1 mt -132.35 138.5 52.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -107.93 136.04 48.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 170.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -123.13 160.47 26.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.248 1.819 . . . . 0.0 108.746 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.08 178.16 39.56 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? . . . . . 0 CA--C 1.54 0.558 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.826 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 m -131.57 141.16 49.63 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.235 1.414 . . . . 0.0 107.327 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -145.67 167.47 23.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.465 1.506 . . . . 0.0 109.941 -170.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.4 m -144.16 175.1 10.32 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.594 2.357 . . . . 0.0 106.304 169.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -134.78 162.21 59.1 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.517 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.01 149.42 28.87 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.373 1.169 . . . . 0.0 112.429 -10.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -157.9 150.58 22.68 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.403 1.481 . . . . 0.0 107.243 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.79 59.63 3.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.195 0.998 . . . . 0.0 110.414 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.9 tp -140.11 135.74 32.85 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.833 2.453 . . . . 0.0 105.524 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -145.92 145.21 30.6 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.5 mt -130.58 154.05 48.25 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.79 1.636 . . . . 0.0 107.432 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 156.26 45.6 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.558 0.617 . . . . 0.0 110.793 -178.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.5 tp -90.65 128.26 36.56 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.902 1.281 . . . . 0.0 108.137 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -156.91 145.23 19.6 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.587 1.155 . . . . 0.0 108.137 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.8 t70 51.81 37.79 21.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.175 0.99 . . . . 0.0 111.404 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 55.23 17.57 2.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.301 2.241 . . . . 0.0 114.414 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.08 161.92 20.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.84 1.256 . . . . 0.0 108.216 174.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.4 t -97.5 134.54 35.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.46 150.48 41.49 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.198 1.399 . . . . 0.0 107.623 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.52 117.37 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.15 -29.41 31.59 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.06 0.544 . . . . 0.0 111.497 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 C--O 1.232 0.184 0 C-N-CA 125.014 1.325 . . . . 0.0 107.494 174.923 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 121.32 0.581 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.34 -15.64 38.84 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.031 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -76.95 148.24 36.46 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.948 1.374 . . . . 0.0 108.649 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.54 141.84 29.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.39 1.076 . . . . 0.0 109.319 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.8 t -72.62 141.49 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.0 mt -128.97 -30.65 2.21 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.427 1.091 . . . . 0.0 111.139 -172.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.61 158.97 41.95 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.122 1.328 . . . . 0.0 110.089 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.0 mt -140.72 135.26 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 106.176 -1.786 . . . . 0.0 106.176 173.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 50.27 28.7 3.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.542 1.537 . . . . 0.0 112.093 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.33 -9.53 63.95 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.805 1.193 . . . . 0.0 113.68 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.4 mtt -77.72 108.61 11.06 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.088 1.444 . . . . 0.0 108.495 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.74 114.4 1.54 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.286 1.434 . . . . 0.0 109.68 169.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.53 142.52 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 124.198 0.999 . . . . 0.0 108.447 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -125.31 113.57 17.77 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.158 2.183 . . . . 0.0 105.355 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.61 -113.83 5.98 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -116.84 23.5 11.9 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.354 1.061 . . . . 0.0 110.672 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -126.65 140.08 52.68 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.1 p -67.39 176.85 2.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.541 1.064 . . . . 0.0 110.013 174.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.95 -39.27 74.25 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.85 169.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.32 -39.56 74.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.546 0.738 . . . . 0.0 111.098 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.53 -2.59 6.12 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.655 1.122 . . . . 0.0 113.736 171.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -61.11 133.43 56.0 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.007 1.404 . . . . 0.0 109.182 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -59.78 120.38 9.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.6 t -54.47 -44.53 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.95 1.3 . . . . 0.0 111.696 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.71 -38.17 83.27 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.375 0.534 . . . . 0.0 110.392 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.37 -38.01 63.29 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.301 0.5 . . . . 0.0 110.272 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -58.69 -44.62 90.34 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.473 1.109 . . . . 0.0 110.296 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.25 -34.99 61.46 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.66 0.784 . . . . 0.0 110.983 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.7 -33.5 87.41 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.368 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -60.29 114.93 11.25 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.659 1.184 . . . . 0.0 110.071 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 73.6 Cg_endo -70.73 -15.01 33.46 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.792 1.661 . . . . 0.0 113.912 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.53 -14.82 54.92 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.36 0.982 . . . . 0.0 110.899 169.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -134.28 33.91 3.31 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.826 2.45 . . . . 0.0 108.721 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.458 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -64.54 -53.24 46.54 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.186 -1.387 . . . . 0.0 111.289 169.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.97 123.76 9.56 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 121.717 1.649 . . . . 0.0 109.262 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -150.95 164.47 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 124.214 1.006 . . . . 0.0 110.873 -172.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -118.51 140.63 49.57 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.2 mt -136.55 139.49 45.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -171.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.7 ttt85 -115.55 135.95 53.57 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 172.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -146.85 164.09 33.98 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.943 1.297 . . . . 0.0 108.467 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.26 -169.0 40.56 Favored Glycine 0 C--N 1.33 0.21 0 O-C-N 121.518 -0.738 . . . . 0.0 112.135 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 . . . . . 0 C--O 1.239 0.511 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.232 172.015 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 121.022 0.439 . . . . 0.0 110.334 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 p -78.3 143.05 37.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.024 1.73 . . . . 0.0 108.574 169.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -144.48 167.79 21.66 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.171 0.988 . . . . 0.0 110.048 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.4 m -137.71 166.66 23.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.369 1.868 . . . . 0.0 107.219 171.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.01 153.83 39.77 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.739 -175.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.8 133.69 15.75 Favored 'Cis proline' 0 C--N 1.35 0.638 0 CA-C-N 120.7 1.286 . . . . 0.0 110.155 -7.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.8 tp -66.59 123.86 21.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.682 0.793 . . . . 0.0 111.147 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -62.67 -42.63 99.73 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 111.485 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 tp -75.56 57.54 0.97 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.704 1.601 . . . . 0.0 109.113 170.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 46.1 tp -53.64 141.37 26.24 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.338 -0.851 . . . . 0.0 109.342 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.1 mt -125.27 155.99 39.29 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.249 1.019 . . . . 0.0 109.635 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.67 153.66 50.84 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 tt -92.65 123.98 36.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -150.95 136.46 17.88 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.718 1.207 . . . . 0.0 108.386 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.29 39.97 17.16 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.271 1.428 . . . . 0.0 111.819 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 59.44 0.43 0.21 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.411 2.285 . . . . 0.0 115.272 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -95.99 -177.72 4.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 120.67 1.577 . . . . 0.0 107.777 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.2 m -123.35 139.95 48.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 169.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.5 mt -133.13 151.45 51.99 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.113 0.965 . . . . 0.0 108.828 -175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.55 105.66 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.514 1.526 . . . . 0.0 107.651 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.26 60.06 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.678 1.591 . . . . 0.0 111.706 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 t80 . . . . . 0 C--O 1.232 0.137 0 C-N-CA 123.851 0.861 . . . . 0.0 109.327 179.845 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.6 t . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.32 0.75 86.56 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.26 -0.745 . . . . 0.0 114.271 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -72.1 162.82 28.91 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.599 1.2 . . . . 0.0 108.866 169.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.19 156.1 17.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.032 0.933 . . . . 0.0 109.131 170.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.42 144.61 11.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 169.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -114.35 -30.67 6.51 Favored 'General case' 0 CA--C 1.524 -0.034 0 CA-C-O 117.405 -1.283 . . . . 0.0 110.544 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.41 160.04 42.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.879 1.672 . . . . 0.0 111.793 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.9 mt -138.62 136.73 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 50.46 29.15 3.75 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.598 1.559 . . . . 0.0 112.272 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.21 -9.0 56.5 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.698 1.142 . . . . 0.0 113.65 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.4 mtt -80.37 111.97 17.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.091 1.445 . . . . 0.0 108.3 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -53.43 130.63 36.1 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 169.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -89.35 124.14 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.782 0.801 . . . . 0.0 109.496 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -76.48 80.24 3.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.018 1.327 . . . . 0.0 107.534 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.15 -58.73 1.08 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.91 2.195 . . . . 0.0 114.614 172.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -143.55 2.38 1.24 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.283 1.833 . . . . 0.0 111.874 176.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.79 151.75 38.33 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 119.424 1.011 . . . . 0.0 108.327 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 p -68.07 173.81 4.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.608 1.095 . . . . 0.0 109.528 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.82 -38.15 72.19 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.764 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.83 -37.84 76.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.582 0.753 . . . . 0.0 111.573 175.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.53 3.17 6.13 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.498 1.047 . . . . 0.0 114.112 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.23 129.68 40.65 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.044 1.422 . . . . 0.0 107.805 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.1 129.83 41.15 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 174.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 t -52.67 -44.19 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.396 1.478 . . . . 0.0 112.826 -169.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.2 mt -67.1 -42.48 84.5 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.978 0.808 . . . . 0.0 110.435 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -69.03 -40.84 78.37 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -59.88 -43.79 94.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.254 1.022 . . . . 0.0 111.158 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.87 -36.88 62.3 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.276 0.631 . . . . 0.0 110.476 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.04 -31.15 78.54 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.772 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -54.83 118.72 18.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.017 1.327 . . . . 0.0 110.157 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 60.0 Cg_endo -66.79 -17.67 52.31 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.365 2.043 . . . . 0.0 113.741 -176.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.45 -13.83 62.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.13 0.877 . . . . 0.0 112.356 170.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -135.18 37.01 3.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.922 1.689 . . . . 0.0 109.617 -171.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.0 m-30 -63.48 -57.36 20.27 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.359 -1.305 . . . . 0.0 111.348 169.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.23 126.96 11.51 Favored 'Trans proline' 0 C--N 1.352 0.719 0 CA-C-N 121.459 1.557 . . . . 0.0 109.101 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 m -150.31 171.42 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.378 1.071 . . . . 0.0 110.365 -172.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.2 m -125.83 139.55 53.4 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 168.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.5 mt -136.27 140.2 44.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -118.56 132.33 56.21 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 172.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -141.66 163.4 33.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.561 1.545 . . . . 0.0 109.312 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.31 -165.37 38.56 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -170.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' H ' ' HD2' ' A' ' 90' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.375 0.131 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.22 -61.43 4.39 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.779 1.181 . . . . 0.0 112.068 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 47.05 38.78 6.87 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.163 1.785 . . . . 0.0 112.302 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -64.07 155.49 31.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.168 0.987 . . . . 0.0 110.595 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -152.71 159.52 43.15 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.023 1.329 . . . . 0.0 108.336 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -152.94 155.38 36.88 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.69 1.596 . . . . 0.0 107.693 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -153.44 163.8 39.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.704 1.202 . . . . 0.0 109.582 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -66.21 172.68 3.67 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.579 1.151 . . . . 0.0 110.327 172.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 tp -46.52 122.44 4.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.024 1.33 . . . . 0.0 110.162 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -55.32 -32.79 62.76 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.52 1.528 . . . . 0.0 113.11 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -64.37 -22.64 67.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.52 1.128 . . . . 0.0 113.353 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.14 164.12 12.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -169.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -162.55 159.24 20.15 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.953 2.501 . . . . 0.0 106.862 169.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -49.21 150.69 7.16 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.761 2.974 . . . . 0.0 113.356 172.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -55.03 158.51 2.81 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.733 1.213 . . . . 0.0 113.085 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.22 158.08 27.15 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.748 0.819 . . . . 0.0 110.845 171.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -86.43 167.77 14.4 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 171.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.36 160.43 16.07 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.478 0.711 . . . . 0.0 111.187 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -61.28 142.34 56.91 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.259 0.624 . . . . 0.0 109.463 172.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -142.41 142.22 32.36 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.267 1.027 . . . . 0.0 108.4 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.5 p -72.09 145.41 48.2 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.838 1.255 . . . . 0.0 110.823 173.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -139.95 159.08 42.99 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.965 1.306 . . . . 0.0 108.723 172.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.0 m -158.87 174.89 14.3 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.307 2.243 . . . . 0.0 106.701 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -141.5 159.6 59.94 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.733 0.813 . . . . 0.0 109.233 -173.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -64.4 154.27 74.63 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 120.036 1.049 . . . . 0.0 110.976 -10.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 tp -157.36 155.94 31.44 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.242 1.417 . . . . 0.0 107.67 -173.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -76.01 58.93 1.24 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.71 1.204 . . . . 0.0 110.224 171.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -153.23 133.62 13.57 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.73 2.012 . . . . 0.0 106.048 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.7 tp -139.25 145.44 39.21 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.0 mt -125.21 155.57 39.85 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.996 1.318 . . . . 0.0 108.605 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.99 164.64 29.52 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.209 1.404 . . . . 0.0 109.757 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.2 tp -98.19 127.45 44.14 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.33 138.24 27.72 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.292 1.437 . . . . 0.0 107.514 169.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 44.8 48.45 9.02 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.598 1.559 . . . . 0.0 113.18 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 56.91 30.45 18.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.278 1.431 . . . . 0.0 113.252 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -134.8 148.85 50.29 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.742 1.217 . . . . 0.0 108.379 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -92.32 125.68 44.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 170.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 mp -123.61 152.97 41.34 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 125.961 1.704 . . . . 0.0 108.926 -173.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.72 121.04 14.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.34 -38.05 14.44 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.904 1.282 . . . . 0.0 111.306 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -160.78 157.04 26.15 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.815 1.246 . . . . 0.0 108.355 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.57 -3.34 2.91 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.781 1.182 . . . . 0.0 112.55 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -57.93 141.82 48.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.242 1.817 . . . . 0.0 111.998 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.1 tpt85 -72.49 -30.01 64.13 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.5 169.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.3 -38.82 0.11 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.877 0.871 . . . . 0.0 111.793 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.42 -31.51 0.06 OUTLIER Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.421 -0.655 . . . . 0.0 114.047 177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 pt -70.29 31.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 126.159 1.783 . . . . 0.0 115.185 -172.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 -42.24 0.6 Allowed 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.236 -1.54 . . . . 0.0 111.979 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 m -58.35 143.57 12.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 119.675 1.125 . . . . 0.0 109.809 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.86 -11.09 60.7 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.537 -1.146 . . . . 0.0 113.647 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -66.96 155.62 38.07 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.595 1.698 . . . . 0.0 108.291 169.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.67 140.64 52.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.922 1.289 . . . . 0.0 110.156 -169.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.14 146.2 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.9 mt -130.12 -35.17 1.61 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.695 1.198 . . . . 0.0 110.595 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.07 159.98 43.55 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.461 1.028 . . . . 0.0 110.117 169.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 77.3 mt -134.96 131.82 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 106.306 -1.738 . . . . 0.0 106.306 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.5 p30 42.92 24.2 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.579 2.352 . . . . 0.0 115.139 -173.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.25 -14.27 58.3 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.112 1.339 . . . . 0.0 112.902 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.6 mtt -74.73 105.86 6.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.813 1.307 . . . . 0.0 108.603 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.35 122.38 12.43 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.6 m -77.68 132.17 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.491 0.662 . . . . 0.0 109.385 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -74.79 73.46 2.08 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.768 1.627 . . . . 0.0 107.146 169.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.02 -72.29 0.4 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.627 2.06 . . . . 0.0 112.808 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -133.74 11.02 4.01 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.878 1.671 . . . . 0.0 111.947 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -120.79 154.88 35.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.4 p -69.62 175.39 4.19 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.483 1.038 . . . . 0.0 109.911 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.85 -37.89 77.49 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.407 169.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.43 -37.25 74.37 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.717 0.807 . . . . 0.0 111.661 176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.98 6.24 7.77 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.528 1.061 . . . . 0.0 114.099 172.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.71 136.04 54.93 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.066 1.433 . . . . 0.0 107.385 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -66.43 128.07 34.76 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.0 t -56.45 -39.95 64.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 124.669 1.188 . . . . 0.0 111.633 -170.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.5 -40.47 93.1 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.702 0.683 . . . . 0.0 110.585 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.55 -39.17 67.67 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.414 0.552 . . . . 0.0 110.029 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -59.58 -46.54 88.63 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.6 1.16 . . . . 0.0 110.518 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.56 -33.9 60.67 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.66 0.784 . . . . 0.0 110.749 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.62 -30.84 75.18 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.381 -0.677 . . . . 0.0 112.742 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -62.28 115.32 15.46 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.511 1.125 . . . . 0.0 109.861 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.453 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.6 Cg_endo -70.47 -16.1 34.52 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.67 1.58 . . . . 0.0 114.003 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.35 -14.86 54.55 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.335 0.97 . . . . 0.0 111.147 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -134.64 28.93 3.58 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.376 2.27 . . . . 0.0 109.251 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.2 m-30 -60.77 -54.41 54.78 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 117.158 -1.401 . . . . 0.0 111.815 170.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.59 122.17 8.02 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.629 1.617 . . . . 0.0 109.673 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.5 m -149.74 172.02 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.734 1.214 . . . . 0.0 109.778 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -125.75 139.93 53.11 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 169.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.2 mt -133.41 147.72 31.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -170.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -119.47 130.6 55.32 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -152.71 164.77 37.1 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -170.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.28 -165.22 33.89 Favored Glycine 0 N--CA 1.453 -0.207 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -170.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.08 142.23 98.56 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.36 167.26 17.06 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.417 2.078 . . . . 0.0 110.082 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 51.93 40.19 27.59 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.554 1.142 . . . . 0.0 111.686 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.3 tp -54.2 -37.47 64.58 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.543 -0.723 . . . . 0.0 110.038 170.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 26.6 m -153.49 155.69 36.72 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.9 m -63.92 -19.08 64.84 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 . . . . . 0 C--O 1.249 1.063 0 C-N-CA 125.433 1.493 . . . . 0.0 107.913 177.445 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 145.93 -179.02 23.27 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-N 119.783 1.174 . . . . 0.0 110.924 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -62.08 -11.2 12.77 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.671 1.188 . . . . 0.0 113.169 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -59.0 -25.15 63.38 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.727 1.211 . . . . 0.0 111.993 169.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.8 m80 54.17 17.56 1.5 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.238 1.815 . . . . 0.0 114.138 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -148.06 161.25 41.78 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.364 1.465 . . . . 0.0 108.306 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -144.11 167.91 21.28 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.435 1.494 . . . . 0.0 107.583 170.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -60.44 130.42 46.49 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 173.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.3 mt -84.4 62.47 7.24 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -76.57 64.84 2.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.382 1.473 . . . . 0.0 109.969 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 p -155.23 158.78 39.39 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.12 1.368 . . . . 0.0 110.01 -171.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -84.95 -13.63 50.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.715 0.806 . . . . 0.0 111.874 172.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 144.79 90.87 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.925 0.89 . . . . 0.0 111.239 -173.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -59.59 -0.67 0.81 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.644 3.563 . . . . 0.0 116.862 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -56.81 -9.53 0.82 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 -169.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.73 -14.59 53.76 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.514 1.052 . . . . 0.0 111.398 169.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -134.18 163.57 29.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.365 1.866 . . . . 0.0 108.668 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.7 167.08 30.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.47 1.908 . . . . 0.0 108.146 172.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.45 155.58 33.77 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.393 0.677 . . . . 0.0 110.233 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -162.83 164.08 26.26 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.739 0.816 . . . . 0.0 109.663 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -80.04 144.43 33.2 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.201 1.4 . . . . 0.0 107.351 168.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -142.21 171.2 14.38 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.377 1.071 . . . . 0.0 110.234 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.9 m -156.22 175.68 13.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.0 2.52 . . . . 0.0 106.455 175.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -123.87 153.9 67.32 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.552 0.741 . . . . 0.0 109.909 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.17 -39.19 1.34 Allowed 'Cis proline' 0 CA--C 1.537 0.627 0 CA-C-N 119.64 0.907 . . . . 0.0 112.038 -5.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.9 tp 48.04 -75.54 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.087 2.955 . . . . 0.0 114.548 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -166.65 -28.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 127.531 2.333 . . . . 0.0 109.313 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.0 tp -55.69 131.76 47.37 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.806 1.642 . . . . 0.0 112.315 -174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -151.11 128.72 11.48 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 169.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.98 154.96 33.75 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.54 161.74 40.48 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.958 0.903 . . . . 0.0 109.961 -177.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.9 tp -96.25 125.4 40.74 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -153.2 144.15 22.9 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.434 1.093 . . . . 0.0 108.752 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.4 t70 47.87 39.34 10.58 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.583 1.153 . . . . 0.0 111.804 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 64.96 6.09 3.24 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.036 2.135 . . . . 0.0 115.877 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -118.67 149.71 40.96 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.965 1.257 . . . . 0.0 109.403 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.417 HG11 HG21 ' A' ' 72' ' ' VAL . 11.8 p -76.26 135.09 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 76.1 mt -126.49 149.55 49.27 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.868 1.267 . . . . 0.0 108.187 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.4 t -68.88 139.78 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -120.63 -41.6 2.58 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.936 0.895 . . . . 0.0 110.647 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -139.4 165.53 26.97 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.983 1.713 . . . . 0.0 106.766 170.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.79 -20.73 5.1 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.696 1.141 . . . . 0.0 111.338 -175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -139.84 36.6 1.98 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.594 1.558 . . . . 0.0 109.602 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -58.18 -11.34 2.54 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 174.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -53.4 -23.02 8.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.792 1.637 . . . . 0.0 111.775 169.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.19 -171.58 19.35 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.506 1.05 . . . . 0.0 110.952 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.6 pt -81.4 0.97 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 123.672 0.789 . . . . 0.0 112.385 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -70.71 6.53 1.43 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -169.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 m -69.51 168.31 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 120.1 1.318 . . . . 0.0 108.646 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.71 0.43 86.06 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.28 -0.887 . . . . 0.0 113.258 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -75.57 154.89 36.47 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.152 0.976 . . . . 0.0 109.544 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.84 147.06 27.0 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.7 t -74.28 144.56 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 172.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -111.1 -33.39 6.49 Favored 'General case' 0 CA--C 1.527 0.08 0 C-N-CA 124.986 1.314 . . . . 0.0 109.847 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.47 160.22 41.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 120.198 1.363 . . . . 0.0 111.738 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.1 mt -136.05 135.74 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 172.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 49.34 30.34 3.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.035 1.734 . . . . 0.0 112.076 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.87 -9.14 57.7 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.823 1.201 . . . . 0.0 113.686 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.2 mmt -84.27 119.12 24.68 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.102 1.451 . . . . 0.0 107.922 173.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -49.02 142.8 6.25 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.516 1.127 . . . . 0.0 109.834 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.3 m -111.3 149.1 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-O 121.822 0.82 . . . . 0.0 110.026 172.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -125.21 101.64 7.09 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.116 2.167 . . . . 0.0 105.907 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.02 -80.29 0.19 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.19 1.376 . . . . 0.0 110.622 -176.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.42 25.49 0.87 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.996 1.318 . . . . 0.0 111.116 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -127.79 143.54 51.12 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.6 p -70.13 172.5 7.92 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.009 0.822 . . . . 0.0 110.387 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -54.87 -38.66 67.8 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.997 0.919 . . . . 0.0 110.861 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -71.51 -38.07 71.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.494 0.717 . . . . 0.0 111.529 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.71 3.1 7.2 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.907 1.241 . . . . 0.0 113.737 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -63.93 133.65 53.64 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.809 1.304 . . . . 0.0 108.167 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.22 120.82 13.43 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.417 HG21 HG11 ' A' ' 37' ' ' VAL . 27.3 m -58.9 -40.16 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -169.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.5 mt -72.13 -40.52 68.03 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.986 1.266 . . . . 0.0 109.758 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.29 -44.81 93.97 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.792 0.724 . . . . 0.0 110.11 172.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -58.49 -44.42 89.4 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.164 0.986 . . . . 0.0 111.209 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 63.0 mt -71.08 -37.8 72.45 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.289 1.036 . . . . 0.0 110.786 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.5 -30.62 73.19 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.124 0.869 . . . . 0.0 112.333 -175.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -58.01 114.45 8.58 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.31 1.044 . . . . 0.0 109.629 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 72.0 Cg_endo -70.87 -13.73 32.08 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.558 1.505 . . . . 0.0 113.749 -175.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.27 -15.24 56.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.417 1.008 . . . . 0.0 110.612 169.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -132.59 34.22 3.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.309 2.644 . . . . 0.0 108.468 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.449 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.3 OUTLIER -65.0 -52.52 48.63 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 117.18 -1.39 . . . . 0.0 111.498 169.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.36 125.41 11.27 Favored 'Trans proline' 0 C--N 1.351 0.663 0 CA-C-N 121.667 1.631 . . . . 0.0 108.87 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.8 m -148.05 171.04 2.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.195 0.998 . . . . 0.0 110.524 -170.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.5 m -125.61 138.85 53.94 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 169.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.3 mt -136.48 139.58 44.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.6 mtp-105 -117.24 132.66 56.58 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 172.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -143.76 167.05 23.21 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.361 1.464 . . . . 0.0 109.185 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.52 -165.72 38.96 Favored Glycine 0 CA--C 1.52 0.399 0 O-C-N 121.543 -0.723 . . . . 0.0 111.656 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -59.15 142.4 85.91 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 117.983 -1.008 . . . . 0.0 108.301 170.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -47.64 -42.25 29.82 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.415 2.743 . . . . 0.0 113.037 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -150.32 165.89 31.67 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.408 1.883 . . . . 0.0 105.954 169.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 46.9 tp -59.27 -30.54 68.37 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.318 -0.864 . . . . 0.0 111.923 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.2 p -68.51 -19.07 64.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.029 0.931 . . . . 0.0 112.669 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.1 m -78.67 36.64 0.27 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.611 1.564 . . . . 0.0 111.805 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 . . . . . 0 C--O 1.249 1.055 0 C-N-CA 125.928 1.691 . . . . 0.0 107.789 179.815 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -167.67 168.16 40.45 Favored Glycine 0 C--N 1.334 0.463 0 O-C-N 121.493 -0.754 . . . . 0.0 111.687 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -140.63 112.41 7.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.6 t60 65.79 -37.39 0.25 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.633 2.373 . . . . 0.0 113.295 -169.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -149.1 169.24 21.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.417 1.887 . . . . 0.0 107.795 169.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -52.47 139.23 25.68 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.868 1.267 . . . . 0.0 110.73 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -68.95 151.44 46.53 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -155.5 161.1 40.99 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.042 1.337 . . . . 0.0 108.246 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.99 147.61 42.9 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.698 0.799 . . . . 0.0 109.366 170.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -139.06 155.4 47.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.01 1.324 . . . . 0.0 108.88 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.2 m -63.25 155.47 28.35 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.937 1.295 . . . . 0.0 112.147 -174.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -67.55 166.47 14.79 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.852 0.861 . . . . 0.0 109.972 169.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.53 150.34 37.55 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 124.031 0.932 . . . . 0.0 109.062 174.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.53 135.15 33.38 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.426 2.75 . . . . 0.0 111.214 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -69.96 141.74 52.98 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -158.48 173.29 16.85 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.839 1.655 . . . . 0.0 107.813 -171.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -139.29 -0.52 1.81 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 174.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.22 147.73 29.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.58 141.32 18.01 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 171.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.2 tttp -167.49 174.07 8.18 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.909 0.884 . . . . 0.0 109.648 -174.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.6 m -91.31 142.2 27.96 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -139.09 162.77 34.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.064 1.345 . . . . 0.0 109.28 -176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.5 p -153.94 176.67 11.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.017 2.527 . . . . 0.0 107.402 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -135.22 156.29 78.21 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 124.243 1.017 . . . . 0.0 109.481 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.11 -23.88 9.07 Favored 'Cis proline' 0 C--N 1.351 0.675 0 CA-C-N 119.945 1.016 . . . . 0.0 113.518 -0.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 tt 37.7 -91.39 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.603 2.761 . . . . 0.0 113.06 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -160.58 -38.79 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.471 1.508 . . . . 0.0 110.06 177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.2 tp -57.51 130.57 46.94 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.961 0.904 . . . . 0.0 109.533 171.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.1 mt -142.54 153.17 43.34 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.337 1.455 . . . . 0.0 107.729 170.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -121.44 154.53 36.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.676 1.19 . . . . 0.0 108.902 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.14 154.89 46.1 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.441 1.096 . . . . 0.0 109.122 170.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.4 tp -92.52 132.48 36.78 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.532 1.133 . . . . 0.0 108.374 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -153.61 139.66 18.3 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.624 1.17 . . . . 0.0 107.958 169.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.9 t70 44.3 49.61 7.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.649 1.58 . . . . 0.0 112.672 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 59.08 22.87 11.0 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.637 1.575 . . . . 0.0 114.211 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.0 mtt85 -129.41 156.64 43.76 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 120.931 -1.106 . . . . 0.0 108.841 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.26 130.88 52.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.41 153.5 38.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.882 1.273 . . . . 0.0 108.39 -173.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.5 t -60.11 104.07 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 125.905 1.682 . . . . 0.0 107.339 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.31 -39.54 68.16 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.678 0.791 . . . . 0.0 109.814 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -146.29 138.18 24.92 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.1 144.61 4.1 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -151.88 157.84 42.39 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.383 1.073 . . . . 0.0 110.302 -172.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.4 mmp_? 62.28 168.49 0.12 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.248 2.619 . . . . 0.0 113.517 174.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t0 43.85 42.58 4.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.307 1.843 . . . . 0.0 112.674 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.11 -18.35 28.03 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.911 1.243 . . . . 0.0 113.959 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.2 mm -70.75 129.61 34.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 173.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -146.64 149.7 34.01 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.9 t -59.11 141.33 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.95 -10.22 63.58 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.745 -1.031 . . . . 0.0 113.57 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -71.59 170.66 12.93 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 119.272 1.536 . . . . 0.0 108.674 169.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.57 143.65 50.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.208 1.003 . . . . 0.0 109.662 -172.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 p -70.27 140.82 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 169.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -116.77 -32.39 5.15 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.791 1.636 . . . . 0.0 109.867 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -154.51 158.61 40.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.091 0.859 . . . . 0.0 110.394 169.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.2 mt -131.65 130.17 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.1 p30 40.15 27.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.918 2.487 . . . . 0.0 115.314 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.33 -16.18 57.0 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.161 1.363 . . . . 0.0 112.789 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.65 109.29 11.5 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.645 1.223 . . . . 0.0 108.102 171.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -51.62 141.1 17.08 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.691 1.197 . . . . 0.0 108.881 169.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -103.87 116.33 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 122.387 1.089 . . . . 0.0 110.223 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -76.92 86.67 3.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.659 1.584 . . . . 0.0 108.041 169.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.02 -78.71 0.4 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.01 1.291 . . . . 0.0 111.963 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -135.84 13.63 3.39 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.927 1.291 . . . . 0.0 112.639 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -126.42 145.69 50.37 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.7 p -69.76 170.25 11.35 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.823 0.82 . . . . 0.0 110.155 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.5 -38.06 68.67 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.728 169.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.8 -37.09 73.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.657 0.783 . . . . 0.0 111.784 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.3 4.24 7.74 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.769 1.176 . . . . 0.0 113.944 172.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -67.93 137.69 55.39 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.903 1.352 . . . . 0.0 107.867 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -67.88 127.69 33.73 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 171.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.82 -40.56 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.536 0.734 . . . . 0.0 111.419 -170.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.7 mt -65.36 -36.8 85.11 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.072 0.851 . . . . 0.0 110.815 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -74.46 -40.61 61.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.455 0.57 . . . . 0.0 109.688 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -59.24 -51.05 71.66 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.775 0.83 . . . . 0.0 110.103 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.29 -30.0 64.39 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.601 0.76 . . . . 0.0 110.627 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.7 -38.06 95.65 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.517 -0.602 . . . . 0.0 111.812 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -63.93 117.08 32.25 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 117.738 0.769 . . . . 0.0 109.003 173.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 65.9 Cg_endo -67.34 -12.14 34.73 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.987 1.792 . . . . 0.0 114.009 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.57 -17.55 46.98 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.455 1.025 . . . . 0.0 111.211 169.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -120.67 21.05 11.64 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.703 1.601 . . . . 0.0 110.332 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 3.1 m-30 -61.06 -59.25 14.38 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 117.075 -1.441 . . . . 0.0 110.166 170.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -73.55 106.13 2.13 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.833 1.689 . . . . 0.0 109.603 176.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.02 156.45 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 123.197 0.599 . . . . 0.0 110.438 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.6 m -84.28 142.19 30.42 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 169.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.6 mt -139.73 147.04 24.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.0 mtp-105 -121.3 138.13 54.38 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -133.28 151.77 51.91 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.299 1.84 . . . . 0.0 109.655 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -159.96 -168.93 22.61 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 165.53 22.69 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 169.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.67 156.42 4.44 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 121.66 1.574 . . . . 0.0 110.691 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.95 -28.97 10.93 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 54.7 tp -51.71 -28.2 14.23 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.684 1.193 . . . . 0.0 112.858 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -129.82 23.63 5.36 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.77 1.228 . . . . 0.0 110.226 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.9 m -148.75 76.36 1.34 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.361 1.464 . . . . 0.0 107.891 178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.049 175.608 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.14 -43.7 0.23 Allowed Glycine 0 C--N 1.34 0.765 0 O-C-N 121.971 -0.455 . . . . 0.0 112.455 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -62.86 -9.82 11.04 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -171.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -64.96 -25.44 67.87 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.908 0.776 . . . . 0.0 112.21 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -68.09 161.26 27.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.227 0.611 . . . . 0.0 111.033 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -148.73 160.18 43.43 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.806 1.642 . . . . 0.0 107.385 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -60.14 147.22 40.4 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.899 0.48 . . . . 0.0 109.997 172.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -154.03 164.68 38.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.539 1.536 . . . . 0.0 108.264 173.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.3 tp -62.54 136.72 58.03 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -145.71 152.86 40.28 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.154 1.382 . . . . 0.0 107.365 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.8 m -62.79 -30.5 71.51 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.71 1.204 . . . . 0.0 112.005 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -157.02 177.36 11.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.184 1.794 . . . . 0.0 107.894 172.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.58 146.31 55.04 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.393 1.077 . . . . 0.0 108.165 173.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.66 163.41 35.24 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.93 2.42 . . . . 0.0 111.419 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -74.8 17.73 0.2 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.984 0.914 . . . . 0.0 112.071 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.66 132.78 54.87 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.188 -0.945 . . . . 0.0 109.552 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.28 11.1 pt-20 45.47 36.5 2.48 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.403 1.881 . . . . 0.0 112.499 -174.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.81 176.18 9.64 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.783 2.033 . . . . 0.0 108.442 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -151.87 155.75 38.77 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.719 0.808 . . . . 0.0 110.718 -172.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -158.82 166.96 30.71 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.749 1.22 . . . . 0.0 108.832 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -73.75 145.72 44.89 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.951 1.3 . . . . 0.0 109.632 169.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -142.74 163.7 32.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.405 1.482 . . . . 0.0 109.599 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.3 p -158.47 175.47 13.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.025 2.13 . . . . 0.0 107.612 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -137.22 158.86 71.68 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 123.816 0.847 . . . . 0.0 110.167 -172.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.96 156.95 79.49 Favored 'Cis proline' 0 C--N 1.35 0.613 0 CA-C-N 119.759 0.949 . . . . 0.0 111.271 -9.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.6 tp -158.03 159.36 36.29 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.768 1.227 . . . . 0.0 108.579 -173.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.0 -31.57 72.73 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.795 0.838 . . . . 0.0 112.18 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 tt -67.59 121.47 15.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.1 mt -133.58 156.22 48.22 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.084 1.754 . . . . 0.0 107.94 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.6 mt -131.79 155.4 47.82 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.172 0.989 . . . . 0.0 111.215 -169.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.53 153.72 40.71 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.723 1.209 . . . . 0.0 110.112 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.3 tp -78.66 130.75 36.21 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -153.55 138.49 17.2 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.831 1.252 . . . . 0.0 107.932 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 36.1 t70 48.44 43.56 19.8 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.19 1.396 . . . . 0.0 113.091 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 58.25 25.41 12.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.823 1.649 . . . . 0.0 113.336 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -130.15 167.99 17.5 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.305 1.842 . . . . 0.0 108.167 173.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.5 t -112.91 116.03 51.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.02 152.13 26.3 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.146 1.378 . . . . 0.0 109.201 -170.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 89.0 t -64.05 104.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.979 1.712 . . . . 0.0 107.561 172.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.94 -32.6 57.46 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.827 1.251 . . . . 0.0 110.874 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -155.34 156.07 34.8 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.46 8.11 0.03 OUTLIER Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.181 0.896 . . . . 0.0 113.31 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -64.11 -13.13 45.59 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.729 1.211 . . . . 0.0 113.126 -170.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -112.23 -27.43 8.34 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.708 1.14 . . . . 0.0 110.58 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.11 -46.43 89.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.064 0.847 . . . . 0.0 109.128 169.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.22 33.29 0.54 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.526 1.06 . . . . 0.0 112.76 176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.9 tt -142.74 120.11 6.68 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 CA-C-N 119.348 1.574 . . . . 0.0 108.298 174.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -75.72 149.81 37.98 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m -62.35 154.61 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 123.892 0.877 . . . . 0.0 110.958 -174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.83 -16.17 60.7 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.119 -0.823 . . . . 0.0 113.333 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -69.19 166.49 18.24 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 118.708 1.254 . . . . 0.0 108.255 169.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.45 152.29 51.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.269 0.628 . . . . 0.0 111.124 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 83.4 t -66.24 142.45 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -126.4 -30.11 2.9 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.605 1.162 . . . . 0.0 110.906 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.79 158.01 43.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 120.06 1.3 . . . . 0.0 110.551 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 54.4 mt -139.97 135.15 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 49.6 28.84 2.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.604 1.562 . . . . 0.0 112.229 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.35 -11.28 66.12 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.119 1.342 . . . . 0.0 113.734 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.3 mtt -82.81 111.96 19.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 118.938 1.369 . . . . 0.0 109.076 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -57.74 131.48 50.42 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.3 m -90.42 119.43 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -72.91 98.49 2.48 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.085 1.354 . . . . 0.0 107.949 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.2 -93.59 0.09 OUTLIER Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -175.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.2 ptt85 -124.78 14.32 8.63 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.755 1.622 . . . . 0.0 112.226 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -123.54 148.08 46.66 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 68.5 p -68.87 172.93 5.83 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 119.563 1.074 . . . . 0.0 110.355 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.61 -38.56 75.13 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.596 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.69 -39.14 77.11 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.818 0.847 . . . . 0.0 111.412 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 126.3 1.59 7.22 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.604 1.097 . . . . 0.0 113.988 172.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -61.29 140.92 57.88 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 119.092 1.446 . . . . 0.0 108.776 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.71 127.37 31.69 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.3 t -56.45 -43.38 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.61 0.764 . . . . 0.0 111.698 -173.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.6 mt -66.9 -36.7 82.87 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.351 0.523 . . . . 0.0 110.458 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.28 -42.92 68.12 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.293 0.497 . . . . 0.0 109.691 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -58.88 -46.53 87.6 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.718 1.207 . . . . 0.0 110.634 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.16 -33.67 59.37 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.492 0.717 . . . . 0.0 111.005 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.1 -32.02 79.31 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.308 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -61.18 114.17 9.93 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.154 . . . . 0.0 109.939 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.451 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 84.2 Cg_endo -71.06 -14.66 32.12 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.638 1.559 . . . . 0.0 113.789 -176.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.23 -15.42 57.03 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.436 1.017 . . . . 0.0 110.869 169.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -133.36 32.83 3.63 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.884 2.474 . . . . 0.0 108.639 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.451 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -64.97 -53.78 39.53 Favored Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 117.189 -1.386 . . . . 0.0 110.398 169.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.02 124.36 10.49 Favored 'Trans proline' 0 C--N 1.352 0.756 0 CA-C-N 121.559 1.593 . . . . 0.0 109.369 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.1 m -150.66 172.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 125.251 1.42 . . . . 0.0 109.778 -172.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 m -121.46 138.22 54.38 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 169.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.5 mt -136.49 140.39 43.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -114.62 138.12 51.05 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.734 1.614 . . . . 0.0 106.852 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -125.54 169.47 12.41 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.899 1.28 . . . . 0.0 110.164 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.55 -160.92 25.51 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -67.27 152.97 95.58 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 170.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -49.04 -45.11 30.48 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.296 2.664 . . . . 0.0 113.357 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -147.03 161.94 39.8 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.977 1.711 . . . . 0.0 106.489 171.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 38.5 tp -149.55 152.92 36.34 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 p -65.72 -39.43 91.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.287 1.035 . . . . 0.0 111.172 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.4 m 49.48 36.16 9.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.007 1.723 . . . . 0.0 112.692 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 123.71 0.804 . . . . 0.0 110.087 176.673 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 159.08 -35.39 0.49 Allowed Glycine 0 C--N 1.34 0.77 0 C-N-CA 123.086 0.374 . . . . 0.0 112.76 172.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -62.76 -20.65 65.17 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.298 1.049 . . . . 0.0 112.641 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -62.88 -12.89 28.0 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.112 -0.993 . . . . 0.0 112.977 171.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -131.55 -23.45 2.34 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.827 1.251 . . . . 0.0 112.436 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -140.6 -167.81 2.43 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.507 1.049 . . . . 0.0 111.834 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -54.43 166.19 0.46 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.197 2.199 . . . . 0.0 112.517 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -49.74 -40.99 42.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.88 1.272 . . . . 0.0 114.165 -169.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.8 mt -144.59 154.72 43.14 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.238 1.415 . . . . 0.0 108.955 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -146.97 -21.82 0.41 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.747 1.619 . . . . 0.0 111.613 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 m -65.32 164.04 14.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.571 1.948 . . . . 0.0 112.599 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -65.87 -16.95 64.31 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.01 146.5 77.04 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.478 0.711 . . . . 0.0 111.217 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -51.41 143.16 35.89 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.504 2.803 . . . . 0.0 112.617 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -83.66 -13.35 54.37 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.55 159.53 18.53 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.439 0.638 . . . . 0.0 110.538 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -129.35 166.26 19.85 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.478 1.911 . . . . 0.0 108.049 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.63 149.13 31.23 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.262 0.625 . . . . 0.0 111.713 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.4 mp0 -63.04 153.04 35.25 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.009 0.924 . . . . 0.0 110.662 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -147.21 143.23 28.03 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -79.84 141.49 36.14 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -138.25 161.29 37.25 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.008 1.323 . . . . 0.0 109.024 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.0 p -156.63 175.32 14.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.319 2.248 . . . . 0.0 106.983 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -139.83 161.5 55.86 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 123.924 0.89 . . . . 0.0 109.125 -171.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.08 145.83 60.99 Favored 'Cis proline' 0 C--N 1.351 0.669 0 CA-C-N 120.261 1.129 . . . . 0.0 111.262 -6.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 tp -159.74 162.07 34.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.125 1.77 . . . . 0.0 107.009 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.57 -28.69 69.52 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.369 0.668 . . . . 0.0 112.502 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.7 tp -57.54 126.0 25.39 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.967 0.907 . . . . 0.0 110.101 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.9 tp -147.47 151.61 36.69 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.204 1.401 . . . . 0.0 107.535 172.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.3 mt -121.31 156.04 33.43 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.633 1.173 . . . . 0.0 109.598 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.51 151.65 51.26 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.688 0.795 . . . . 0.0 109.321 169.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.19 124.43 28.06 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -152.82 142.45 21.87 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.489 1.115 . . . . 0.0 108.337 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 47.69 44.11 17.24 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.487 1.515 . . . . 0.0 112.126 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 59.36 6.86 0.83 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.718 2.007 . . . . 0.0 115.319 -176.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -109.56 -178.75 3.63 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.464 1.906 . . . . 0.0 107.439 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.55 130.37 74.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 169.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 68.5 mt -127.93 154.87 45.06 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.402 1.081 . . . . 0.0 108.769 -169.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.6 t -58.72 111.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.244 1.418 . . . . 0.0 108.094 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.07 -36.55 24.81 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.573 1.149 . . . . 0.0 110.463 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -145.16 135.12 23.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.79 125.17 1.24 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.52 172.82 16.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.847 1.259 . . . . 0.0 109.205 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? 64.31 -33.54 0.14 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 128.671 2.788 . . . . 0.0 115.377 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -60.31 -36.57 78.22 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.796 1.18 . . . . 0.0 111.569 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.09 -46.27 0.51 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.4 pt -65.22 162.28 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 123.7 0.8 . . . . 0.0 109.251 169.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -141.81 163.15 33.69 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.9 m -51.41 143.32 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.063 0.459 . . . . 0.0 110.846 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.06 -9.63 65.76 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.214 -1.326 . . . . 0.0 113.939 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -68.44 155.2 40.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.093 1.947 . . . . 0.0 109.278 169.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.23 146.48 30.26 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.924 0.889 . . . . 0.0 109.619 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -81.09 139.1 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 169.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.75 -37.44 3.93 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.437 1.495 . . . . 0.0 109.761 -174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.7 160.18 44.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.667 1.121 . . . . 0.0 110.676 170.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 76.5 mt -136.82 131.41 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.285 0.0 OUTLIER 36.83 34.58 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 128.564 2.746 . . . . 0.0 114.817 -176.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.84 -15.85 57.94 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.469 1.509 . . . . 0.0 113.15 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.4 mtt -82.94 108.75 16.49 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.497 1.149 . . . . 0.0 108.948 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.03 133.26 55.38 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 169.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 m -98.01 125.24 51.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -88.84 100.05 12.86 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.266 1.826 . . . . 0.0 107.53 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.78 -80.96 0.23 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.855 1.217 . . . . 0.0 110.781 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.23 23.16 1.5 Allowed 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.131 1.372 . . . . 0.0 111.767 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -126.23 146.72 49.87 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.9 p -68.54 173.58 4.91 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.795 0.807 . . . . 0.0 110.338 174.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.16 -38.41 73.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.666 169.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -70.05 -39.52 75.67 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.744 0.818 . . . . 0.0 111.406 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.6 -1.59 6.45 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.653 1.12 . . . . 0.0 114.089 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.9 mmtm -61.9 134.29 56.5 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.095 1.447 . . . . 0.0 108.566 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.14 126.11 26.67 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 172.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.4 t -56.68 -38.31 57.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.367 1.067 . . . . 0.0 111.703 -169.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.12 -40.25 94.22 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.548 0.613 . . . . 0.0 110.33 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -74.43 -38.29 63.07 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.939 0.496 . . . . 0.0 110.136 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -59.32 -45.99 89.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.365 1.066 . . . . 0.0 110.454 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.5 mt -76.97 -31.49 56.58 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.462 0.705 . . . . 0.0 110.874 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.26 -33.64 87.35 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.404 -0.664 . . . . 0.0 112.502 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -63.2 114.47 12.83 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.562 1.145 . . . . 0.0 110.136 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.464 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 88.5 Cg_endo -71.64 -15.75 30.36 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.632 1.555 . . . . 0.0 113.905 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.97 -14.24 44.99 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.313 0.96 . . . . 0.0 111.201 169.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -132.1 22.49 4.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.026 2.13 . . . . 0.0 109.881 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.464 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.7 m-30 -59.37 -53.63 64.15 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 116.942 -1.504 . . . . 0.0 112.117 171.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.84 112.06 3.45 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.827 1.688 . . . . 0.0 109.681 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 m -148.42 152.22 12.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 123.889 0.875 . . . . 0.0 110.069 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.4 m -84.58 144.11 28.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 168.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.0 mt -134.0 135.94 54.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -103.6 121.9 43.88 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -106.99 176.09 5.29 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.55 1.14 . . . . 0.0 108.348 173.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.03 173.31 44.67 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 173.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.31 140.63 92.98 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 169.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.11 151.47 50.53 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 121.803 1.668 . . . . 0.0 110.71 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -63.85 150.42 44.86 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 169.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.4 tp -134.15 -173.75 3.35 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.933 1.693 . . . . 0.0 107.284 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.4 p -56.08 -53.29 58.84 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.977 -1.077 . . . . 0.0 109.31 169.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.3 m -58.4 153.1 16.35 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.374 1.07 . . . . 0.0 111.5 171.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.839 0 CA-C-O 117.886 -1.054 . . . . 0.0 108.25 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ttt . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.61 -50.57 0.02 OUTLIER Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.2 m-70 -61.89 152.85 30.71 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 66.87 -46.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 127.478 2.311 . . . . 0.0 111.906 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -69.93 -42.35 73.39 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.952 0.901 . . . . 0.0 110.833 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -66.77 126.74 29.98 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -157.56 166.86 31.79 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.881 1.673 . . . . 0.0 106.956 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -151.07 174.42 13.21 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.435 1.094 . . . . 0.0 109.494 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 tp -56.28 145.44 26.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.883 0.873 . . . . 0.0 110.148 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -53.34 -34.55 57.96 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.611 1.564 . . . . 0.0 113.629 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 m -64.2 174.31 1.64 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.907 2.083 . . . . 0.0 113.037 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -63.23 164.23 9.09 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.367 0.604 . . . . 0.0 110.194 169.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.06 169.28 9.9 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.881 1.673 . . . . 0.0 107.808 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -51.01 -20.46 7.24 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.799 3.0 . . . . 0.0 116.519 -176.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -134.36 15.72 3.76 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.085 0.857 . . . . 0.0 113.003 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.14 139.5 41.23 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.786 1.175 . . . . 0.0 110.117 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -99.62 26.77 5.86 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.507 1.523 . . . . 0.0 112.204 -169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 72.82 166.64 0.3 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.743 2.417 . . . . 0.0 113.961 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -84.16 137.18 33.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.187 0.995 . . . . 0.0 109.887 171.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -138.58 157.47 46.08 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 169.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.5 p -78.7 145.32 34.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.3 1.04 . . . . 0.0 109.515 169.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -141.08 158.49 43.85 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.51 1.524 . . . . 0.0 110.009 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.8 m -146.67 175.15 10.82 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.608 2.763 . . . . 0.0 106.84 175.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -140.05 165.05 33.43 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.428 1.091 . . . . 0.0 109.108 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.96 -31.77 0.68 Allowed 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 120.591 1.247 . . . . 0.0 114.446 -7.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 18.7 tp 44.52 -123.59 0.95 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.565 1.546 . . . . 0.0 109.736 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.55 43.85 0.59 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.973 1.26 . . . . 0.0 110.625 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.45 161.55 39.43 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.046 1.338 . . . . 0.0 109.75 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.8 tp -154.44 152.49 30.21 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.874 1.27 . . . . 0.0 108.613 -175.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.1 mt -121.76 155.37 35.42 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.807 1.243 . . . . 0.0 109.617 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.25 154.82 43.48 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.515 1.126 . . . . 0.0 109.451 172.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.88 126.85 33.38 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -155.67 144.76 20.71 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.044 1.338 . . . . 0.0 108.258 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 50.72 43.21 28.03 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.335 1.054 . . . . 0.0 111.823 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . 0.282 10.5 pt-20 50.41 26.46 2.33 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.174 2.59 . . . . 0.0 115.298 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 mtp-105 -134.68 159.84 40.0 Favored 'General case' 0 C--N 1.34 0.174 0 O-C-N 121.157 -0.965 . . . . 0.0 110.76 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 m -80.37 131.85 33.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 169.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.0 mt -120.07 154.06 35.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.63 1.172 . . . . 0.0 108.252 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.6 t -61.99 106.34 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.988 1.315 . . . . 0.0 107.476 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.05 -37.07 66.99 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.703 0.801 . . . . 0.0 110.022 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -154.13 150.03 27.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.003 1.321 . . . . 0.0 107.697 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.52 -44.79 0.18 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 42.19 38.63 1.17 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.126 2.57 . . . . 0.0 115.134 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -139.61 158.2 44.51 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -54.76 123.17 12.47 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.31 -16.9 56.45 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 117.916 -1.491 . . . . 0.0 113.531 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.7 pt -141.83 54.89 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.74 2.016 . . . . 0.0 108.244 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -62.79 134.76 56.75 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.7 t -59.86 136.45 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.93 -7.56 74.08 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.107 -1.385 . . . . 0.0 114.021 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -73.22 163.95 27.38 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.015 1.908 . . . . 0.0 108.613 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.09 155.66 21.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.52 1.128 . . . . 0.0 110.467 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.9 t -71.86 136.88 24.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 169.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -111.71 -36.75 5.37 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.669 1.188 . . . . 0.0 109.473 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.67 160.24 43.7 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.305 0.957 . . . . 0.0 111.094 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 96.1 mt -132.84 132.66 59.38 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 170.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 45.76 32.76 1.31 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.503 1.921 . . . . 0.0 112.118 -174.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.5 -9.46 73.38 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.0 1.286 . . . . 0.0 114.069 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 46.2 mtt -83.4 115.94 22.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 119.067 1.434 . . . . 0.0 108.808 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -49.66 124.73 10.13 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.755 1.222 . . . . 0.0 110.335 169.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.08 140.34 16.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 109.91 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -79.32 67.68 5.11 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.556 1.542 . . . . 0.0 108.535 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.74 -66.0 1.11 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.203 1.859 . . . . 0.0 113.974 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -136.74 9.14 3.08 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.892 1.677 . . . . 0.0 111.79 174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -120.4 152.16 38.3 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.4 p -66.84 171.47 5.29 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.851 0.834 . . . . 0.0 109.427 172.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.08 76.44 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.599 169.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -70.28 -37.84 74.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.556 0.742 . . . . 0.0 111.578 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.76 1.94 6.32 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.359 -1.245 . . . . 0.0 115.878 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -69.11 144.52 53.88 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 120.315 2.058 . . . . 0.0 107.578 174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -64.28 131.46 47.38 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.8 t -57.2 -37.39 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 124.345 1.058 . . . . 0.0 110.748 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.4 mt -62.21 -40.22 95.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.082 0.401 . . . . 0.0 110.368 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -73.86 -41.79 61.72 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.391 0.541 . . . . 0.0 110.005 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -58.65 -51.1 71.34 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 123.251 0.62 . . . . 0.0 110.103 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.9 mt -76.76 -30.32 56.5 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.783 0.833 . . . . 0.0 110.848 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -63.3 -36.73 93.8 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.456 -0.636 . . . . 0.0 112.0 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -62.92 117.06 28.92 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 117.918 0.859 . . . . 0.0 109.067 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.472 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 68.4 Cg_endo -67.79 -11.8 33.3 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.875 1.717 . . . . 0.0 114.165 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.82 -17.47 49.89 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.42 1.009 . . . . 0.0 111.012 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -121.85 23.61 10.01 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.18 1.792 . . . . 0.0 110.099 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.472 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.8 m-30 -61.54 -57.62 23.82 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 117.087 -1.435 . . . . 0.0 110.501 169.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.88 107.15 2.41 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.903 1.736 . . . . 0.0 109.715 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 m -147.93 171.23 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.135 0.974 . . . . 0.0 109.829 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.5 m -105.9 143.12 34.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.2 mt -139.35 148.21 23.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -120.61 136.41 54.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -121.27 162.47 20.2 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.154 1.382 . . . . 0.0 107.938 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.69 -175.54 41.47 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 70.6 mmt-85 -64.02 143.77 98.21 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-O 117.796 -1.097 . . . . 0.0 108.467 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.24 -170.35 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 124.576 3.518 . . . . 0.0 114.787 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 30.0 ttp-105 -51.98 -38.26 56.02 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.292 -0.88 . . . . 0.0 111.225 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.22 133.11 36.75 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 169.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.9 m -70.66 -25.45 63.01 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.749 0.42 . . . . 0.0 111.935 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 p -64.61 135.95 56.49 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.536 0.734 . . . . 0.0 109.234 169.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 C--O 1.247 0.94 0 C-N-CA 123.715 0.806 . . . . 0.0 109.801 -178.634 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.88 46.4 0.29 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -63.27 -26.19 68.67 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.96 0.904 . . . . 0.0 112.092 -176.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -150.74 174.74 12.68 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.464 1.906 . . . . 0.0 107.691 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -143.86 139.44 29.26 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 171.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -140.99 156.2 46.09 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.183 1.793 . . . . 0.0 106.753 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -57.94 123.88 17.35 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.84 124.75 25.51 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -171.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.5 tp -58.05 142.56 46.43 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.261 1.025 . . . . 0.0 108.318 169.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -63.13 137.61 58.29 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -169.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.6 p -124.82 -18.2 5.64 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.501 2.32 . . . . 0.0 112.981 -173.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -158.36 -13.97 0.07 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.7 144.04 97.93 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 120.928 1.694 . . . . 0.0 111.345 -169.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.42 169.31 20.05 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.041 2.494 . . . . 0.0 112.017 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 56.82 112.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.422 2.689 . . . . 0.0 114.441 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.4 76.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.497 169.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -155.29 158.14 38.32 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.789 1.236 . . . . 0.0 109.042 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.76 170.05 20.72 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.058 1.743 . . . . 0.0 108.951 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -142.44 137.13 30.13 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -156.79 166.02 34.57 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.838 0.855 . . . . 0.0 109.081 -175.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.4 m -126.09 142.72 51.4 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.395 1.078 . . . . 0.0 108.593 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -142.05 -178.79 5.87 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 127.006 2.122 . . . . 0.0 107.46 -172.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.5 m -151.56 157.2 41.92 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 120.798 -1.189 . . . . 0.0 108.685 169.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -77.25 154.95 82.26 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -81.68 0.87 47.56 Favored 'Cis proline' 0 CA--C 1.544 1.011 0 CA-C-N 119.823 0.972 . . . . 0.0 111.909 -10.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -54.92 -38.89 68.21 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 124.662 1.185 . . . . 0.0 111.482 -172.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -144.22 142.4 30.48 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 121.215 0.531 . . . . 0.0 109.924 169.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -160.17 13.9 0.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.39 2.676 . . . . 0.0 110.024 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.9 mt -82.22 69.45 8.95 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.903 1.281 . . . . 0.0 110.635 -169.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mp -134.48 155.59 50.08 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.245 1.418 . . . . 0.0 108.744 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.6 150.84 46.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.385 0.674 . . . . 0.0 110.624 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 tt -79.11 124.78 28.64 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -155.29 143.16 19.91 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.593 1.157 . . . . 0.0 108.298 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 47.91 41.94 15.48 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.522 1.529 . . . . 0.0 112.612 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 53.47 26.78 5.8 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.292 1.837 . . . . 0.0 113.35 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -126.17 -176.1 3.55 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.94 2.496 . . . . 0.0 106.203 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.33 132.49 71.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 169.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.0 mp -121.0 147.15 45.89 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.652 1.181 . . . . 0.0 108.734 -169.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.9 t -60.18 111.24 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 170.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -80.42 -30.49 37.7 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.692 0.797 . . . . 0.0 111.252 -176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -155.75 157.68 36.95 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.336 1.454 . . . . 0.0 107.541 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -178.36 0.79 0.03 OUTLIER Glycine 0 CA--C 1.527 0.794 0 CA-C-O 118.491 -1.172 . . . . 0.0 114.956 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -62.39 -35.61 79.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.955 1.878 . . . . 0.0 111.287 -176.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -65.3 -40.65 94.09 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.067 0.547 . . . . 0.0 110.521 177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -70.21 -39.15 75.32 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.805 0.442 . . . . 0.0 110.912 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.55 25.36 1.44 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.89 1.233 . . . . 0.0 113.146 173.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.5 pt -130.27 151.8 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 119.251 1.525 . . . . 0.0 109.838 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.5 ttt-85 -69.0 141.53 54.87 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.2 t -68.47 155.98 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.55 -6.28 77.94 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 118.547 -1.14 . . . . 0.0 114.139 169.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -62.51 135.27 57.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.476 1.638 . . . . 0.0 107.47 169.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.13 147.88 26.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.048 0.939 . . . . 0.0 108.511 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.2 t -74.0 136.48 25.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.31 -37.18 7.76 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.159 1.784 . . . . 0.0 108.942 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.1 159.51 44.45 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.219 0.918 . . . . 0.0 111.068 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.57 139.53 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.65 34.11 3.46 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.685 1.994 . . . . 0.0 112.444 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.36 13.84 82.83 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.018 -0.879 . . . . 0.0 113.534 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.3 mmt -118.56 121.61 40.64 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.19 1.396 . . . . 0.0 107.508 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -50.8 139.1 17.41 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.593 1.157 . . . . 0.0 110.011 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.3 m -102.21 122.17 54.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -73.17 85.28 1.37 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.566 1.546 . . . . 0.0 107.187 169.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.34 -100.92 0.39 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -106.75 8.61 31.0 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.195 1.398 . . . . 0.0 111.887 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -127.82 150.02 50.02 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 119.291 0.95 . . . . 0.0 109.17 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 71.1 p -69.77 175.45 4.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.624 0.726 . . . . 0.0 110.457 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.51 -38.81 72.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.437 0.695 . . . . 0.0 110.696 169.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -71.72 -39.89 69.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.769 0.828 . . . . 0.0 111.371 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.2 -0.67 7.07 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.502 1.048 . . . . 0.0 113.94 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -58.75 135.95 57.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.936 1.368 . . . . 0.0 108.008 175.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -65.99 131.14 45.53 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.29 -38.63 70.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.009 0.924 . . . . 0.0 113.251 -169.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.6 mt -69.35 -38.72 78.25 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.337 0.971 . . . . 0.0 110.692 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.0 -41.93 85.85 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -60.46 -46.22 90.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.18 0.992 . . . . 0.0 111.323 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.0 mt -70.78 -38.35 73.39 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.978 0.511 . . . . 0.0 109.927 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.68 -28.13 69.75 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.763 0.697 . . . . 0.0 112.929 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -53.45 118.14 13.8 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.27 1.428 . . . . 0.0 109.96 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.39 -14.36 39.88 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.0 1.8 . . . . 0.0 113.504 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.7 -12.69 61.05 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.375 0.989 . . . . 0.0 112.026 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -128.79 41.41 3.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.94 2.096 . . . . 0.0 108.599 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -47.1 96.68 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.486 -1.245 . . . . 0.0 113.398 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.27 138.91 18.28 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 121.527 1.581 . . . . 0.0 108.356 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.63 130.72 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -172.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.9 m -105.06 138.93 40.51 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 mt -140.55 139.47 35.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 -115.23 133.2 56.25 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -148.5 160.78 42.74 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.523 1.129 . . . . 0.0 109.035 -169.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.38 -173.74 43.15 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -176.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.453 ' H ' ' HD2' ' A' ' 90' ' ' ARG . 0.7 OUTLIER -68.27 142.34 94.65 Favored Pre-proline 0 CA--C 1.539 0.521 0 O-C-N 121.192 -1.181 . . . . 0.0 107.878 173.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.47 -27.83 62.23 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.487 2.124 . . . . 0.0 112.059 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -139.2 143.09 37.93 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 169.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -61.02 122.37 14.77 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 122.127 0.965 . . . . 0.0 108.799 -174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 m -155.08 136.72 14.32 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 126.892 2.077 . . . . 0.0 106.161 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.4 p -158.16 10.16 0.16 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.261 0.625 . . . . 0.0 112.498 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.1 t30 . . . . . 0 C--O 1.247 0.952 0 C-N-CA 125.645 1.578 . . . . 0.0 108.176 -175.463 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.53 -176.22 47.78 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 109.956 -1.257 . . . . 0.0 109.956 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -130.33 10.43 5.29 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.227 1.011 . . . . 0.0 111.989 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 49.47 37.54 12.34 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.674 1.59 . . . . 0.0 112.305 -177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -151.6 160.26 43.73 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.757 1.623 . . . . 0.0 108.153 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -152.75 162.01 41.83 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.48 1.512 . . . . 0.0 108.124 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -58.98 124.45 19.94 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -81.64 -8.86 59.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.88 0.472 . . . . 0.0 111.61 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tt -74.21 65.09 1.14 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.319 1.448 . . . . 0.0 108.437 171.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -146.22 -31.87 0.35 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.355 1.862 . . . . 0.0 111.063 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 m -62.82 158.62 18.4 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.686 1.194 . . . . 0.0 111.532 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -144.63 -47.05 0.25 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.557 1.143 . . . . 0.0 110.177 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.1 -31.35 5.28 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 115.562 1.69 . . . . 0.0 115.562 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -66.29 -10.82 28.89 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.629 2.219 . . . . 0.0 115.921 174.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.7 tpt85 -51.39 120.82 5.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.928 1.24 . . . . 0.0 111.067 -171.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.94 159.76 43.16 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.05 1.34 . . . . 0.0 108.834 176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -74.76 167.78 21.15 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.056 0.943 . . . . 0.0 108.466 169.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.1 -38.71 82.6 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.404 -0.81 . . . . 0.0 111.391 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 47.98 -155.8 0.07 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.85 1.66 . . . . 0.0 112.949 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HE2' ' CE2' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -158.12 174.07 15.77 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.828 2.051 . . . . 0.0 108.797 -169.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.9 m -79.67 142.75 35.25 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.42 ' CE2' ' HE2' ' A' ' 20' ' ' LYS . 89.3 m-85 -116.27 165.12 13.54 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.313 1.845 . . . . 0.0 109.324 -174.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -146.98 167.45 23.96 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.05 1.74 . . . . 0.0 107.079 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -116.36 161.0 33.78 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.211 1.004 . . . . 0.0 109.499 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -62.08 160.92 51.46 Favored 'Cis proline' 0 C--N 1.35 0.633 0 CA-C-N 119.762 0.951 . . . . 0.0 110.93 -10.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.434 ' HG ' ' H ' ' A' ' 28' ' ' LEU . 51.8 tp -139.67 149.75 44.07 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.771 0.829 . . . . 0.0 110.417 -169.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -66.4 -31.9 72.95 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.903 1.281 . . . . 0.0 112.586 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 26' ' ' LEU . 55.2 mt -63.59 144.81 56.7 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.284 0.634 . . . . 0.0 110.146 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -140.41 132.36 27.72 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 174.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.9 mt -113.56 155.58 25.15 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.696 0.798 . . . . 0.0 110.209 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 145.74 50.97 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.573 1.149 . . . . 0.0 108.836 170.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tt -75.5 130.69 39.29 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -150.62 130.13 13.01 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.285 1.034 . . . . 0.0 108.234 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.2 t0 47.93 47.48 18.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.416 1.486 . . . . 0.0 112.188 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 61.12 10.79 3.09 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.566 1.946 . . . . 0.0 114.876 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 80.8 mtm-85 -110.36 179.37 4.1 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.447 1.499 . . . . 0.0 108.537 169.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.8 m -123.27 131.74 72.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 169.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.4 mp -120.23 143.36 48.32 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.833 1.253 . . . . 0.0 108.245 -171.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.5 t -66.52 105.5 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 125.851 1.66 . . . . 0.0 107.534 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.95 -29.6 24.98 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 124.334 1.054 . . . . 0.0 111.26 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -149.57 152.61 35.79 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 173.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 173.17 40.03 0.04 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -70.02 -4.13 19.48 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -116.24 -37.41 3.8 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.473 1.488 . . . . 0.0 110.177 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.63 -26.39 62.54 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.936 0.789 . . . . 0.0 111.405 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.58 -150.0 5.7 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.233 1.873 . . . . 0.0 109.158 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 tp -153.04 -38.12 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 117.451 0.625 . . . . 0.0 112.145 175.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -77.73 82.95 4.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.925 0.784 . . . . 0.0 110.363 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.9 m -56.97 158.69 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 123.467 0.707 . . . . 0.0 109.135 169.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.17 -6.49 66.31 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.985 -0.897 . . . . 0.0 112.702 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -63.96 158.97 20.96 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -124.11 153.12 41.91 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.308 1.043 . . . . 0.0 109.103 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.8 t -64.15 137.4 24.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.31 -36.81 3.02 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.507 1.123 . . . . 0.0 110.058 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.98 157.73 43.71 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.734 0.697 . . . . 0.0 109.889 169.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 83.9 mt -136.48 139.53 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 170.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 42.33 38.95 1.31 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.515 2.326 . . . . 0.0 112.626 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.56 10.14 77.32 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.725 -1.042 . . . . 0.0 114.075 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 98.7 mmm -121.65 120.28 34.28 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.029 1.415 . . . . 0.0 108.485 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -55.62 129.05 37.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.601 1.161 . . . . 0.0 109.161 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.3 m -89.15 144.37 9.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 121.54 0.686 . . . . 0.0 111.369 -171.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -78.82 62.91 3.42 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.047 1.339 . . . . 0.0 107.603 169.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.78 -112.58 4.21 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.407 1.004 . . . . 0.0 110.978 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.05 2.09 28.65 Favored 'General case' 0 N--CA 1.46 0.062 0 C-N-CA 123.697 0.799 . . . . 0.0 112.023 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -119.68 147.99 43.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 119.091 0.86 . . . . 0.0 109.613 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.8 p -69.95 175.63 4.28 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.722 0.773 . . . . 0.0 110.038 172.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.99 -38.63 79.61 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.59 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.14 -37.11 69.5 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.793 0.837 . . . . 0.0 111.598 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.36 6.4 8.89 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.498 1.047 . . . . 0.0 114.072 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -63.13 140.28 58.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.292 1.546 . . . . 0.0 107.83 170.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.62 125.2 26.15 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 169.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.0 m -60.56 -33.18 53.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.049 0.54 . . . . 0.0 111.577 -171.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.0 mt -64.1 -42.02 97.05 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.326 0.512 . . . . 0.0 110.034 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -68.58 -46.1 70.29 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.08 -46.17 85.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.436 0.694 . . . . 0.0 111.375 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 81.6 mt -78.12 -33.98 50.24 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.105 0.962 . . . . 0.0 110.436 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.33 -31.31 68.72 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.367 -0.685 . . . . 0.0 112.509 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -53.97 116.46 10.31 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.171 1.389 . . . . 0.0 110.67 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.428 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 61.2 Cg_endo -68.37 -17.44 44.25 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.028 1.819 . . . . 0.0 113.543 -175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.24 -11.64 59.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.927 0.785 . . . . 0.0 112.497 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -129.67 31.96 4.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.573 1.549 . . . . 0.0 110.07 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.6 m-30 -53.53 -51.26 77.65 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-O 116.776 -1.583 . . . . 0.0 113.629 176.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.43 125.3 8.95 Favored 'Trans proline' 0 C--N 1.349 0.581 0 CA-C-N 122.153 1.805 . . . . 0.0 109.513 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.1 135.63 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.748 0.819 . . . . 0.0 108.984 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 m -84.62 134.52 34.38 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 169.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.8 mt -140.56 147.35 23.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -124.65 140.71 52.68 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 169.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -120.73 153.83 36.44 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -157.91 -179.99 33.21 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 48.4 mmt-85 -68.24 158.46 84.34 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 169.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.8 162.31 3.83 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.578 1.519 . . . . 0.0 109.561 168.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -58.87 -18.04 29.34 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -173.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 43.9 tp -56.23 -17.0 6.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.3 1.44 . . . . 0.0 112.662 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 m 64.58 46.39 3.24 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.263 1.425 . . . . 0.0 110.197 176.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m -71.03 58.3 0.22 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.202 2.201 . . . . 0.0 111.832 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.4 t30 . . . . . 0 C--O 1.249 1.073 0 C-N-CA 124.978 1.311 . . . . 0.0 111.731 -174.21 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.13 -176.37 40.25 Favored Glycine 0 C--N 1.339 0.702 0 O-C-N 121.705 -0.622 . . . . 0.0 111.95 -174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -59.41 -19.78 49.81 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.727 1.611 . . . . 0.0 114.1 -169.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -128.01 13.29 6.76 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.938 0.895 . . . . 0.0 110.901 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -138.63 51.97 1.82 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 127.01 2.124 . . . . 0.0 106.241 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -68.29 90.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -57.95 161.8 3.72 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.394 1.078 . . . . 0.0 110.896 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -66.78 12.57 0.07 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 128.18 2.592 . . . . 0.0 114.636 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.1 tp -55.48 153.71 7.25 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.89 2.076 . . . . 0.0 111.369 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -58.99 -6.22 0.77 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.683 1.993 . . . . 0.0 114.354 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -51.93 -21.51 3.08 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.909 1.684 . . . . 0.0 113.225 169.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -141.63 166.42 24.79 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.504 1.121 . . . . 0.0 109.153 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.619 ' H ' ' CD ' ' A' ' 14' ' ' PRO . . . -143.0 -25.35 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 CA-C-O 116.45 -1.738 . . . . 0.0 114.922 -177.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.619 ' CD ' ' H ' ' A' ' 13' ' ' ALA . 80.0 Cg_exo -51.69 156.79 6.08 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.56 2.173 . . . . 0.0 114.163 175.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.24 -5.21 1.64 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.81 0.844 . . . . 0.0 113.095 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.06 154.29 43.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.807 1.243 . . . . 0.0 107.799 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 50.75 45.03 27.63 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.651 1.18 . . . . 0.0 109.826 -171.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.36 160.65 38.96 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.537 1.535 . . . . 0.0 108.674 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -141.12 142.71 34.07 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.439 1.096 . . . . 0.0 108.975 -169.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -146.18 147.48 31.53 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.573 1.149 . . . . 0.0 110.075 -173.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.1 p -76.41 142.45 41.09 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 169.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -143.0 153.41 42.95 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.609 0.764 . . . . 0.0 109.587 172.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -144.07 174.71 10.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.038 2.135 . . . . 0.0 106.235 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -137.05 160.18 67.08 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.881 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -64.96 155.37 76.45 Favored 'Cis proline' 0 C--N 1.351 0.68 0 CA-C-N 120.249 1.125 . . . . 0.0 111.903 -5.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -157.58 155.38 30.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.425 1.49 . . . . 0.0 107.995 -173.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.25 -31.82 72.43 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.292 0.637 . . . . 0.0 112.164 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.44 139.96 56.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.732 1.213 . . . . 0.0 109.657 173.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.8 tp -146.55 153.78 40.76 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.9 mt -122.49 155.6 35.86 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.317 1.447 . . . . 0.0 108.291 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.18 153.49 51.24 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.437 0.562 . . . . 0.0 110.387 170.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.9 tp -90.94 123.8 34.71 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.294 1.438 . . . . 0.0 107.168 175.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -149.16 137.13 20.61 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 124.729 1.212 . . . . 0.0 108.34 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.2 t70 45.82 43.1 9.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.521 1.529 . . . . 0.0 112.605 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 53.98 32.02 14.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.757 1.623 . . . . 0.0 113.991 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -130.29 164.2 25.13 Favored 'General case' 0 C--O 1.23 0.07 0 C-N-CA 125.779 1.631 . . . . 0.0 107.511 169.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.2 t -122.28 117.88 53.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -116.45 147.36 41.77 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.211 1.404 . . . . 0.0 108.061 -169.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.84 108.98 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 173.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.03 -40.95 21.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.747 1.219 . . . . 0.0 111.578 -173.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -147.8 159.54 43.72 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.685 1.194 . . . . 0.0 108.512 -176.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 165.06 50.96 0.02 OUTLIER Glycine 0 CA--C 1.52 0.403 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -63.32 -30.52 71.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.627 0.713 . . . . 0.0 110.875 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -65.82 -30.02 70.59 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.011 0.524 . . . . 0.0 110.939 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -82.31 -57.16 3.49 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.381 0.672 . . . . 0.0 110.721 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.39 -16.73 58.69 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 117.35 -1.806 . . . . 0.0 115.165 170.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.0 tt -146.31 -25.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 121.013 2.407 . . . . 0.0 114.62 -170.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -17.96 64.24 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.715 -1.241 . . . . 0.0 111.723 173.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -54.76 145.17 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 119.765 1.166 . . . . 0.0 109.825 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.08 -12.79 57.18 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.3 0.952 . . . . 0.0 113.911 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -79.68 174.75 11.27 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.851 1.325 . . . . 0.0 109.086 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.64 148.33 51.52 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.087 0.555 . . . . 0.0 111.398 -174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.2 t -61.85 137.25 24.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.8 mt -120.21 -33.1 3.99 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 124.896 1.279 . . . . 0.0 109.423 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.0 159.91 44.27 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.492 1.042 . . . . 0.0 110.9 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.3 mt -132.05 130.94 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.7 p30 41.69 26.25 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.559 2.343 . . . . 0.0 115.091 -174.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 101.63 -15.32 57.3 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.174 1.369 . . . . 0.0 113.151 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 76.7 mtm -75.32 106.93 7.1 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.836 1.318 . . . . 0.0 108.957 172.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.7 125.55 22.8 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.2 m -80.38 128.25 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -75.36 74.95 2.45 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.471 1.509 . . . . 0.0 107.918 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.17 -70.95 0.79 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 126.458 1.98 . . . . 0.0 112.157 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -129.35 -4.82 4.85 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 127.706 2.402 . . . . 0.0 111.522 -176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -117.94 156.18 28.93 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.2 p -70.61 175.65 4.72 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.277 -0.89 . . . . 0.0 109.629 169.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.14 79.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.141 169.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.29 -29.64 67.55 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.548 1.139 . . . . 0.0 111.992 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.66 3.88 19.96 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.075 1.321 . . . . 0.0 113.385 170.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -71.41 136.26 47.63 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.96 129.05 38.51 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 171.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 t -55.75 -41.96 67.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.987 0.915 . . . . 0.0 111.356 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.5 mt -66.55 -37.28 84.65 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.72 0.691 . . . . 0.0 110.927 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.68 -43.48 65.93 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -58.06 -46.78 84.83 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.619 1.168 . . . . 0.0 110.749 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.88 -32.83 59.86 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.65 0.78 . . . . 0.0 111.128 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.89 -32.1 76.82 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.427 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -60.19 114.69 10.57 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.204 1.001 . . . . 0.0 109.814 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.7 Cg_endo -71.06 -15.87 32.22 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.72 1.613 . . . . 0.0 113.838 -175.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.96 -14.54 48.55 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.222 0.919 . . . . 0.0 111.105 169.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -133.52 27.27 4.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.311 2.244 . . . . 0.0 109.438 -175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.449 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.4 m-30 -59.4 -53.15 68.87 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-O 117.046 -1.454 . . . . 0.0 112.264 170.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.16 119.44 6.17 Favored 'Trans proline' 0 C--N 1.351 0.691 0 CA-C-N 121.813 1.683 . . . . 0.0 109.755 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.0 m -147.44 174.05 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.642 1.577 . . . . 0.0 110.031 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.2 m -125.67 137.81 53.87 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.494 -2.41 . . . . 0.0 104.494 168.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.9 mt -131.33 137.72 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 -173.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.1 ttp-105 -116.62 135.01 54.15 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -141.86 165.12 28.34 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 123.852 0.861 . . . . 0.0 110.45 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.74 -173.68 33.64 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 124.28 0.943 . . . . 0.0 111.038 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -63.79 129.06 93.56 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.81 166.96 24.51 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 121.446 1.431 . . . . 0.0 110.703 169.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -64.52 145.54 55.97 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -52.93 -40.89 63.96 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.948 0.899 . . . . 0.0 112.12 -170.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.6 -23.79 29.48 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.705 1.602 . . . . 0.0 113.138 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 m -68.07 -18.99 64.83 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.613 0.765 . . . . 0.0 112.894 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.2 t30 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 124.36 1.064 . . . . 0.0 111.032 -179.581 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.8 mtm . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.6 168.92 38.61 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.384 -0.687 . . . . 0.0 111.384 177.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -74.92 35.51 0.11 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.481 1.912 . . . . 0.0 111.954 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -59.72 -32.04 70.16 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 120.934 -1.104 . . . . 0.0 111.209 173.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -138.35 146.2 42.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.867 2.067 . . . . 0.0 106.075 173.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -63.77 -34.35 77.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.758 0.423 . . . . 0.0 110.868 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -83.0 46.55 1.12 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.039 1.336 . . . . 0.0 110.988 -178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -153.54 -53.13 0.1 Allowed 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.763 1.625 . . . . 0.0 108.449 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 tp -149.79 144.18 25.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.924 2.09 . . . . 0.0 106.336 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -134.45 -33.84 0.97 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.513 0.725 . . . . 0.0 111.644 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.5 m -163.28 169.73 18.71 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.141 2.177 . . . . 0.0 107.729 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 64.05 101.8 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.002 2.121 . . . . 0.0 114.38 169.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.15 148.51 38.43 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.149 1.379 . . . . 0.0 107.721 169.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.2 143.81 24.74 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.655 2.903 . . . . 0.0 112.885 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -148.69 46.28 1.02 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.293 1.037 . . . . 0.0 110.474 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.82 -15.07 57.91 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -145.85 157.96 43.88 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.295 1.438 . . . . 0.0 108.593 175.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.05 169.93 21.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.369 1.868 . . . . 0.0 108.604 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.31 135.71 24.14 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.888 0.875 . . . . 0.0 108.662 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -147.68 153.0 38.77 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.778 0.831 . . . . 0.0 110.334 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -83.58 142.99 30.44 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.834 1.253 . . . . 0.0 108.43 169.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -142.66 174.93 10.2 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.959 0.903 . . . . 0.0 110.343 176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.9 m -151.22 175.53 12.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.905 2.482 . . . . 0.0 106.558 169.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -133.27 160.61 67.98 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.85 0.86 . . . . 0.0 110.24 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.25 -36.14 1.57 Allowed 'Cis proline' 0 C--N 1.351 0.704 0 CA-C-N 119.884 0.994 . . . . 0.0 111.425 -8.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 45.4 30.67 0.74 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.325 2.25 . . . . 0.0 114.156 169.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.7 t0 43.23 57.28 3.85 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.262 1.425 . . . . 0.0 112.192 -172.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.8 tp -144.28 140.7 29.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.932 1.693 . . . . 0.0 107.72 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.3 tp -146.95 142.01 27.09 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.657 0.783 . . . . 0.0 109.692 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -126.46 155.23 42.57 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.978 2.111 . . . . 0.0 107.165 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.42 153.43 41.17 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.053 0.842 . . . . 0.0 111.75 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.0 tp -73.55 127.67 33.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.891 1.676 . . . . 0.0 109.296 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -158.47 144.41 16.92 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.952 1.301 . . . . 0.0 108.406 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.2 t70 51.36 39.81 25.04 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.935 1.294 . . . . 0.0 112.312 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 55.53 15.55 1.53 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.115 2.166 . . . . 0.0 114.658 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -118.71 -174.19 2.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.284 1.833 . . . . 0.0 107.102 170.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.8 m -123.26 142.09 41.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.4 mt -118.26 145.72 44.82 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.55 126.86 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 169.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -107.68 -38.05 5.98 Favored 'General case' 0 C--O 1.231 0.132 0 C-N-CA 123.483 0.713 . . . . 0.0 112.22 -169.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -156.89 154.67 30.16 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.571 0.748 . . . . 0.0 108.995 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.46 15.84 79.08 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.145 -0.809 . . . . 0.0 113.461 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -63.26 102.72 0.42 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.665 1.233 . . . . 0.0 109.962 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -65.61 -26.32 67.78 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.053 -0.405 . . . . 0.0 111.555 178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.69 -31.06 71.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.172 0.989 . . . . 0.0 112.793 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.4 165.98 21.47 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.144 -0.783 . . . . 0.0 111.144 177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -21.01 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -171.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -77.54 74.12 4.11 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.271 0.942 . . . . 0.0 110.046 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 m -53.68 164.79 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.185 0.994 . . . . 0.0 109.847 169.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 1.21 38.8 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-O 117.846 -1.53 . . . . 0.0 113.634 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -60.95 136.68 58.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 120.281 2.04 . . . . 0.0 108.843 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.68 138.04 32.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.2 t -65.97 147.61 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 171.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.3 mt -126.37 -36.11 2.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.705 2.002 . . . . 0.0 109.488 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -148.7 159.48 44.08 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.005 0.82 . . . . 0.0 110.763 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 74.6 mt -136.08 136.0 49.82 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 45.78 32.67 1.3 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.918 2.087 . . . . 0.0 112.882 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.61 7.57 75.17 Favored Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.159 176.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.5 mmt -114.18 120.64 41.2 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 118.92 1.36 . . . . 0.0 107.894 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -53.43 133.87 40.47 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.275 1.03 . . . . 0.0 109.132 169.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.24 145.67 12.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.462 0.649 . . . . 0.0 110.133 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -78.06 62.59 2.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.762 1.625 . . . . 0.0 108.264 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.04 -107.79 1.07 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.876 1.227 . . . . 0.0 111.137 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -76.91 -6.88 54.25 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.339 1.056 . . . . 0.0 112.372 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -120.62 146.56 46.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 119.042 0.837 . . . . 0.0 109.247 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.6 p -69.17 177.32 2.79 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.66 0.743 . . . . 0.0 110.386 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.76 75.0 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.563 169.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.11 -38.2 63.89 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.753 0.821 . . . . 0.0 111.633 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.57 4.72 8.05 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.551 1.072 . . . . 0.0 113.92 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -61.8 140.66 58.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.198 1.499 . . . . 0.0 107.995 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -68.26 124.8 24.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.29 -32.9 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 122.93 0.492 . . . . 0.0 111.629 -170.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.89 -39.84 95.11 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.91 0.777 . . . . 0.0 110.662 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -70.22 -42.69 71.95 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -58.7 -44.69 90.4 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.8 0.84 . . . . 0.0 111.283 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 96.4 mt -77.53 -32.17 53.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.482 1.113 . . . . 0.0 110.829 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.35 -28.31 73.33 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.94 0.781 . . . . 0.0 112.522 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -61.41 114.36 10.69 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 124.373 1.069 . . . . 0.0 109.279 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.465 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 94.4 Cg_endo -71.52 -13.05 30.0 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.347 1.365 . . . . 0.0 113.847 -175.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.66 -14.78 55.14 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.429 1.013 . . . . 0.0 110.66 169.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -132.91 33.43 3.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.297 2.639 . . . . 0.0 108.749 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -66.57 -53.49 28.97 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 117.099 -1.429 . . . . 0.0 111.562 169.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.7 125.84 12.07 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 121.786 1.673 . . . . 0.0 108.974 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.8 m -149.53 170.88 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.781 0.832 . . . . 0.0 111.302 -169.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.8 m -125.59 133.22 52.34 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 169.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.2 mm -128.93 137.47 57.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.3 ttt85 -112.29 133.41 54.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -144.69 166.41 25.27 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.773 1.229 . . . . 0.0 108.565 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.5 -173.22 37.59 Favored Glycine 0 N--CA 1.452 -0.28 0 O-C-N 121.813 -0.554 . . . . 0.0 111.805 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -60.41 132.6 90.74 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.507 -0.758 . . . . 0.0 109.093 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.81 -15.53 50.74 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.903 2.402 . . . . 0.0 113.858 169.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -129.24 157.86 40.65 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.584 2.353 . . . . 0.0 107.415 -169.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 62.7 tp -59.07 -49.18 78.85 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.685 0.675 . . . . 0.0 110.301 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -69.1 140.38 54.79 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.984 1.314 . . . . 0.0 109.187 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m -68.97 -21.54 64.17 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 174.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 117.98 -1.009 . . . . 0.0 108.766 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.5 mtm . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.27 46.17 0.22 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 -177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -60.28 -22.9 63.68 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -176.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -66.5 -40.13 89.09 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.699 0.681 . . . . 0.0 111.432 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -72.76 -35.38 67.46 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.35 0.66 . . . . 0.0 109.945 171.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 67.11 172.11 0.26 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.208 2.203 . . . . 0.0 111.476 -172.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -70.48 -174.9 0.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.963 1.705 . . . . 0.0 111.254 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -57.06 -34.43 68.24 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.943 0.897 . . . . 0.0 111.914 175.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.54 127.71 32.98 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.91 -29.71 69.75 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -172.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -146.21 170.27 17.07 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.722 2.009 . . . . 0.0 107.661 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -62.88 158.32 19.3 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 169.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.48 134.38 7.9 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 173.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -52.19 -18.41 7.47 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.364 3.376 . . . . 0.0 116.752 -172.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -61.38 -22.96 65.45 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.226 -0.921 . . . . 0.0 112.109 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.85 -37.92 0.48 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.944 0.898 . . . . 0.0 113.296 -175.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -146.84 158.32 43.88 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.243 1.017 . . . . 0.0 111.101 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -148.23 166.38 28.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.649 1.179 . . . . 0.0 109.079 169.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -152.55 131.71 12.71 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -150.56 170.93 17.95 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.3 1.44 . . . . 0.0 109.483 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -137.09 142.61 42.35 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -142.85 175.45 9.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.468 1.507 . . . . 0.0 110.529 -171.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.9 m -150.72 174.16 13.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.181 2.592 . . . . 0.0 106.197 169.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -132.78 159.59 71.93 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 118.524 -0.751 . . . . 0.0 109.922 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.62 155.96 82.55 Favored 'Cis proline' 0 CA--C 1.535 0.575 0 CA-C-N 120.009 1.039 . . . . 0.0 111.492 -6.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 tp -156.0 154.33 30.91 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.147 1.379 . . . . 0.0 108.267 -174.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -77.6 56.46 1.45 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.16 1.384 . . . . 0.0 110.756 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.1 tp -142.91 135.98 28.15 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.924 2.09 . . . . 0.0 106.368 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.1 tp -145.84 143.65 29.76 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.0 mp -128.94 154.28 46.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.317 1.847 . . . . 0.0 107.365 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.91 152.69 42.33 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.041 0.837 . . . . 0.0 111.748 177.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.7 tp -71.82 129.26 38.19 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.906 1.282 . . . . 0.0 108.556 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -154.37 134.35 13.07 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.086 1.355 . . . . 0.0 108.087 172.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.3 t70 48.7 46.53 21.43 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.288 1.435 . . . . 0.0 112.578 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 55.69 16.1 1.84 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.41 1.884 . . . . 0.0 114.396 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.59 174.62 5.97 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 125.331 1.452 . . . . 0.0 107.387 169.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.65 133.8 62.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.0 mt -121.01 153.28 37.57 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.419 1.088 . . . . 0.0 108.313 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.8 122.35 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.75 -36.94 11.5 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.456 1.503 . . . . 0.0 111.235 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -154.14 151.22 28.99 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.869 1.267 . . . . 0.0 107.935 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.5 -5.91 1.2 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.364 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -60.17 157.54 13.04 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.925 1.362 . . . . 0.0 111.487 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 56.45 25.57 9.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.33 1.452 . . . . 0.0 112.592 -174.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -153.2 -37.99 0.1 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.875 1.27 . . . . 0.0 110.08 172.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -141.66 -158.45 7.54 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.686 2.088 . . . . 0.0 109.461 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.0 mm -55.28 140.3 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.465 1.106 . . . . 0.0 109.766 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -67.64 151.71 46.84 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 122.26 -0.275 . . . . 0.0 110.427 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.7 m -51.99 150.5 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.406 1.082 . . . . 0.0 111.578 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.82 -11.29 64.87 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.742 -1.032 . . . . 0.0 113.928 174.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 64.4 m80 -68.61 139.24 55.51 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.323 1.562 . . . . 0.0 107.478 169.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.36 143.4 27.27 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 p -76.02 135.38 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 168.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.6 mp -115.62 -29.43 6.47 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.668 1.587 . . . . 0.0 110.071 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.39 160.25 43.85 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.573 1.079 . . . . 0.0 110.626 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.5 mt -138.71 134.54 42.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 44.8 36.08 1.71 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.328 1.851 . . . . 0.0 111.972 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.89 -16.3 57.19 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.449 1.499 . . . . 0.0 113.671 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.4 mmt -88.44 121.49 30.88 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 118.846 1.323 . . . . 0.0 109.014 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.42 135.98 32.38 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.337 1.055 . . . . 0.0 109.84 169.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.8 m -93.2 128.93 44.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.667 0.746 . . . . 0.0 109.029 176.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -73.81 76.93 1.6 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.849 1.66 . . . . 0.0 107.424 169.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.61 -79.06 0.25 Allowed Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.68 1.61 . . . . 0.0 111.968 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -128.91 11.07 6.03 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.399 1.479 . . . . 0.0 112.048 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.51 152.15 42.05 Favored 'General case' 0 C--N 1.334 -0.077 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 173.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.2 p -71.64 174.69 6.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.36 0.982 . . . . 0.0 110.118 173.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.39 75.13 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.506 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.47 -37.61 71.31 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.784 0.834 . . . . 0.0 111.576 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.67 5.86 8.18 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.553 1.073 . . . . 0.0 114.088 173.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -63.28 137.81 58.32 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.171 1.486 . . . . 0.0 107.729 172.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -68.41 131.61 45.6 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 169.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.5 t -56.57 -41.42 73.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 124.576 1.15 . . . . 0.0 110.912 -174.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.4 mt -65.42 -37.65 87.55 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 118.091 0.405 . . . . 0.0 110.723 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.63 -45.32 68.76 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -60.14 -45.26 93.62 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.468 0.707 . . . . 0.0 111.405 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.49 -30.25 33.35 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.811 0.444 . . . . 0.0 111.156 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.43 -34.93 63.4 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 118.696 0.68 . . . . 0.0 112.0 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -60.39 117.66 26.53 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 124.353 1.061 . . . . 0.0 110.219 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.72 -31.57 32.19 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.771 1.647 . . . . 0.0 111.955 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.42 -3.56 1.46 Allowed 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -169.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.41 45.18 2.84 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.14 1.376 . . . . 0.0 111.503 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -40.86 -55.15 4.87 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.36 117.97 5.39 Favored 'Trans proline' 0 C--N 1.352 0.724 0 CA-C-N 122.264 1.844 . . . . 0.0 109.713 -172.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.52 131.13 34.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.7 m -98.8 139.02 35.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 mm -132.17 142.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -172.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.9 mtp-105 -119.79 139.88 51.64 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 169.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -128.35 170.41 13.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.229 1.412 . . . . 0.0 108.438 -173.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -168.85 -178.73 40.54 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -66.76 149.34 98.37 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.4 -19.11 49.73 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.448 2.098 . . . . 0.0 113.214 -177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -138.08 151.02 47.42 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.044 1.338 . . . . 0.0 107.503 169.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.1 152.03 49.99 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 175.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.1 p -60.88 123.46 17.61 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.797 0.839 . . . . 0.0 109.885 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.0 m 52.1 28.99 5.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.533 1.533 . . . . 0.0 113.821 177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 C--O 1.25 1.117 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -178.096 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.55 -178.83 48.76 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -141.51 161.73 37.2 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.53 1.532 . . . . 0.0 108.301 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -143.01 161.75 37.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.918 1.287 . . . . 0.0 108.993 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -136.74 166.56 23.3 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.373 1.869 . . . . 0.0 107.221 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -137.87 142.83 40.7 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.497 1.119 . . . . 0.0 108.263 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -146.84 159.33 43.65 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.503 1.521 . . . . 0.0 107.736 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -138.94 -169.19 2.58 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.892 1.677 . . . . 0.0 108.099 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.8 tp -51.33 117.72 2.8 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.275 1.03 . . . . 0.0 109.958 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.0 t0 42.77 34.51 0.59 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.723 2.409 . . . . 0.0 115.343 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.3 m -65.61 169.81 5.8 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.565 -0.709 . . . . 0.0 110.938 169.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -59.0 160.92 5.47 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 169.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -147.42 166.71 15.29 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.883 1.273 . . . . 0.0 108.982 -174.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.41 -6.01 1.31 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.264 3.309 . . . . 0.0 116.716 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -110.07 11.32 23.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.022 1.329 . . . . 0.0 111.546 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.41 172.35 3.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.745 0.702 . . . . 0.0 110.104 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -77.7 -176.8 4.52 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.698 0.799 . . . . 0.0 110.374 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.41 165.82 4.44 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.774 1.273 . . . . 0.0 113.314 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -135.89 120.42 18.18 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 102.474 -3.158 . . . . 0.0 102.474 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -152.64 154.44 35.34 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.247 0.93 . . . . 0.0 112.345 -169.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -83.73 143.07 30.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.922 2.089 . . . . 0.0 110.62 172.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -140.1 162.71 34.57 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.461 1.104 . . . . 0.0 109.194 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.4 m -153.42 167.7 28.55 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.075 1.75 . . . . 0.0 107.044 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -130.63 175.87 3.32 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 117.392 -1.289 . . . . 0.0 109.73 -169.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.85 148.6 7.81 Favored 'Cis proline' 0 C--N 1.356 0.957 0 CA-C-N 122.614 1.969 . . . . 0.0 115.87 6.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.94 138.9 57.22 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.352 1.061 . . . . 0.0 111.014 -171.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -136.12 20.48 3.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.622 1.569 . . . . 0.0 109.809 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 pp -148.15 169.36 20.19 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.234 3.014 . . . . 0.0 105.624 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.1 mt -143.21 145.82 33.12 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -174.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.9 mp -127.14 154.79 44.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.975 1.71 . . . . 0.0 107.178 174.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.86 154.08 43.79 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.738 0.815 . . . . 0.0 110.16 174.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.5 tp -76.29 121.86 23.57 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 171.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -153.25 144.2 22.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.288 1.435 . . . . 0.0 108.485 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 t70 43.16 50.77 5.67 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.223 1.409 . . . . 0.0 111.753 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 60.05 7.76 1.28 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.821 2.048 . . . . 0.0 115.943 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 -125.87 160.62 29.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.945 1.248 . . . . 0.0 109.851 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.31 124.41 40.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 168.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.4 mt -114.84 148.63 38.27 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.8 t -65.96 109.9 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.43 -38.11 71.4 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.8 1.24 . . . . 0.0 110.37 175.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -158.83 142.23 14.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.174 0.99 . . . . 0.0 109.146 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.3 22.77 0.09 OUTLIER Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.468 1.033 . . . . 0.0 110.6 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -69.59 -25.96 64.23 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.05 0.925 . . . . 0.0 112.539 -169.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.4 mtm105 -68.73 -36.66 78.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.07 0.85 . . . . 0.0 111.214 174.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.14 -41.7 85.64 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 170.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.64 -11.34 2.18 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.676 1.608 . . . . 0.0 112.376 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.8 mt -71.38 120.98 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.52 1.128 . . . . 0.0 109.369 -169.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -61.56 137.39 58.24 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 169.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.4 t -60.88 144.1 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.698 0.799 . . . . 0.0 109.069 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.4 0.55 70.05 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.733 -1.037 . . . . 0.0 114.013 171.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 64.5 m170 -65.89 136.38 56.06 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.235 1.517 . . . . 0.0 108.736 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.84 140.48 29.63 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.623 1.169 . . . . 0.0 108.988 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.4 t -66.99 142.62 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.2 mt -120.05 -32.57 4.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.313 1.045 . . . . 0.0 109.803 178.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.37 159.7 42.5 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.676 1.125 . . . . 0.0 110.75 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.433 ' CD1' HG13 ' A' ' 72' ' ' VAL . 96.9 mt -136.12 135.74 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 171.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 49.93 29.13 3.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.078 1.751 . . . . 0.0 112.122 -178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.63 -9.49 67.93 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.943 1.258 . . . . 0.0 113.795 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.3 mmt -85.62 115.16 23.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.973 1.387 . . . . 0.0 108.302 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -51.58 132.73 30.58 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.483 1.113 . . . . 0.0 109.559 169.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.71 133.97 32.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -78.15 71.77 4.64 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.325 1.45 . . . . 0.0 107.34 169.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.45 -59.6 0.29 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 128.032 2.729 . . . . 0.0 114.342 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -137.36 -4.61 1.86 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.003 2.121 . . . . 0.0 111.658 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -117.56 154.1 32.08 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.7 p -69.88 177.22 3.21 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.188 0.904 . . . . 0.0 110.113 171.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.32 -38.69 74.44 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.612 169.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.36 -37.93 68.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.672 0.789 . . . . 0.0 111.558 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.47 4.88 7.39 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.548 1.071 . . . . 0.0 113.874 174.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -64.22 136.93 57.66 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.785 1.292 . . . . 0.0 107.736 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -65.05 125.99 26.66 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.433 HG13 ' CD1' ' A' ' 56' ' ' ILE . 38.6 t -57.33 -37.39 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.191 0.596 . . . . 0.0 111.707 -170.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.47 -42.42 98.6 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.674 0.67 . . . . 0.0 110.09 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -71.66 -37.5 70.8 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.059 -0.401 . . . . 0.0 110.212 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -60.12 -43.62 95.48 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.801 0.84 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.62 -36.06 60.35 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.441 0.696 . . . . 0.0 110.575 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.13 -33.01 86.1 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.688 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -59.65 116.07 15.22 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.93 1.292 . . . . 0.0 110.453 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.474 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.6 Cg_endo -70.25 -14.6 34.7 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.92 1.746 . . . . 0.0 114.086 -177.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.51 -14.12 55.68 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.536 1.062 . . . . 0.0 110.901 169.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -135.58 34.74 2.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.764 2.426 . . . . 0.0 108.638 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.474 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -63.28 -55.4 36.48 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.669 -1.157 . . . . 0.0 111.583 171.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.32 127.99 13.24 Favored 'Trans proline' 0 C--N 1.351 0.677 0 CA-C-N 121.382 1.529 . . . . 0.0 109.219 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.3 m -149.16 169.32 2.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 123.992 0.917 . . . . 0.0 110.852 -172.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.4 m -126.04 137.17 53.62 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 169.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.1 mt -132.73 143.59 39.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -123.55 130.81 53.22 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.497 -2.409 . . . . 0.0 104.497 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -138.47 172.2 13.25 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.054 0.942 . . . . 0.0 108.788 -176.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.55 -176.46 39.41 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.34 147.28 98.91 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 169.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.96 -20.18 70.89 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.972 2.448 . . . . 0.0 112.642 175.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -126.67 95.93 4.5 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 101.817 -3.401 . . . . 0.0 101.817 169.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.0 tp -45.14 -44.89 11.01 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -169.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 p -81.55 2.07 30.78 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.591 1.157 . . . . 0.0 113.577 -172.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 69.4 p -67.9 -8.63 38.31 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.444 1.02 . . . . 0.0 113.224 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.915 0 C-N-CA 126.088 1.755 . . . . 0.0 106.38 175.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.77 6.9 0.65 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.567 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -68.78 -3.64 13.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.08 1.44 . . . . 0.0 113.24 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -61.63 -28.81 69.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.734 0.814 . . . . 0.0 111.709 172.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -65.68 137.34 57.24 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.451 0.569 . . . . 0.0 109.957 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -144.87 163.96 32.53 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.182 1.793 . . . . 0.0 107.816 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -59.27 139.16 57.25 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.907 0.483 . . . . 0.0 109.715 175.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -157.0 -32.86 0.08 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.41 1.084 . . . . 0.0 111.628 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.88 141.71 54.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.326 1.05 . . . . 0.0 109.315 173.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -67.45 -30.29 69.97 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.453 0.701 . . . . 0.0 112.796 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 m -59.7 155.6 15.49 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.336 1.454 . . . . 0.0 111.895 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -64.59 168.06 6.43 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.31 0.576 . . . . 0.0 110.739 172.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.08 163.01 40.32 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.601 1.56 . . . . 0.0 108.366 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.56 149.11 4.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.422 2.748 . . . . 0.0 112.667 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -109.14 41.65 1.59 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.164 0.986 . . . . 0.0 109.512 -172.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.2 153.34 18.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.411 0.684 . . . . 0.0 110.275 175.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -131.54 -5.29 3.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.307 1.443 . . . . 0.0 110.854 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.99 154.03 36.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.767 1.227 . . . . 0.0 109.564 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -153.95 101.53 2.44 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 169.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -155.07 154.93 33.19 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -171.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 p -73.17 145.06 46.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.67 1.188 . . . . 0.0 109.162 169.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -140.81 162.3 35.76 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.054 1.342 . . . . 0.0 108.849 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.1 m -148.34 175.64 10.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.384 2.274 . . . . 0.0 106.788 177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -137.49 153.56 74.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.581 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.06 152.71 87.55 Favored 'Cis proline' 0 CA--C 1.538 0.691 0 CA-C-N 119.642 0.908 . . . . 0.0 110.412 -10.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.5 tp -160.66 170.88 19.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.222 1.409 . . . . 0.0 108.143 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -58.11 -33.21 68.88 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.286 1.035 . . . . 0.0 112.168 174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 tp -62.56 128.34 35.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.65 0.78 . . . . 0.0 109.841 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.6 tp -142.48 150.33 40.37 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.772 1.629 . . . . 0.0 107.2 172.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.4 mt -132.59 155.54 48.51 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.507 1.123 . . . . 0.0 109.833 -170.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 155.42 44.83 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.788 0.835 . . . . 0.0 110.333 172.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.41 131.12 40.41 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.895 1.278 . . . . 0.0 107.83 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -152.72 138.76 18.19 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 169.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.7 t70 44.42 49.17 8.21 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.518 1.527 . . . . 0.0 112.839 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 60.22 14.54 4.64 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.991 1.716 . . . . 0.0 114.702 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 155.77 28.68 Favored 'General case' 0 CA--C 1.52 -0.183 0 O-C-N 120.975 -1.078 . . . . 0.0 108.78 171.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.5 t -102.49 130.74 51.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 169.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.73 150.61 40.1 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.133 1.373 . . . . 0.0 107.967 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.56 108.01 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.74 -29.79 23.6 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.588 1.155 . . . . 0.0 111.759 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -146.64 144.54 29.57 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 161.03 93.91 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 106.283 -2.727 . . . . 0.0 106.283 -169.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -145.21 174.99 10.6 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.003 0.921 . . . . 0.0 110.527 -170.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 67.09 -47.13 0.48 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 128.236 2.614 . . . . 0.0 113.523 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.79 -35.72 80.78 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.051 0.841 . . . . 0.0 110.58 172.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.18 178.6 48.4 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.588 -2.205 . . . . 0.0 107.588 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.6 pt -76.67 54.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.258 1.023 . . . . 0.0 110.339 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -66.14 -30.61 71.12 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.928 -1.107 . . . . 0.0 111.748 -169.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -44.66 141.46 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.323 1.049 . . . . 0.0 112.65 173.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.99 -15.8 46.26 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.694 1.14 . . . . 0.0 114.03 173.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -72.33 158.6 35.5 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.095 1.447 . . . . 0.0 109.932 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.73 144.1 33.86 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.705 1.202 . . . . 0.0 109.271 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -63.61 152.04 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 174.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.6 mt -132.62 -41.5 0.95 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.645 1.178 . . . . 0.0 110.63 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -151.56 158.84 44.08 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.375 0.989 . . . . 0.0 110.368 174.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 78.4 mt -138.54 139.94 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 176.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 46.67 31.02 1.27 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.872 2.069 . . . . 0.0 112.745 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.66 18.48 65.81 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.709 -1.051 . . . . 0.0 113.816 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.5 ptt? -125.29 133.05 52.78 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.036 1.418 . . . . 0.0 109.198 170.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -50.71 141.86 12.18 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.391 1.076 . . . . 0.0 109.579 169.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.4 m -115.13 128.74 72.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 122.146 0.975 . . . . 0.0 109.164 174.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -76.35 74.9 3.13 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.969 2.107 . . . . 0.0 108.967 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.93 -66.74 1.13 Allowed Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.382 1.944 . . . . 0.0 112.943 172.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.59 9.47 2.43 Favored 'General case' 0 CA--C 1.526 0.051 0 C-N-CA 125.146 1.378 . . . . 0.0 112.457 175.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -121.51 143.68 49.13 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.7 p -71.64 174.01 7.32 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.257 0.935 . . . . 0.0 110.152 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.14 -38.18 76.05 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.469 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.67 -39.58 73.49 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.972 0.909 . . . . 0.0 111.406 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.78 -0.21 7.84 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.648 1.118 . . . . 0.0 114.187 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -61.48 143.69 55.49 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.181 1.49 . . . . 0.0 108.499 173.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -69.34 134.73 49.44 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 t -55.25 -45.7 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.771 1.228 . . . . 0.0 111.014 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.41 -36.41 81.22 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.478 0.581 . . . . 0.0 110.669 -176.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -70.63 -43.2 69.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.412 0.551 . . . . 0.0 109.746 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -60.28 -45.05 94.69 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.506 1.123 . . . . 0.0 110.703 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.39 -33.18 60.97 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.685 0.794 . . . . 0.0 111.001 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.43 -30.66 73.33 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 123.843 0.735 . . . . 0.0 112.456 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -60.49 114.56 10.46 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.285 1.034 . . . . 0.0 109.674 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.457 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 80.5 Cg_endo -70.87 -14.61 32.69 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 121.627 1.552 . . . . 0.0 113.832 -175.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.41 -15.04 56.41 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.393 0.997 . . . . 0.0 110.857 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -133.68 33.35 3.5 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.883 2.473 . . . . 0.0 108.648 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -65.24 -52.6 45.95 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 117.085 -1.436 . . . . 0.0 111.121 169.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.93 125.4 10.95 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.794 1.677 . . . . 0.0 109.251 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.1 m -150.45 171.83 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.188 1.395 . . . . 0.0 110.127 -170.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.6 m -125.74 138.72 53.88 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 169.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.9 mt -138.63 143.65 31.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -118.45 132.77 56.23 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 169.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -145.0 166.25 25.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.214 1.406 . . . . 0.0 107.317 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.74 -156.97 28.31 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -68.94 158.3 86.68 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.31 154.91 43.62 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.906 1.737 . . . . 0.0 110.435 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -72.61 -7.35 49.82 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.0 tp -137.83 161.1 37.5 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.287 1.835 . . . . 0.0 107.228 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.3 p -62.2 -23.11 66.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.583 1.153 . . . . 0.0 113.315 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 m -56.65 126.91 28.85 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.607 1.163 . . . . 0.0 110.078 175.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.027 179.504 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.88 -168.57 39.15 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -56.66 -19.49 16.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.566 1.147 . . . . 0.0 113.999 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.555 ' HD1' ' CG ' ' A' ' 6' ' ' HIS . 9.6 p80 -61.49 -22.87 65.48 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.173 0.989 . . . . 0.0 112.918 174.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.3 m80 41.61 51.03 3.89 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.523 1.929 . . . . 0.0 114.253 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.555 ' CG ' ' HD1' ' A' ' 4' ' ' HIS . 62.2 m170 -69.13 -10.13 56.13 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.44 -0.788 . . . . 0.0 111.416 169.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -140.24 164.11 30.96 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.671 1.989 . . . . 0.0 107.482 171.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.98 144.7 56.88 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 122.825 0.45 . . . . 0.0 109.911 173.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.8 tp -81.81 69.66 8.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.91 152.38 16.25 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.665 0.786 . . . . 0.0 110.697 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.5 m -64.65 -33.46 75.99 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.88 139.62 50.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -169.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -162.16 154.99 16.92 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.268 2.227 . . . . 0.0 106.363 169.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.29 -33.98 57.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.895 3.063 . . . . 0.0 113.54 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -141.61 133.78 27.81 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 169.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.46 19.74 1.53 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.793 1.237 . . . . 0.0 110.378 -172.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -130.82 157.86 41.74 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.689 1.596 . . . . 0.0 110.176 -169.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.0 174.08 15.14 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.38 1.872 . . . . 0.0 108.608 173.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -142.64 146.89 34.94 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.136 0.974 . . . . 0.0 108.62 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -153.96 172.74 16.96 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.663 1.185 . . . . 0.0 108.877 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 p -123.71 142.49 51.02 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.394 1.478 . . . . 0.0 108.086 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -141.73 167.18 22.77 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.607 0.718 . . . . 0.0 110.607 -173.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.8 m -155.07 174.47 15.13 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.719 2.008 . . . . 0.0 107.08 171.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -136.56 163.78 47.33 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.64 6.63 21.13 Favored 'Cis proline' 0 CA--C 1.541 0.856 0 CA-C-N 121.74 1.657 . . . . 0.0 114.562 5.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.1 tp -44.9 130.61 7.31 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.254 1.022 . . . . 0.0 110.023 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -58.59 123.88 17.79 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.251 1.02 . . . . 0.0 112.813 -169.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.6 tp -161.27 153.41 19.87 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.763 2.425 . . . . 0.0 104.835 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 44.2 tp -147.05 137.21 23.37 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.642 1.11 . . . . 0.0 109.674 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.5 mp -131.06 150.62 52.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.433 2.293 . . . . 0.0 106.172 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.0 154.4 41.85 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.251 0.932 . . . . 0.0 111.196 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.8 tp -77.4 124.61 28.11 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 173.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -154.73 144.72 21.76 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.235 1.414 . . . . 0.0 109.044 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.2 t0 46.79 45.07 14.77 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.484 1.135 . . . . 0.0 111.655 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 62.5 0.92 0.68 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.378 2.271 . . . . 0.0 116.609 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -119.79 159.58 24.29 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 121.12 1.782 . . . . 0.0 109.97 173.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.84 131.76 33.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 169.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.9 mt -118.22 153.32 34.07 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.072 1.349 . . . . 0.0 107.572 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.43 121.77 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 172.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.07 -39.51 23.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.601 0.76 . . . . 0.0 110.409 171.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -150.71 132.67 15.16 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.154 0.982 . . . . 0.0 109.913 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.98 26.83 0.25 Allowed Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.612 1.577 . . . . 0.0 110.954 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -60.45 -27.15 67.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.803 0.841 . . . . 0.0 112.595 -169.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 53.5 ptt85 -60.19 -29.19 68.54 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 118.796 -0.621 . . . . 0.0 112.323 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -91.31 -41.25 11.03 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.769 0.713 . . . . 0.0 110.578 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.8 -164.77 37.17 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.1 pt -70.59 33.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 125.9 1.68 . . . . 0.0 113.73 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -25.66 63.54 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 120.582 -1.324 . . . . 0.0 112.395 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.6 t -46.01 129.42 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.272 1.029 . . . . 0.0 110.066 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.66 -8.76 67.59 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.809 -0.995 . . . . 0.0 113.719 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -77.93 143.98 37.22 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.302 1.551 . . . . 0.0 108.351 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.04 143.75 28.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.968 1.307 . . . . 0.0 109.724 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.04 143.53 15.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 169.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -127.95 -32.39 2.31 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.398 1.079 . . . . 0.0 110.583 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.61 158.83 44.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.902 1.228 . . . . 0.0 110.266 169.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -139.98 134.94 37.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 105.834 -1.914 . . . . 0.0 105.834 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 49.56 28.2 2.42 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.658 1.583 . . . . 0.0 112.46 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.17 -11.74 68.55 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.944 1.259 . . . . 0.0 113.799 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 78.8 mtm -80.35 112.63 17.87 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 119.303 1.551 . . . . 0.0 108.056 173.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.47 124.26 19.8 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 169.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.5 m -96.95 138.2 22.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 122.014 0.911 . . . . 0.0 110.865 -169.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -76.29 70.39 2.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.725 2.01 . . . . 0.0 108.622 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.13 -59.71 0.8 Allowed Glycine 0 C--N 1.336 0.562 0 C-N-CA 127.794 2.616 . . . . 0.0 114.395 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -142.86 0.89 1.26 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.792 2.037 . . . . 0.0 111.073 -174.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -124.76 144.64 50.14 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.8 p -68.35 175.58 3.26 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.034 0.834 . . . . 0.0 110.386 175.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.31 -38.43 74.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.671 169.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.22 -38.09 72.03 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.553 0.741 . . . . 0.0 111.502 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.4 4.7 7.5 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.827 1.203 . . . . 0.0 113.68 173.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -63.34 134.16 55.31 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -64.79 126.69 28.75 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.3 t -55.32 -42.44 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.476 1.111 . . . . 0.0 111.745 -170.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.67 -40.7 88.7 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.593 0.633 . . . . 0.0 110.311 -176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -69.95 -41.04 75.06 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.842 0.457 . . . . 0.0 110.034 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -59.33 -44.98 92.55 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.41 1.084 . . . . 0.0 110.875 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.1 mt -74.17 -35.28 63.99 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.457 0.703 . . . . 0.0 110.629 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.67 -30.74 74.98 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.865 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -59.57 116.76 17.83 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.668 1.187 . . . . 0.0 110.149 177.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.47 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 74.2 Cg_endo -69.62 -15.66 37.74 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.896 1.731 . . . . 0.0 114.136 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.91 -14.26 52.14 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.439 1.018 . . . . 0.0 111.088 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -135.39 33.68 3.03 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.674 2.39 . . . . 0.0 108.828 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.4 OUTLIER -62.4 -55.29 41.09 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.768 172.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.44 128.34 13.52 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 121.661 1.629 . . . . 0.0 109.41 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 m -147.93 164.69 5.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 123.551 0.74 . . . . 0.0 111.323 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -122.14 137.54 54.79 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 169.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.7 mt -137.76 133.94 45.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.6 ttp85 -107.13 138.01 44.11 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -145.22 168.6 20.02 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.748 1.219 . . . . 0.0 108.193 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.45 -174.18 44.48 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.0 mmm-85 -60.02 145.89 83.78 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.27 138.07 46.09 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.819 2.346 . . . . 0.0 112.841 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -143.87 162.87 35.0 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.311 -1.736 . . . . 0.0 106.311 169.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.9 mt -142.82 156.25 44.92 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.389 1.076 . . . . 0.0 108.436 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.4 p -68.58 164.18 21.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.554 1.142 . . . . 0.0 110.751 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.1 m -63.97 -15.61 59.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.498 1.119 . . . . 0.0 112.914 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 t30 . . . . . 0 C--O 1.247 0.932 0 C-N-CA 127.027 2.131 . . . . 0.0 106.592 175.37 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.2 177.15 48.29 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -143.44 148.97 36.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.1 1.36 . . . . 0.0 107.904 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.5 m80 54.91 -168.57 0.08 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.651 1.18 . . . . 0.0 111.23 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -64.57 152.28 42.42 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.429 -0.794 . . . . 0.0 109.587 173.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.97 169.73 17.51 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.994 1.718 . . . . 0.0 108.711 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -133.74 166.56 22.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.095 1.758 . . . . 0.0 107.746 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -147.74 168.28 22.52 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.91 1.284 . . . . 0.0 108.174 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 92.8 mt -67.77 157.41 34.79 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.132 0.573 . . . . 0.0 109.761 173.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.8 t70 54.81 -16.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 129.798 3.239 . . . . 0.0 118.867 169.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.4 p -61.54 -27.71 68.81 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.579 1.536 . . . . 0.0 113.216 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -77.02 -29.66 55.47 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.593 1.557 . . . . 0.0 112.537 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.64 -40.87 80.17 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -169.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.05 -34.43 77.6 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.805 2.336 . . . . 0.0 113.952 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 -94.7 -47.17 6.61 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.026 0.83 . . . . 0.0 110.097 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.62 123.66 13.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.17 -28.55 67.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -169.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.09 171.41 17.54 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.135 0.974 . . . . 0.0 110.211 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -136.57 136.88 39.63 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 169.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -141.13 149.82 42.03 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.511 0.724 . . . . 0.0 109.541 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -82.2 143.22 31.54 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.899 1.28 . . . . 0.0 109.019 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -143.66 168.44 19.88 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.23 1.412 . . . . 0.0 109.81 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.7 m -142.66 175.25 9.95 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.07 2.548 . . . . 0.0 105.951 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -133.96 159.74 71.22 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 119.071 0.851 . . . . 0.0 110.193 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.66 155.08 27.54 Favored 'Cis proline' 0 C--N 1.351 0.678 0 CA-C-N 120.261 1.129 . . . . 0.0 112.826 -10.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.454 HD13 ' H ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -153.6 156.34 37.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.93 1.292 . . . . 0.0 107.562 -176.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' H ' HD13 ' A' ' 26' ' ' LEU . 27.6 t70 -67.26 -30.4 70.28 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.96 0.904 . . . . 0.0 112.361 177.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 66.0 tp -59.03 133.8 56.42 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.341 1.056 . . . . 0.0 109.223 173.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.2 tp -140.14 141.97 36.02 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.86 1.264 . . . . 0.0 107.822 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.6 mp -127.09 155.4 43.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.294 1.838 . . . . 0.0 107.882 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.73 152.45 45.29 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.531 0.732 . . . . 0.0 110.58 173.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 tt -78.12 128.72 34.23 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -151.68 138.27 18.71 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.48 1.112 . . . . 0.0 108.369 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 34.8 t70 44.8 50.5 8.72 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.828 1.651 . . . . 0.0 112.558 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 56.5 16.43 2.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.986 2.114 . . . . 0.0 114.456 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 83.8 mtm180 -126.38 -169.7 2.07 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.131 2.172 . . . . 0.0 107.553 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.38 136.48 56.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.6 mt -127.45 156.23 42.45 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.894 1.278 . . . . 0.0 108.601 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.6 t -65.43 122.33 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.98 -38.35 19.38 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.4 1.08 . . . . 0.0 110.623 172.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -157.51 138.8 13.64 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.72 26.98 0.02 OUTLIER Glycine 0 CA--C 1.526 0.748 0 CA-C-O 119.09 -0.839 . . . . 0.0 113.389 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.59 117.88 4.65 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.584 1.192 . . . . 0.0 108.44 -177.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.0 tpp85 -157.81 118.58 3.48 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 64.44 -25.15 0.08 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.322 2.249 . . . . 0.0 114.0 -169.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.82 175.06 40.83 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 127.343 2.402 . . . . 0.0 108.253 170.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.98 147.66 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 117.588 0.694 . . . . 0.0 109.322 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -136.1 -7.55 2.06 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 118.406 -0.807 . . . . 0.0 113.106 -177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.2 t -53.69 135.99 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 119.647 1.112 . . . . 0.0 108.897 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.85 -7.6 73.56 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.638 -1.09 . . . . 0.0 113.688 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -72.22 158.92 34.97 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.443 1.621 . . . . 0.0 108.028 169.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.86 141.03 47.15 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 123.203 0.601 . . . . 0.0 110.52 -169.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 p -79.11 134.28 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.92 -25.58 4.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.865 0.866 . . . . 0.0 109.921 -172.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -144.44 153.83 42.32 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.72 1.145 . . . . 0.0 109.446 168.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 94.6 mt -136.64 137.19 47.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 176.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 46.79 33.5 2.18 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.089 1.756 . . . . 0.0 112.418 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.06 11.27 79.09 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 118.818 -0.99 . . . . 0.0 113.733 176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 26.6 mmt -120.18 121.77 39.48 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.849 1.325 . . . . 0.0 108.294 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -55.75 124.28 16.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.341 1.056 . . . . 0.0 109.283 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.4 m -73.24 140.82 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -79.87 61.6 3.84 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.176 1.39 . . . . 0.0 107.849 169.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' A' ' 94' ' ' THR . . . 57.95 -112.1 3.58 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.103 1.335 . . . . 0.0 110.843 -172.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -72.32 -13.23 61.44 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 124.449 1.099 . . . . 0.0 111.959 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -112.03 155.43 23.82 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.394 0.678 . . . . 0.0 109.397 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.2 p -71.95 175.44 5.87 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.41 -0.806 . . . . 0.0 109.454 169.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.65 80.33 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.517 169.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.61 -36.34 68.06 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.427 0.691 . . . . 0.0 111.457 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.41 -1.22 7.03 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.554 -1.137 . . . . 0.0 114.96 169.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -67.43 147.77 52.44 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.925 1.863 . . . . 0.0 107.829 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -66.33 130.95 44.95 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 170.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 t -53.99 -41.75 51.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 125.192 1.397 . . . . 0.0 111.311 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 83.2 mt -66.98 -39.67 87.23 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.547 0.612 . . . . 0.0 110.546 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -71.5 -37.9 71.21 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.349 0.522 . . . . 0.0 110.226 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -60.97 -53.74 53.61 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.019 0.928 . . . . 0.0 109.929 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.26 -32.5 73.96 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 122.05 -0.406 . . . . 0.0 110.122 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.53 -9.67 78.43 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 118.236 -1.313 . . . . 0.0 114.187 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -83.33 112.51 39.61 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 119.979 1.89 . . . . 0.0 110.343 -178.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.515 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 84.0 Cg_endo -72.23 -16.33 28.27 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 121.651 1.567 . . . . 0.0 114.669 -170.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.19 -11.9 24.23 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.06 0.845 . . . . 0.0 112.136 169.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.8 31.1 3.06 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.952 1.301 . . . . 0.0 111.829 173.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.515 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 1.1 m-30 -53.52 -40.51 80.83 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 116.136 -1.888 . . . . 0.0 115.519 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.68 122.08 9.01 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 CA-C-N 123.117 2.149 . . . . 0.0 109.206 172.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.23 169.66 7.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.998 1.319 . . . . 0.0 110.374 -172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.0 m -126.19 138.1 53.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.2 mm -128.87 140.77 48.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 -174.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -130.08 127.04 39.05 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -144.55 163.29 34.32 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.121 0.968 . . . . 0.0 111.321 -169.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.69 -170.93 37.0 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.5 140.78 88.55 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 170.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -55.45 148.63 51.39 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.241 2.627 . . . . 0.0 112.331 -171.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.1 tpp85 -151.35 173.12 14.88 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.681 1.192 . . . . 0.0 108.916 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 32.2 tp -66.08 151.07 47.68 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 171.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 63' ' ' GLY . 10.2 p -141.43 27.82 1.87 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.343 1.457 . . . . 0.0 110.031 -172.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 p -160.36 174.49 14.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.205 1.402 . . . . 0.0 108.9 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 . . . . . 0 C--O 1.249 1.064 0 C-N-CA 124.905 1.282 . . . . 0.0 108.21 175.477 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 ttm . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.09 58.48 4.58 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.732 1.158 . . . . 0.0 111.576 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -144.6 151.22 38.71 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.151 1.38 . . . . 0.0 107.964 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -60.12 143.9 51.1 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.358 0.663 . . . . 0.0 109.991 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -146.77 161.28 40.97 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.918 1.687 . . . . 0.0 108.073 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -128.76 -6.57 5.09 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.586 1.155 . . . . 0.0 112.23 -178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -138.5 150.0 45.97 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.188 1.795 . . . . 0.0 106.397 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -146.45 166.26 26.92 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.916 1.287 . . . . 0.0 108.769 -174.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 79.9 mt -138.08 153.28 49.31 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.635 1.574 . . . . 0.0 107.369 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.18 -0.37 7.74 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.83 1.252 . . . . 0.0 113.588 -174.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.5 m -52.14 -26.31 11.03 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.398 2.279 . . . . 0.0 114.871 -172.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -74.85 -20.96 59.53 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.729 0.812 . . . . 0.0 112.892 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.66 133.91 95.24 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.055 0.843 . . . . 0.0 109.269 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.28 -26.81 41.48 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.293 1.996 . . . . 0.0 112.685 -173.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -71.18 -8.74 55.62 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.376 -0.821 . . . . 0.0 112.215 175.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.57 173.72 9.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.759 1.163 . . . . 0.0 110.638 -172.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -133.95 175.24 9.64 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.923 1.689 . . . . 0.0 108.347 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.33 162.66 14.44 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.784 0.833 . . . . 0.0 111.153 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -88.69 154.73 20.06 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.053 0.541 . . . . 0.0 109.741 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -143.09 166.75 23.79 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.59 1.556 . . . . 0.0 108.589 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 m -106.86 142.77 35.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.352 1.061 . . . . 0.0 108.346 -176.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -141.55 161.81 37.01 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.889 1.276 . . . . 0.0 109.695 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 57.4 m -155.96 170.9 21.07 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.522 1.929 . . . . 0.0 107.189 170.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -136.94 161.83 59.29 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.85 0.86 . . . . 0.0 109.521 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.92 141.76 61.27 Favored 'Cis proline' 0 CA--C 1.536 0.612 0 CA-C-N 119.966 1.023 . . . . 0.0 110.317 -10.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.1 tp -161.54 -58.02 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.606 1.162 . . . . 0.0 107.985 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -161.76 135.44 6.52 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 126.481 1.913 . . . . 0.0 106.636 176.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.6 tp -145.32 31.56 1.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.285 1.034 . . . . 0.0 109.163 171.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.56 68.93 2.93 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.461 1.104 . . . . 0.0 109.579 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.04 155.73 30.94 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.045 2.138 . . . . 0.0 106.996 172.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.25 154.01 49.08 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.541 0.609 . . . . 0.0 110.375 171.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.2 tt -81.99 122.6 28.0 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -157.26 145.49 19.33 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.698 1.199 . . . . 0.0 107.964 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.1 t70 54.66 37.66 28.59 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.477 1.111 . . . . 0.0 111.716 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 52.93 25.28 3.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.244 1.817 . . . . 0.0 113.136 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -128.6 -177.3 4.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 127.547 2.339 . . . . 0.0 107.289 175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.2 t -120.75 127.82 75.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 169.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 48.2 mt -123.19 157.45 32.98 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.7 1.2 . . . . 0.0 109.09 -171.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.26 120.18 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.391 1.077 . . . . 0.0 108.4 171.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.41 -29.27 20.36 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.903 0.881 . . . . 0.0 111.314 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -147.45 128.05 14.18 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 171.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 170.68 149.95 6.72 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -157.38 38.08 0.29 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.906 0.853 . . . . 0.0 110.726 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -123.75 160.48 27.2 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.879 1.271 . . . . 0.0 107.655 173.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -54.72 127.51 28.54 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.585 0.754 . . . . 0.0 110.882 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.14 -4.77 74.82 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.992 -0.893 . . . . 0.0 114.215 177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.9 tp -144.25 26.53 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 118.815 1.307 . . . . 0.0 109.881 -176.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -67.15 155.35 38.98 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.644 -1.285 . . . . 0.0 108.445 169.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.6 m -43.96 135.08 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.062 0.945 . . . . 0.0 110.945 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.49 -13.22 68.04 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 118.327 -1.263 . . . . 0.0 113.989 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -67.14 153.44 43.66 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.792 1.796 . . . . 0.0 107.764 169.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.61 146.5 44.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.281 1.432 . . . . 0.0 110.151 -170.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -68.21 138.15 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 169.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 64.8 mt -121.9 -29.09 4.35 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.47 1.108 . . . . 0.0 111.013 178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -150.91 158.29 43.96 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 120.084 1.311 . . . . 0.0 110.558 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 57.9 mt -140.38 135.12 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 50.46 27.9 3.06 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.774 1.63 . . . . 0.0 112.377 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.07 -11.0 63.86 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.845 1.212 . . . . 0.0 113.633 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.5 mtt -78.69 107.92 11.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.958 1.379 . . . . 0.0 108.518 172.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.34 121.77 12.26 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 169.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.6 m -76.44 137.0 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.718 0.77 . . . . 0.0 110.755 -169.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -79.31 67.04 4.94 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 169.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.41 -107.54 1.03 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.828 1.204 . . . . 0.0 111.302 -173.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -77.66 -10.55 59.58 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.61 1.164 . . . . 0.0 112.121 -177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -116.02 155.28 28.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.016 0.826 . . . . 0.0 109.54 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.1 p -71.14 177.65 3.69 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.26 -0.9 . . . . 0.0 109.703 169.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.68 82.19 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.346 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.6 -38.99 74.07 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.895 0.878 . . . . 0.0 111.412 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.08 -2.61 6.79 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.517 1.056 . . . . 0.0 114.161 173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -60.51 135.36 57.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.05 1.425 . . . . 0.0 108.265 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -68.43 129.96 41.46 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.6 t -53.96 -43.57 58.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 125.185 1.394 . . . . 0.0 112.087 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.5 mt -66.67 -39.76 88.31 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 118.859 0.754 . . . . 0.0 110.502 -176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -69.51 -41.16 76.42 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -59.7 -45.2 92.83 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.248 1.019 . . . . 0.0 110.801 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.53 -34.49 60.77 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.21 0.604 . . . . 0.0 110.895 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.39 -32.12 78.59 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.513 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -60.22 115.55 13.76 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.754 1.222 . . . . 0.0 110.179 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 71.5 Cg_endo -70.49 -15.03 34.32 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.844 1.696 . . . . 0.0 113.988 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.97 -14.72 56.08 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.412 1.006 . . . . 0.0 110.986 169.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -135.26 34.96 3.02 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.744 2.418 . . . . 0.0 108.607 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.462 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.5 OUTLIER -64.72 -54.59 34.89 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 117.543 -1.217 . . . . 0.0 111.371 169.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.82 125.04 10.68 Favored 'Trans proline' 0 C--N 1.351 0.69 0 CA-C-N 121.521 1.579 . . . . 0.0 109.133 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.3 m -149.97 170.9 1.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.165 0.986 . . . . 0.0 110.402 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.6 m -125.61 139.9 53.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 169.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.3 mt -137.27 145.1 30.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -120.19 140.33 51.3 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 171.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -124.55 172.81 8.92 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.459 1.504 . . . . 0.0 109.16 -177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.41 -154.82 13.7 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.27 149.99 39.43 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.79 135.89 50.32 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.736 2.291 . . . . 0.0 111.602 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -73.97 -15.15 61.12 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 118.775 -0.631 . . . . 0.0 112.517 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 30.3 tp 64.14 -36.58 0.18 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 129.032 2.933 . . . . 0.0 115.058 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.2 p 45.48 46.52 10.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.714 2.006 . . . . 0.0 112.642 174.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m -49.22 122.61 6.19 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.435 1.494 . . . . 0.0 110.749 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.9 p30 . . . . . 0 C--O 1.25 1.117 0 C-N-CA 126.133 1.773 . . . . 0.0 107.991 -177.801 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.8 -20.3 72.2 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 123.596 0.617 . . . . 0.0 113.338 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -146.77 160.41 42.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.388 1.875 . . . . 0.0 107.447 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -80.09 33.77 0.29 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.714 1.206 . . . . 0.0 112.53 -170.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -143.81 160.16 41.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.999 1.72 . . . . 0.0 108.592 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -63.46 -28.62 70.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.959 0.504 . . . . 0.0 112.073 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -156.79 171.75 19.85 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.95 1.7 . . . . 0.0 108.568 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.77 164.41 6.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.061 0.945 . . . . 0.0 111.189 174.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 tp 44.59 54.47 6.47 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.281 1.833 . . . . 0.0 112.375 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -125.04 7.46 7.96 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.468 1.507 . . . . 0.0 110.869 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 m -65.74 -12.57 54.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.09 1.756 . . . . 0.0 113.716 -177.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -59.44 155.35 15.11 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.402 1.081 . . . . 0.0 111.786 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.5 ' H ' ' CD ' ' A' ' 14' ' ' PRO . . . -148.23 -38.51 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 116.707 -1.616 . . . . 0.0 113.584 177.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.5 ' CD ' ' H ' ' A' ' 13' ' ' ALA . 74.5 Cg_exo -55.16 143.47 74.52 Favored 'Trans proline' 0 C--N 1.353 0.797 0 CA-C-N 122.173 1.812 . . . . 0.0 112.514 174.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.7 ttp85 -82.99 45.09 0.98 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.599 1.16 . . . . 0.0 108.983 174.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.32 170.59 15.67 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.534 1.133 . . . . 0.0 112.799 -169.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -101.28 167.67 10.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.347 1.459 . . . . 0.0 109.8 -177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.39 155.0 36.76 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.437 0.695 . . . . 0.0 111.07 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.59 138.17 56.23 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 170.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -144.05 155.06 43.84 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.861 0.864 . . . . 0.0 108.941 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.2 p -78.88 142.88 36.44 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.594 1.158 . . . . 0.0 109.803 172.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.65 162.73 34.39 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.567 1.547 . . . . 0.0 109.29 177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -159.0 175.18 13.86 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.59 2.756 . . . . 0.0 106.837 178.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -132.56 156.97 79.48 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.758 0.823 . . . . 0.0 109.569 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.5 156.38 81.87 Favored 'Cis proline' 0 CA--C 1.536 0.584 0 CA-C-N 119.729 0.939 . . . . 0.0 111.824 -5.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.33 167.68 29.57 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.37 1.468 . . . . 0.0 107.59 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -78.64 61.61 3.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.932 1.293 . . . . 0.0 110.056 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.5 mt -139.15 154.37 48.08 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.081 1.752 . . . . 0.0 108.683 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.3 tp -148.45 127.66 12.94 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -123.34 149.83 44.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.96 164.45 33.72 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.8 1.24 . . . . 0.0 110.114 -176.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.6 tp -86.73 133.98 33.62 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 171.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -150.18 129.43 12.82 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.84 1.256 . . . . 0.0 108.066 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 45.25 50.01 9.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.317 1.447 . . . . 0.0 112.367 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 62.35 18.45 10.28 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.704 1.602 . . . . 0.0 114.318 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 -127.72 143.51 51.14 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.75 -1.218 . . . . 0.0 109.179 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.28 127.74 39.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 169.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.43 145.37 48.85 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.641 1.576 . . . . 0.0 108.599 -176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.08 107.62 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 125.81 1.644 . . . . 0.0 106.861 171.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.89 -29.68 44.52 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.788 0.835 . . . . 0.0 111.826 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -147.95 143.18 27.15 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.1 4.4 0.1 OUTLIER Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.341 -0.699 . . . . 0.0 113.915 -174.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -136.11 46.54 2.29 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.319 1.447 . . . . 0.0 109.225 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.7 -19.28 10.29 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -61.17 -19.84 62.03 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.58 1.552 . . . . 0.0 112.594 172.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.88 -138.16 2.39 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.2 pt -128.68 20.74 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.92 1.288 . . . . 0.0 110.911 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -75.33 20.27 0.15 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.833 1.253 . . . . 0.0 113.247 -171.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.7 m -61.8 172.74 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 O-C-N 120.764 -1.21 . . . . 0.0 110.474 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.49 3.94 64.43 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.721 -1.044 . . . . 0.0 112.626 -177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -55.81 128.46 35.05 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.936 1.368 . . . . 0.0 108.096 169.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.02 141.13 30.52 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 171.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.4 t -69.36 140.59 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 89.6 mt -122.52 -32.31 3.62 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.616 -174.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.29 160.12 42.66 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.773 1.169 . . . . 0.0 110.672 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 80.0 mt -140.4 139.21 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 173.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.0 p30 47.27 21.58 0.2 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.102 2.161 . . . . 0.0 114.556 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.86 -27.84 18.46 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.484 1.516 . . . . 0.0 113.013 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 73.7 mtm -74.79 117.93 17.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.709 1.254 . . . . 0.0 109.675 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -56.72 135.54 55.22 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 169.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.4 m -97.87 126.9 50.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-O 121.596 0.712 . . . . 0.0 109.578 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -72.88 74.93 1.16 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.909 1.684 . . . . 0.0 107.874 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.34 -70.85 0.35 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 126.823 2.154 . . . . 0.0 113.12 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -134.21 12.84 3.89 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 124.936 1.295 . . . . 0.0 112.209 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -125.9 146.14 49.96 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.0 p -69.76 171.75 8.67 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.99 0.814 . . . . 0.0 109.924 172.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.98 -38.03 75.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.56 169.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.06 -40.08 78.75 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 111.512 175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.31 0.26 6.88 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.459 1.028 . . . . 0.0 114.378 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -59.69 136.24 57.93 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.375 1.587 . . . . 0.0 108.305 174.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.86 128.89 38.16 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 169.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.32 -41.74 88.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 124.283 1.033 . . . . 0.0 111.162 -171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.9 mt -66.66 -42.46 86.58 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 119.317 0.962 . . . . 0.0 110.295 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.52 -42.43 92.05 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -60.91 -53.14 60.97 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.845 0.858 . . . . 0.0 110.248 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.3 mt -66.27 -26.95 67.58 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.766 -0.584 . . . . 0.0 110.477 -178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.77 -15.31 77.99 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.421 -1.211 . . . . 0.0 113.778 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -84.39 112.99 45.9 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.787 1.793 . . . . 0.0 110.464 -177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.513 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 64.7 Cg_endo -68.24 -22.42 40.32 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.939 1.759 . . . . 0.0 114.117 -171.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.57 -10.99 21.07 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.761 0.71 . . . . 0.0 112.825 174.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.71 28.21 3.6 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.39 1.076 . . . . 0.0 111.956 173.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.513 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 6.4 m-30 -53.14 -47.57 95.35 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 116.643 -1.646 . . . . 0.0 112.633 169.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.22 104.82 1.6 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 CA-C-N 122.102 1.787 . . . . 0.0 110.581 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.81 157.65 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.597 0.759 . . . . 0.0 109.961 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.6 m -84.27 146.25 27.86 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 169.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.0 mt -136.46 144.89 31.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -117.81 132.46 56.44 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 169.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -141.53 165.05 28.57 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.01 -174.16 37.99 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -173.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -68.09 158.72 83.11 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.789 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -49.94 157.34 2.78 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 123.525 2.817 . . . . 0.0 115.091 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -61.64 -10.02 7.46 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.935 1.694 . . . . 0.0 113.552 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -139.39 179.94 6.25 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.853 2.061 . . . . 0.0 108.881 -173.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.46 -16.34 3.64 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.912 2.085 . . . . 0.0 115.383 -169.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.1 m -51.58 135.37 28.44 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.482 1.037 . . . . 0.0 110.559 173.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 . . . . . 0 C--O 1.249 1.04 0 C-N-CA 123.807 0.843 . . . . 0.0 111.794 -169.955 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.482 1.15 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.25 172.48 44.48 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -60.38 -29.8 69.18 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.282 0.541 . . . . 0.0 112.448 -172.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -62.55 -46.98 85.87 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.812 -0.555 . . . . 0.0 110.443 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -69.12 -33.75 73.98 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.05 0.54 . . . . 0.0 110.244 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -62.57 -17.69 60.58 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.363 1.065 . . . . 0.0 111.838 172.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 66.9 m80 46.74 47.52 15.0 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.219 1.807 . . . . 0.0 110.762 -170.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -153.78 171.57 18.69 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.071 0.948 . . . . 0.0 109.942 -173.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -75.19 169.5 17.9 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -104.59 144.75 31.27 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.487 1.115 . . . . 0.0 108.407 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.3 p -149.3 158.72 44.41 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.641 0.776 . . . . 0.0 110.081 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -82.67 -24.25 33.81 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.652 1.181 . . . . 0.0 111.997 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.96 18.88 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -169.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.0 145.5 32.93 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.986 2.458 . . . . 0.0 113.163 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -152.32 151.62 31.1 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.748 1.219 . . . . 0.0 108.15 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.28 161.71 24.34 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 169.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 46.95 43.12 13.31 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.331 1.453 . . . . 0.0 112.357 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.48 145.14 41.64 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 169.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -143.16 137.64 29.2 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.265 0.938 . . . . 0.0 109.549 -173.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -159.37 156.78 29.13 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.305 1.042 . . . . 0.0 109.32 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -79.44 142.46 35.88 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.936 1.695 . . . . 0.0 110.414 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -144.07 160.53 40.73 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.341 1.056 . . . . 0.0 110.296 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.3 m -150.87 175.13 12.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.271 2.228 . . . . 0.0 107.388 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.8 m-30 -127.19 158.99 67.44 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 0.0 108.269 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.64 145.14 45.47 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 120.058 1.056 . . . . 0.0 111.404 -10.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.7 tp -160.38 158.44 29.57 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.551 1.541 . . . . 0.0 107.297 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.21 -22.56 61.99 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.3 tp -59.64 127.3 31.33 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 169.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.7 mt -138.79 157.0 46.88 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 173.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -124.27 153.22 42.02 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.901 1.28 . . . . 0.0 108.211 -174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.01 164.99 28.58 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.777 1.231 . . . . 0.0 109.072 173.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.1 tp -108.03 127.05 53.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -150.78 140.83 22.07 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.432 1.093 . . . . 0.0 108.241 175.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 46.73 43.89 13.37 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.184 1.393 . . . . 0.0 112.606 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 58.87 24.78 12.85 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.911 1.684 . . . . 0.0 113.75 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -130.03 139.15 51.05 Favored 'General case' 0 CA--C 1.52 -0.2 0 O-C-N 120.834 -1.166 . . . . 0.0 108.33 174.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.8 t -85.34 127.46 39.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 170.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 mt -126.44 155.75 41.73 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.617 1.567 . . . . 0.0 109.036 -172.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.16 117.94 3.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 124.693 1.197 . . . . 0.0 107.905 170.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.13 -41.86 14.37 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.592 1.157 . . . . 0.0 110.881 175.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -150.49 160.52 43.72 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.401 1.881 . . . . 0.0 107.546 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.36 -9.72 3.51 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.197 -0.78 . . . . 0.0 113.298 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.09 -35.24 78.1 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.324 1.562 . . . . 0.0 113.474 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -66.46 -29.68 69.85 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 118.893 -0.575 . . . . 0.0 112.13 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.52 -39.15 53.8 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.827 0.74 . . . . 0.0 109.855 170.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.59 -17.38 0.42 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.679 1.133 . . . . 0.0 113.774 169.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 21.6 mm -89.17 97.95 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 118.918 1.359 . . . . 0.0 108.221 -169.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -57.93 129.51 42.25 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.762 0.825 . . . . 0.0 111.173 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 78.5 t -54.76 149.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.18 1.392 . . . . 0.0 110.364 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.61 -7.98 74.16 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 119.037 -0.869 . . . . 0.0 114.177 171.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -70.89 151.17 45.01 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.942 1.371 . . . . 0.0 108.074 169.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.67 147.76 25.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.286 1.035 . . . . 0.0 109.786 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.39 137.86 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 169.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.63 -37.55 3.94 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.824 1.249 . . . . 0.0 109.486 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -152.47 160.49 43.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.238 0.926 . . . . 0.0 110.391 169.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 93.1 mt -135.59 133.28 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 N-CA-C 105.912 -1.885 . . . . 0.0 105.912 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.597 HD21 HG12 ' A' ' 84' ' ' VAL . 80.8 m-20 48.23 31.21 2.5 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.008 1.723 . . . . 0.0 112.561 178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.74 -12.75 66.25 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.974 1.273 . . . . 0.0 113.635 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.9 mtt -80.09 108.41 13.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 119.01 1.405 . . . . 0.0 108.755 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -56.65 124.33 17.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.1 m -82.05 133.54 28.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 121.685 0.755 . . . . 0.0 109.407 -173.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -78.6 70.69 4.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.71 -58.46 0.33 Allowed Glycine 0 CA--C 1.53 1.0 0 C-N-CA 128.187 2.803 . . . . 0.0 114.828 174.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -134.84 -5.28 2.45 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.894 2.078 . . . . 0.0 111.529 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -120.2 155.57 32.88 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.9 p -71.08 177.08 3.94 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.405 1.002 . . . . 0.0 110.085 170.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.34 -38.73 77.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.601 169.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.33 -36.85 71.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.649 0.78 . . . . 0.0 111.532 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.87 4.8 8.51 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.625 1.107 . . . . 0.0 113.727 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -63.17 134.47 56.03 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 174.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -66.67 128.7 37.25 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.8 t -58.51 -39.79 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.701 0.801 . . . . 0.0 111.263 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.6 mt -65.45 -42.74 92.02 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.738 0.699 . . . . 0.0 110.328 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.51 -41.71 83.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.017 0.527 . . . . 0.0 109.687 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -59.82 -52.43 65.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.137 0.975 . . . . 0.0 110.395 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.5 mt -67.0 -34.15 77.12 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 122.641 0.376 . . . . 0.0 109.998 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.92 -17.89 73.9 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 118.517 -1.157 . . . . 0.0 113.783 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -75.31 114.12 32.5 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 119.545 1.672 . . . . 0.0 110.596 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.481 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 61.4 Cg_endo -67.54 -21.09 46.68 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.34 2.027 . . . . 0.0 114.014 -171.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.86 -11.35 55.39 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 176.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.95 28.52 2.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.507 1.049 . . . . 0.0 112.756 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.481 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 6.4 m-30 -48.75 -48.68 69.54 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 116.438 -1.744 . . . . 0.0 115.015 175.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.49 120.61 7.41 Favored 'Trans proline' 0 C--N 1.35 0.635 0 CA-C-N 122.497 1.928 . . . . 0.0 109.948 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.597 HG12 HD21 ' A' ' 57' ' ' ASN . 28.9 m -146.38 171.6 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.519 1.528 . . . . 0.0 109.926 -175.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -120.38 137.06 54.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.24 -2.134 . . . . 0.0 105.24 169.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.1 mt -132.35 138.5 52.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -107.93 136.04 48.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 170.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -123.13 160.47 26.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.248 1.819 . . . . 0.0 108.746 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.08 178.16 39.56 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -70.97 147.03 93.7 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.49 161.59 34.38 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.314 2.009 . . . . 0.0 111.148 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 55.9 -174.65 0.05 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.9 1.68 . . . . 0.0 112.101 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -154.45 173.36 16.36 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.981 1.712 . . . . 0.0 108.48 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.5 p -59.29 -22.09 60.68 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.861 1.265 . . . . 0.0 113.835 -174.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m -65.46 -14.57 61.25 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.845 1.258 . . . . 0.0 113.321 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 124.611 1.165 . . . . 0.0 110.15 175.462 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mtp . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.63 175.77 47.68 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -135.77 14.64 3.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.411 1.085 . . . . 0.0 111.515 -173.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -151.25 159.89 44.11 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.647 1.579 . . . . 0.0 108.478 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -144.07 160.76 40.33 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.693 1.597 . . . . 0.0 108.109 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -133.71 10.62 4.0 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.734 0.814 . . . . 0.0 112.003 -171.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.27 142.79 51.05 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.347 0.659 . . . . 0.0 109.45 169.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.1 p-80 -159.24 173.53 16.19 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.58 1.152 . . . . 0.0 109.468 -173.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -135.25 123.4 22.93 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -145.13 66.87 1.24 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.48 1.112 . . . . 0.0 109.166 -169.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -56.89 159.5 4.06 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.16 0.984 . . . . 0.0 111.005 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -69.8 179.3 2.26 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.976 0.51 . . . . 0.0 110.261 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.05 158.65 73.37 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.596 1.158 . . . . 0.0 109.753 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.22 140.19 20.33 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.406 2.737 . . . . 0.0 112.235 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.3 tpm_? -61.92 -35.43 78.37 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.962 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.47 -42.55 0.1 Allowed 'General case' 0 C--O 1.229 -0.024 0 C-N-CA 124.442 1.097 . . . . 0.0 109.599 170.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -159.75 161.09 34.64 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.222 1.409 . . . . 0.0 109.084 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.08 173.82 14.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.025 1.73 . . . . 0.0 108.783 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -145.95 143.71 29.68 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.787 0.835 . . . . 0.0 108.879 -172.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -148.79 173.12 13.59 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.778 1.631 . . . . 0.0 109.29 -174.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 m -131.57 141.16 49.63 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.235 1.414 . . . . 0.0 107.327 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -145.67 167.47 23.02 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.465 1.506 . . . . 0.0 109.941 -170.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.4 m -144.16 175.1 10.32 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.594 2.357 . . . . 0.0 106.304 169.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -134.78 162.21 59.1 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.517 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.01 149.42 28.87 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.373 1.169 . . . . 0.0 112.429 -10.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -157.9 150.58 22.68 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.403 1.481 . . . . 0.0 107.243 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -79.79 59.63 3.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.195 0.998 . . . . 0.0 110.414 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.9 tp -140.11 135.74 32.85 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.833 2.453 . . . . 0.0 105.524 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -145.92 145.21 30.6 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.5 mt -130.58 154.05 48.25 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.79 1.636 . . . . 0.0 107.432 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.75 156.26 45.6 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.558 0.617 . . . . 0.0 110.793 -178.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 68.5 tp -90.65 128.26 36.56 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.902 1.281 . . . . 0.0 108.137 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -156.91 145.23 19.6 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.587 1.155 . . . . 0.0 108.137 169.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.8 t70 51.81 37.79 21.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.175 0.99 . . . . 0.0 111.404 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 55.23 17.57 2.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.301 2.241 . . . . 0.0 114.414 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.08 161.92 20.9 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.84 1.256 . . . . 0.0 108.216 174.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.4 t -97.5 134.54 35.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.46 150.48 41.49 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.198 1.399 . . . . 0.0 107.623 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.7 t -67.52 117.37 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 169.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.15 -29.41 31.59 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.06 0.544 . . . . 0.0 111.497 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -154.78 138.51 16.15 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.014 1.325 . . . . 0.0 107.494 174.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.63 102.89 0.16 Allowed Glycine 0 CA--C 1.52 0.359 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 -177.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -121.51 -17.84 7.41 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.507 0.723 . . . . 0.0 112.504 -171.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -81.79 146.66 29.8 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 62.74 -26.4 0.06 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.452 2.301 . . . . 0.0 114.074 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.49 167.88 38.1 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.55 1.547 . . . . 0.0 109.44 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.5 pt -73.61 64.2 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 122.436 1.113 . . . . 0.0 109.44 170.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.1 mtm180 -61.45 -23.03 65.57 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.589 1.156 . . . . 0.0 111.065 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 p -44.63 139.31 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 119.271 0.941 . . . . 0.0 110.639 169.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.34 -15.64 38.84 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.985 -0.897 . . . . 0.0 113.031 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -76.95 148.24 36.46 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.948 1.374 . . . . 0.0 108.649 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.54 141.84 29.58 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.39 1.076 . . . . 0.0 109.319 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.8 t -72.62 141.49 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.0 mt -128.97 -30.65 2.21 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.427 1.091 . . . . 0.0 111.139 -172.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.61 158.97 41.95 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.122 1.328 . . . . 0.0 110.089 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.0 mt -140.72 135.26 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 106.176 -1.786 . . . . 0.0 106.176 173.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 50.27 28.7 3.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.542 1.537 . . . . 0.0 112.093 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.33 -9.53 63.95 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.805 1.193 . . . . 0.0 113.68 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 62.4 mtt -77.72 108.61 11.06 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.088 1.444 . . . . 0.0 108.495 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.74 114.4 1.54 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.286 1.434 . . . . 0.0 109.68 169.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.53 142.52 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 124.198 0.999 . . . . 0.0 108.447 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -125.31 113.57 17.77 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.158 2.183 . . . . 0.0 105.355 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.61 -113.83 5.98 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -116.84 23.5 11.9 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.354 1.061 . . . . 0.0 110.672 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -126.65 140.08 52.68 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -169.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.1 p -67.39 176.85 2.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.541 1.064 . . . . 0.0 110.013 174.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.95 -39.27 74.25 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.85 169.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.32 -39.56 74.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.546 0.738 . . . . 0.0 111.098 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.53 -2.59 6.12 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.655 1.122 . . . . 0.0 113.736 171.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -61.11 133.43 56.0 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.007 1.404 . . . . 0.0 109.182 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -59.78 120.38 9.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.6 t -54.47 -44.53 68.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 124.95 1.3 . . . . 0.0 111.696 -170.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.71 -38.17 83.27 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.375 0.534 . . . . 0.0 110.392 -174.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -74.37 -38.01 63.29 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.301 0.5 . . . . 0.0 110.272 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -58.69 -44.62 90.34 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.473 1.109 . . . . 0.0 110.296 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.25 -34.99 61.46 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.66 0.784 . . . . 0.0 110.983 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.7 -33.5 87.41 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.427 -0.652 . . . . 0.0 112.368 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -60.29 114.93 11.25 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 124.659 1.184 . . . . 0.0 110.071 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 73.6 Cg_endo -70.73 -15.01 33.46 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.792 1.661 . . . . 0.0 113.912 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.53 -14.82 54.92 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.36 0.982 . . . . 0.0 110.899 169.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -134.28 33.91 3.31 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.826 2.45 . . . . 0.0 108.721 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.458 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 0.6 OUTLIER -64.54 -53.24 46.54 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 117.186 -1.387 . . . . 0.0 111.289 169.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.97 123.76 9.56 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 121.717 1.649 . . . . 0.0 109.262 177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -150.95 164.47 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 124.214 1.006 . . . . 0.0 110.873 -172.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -118.51 140.63 49.57 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.2 mt -136.55 139.49 45.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -171.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 54.7 ttt85 -115.55 135.95 53.57 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 172.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -146.85 164.09 33.98 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.943 1.297 . . . . 0.0 108.467 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.26 -169.0 40.56 Favored Glycine 0 C--N 1.33 0.21 0 O-C-N 121.518 -0.738 . . . . 0.0 112.135 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -58.85 143.83 82.42 Favored Pre-proline 0 C--O 1.239 0.511 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.232 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -48.49 160.64 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.871 3.047 . . . . 0.0 113.761 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.79 169.91 19.41 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.883 1.273 . . . . 0.0 108.31 -177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.37 151.53 46.74 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.8 p -139.67 157.61 45.48 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.897 1.279 . . . . 0.0 108.053 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.7 m -68.86 -27.4 65.78 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.444 0.698 . . . . 0.0 111.577 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 C--O 1.248 1.009 0 C-N-CA 125.415 1.486 . . . . 0.0 109.689 171.72 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 119.481 -0.295 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.97 179.33 48.8 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.8 t60 46.2 47.47 13.26 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.633 1.573 . . . . 0.0 111.821 -176.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -61.17 157.65 15.6 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.617 0.767 . . . . 0.0 109.949 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -56.89 145.83 28.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.047 0.539 . . . . 0.0 109.78 171.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -154.94 167.14 31.31 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.494 1.517 . . . . 0.0 108.436 -174.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 153.42 14.49 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.977 0.911 . . . . 0.0 111.55 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -135.15 171.55 14.28 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.857 1.663 . . . . 0.0 107.644 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.3 tp -125.76 52.68 1.64 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.384 1.474 . . . . 0.0 108.637 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -63.59 -30.31 71.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.246 1.018 . . . . 0.0 112.411 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.0 p -152.69 161.87 42.01 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.833 1.653 . . . . 0.0 107.669 172.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -58.46 -47.43 84.06 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.773 -0.579 . . . . 0.0 111.869 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.595 ' H ' ' CD ' ' A' ' 14' ' ' PRO . . . -145.83 -21.92 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 116.542 -1.694 . . . . 0.0 115.326 -176.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.595 ' CD ' ' H ' ' A' ' 13' ' ' ALA . 71.2 Cg_exo -55.97 -13.29 8.7 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.65 2.234 . . . . 0.0 115.725 172.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -50.96 125.96 14.94 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.38 1.072 . . . . 0.0 110.466 169.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -166.15 -82.53 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 169.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 35.84 51.62 0.74 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.924 2.089 . . . . 0.0 112.222 -175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.15 144.94 56.36 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -145.61 138.33 25.9 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -176.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.9 158.45 38.01 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.458 0.703 . . . . 0.0 110.334 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.7 p -78.3 143.05 37.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.024 1.73 . . . . 0.0 108.574 169.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -144.48 167.79 21.66 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.171 0.988 . . . . 0.0 110.048 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.4 m -137.71 166.66 23.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.369 1.868 . . . . 0.0 107.219 171.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.01 153.83 39.77 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.739 -175.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.8 133.69 15.75 Favored 'Cis proline' 0 C--N 1.35 0.638 0 CA-C-N 120.7 1.286 . . . . 0.0 110.155 -7.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.8 tp -66.59 123.86 21.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.682 0.793 . . . . 0.0 111.147 -169.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -62.67 -42.63 99.73 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 111.485 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 tp -75.56 57.54 0.97 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.704 1.601 . . . . 0.0 109.113 170.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 46.1 tp -53.64 141.37 26.24 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.338 -0.851 . . . . 0.0 109.342 -174.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.1 mt -125.27 155.99 39.29 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.249 1.019 . . . . 0.0 109.635 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.67 153.66 50.84 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 169.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 tt -92.65 123.98 36.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -150.95 136.46 17.88 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 124.718 1.207 . . . . 0.0 108.386 -173.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.29 39.97 17.16 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.271 1.428 . . . . 0.0 111.819 -176.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 59.44 0.43 0.21 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.411 2.285 . . . . 0.0 115.272 -172.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -95.99 -177.72 4.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 120.67 1.577 . . . . 0.0 107.777 172.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.2 m -123.35 139.95 48.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 169.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.5 mt -133.13 151.45 51.99 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.113 0.965 . . . . 0.0 108.828 -175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.55 105.66 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.514 1.526 . . . . 0.0 107.651 174.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.83 -33.26 60.06 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 125.678 1.591 . . . . 0.0 111.706 178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -150.94 159.16 44.74 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.851 0.861 . . . . 0.0 109.327 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 172.3 -23.54 0.08 OUTLIER Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.542 1.068 . . . . 0.0 111.138 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -142.61 154.89 44.81 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.222 2.209 . . . . 0.0 105.046 169.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -57.75 -37.11 73.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.606 0.639 . . . . 0.0 110.593 174.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -161.87 125.01 3.06 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.74 169.89 31.83 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 118.424 0.556 . . . . 0.0 111.918 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 pt -63.02 -17.55 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.694 1.198 . . . . 0.0 114.095 -169.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -61.53 -37.61 84.38 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.957 1.253 . . . . 0.0 110.617 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.47 148.95 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.406 1.082 . . . . 0.0 108.884 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.32 0.75 86.56 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.26 -0.745 . . . . 0.0 114.271 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -72.1 162.82 28.91 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.599 1.2 . . . . 0.0 108.866 169.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -101.19 156.1 17.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.032 0.933 . . . . 0.0 109.131 170.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.42 144.61 11.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 169.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -114.35 -30.67 6.51 Favored 'General case' 0 CA--C 1.524 -0.034 0 CA-C-O 117.405 -1.283 . . . . 0.0 110.544 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.41 160.04 42.53 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.879 1.672 . . . . 0.0 111.793 172.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 71.9 mt -138.62 136.73 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 170.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 50.46 29.15 3.75 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.598 1.559 . . . . 0.0 112.272 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.21 -9.0 56.5 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.698 1.142 . . . . 0.0 113.65 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.4 mtt -80.37 111.97 17.26 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.091 1.445 . . . . 0.0 108.3 172.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -53.43 130.63 36.1 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 169.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.4 m -89.35 124.14 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.782 0.801 . . . . 0.0 109.496 -177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -76.48 80.24 3.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.018 1.327 . . . . 0.0 107.534 169.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.15 -58.73 1.08 Allowed Glycine 0 CA--C 1.524 0.615 0 C-N-CA 126.91 2.195 . . . . 0.0 114.614 172.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -143.55 2.38 1.24 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.283 1.833 . . . . 0.0 111.874 176.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.79 151.75 38.33 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 119.424 1.011 . . . . 0.0 108.327 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 p -68.07 173.81 4.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.608 1.095 . . . . 0.0 109.528 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.82 -38.15 72.19 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.764 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.83 -37.84 76.35 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.582 0.753 . . . . 0.0 111.573 175.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.53 3.17 6.13 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.498 1.047 . . . . 0.0 114.112 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.23 129.68 40.65 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.044 1.422 . . . . 0.0 107.805 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.1 129.83 41.15 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 174.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 t -52.67 -44.19 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 125.396 1.478 . . . . 0.0 112.826 -169.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.2 mt -67.1 -42.48 84.5 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.978 0.808 . . . . 0.0 110.435 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -69.03 -40.84 78.37 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -59.88 -43.79 94.54 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.254 1.022 . . . . 0.0 111.158 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.6 mt -74.87 -36.88 62.3 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.276 0.631 . . . . 0.0 110.476 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.04 -31.15 78.54 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 119.543 -0.587 . . . . 0.0 112.772 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -54.83 118.72 18.11 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.017 1.327 . . . . 0.0 110.157 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HA ' ' CD1' ' A' ' 82' ' ' TYR . 60.0 Cg_endo -66.79 -17.67 52.31 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.365 2.043 . . . . 0.0 113.741 -176.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.45 -13.83 62.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.13 0.877 . . . . 0.0 112.356 170.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -135.18 37.01 3.0 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.922 1.689 . . . . 0.0 109.617 -171.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 2.0 m-30 -63.48 -57.36 20.27 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 117.359 -1.305 . . . . 0.0 111.348 169.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.23 126.96 11.51 Favored 'Trans proline' 0 C--N 1.352 0.719 0 CA-C-N 121.459 1.557 . . . . 0.0 109.101 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 m -150.31 171.42 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.378 1.071 . . . . 0.0 110.365 -172.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.2 m -125.83 139.55 53.4 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 168.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.5 mt -136.27 140.2 44.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -174.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -118.56 132.33 56.21 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 172.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -141.66 163.4 33.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.561 1.545 . . . . 0.0 109.312 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.31 -165.37 38.56 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -170.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' H ' ' HD2' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -67.94 143.0 95.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.605 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.98 160.71 32.58 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.048 1.832 . . . . 0.0 112.225 -174.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -129.85 151.62 50.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 53.0 tp -61.52 144.48 54.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.123 0.487 . . . . 0.0 110.211 -175.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.99 165.69 35.46 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.289 1.836 . . . . 0.0 107.317 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.5 m -62.22 -38.04 87.68 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.767 0.827 . . . . 0.0 112.847 -171.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.992 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 172.882 . . . . . . . . 1 1 . 1 stop_ save_